
<html lang="en"     class="pb-page"  data-request-id="1687bf1c-de0d-4dff-8c11-62b649349afd"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.9b01382;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo" /></meta><meta name="dc.Creator" content="Lars  Wortmann" /></meta><meta name="dc.Creator" content="Bernhard  Lindenthal" /></meta><meta name="dc.Creator" content="Peter  Muhn" /></meta><meta name="dc.Creator" content="Alexander  Walter" /></meta><meta name="dc.Creator" content="Reinhard  Nubbemeyer" /></meta><meta name="dc.Creator" content="Dieter  Heldmann" /></meta><meta name="dc.Creator" content="Lothar  Sobek" /></meta><meta name="dc.Creator" content="Federica  Morandi" /></meta><meta name="dc.Creator" content="Anna K.  Schrey" /></meta><meta name="dc.Creator" content="Dieter  Moosmayer" /></meta><meta name="dc.Creator" content="Judith  Günther" /></meta><meta name="dc.Creator" content="Joachim  Kuhnke" /></meta><meta name="dc.Creator" content="Marcus  Koppitz" /></meta><meta name="dc.Creator" content="Ulrich  Lücking" /></meta><meta name="dc.Creator" content="Ulrike  Röhn" /></meta><meta name="dc.Creator" content="Martina  Schäfer" /></meta><meta name="dc.Creator" content="Katrin  Nowak-Reppel" /></meta><meta name="dc.Creator" content="Ronald  Kühne" /></meta><meta name="dc.Creator" content="Hilmar  Weinmann" /></meta><meta name="dc.Creator" content="Gernot  Langer" /></meta><meta name="dc.Description" content="The human luteinizing hormone receptor (hLH-R) is a member of the glycoprotein hormone family of G-protein-coupled receptors (GPCRs), activated by luteinizing hormone (hLH) and essentially involved..." /></meta><meta name="Description" content="The human luteinizing hormone receptor (hLH-R) is a member of the glycoprotein hormone family of G-protein-coupled receptors (GPCRs), activated by luteinizing hormone (hLH) and essentially involved..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 31, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01382" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2019 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01382" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01382" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01382" /></link>
        
    
    

<title>Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01382" /></meta><meta property="og:title" content="Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0019.jpeg" /></meta><meta property="og:description" content="The human luteinizing hormone receptor (hLH-R) is a member of the glycoprotein hormone family of G-protein-coupled receptors (GPCRs), activated by luteinizing hormone (hLH) and essentially involved in the regulation of sex hormone production. Thus, hLH-R represents a valid target for the treatment of sex hormone-dependent cancers and diseases (polycystic ovary syndrome, uterine fibroids, endometriosis) as well as contraception. Screening of the Bayer compound library led to the discovery of tetrahydrothienopyridine derivatives as novel, small-molecule (SMOL) hLH-R inhibitors and to the development of BAY-298, the first nanomolar hLH-R antagonist reducing sex hormone levels in vivo. Further optimization of physicochemical, pharmacokinetic, and safety parameters led to the identification of BAY-899 with an improved in vitro profile and proven efficacy in vivo. BAY-298 and BAY-899 serve as valuable tool compounds to study hLH-R signaling in vitro and to interfere with the production of sex hormones in vivo." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01382"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01382">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01382&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01382&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01382&amp;href=/doi/10.1021/acs.jmedchem.9b01382" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 10321-10341</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01348" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01400" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Lars Wortmann</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lars Wortmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#a0ecc1d2d38ef7cfd2d4cdc1cecee0c2c1d9c5d28ec3cfcd"><span class="__cf_email__" data-cfemail="f0bc918283dea79f82849d919e9eb09291899582de939f9d">[email protected]</span></a> (L.W.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lars++Wortmann">Lars Wortmann</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6514-947X" title="Orcid link">http://orcid.org/0000-0001-6514-947X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bernhard Lindenthal</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bernhard Lindenthal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#b8faddcad6d0d9cadc96f4d1d6dcddd6ccd0d9d4f8dad9c1ddca96dbd7d5"><span class="__cf_email__" data-cfemail="bdffd8cfd3d5dccfd993f1d4d3d9d8d3c9d5dcd1fddfdcc4d8cf93ded2d0">[email protected]</span></a> (B.L.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bernhard++Lindenthal">Bernhard Lindenthal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter Muhn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter Muhn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Muhn">Peter Muhn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexander Walter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexander Walter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexander++Walter">Alexander Walter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Reinhard Nubbemeyer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Reinhard Nubbemeyer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Reinhard++Nubbemeyer">Reinhard Nubbemeyer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dieter Heldmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dieter Heldmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dieter++Heldmann">Dieter Heldmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lothar Sobek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lothar Sobek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lothar++Sobek">Lothar Sobek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Federica Morandi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Federica Morandi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle Strasse 10, Campus Berlin-Buch, 13125 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Federica++Morandi">Federica Morandi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anna K. Schrey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anna K. Schrey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle Strasse 10, Campus Berlin-Buch, 13125 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anna+K.++Schrey">Anna K. Schrey</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dieter Moosmayer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dieter Moosmayer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dieter++Moosmayer">Dieter Moosmayer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Judith Günther</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Judith Günther</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Judith++G%C3%BCnther">Judith Günther</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joachim Kuhnke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joachim Kuhnke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joachim++Kuhnke">Joachim Kuhnke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marcus Koppitz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marcus Koppitz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marcus++Koppitz">Marcus Koppitz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ulrich Lücking</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ulrich Lücking</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ulrich++L%C3%BCcking">Ulrich Lücking</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ulrike Röhn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ulrike Röhn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ulrike++R%C3%B6hn">Ulrike Röhn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martina Schäfer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martina Schäfer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martina++Sch%C3%A4fer">Martina Schäfer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katrin Nowak-Reppel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katrin Nowak-Reppel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katrin++Nowak-Reppel">Katrin Nowak-Reppel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ronald Kühne</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ronald Kühne</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle Strasse 10, Campus Berlin-Buch, 13125 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ronald++K%C3%BChne">Ronald Kühne</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hilmar Weinmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hilmar Weinmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hilmar++Weinmann">Hilmar Weinmann</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Gernot Langer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gernot Langer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gernot++Langer">Gernot Langer</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01382&amp;href=/doi/10.1021%2Facs.jmedchem.9b01382" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 10321–10341</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 31, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 August 2019</li><li><span class="item_label"><b>Published</b> online</span>31 October 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 November 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01382" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01382</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01382"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1487</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01382" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Lars&quot;,&quot;last_name&quot;:&quot;Wortmann&quot;},{&quot;first_name&quot;:&quot;Bernhard&quot;,&quot;last_name&quot;:&quot;Lindenthal&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Muhn&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;Walter&quot;},{&quot;first_name&quot;:&quot;Reinhard&quot;,&quot;last_name&quot;:&quot;Nubbemeyer&quot;},{&quot;first_name&quot;:&quot;Dieter&quot;,&quot;last_name&quot;:&quot;Heldmann&quot;},{&quot;first_name&quot;:&quot;Lothar&quot;,&quot;last_name&quot;:&quot;Sobek&quot;},{&quot;first_name&quot;:&quot;Federica&quot;,&quot;last_name&quot;:&quot;Morandi&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;K. Schrey&quot;},{&quot;first_name&quot;:&quot;Dieter&quot;,&quot;last_name&quot;:&quot;Moosmayer&quot;},{&quot;first_name&quot;:&quot;Judith&quot;,&quot;last_name&quot;:&quot;Günther&quot;},{&quot;first_name&quot;:&quot;Joachim&quot;,&quot;last_name&quot;:&quot;Kuhnke&quot;},{&quot;first_name&quot;:&quot;Marcus&quot;,&quot;last_name&quot;:&quot;Koppitz&quot;},{&quot;first_name&quot;:&quot;Ulrich&quot;,&quot;last_name&quot;:&quot;Lücking&quot;},{&quot;first_name&quot;:&quot;Ulrike&quot;,&quot;last_name&quot;:&quot;Röhn&quot;},{&quot;first_name&quot;:&quot;Martina&quot;,&quot;last_name&quot;:&quot;Schäfer&quot;},{&quot;first_name&quot;:&quot;Katrin&quot;,&quot;last_name&quot;:&quot;Nowak-Reppel&quot;},{&quot;first_name&quot;:&quot;Ronald&quot;,&quot;last_name&quot;:&quot;Kühne&quot;},{&quot;first_name&quot;:&quot;Hilmar&quot;,&quot;last_name&quot;:&quot;Weinmann&quot;},{&quot;first_name&quot;:&quot;Gernot&quot;,&quot;last_name&quot;:&quot;Langer&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;10321-10341&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01382&quot;},&quot;abstract&quot;:&quot;The human luteinizing hormone receptor (hLH-R) is a member of the glycoprotein hormone family of G-protein-coupled receptors (GPCRs), activated by luteinizing hormone (hLH) and essentially involved in the regulation of sex hormone production. Thus, hLH-R represents a valid target for the treatment of sex hormone-dependent cancers and diseases (polycystic ovary syndrome, uterine fibroids, endometriosis) as well as contraception. Screening of the Bayer compound library led to the discovery of tetrahydrothienopyridine derivatives as novel, small-molecule (SMOL) hLH-R inhibitors and to the development of BAY-298, the first nanomolar hLH-R antagonist reducing sex hormone levels in vivo. Further optimization of physicochemical, pharmacokinetic, and safety parameters led to the identification of BAY-899 with an improved in vitro profile and proven efficacy in vivo. BAY-298 and BAY-899 serve as valuable tool compounds to study hLH-R signaling in vitro and to interfere with the production of sex hormones in vivo.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01382&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01382" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01382&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01382" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01382&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01382" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01382&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01382&amp;href=/doi/10.1021/acs.jmedchem.9b01382" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01382" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01382" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01382%26sid%3Dliteratum%253Aachs%26pmid%3D31670515%26genre%3Darticle%26aulast%3DWortmann%26date%3D2019%26atitle%3DDiscovery%2Bof%2BBAY-298%2Band%2BBAY-899%253A%2BTetrahydro-1%252C6-naphthyridine-Based%252C%2BPotent%252C%2Band%2BSelective%2BAntagonists%2Bof%2Bthe%2BLuteinizing%2BHormone%2BReceptor%2BWhich%2BReduce%2BSex%2BHormone%2BLevels%2Bin%2BVivo%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D22%26spage%3D10321%26epage%3D10341%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291749" title="Thiophenes">Thiophenes</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=290703" title="Pyridines">Pyridines</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/jmcmar.2019.62.issue-22/20191127/jmcmar.2019.62.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The human luteinizing hormone receptor (hLH-R) is a member of the glycoprotein hormone family of G-protein-coupled receptors (GPCRs), activated by luteinizing hormone (hLH) and essentially involved in the regulation of sex hormone production. Thus, hLH-R represents a valid target for the treatment of sex hormone-dependent cancers and diseases (polycystic ovary syndrome, uterine fibroids, endometriosis) as well as contraception. Screening of the Bayer compound library led to the discovery of tetrahydrothienopyridine derivatives as novel, small-molecule (SMOL) hLH-R inhibitors and to the development of BAY-298, the first nanomolar hLH-R antagonist reducing sex hormone levels in vivo. Further optimization of physicochemical, pharmacokinetic, and safety parameters led to the identification of BAY-899 with an improved in vitro profile and proven efficacy in vivo. BAY-298 and BAY-899 serve as valuable tool compounds to study hLH-R signaling in vitro and to interfere with the production of sex hormones in vivo.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44186" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44186" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The hypothalamic–pituitary–gonadal (HPG) axis is the key pathway for the production of the sex hormones estradiol and progesterone in females, as well as testosterone in males.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Sex hormone synthesis is initiated via binding of gonadotropin-releasing hormone (GnRH) to its cognate receptor (GnRH-R) leading to receptor activation and the expression and secretion of two gonadotropins, namely, follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Binding of these glycoprotein hormones to their specific downstream receptors, the FSH and LH receptors (FSH-R, LH-R), then stimulates the production of sex hormones in both ovaries and testes. The actual sex hormone levels produced are tightly controlled by several negative feedback loops.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Given the essential role of sex hormones in a wide variety of developmental and physiological processes, an impressive number of strategies aimed at the modulation of their actual levels and function have been developed to treat hormone-dependent diseases such as certain types of cancers,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> uterine fibroids,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> polycystic ovary syndrome (PCOS),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and endometriosis,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> as well as for female<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and male contraception.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Thus, interfering with hLH-R-dependent hormone production with small-molecule (SMOL) antagonists represents a valid approach not only to study sex hormone physiology but also to tackle sex hormone-dependent disease conditions or contraception.</div><div class="NLM_p">Based on several characteristic features, the hLH-R has been assigned to the δ-group of the rhodopsin family of G-protein-coupled receptors (GPCRs)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and belongs to the glycoprotein hormone receptor cluster, together with the hFSH-R and thyroid-stimulating hormone receptor (TSH-R). Whereas most rhodopsin receptor ligands bind to a rhodopsin-like binding cavity within the 7-transmembrane region (7TMR),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> the glycoprotein hormone receptors are activated by high-affinity agonists binding to a large, glycosylated extracellular domain. Besides FSH, gonadal sex hormone production is predominantly regulated by pituitary-derived LH, a noncovalently linked, heterodimeric glycoprotein consisting of an α- and a β-subunit, the α-subunit being common to all glycoprotein hormones. Whereas agonist–receptor binding first and foremost induces cAMP second messenger signaling,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> it also results in Ca<sup>2+</sup> release as a secondary coupling mechanism.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Receptor activation has also been linked to additional downstream signaling processes<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and high organ responsiveness,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> adding further to complexity.</div><div class="NLM_p">Two tool compound classes for the LH receptor have been described. Heitman et al.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> reported in vitro studies with the LH receptor agonist Org 43553<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and the LH receptor antagonist LUF5771<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported agonist and antagonist for the hLH-R.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">These workers<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> convincingly demonstrated that Org 43553 reversibly binds to an allosteric binding site in the hLH-R without interfering with the binding of the natural ligand LH. Furthermore, follow-up studies<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> by the same group indicated the existence of a second, distinct allosteric binding site (i.e., different from the Org 43553 binding site) to which the antagonist LUF5771 binds, blocking the Org 43553 agonist activity. However, no SMOL hLH-R antagonist suitable for in vivo application has been described so far. Thus, we decided to initiate a lead finding program for this target and now report the identification of the tetrahydro-1,6-naphthyridine-based compounds BAY-298 and BAY-899 as potent and selective antagonists of the hLH-R with a good pharmacokinetic profile and proven activity in several in vivo models.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> High-Throughput Screening and Identification of Screening Hit <b>1</b></h3><div class="NLM_p">High-throughput screening (HTS) was used to identify SMOL antagonists of the hLH receptor. A total of 1.19 million compounds were screened using frozen cells<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> expressing the hLH-R, quantifying the changes in agonist-induced cAMP levels using the time-resolved fluorescence resonance energy transfer (TR-FRET) technology<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21−23)</a> (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01382/suppl_file/jm9b01382_si_001.pdf" class="ext-link">Supporting Information</a> for full details). After removal of compounds interfering with the readout format, the remaining hits were checked for the absence of any unspecific cAMP modulation via interference with adenylyl cyclase activity using forskolin-stimulated HEK293 membranes (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01382/suppl_file/jm9b01382_si_001.pdf" class="ext-link">Supporting Information</a> for assay details). Following a thorough hit-to-lead examination adressing additional off-target, selectivity and species specificity properties, and the removal of compounds with pan-assay interference motifs,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> tetrahydrothienopyridine-based compound <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) was identified as lead structure.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Analysis of the Role of the Absolute Configuration of <b>1</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0009.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="left"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">IC<sub>50</sub> [nM]</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">absolute configuration</th><th class="colsep0 rowsep0" align="center" char=".">hLH</th><th class="colsep0 rowsep0" align="center" char=".">rLH</th><th class="colsep0 rowsep0" align="center">mLH</th><th class="colsep0 rowsep0" align="center">hFSH</th><th class="colsep0 rowsep0" align="center">hTSH</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">racemate</td><td class="colsep0 rowsep0" align="char" char=".">378</td><td class="colsep0 rowsep0" align="char" char=".">212</td><td class="colsep0 rowsep0" align="left">>30 000</td><td class="colsep0 rowsep0" align="left">>16 500</td><td class="colsep0 rowsep0" align="left">>30 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">(<i>S</i>)-(+)-enantiomer</td><td class="colsep0 rowsep0" align="char" char=".">403</td><td class="colsep0 rowsep0" align="char" char=".">412</td><td class="colsep0 rowsep0" align="left">>30 000</td><td class="colsep0 rowsep0" align="left">>16 500</td><td class="colsep0 rowsep0" align="left">>30 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-(−)-enantiomer</td><td class="colsep0 rowsep0" align="char" char=".">6790</td><td class="colsep0 rowsep0" align="char" char=".">4890</td><td class="colsep0 rowsep0" align="left">>30 000</td><td class="colsep0 rowsep0" align="left">>16 500</td><td class="colsep0 rowsep0" align="left">>30 000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are arithmetic means of at least two independent experiments run in duplicates.</p></div></div></div><div class="NLM_p last">Early profiling of <b>1</b> further revealed no residual hLH-R agonist activity as well as no antagonist activity in a panel of closely related glycoprotein hormone and leucine-rich-repeat-containing GPCRs (hFSH-R, hTSH-R, hRXFP1/hLGR7-R). In addition, <b>1</b> was active at the rat LH receptor (rLH-R) with a similar potency, yet inactive at the corresponding murine LH receptor (mLH-R; see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Compound <b>1</b> was of moderate potency (IC<sub>50</sub> (hLH) = 378 nM) and exhibited borderline Lipinski rule of five properties,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> being suboptimal for an oral route of administration. In particular, the lipophilicity of <b>1</b> (log D = 5, TPSA = 42) was considered to be high. At the same time, the Caco-2 permeability was low (<1 nm/s for <i>P</i><sub>app</sub>(A–B)). Therefore, we carefully monitored log D during compound optimization, even though reduction of lipophilicity while simultaneously improving potency was considered challenging as we assumed binding of our ligand to the lipophilic 7TMR.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Synthesis of Screening Hit <b>1</b></h3><div class="NLM_p">Compound <b>1</b> was synthesized as outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Following a literature procedure,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> key intermediate <b>4</b> was prepared in racemic form via a Pictet–Spengler reaction from commercially available 2-(thiophen-2-yl)ethan-1-amine (<b>2</b>) and 4-methoxybenzaldehyde (<b>3</b>). Subsequent reaction of <b>4</b> with 1,3-dichloro-5-isocyanatobenzene furnished urea <b>1</b>. This short and efficient route allowed the introduction of a broad scope of variations by using different benzaldehydes and different capping reactions to functionalize the secondary amine in compound <b>4</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of HTS Hit <b>1</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) triethylamine, EtOH; (b) trifluoroacetic acid (TFA); (c) 1,3-dichloro-5-isocyanatobenzene, triethylamine, dimethyl sulfoxide (DMSO), 26%.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Structure–Activity Relationship and Profiling of the hLH-R Antagonists BAY-298 and BAY-899</h3><div class="NLM_p">We first investigated the role of the absolute configuration of <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Thus, racemate <b>1</b> was separated into its enantiomers <b>1a</b> and <b>1b</b>, with subsequent tests demonstrating that <b>1a</b> is the physiologically relevant enantiomer (hLH-R ∼17 times, rLH-R ∼12 times more active than <b>1b</b>). We were able to obtain diffracting crystals of a closely related derivative of eutomer <b>1a</b>, namely, compound <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) with the (<i>S</i>)-configuration determined by X-ray analysis.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray analysis of compound <b>5</b> determined the (<i>S</i>)-configuration of the eutomer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we investigated the structure–activity relationship of the substituent at the 4-position of tetrahydrothienopyridines (see <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Removal of the <i>p</i>-methoxy group of <b>1</b>, which could be a potential metabolic weak spot, led to significantly reduced activity (see compound <b>6</b>). Investigation of other para substituents (compounds <b>11</b>–<b>14</b>, <b>19</b>), however, clearly demonstrated that target activity was retained upon replacement of the methoxy by a chloro substituent (compound <b>14</b>). All attempts to lower log D values by the introduction of a polar group were detrimental to activity (compare compounds <b>7</b>–<b>9</b>, <b>18</b>, <b>19</b>). Investigation of selected compounds in a human liver microsome assay revealed low to moderate metabolic stability (for classification of the results, the following criteria were used: <i>F</i><sub>max</sub> > 70% (=CL < 0.4 L/(h kg)) was classified as high metabolic stability, <i>F</i><sub>max</sub> 30–70% (CL 0.4–0.9 L/(h kg)) as moderate stability, and <i>F</i><sub>max</sub> < 30% (CL > 0.9 L/(h kg)) as low metabolic stability). A halogen substituent at the para position of the 4-phenyl group seemed to increase metabolic stability significantly (see compounds <b>13</b>–<b>15</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Investigation of the Substituent at the 4-Position<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0022.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0001.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are arithmetic means of at least two independent experiments run in duplicates.</p></div></div><div></div></div><div class="NLM_p">The results of our SAR investigation of the urea capping group at the 5-position are depicted in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Both chloro atoms in <b>1</b> could be replaced either by methyl (compound <b>20</b>) or by methoxy (compound <b>21</b>), reducing log D values while maintaining target activity. Removal of one (compare compounds <b>1</b> and <b>22</b>) or both (compare compounds <b>14</b> and <b>23</b>) chloro atoms led to a significantly lower log D value while retaining LH antagonism. A sterically constrained para substituent (compound <b>24</b>) or a combination of two lipophilic meta and para substituents (compounds <b>25</b>, <b>26</b>) was tolerated without loss of target activity. In the case of polar substituents, the target potency was dramatically reduced (compounds <b>27</b>, <b>28</b>). To our surprise, even a sterically bulky lipophilic substituent at the para or meta position was tolerated (compounds <b>29</b>, <b>30</b>) but led to a significant increase in the log D value. With regard to metabolic stability in human liver microsomes, a combination of R<sup>1</sup> = Cl and a para-substituted R<sup>2</sup> group led to increased stability of <b>26</b> and <b>30</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR Investigation of the Substituent at the 5-Position<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0013.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0002.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are arithmetic means of at least two independent experiments run in duplicates.</p></div></div><div></div></div><div class="NLM_p">The SAR data compiled in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> underscored the importance of the urea moiety, indicating that both the carbonyl and the NH groups are essential for target activity. Thus, <b>31</b> with a thiourea moiety is about 16 times less active than <b>21</b>, implying that the carbonyl group might be incorporated in a binding interaction with the hLH-R. Replacement of the urea NH group by CH<sub>2</sub> (compound <b>32</b>) led to a complete loss of activity (compare compound <b>20</b>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR Investigation of Urea Capping Moiety A<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0014.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0015.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are arithmetic means of at least two independent experiments run in duplicates.</p></div></div><div></div></div><div class="NLM_p">As thiophenes are known to carry a high risk for formation of reactive metabolites<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and to further decrease metabolic stability in human liver microsomes, we investigated potential replacement options for the thiophene moiety (see “A” ring, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). In doing so, we observed that replacement of the thiophene in <b>30</b> (see <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) by a pyridine (see compound <b>33</b>, <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) resulted in retained target activity while significantly improving the metabolic stability in human liver microsomes.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR Investigation of Hetaryl Ring “A” and Identification of 33 (BAY-298) and Chemical Probe 36 (BAY-899)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0003.gif" alt="" id="fx8" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (hLH) [nM]</th><th class="colsep0 rowsep0" align="center" char=".">exp. log D</th><th class="colsep0 rowsep0" align="center" char=".">calc. log D</th><th class="colsep0 rowsep0" align="center" char=".">CL hLM [L/(h kg)]</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><sub>max</sub> hLM [%]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b> (BAY-298)</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="char" char=".">102</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">312</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b> (BAY-899)</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="char" char=".">185</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">89</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are arithmetic means of at least two independent experiments run in duplicates.</p></div></div></div><div class="NLM_p">Given these results, we decided to further profile <b>33</b> (BAY-298) as a potential chemical probe<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> for the hLH-R both in vitro and in vivo (with the results obtained summarized in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Compound <b>33</b> showed potent antagonism at the human, rat, and cynomolgus monkey LH-R (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) and was expected to be inactive at the respective mouse receptor, as previously shown for <b>1</b>. Likewise, <b>33</b> did not show any residual hLH agonism, was inactive in an hFSH-R assay, and exhibited only marginal (i.e., ∼24-fold selective) hTSH-R antagonist activity.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Summary of chemical, physicochemical, safety, in vitro drug metabolism, and pharmacokinetic (DMPK) properties of <b>33</b> (BAY-298).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0017.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Low-dose pharmacokinetic profiles of <b>33</b> (BAY-298) and <b>36</b> (BAY-899) in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>33</b> is characterized by good in vitro pharmacological, physicochemical, safety, and DMPK property profiles (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). With regard to safety, <b>33</b> was moderately active in the hERG assay (IC<sub>50</sub> = 3 μM) and had a mixed CYP inhibition profile (no effect on isoforms 1A2, 2D6, and 3A4 but significant inhibition of 2C8 and 2C9). Compound <b>33</b> performed particularly well in both human and rat liver microsomes and also rat hepatocyte assays, indicative of a low clearance. In addition, it showed good permeability and no efflux in a Caco-2 assay system. In vivo, these properties translated to a low-dose pharmacokinetic profile in rats with low clearance, long half-life, and a high volume of distribution resulting in a good oral bioavailability and high exposure (see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><div class="NLM_p">Our continued efforts to further improve the properties of <b>33</b> (BAY-298) by lowering the log D value led to the discovery of <b>36</b> (BAY-899; see <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). The log D value could be lowered by almost two log units; in turn, compound <b>36</b> was about 10 times more soluble than <b>33</b>, had better permeability in the Caco-2 assay, and showed an improved CYP inhibition as well as hERG profile (compare <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). In addition, the selectivity versus the TSH receptor could be further increased to >100-fold. Investigation of <b>36</b> in a low-dose pharmacokinetic study in rats also revealed a low clearance, a long half-life, and a high volume of distribution, resulting in a good oral bioavailability and high exposure (see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Both compounds (<b>33</b> and <b>36</b>) were investigated in a cell-based panel of 25 GPCRs (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01382/suppl_file/jm9b01382_si_001.pdf" class="ext-link">SI</a>), none of which activated or inhibited a GPCR >70% at 10 μM compound concentration, indicating an excellent selectivity within the target family. <b>33</b> and <b>36</b> both exhibited an appealing in vitro and in vivo profile with <b>36</b> bearing superior properties in several assays tested as discussed above. Thus, <b>36</b> (BAY-899) meets the criteria for chemical probes<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> established by the Structural Genomics Consortium (SGC)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and was handed over to the SGC as a “donated chemical probe”. The less active enantiomer (data not shown) might serve as a negative control compound for future pharmacological experiments.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Summary of chemical, physicochemical, safety, and in vitro DMPK properties of <b>36</b> (BAY-899).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Synthesis of <b>33</b> (BAY-298) and Chemical Probe <b>36</b> (BAY-899)</h3><div class="NLM_p">The synthesis of <b>33</b> (BAY-298) is outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Piperidone intermediate <b>40</b> was synthesized in two steps from commercially available 4-chlorophenylmagnesium bromide (<b>37</b>), benzyl chloroformate (<b>38</b>), and 4-methoxypyridine (<b>39</b>), following a method described by Di Fabio et al.,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> with subsequent zinc reduction<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> of the resulting double bond. A gold-catalyzed reaction<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> with propargylamine furnished naphthyridine <b>41</b> as a mixture with the undesired regioisomer <b>42</b>. The mixture of compounds <b>41</b> and <b>42</b> could be converted into <b>33</b> via deprotection of the carboxybenzyl protecting group, subsequent urea formation using 4-nitrophenyl chloroformate as a reagent, and separation of the regioisomers and enantiomers. The synthesis of chemical probe <b>36</b> (BAY-899) followed a similar route.</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0020.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 33 (BAY-298)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) tetrahydrofuran (THF), 81%; (b) zinc, acetic acid, quantitative; (c) propargylamine, sodium tetrachloroaurate dihydrate, EtOH, 27% (as a mixture of regioisomers); (d) TFA, 76% (as a mixture of regioisomers); (e) 4-nitrophenyl chloroformate, 4-(4-fluorophenoxy)aniline, THF, 17%; (f) high-performance liquid chromatography (HPLC) separation of regioisomers, ∼60%; separation of enantiomers, 39%.</p></p></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Mode of Action Studies</h3><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Antagonist Dose–Response Studies in the Presence of Multiples of the EC<sub>80</sub> Concentration of either hLH or the SMOL hLH-R Agonist Org 43553</h4><div class="NLM_p">To shed light on the mode of action, we performed antagonist dose–response studies with <b>33</b> (BAY-298) in the presence of four different, single concentrations of the natural ligand hLH (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A) or the SMOL hLH-R agonist Org 43553 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B) using the results obtained at 1 × EC<sub>80</sub> as control.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Antagonist dose–response studies with <b>33</b> (BAY-298) in the presence of integral multiples of the EC<sub>80</sub> concentration of hLH-R agonists: (A) the glycoprotein hLH and (B) the SMOL agonist Org 43553.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In both cases (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B), the antagonist efficacy of <b>33</b> remained largely unaffected and potency values clearly showed a limited rightward shift in dose–response indicative of a saturation in antagonist activity not being affected by agonist. Thus, we conclude that <b>33</b> binds to a site different from the actual agonist binding sites of hLH and Org 43553. In both cases, <b>33</b> behaved like a negative allosteric modulator of agonist-induced hLH-R activity. The finding that the antagonist activity of <b>33</b> is neither affected by the binding of hLH nor by the SMOL hLH-R agonist Org 43553 is well in line with previous results. Heitman et al.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> not only demonstrated reversible binding of Org 43553 to a putative rhodopsin-like SMOL binding cavity<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> but also validated the existence of a second, independent SMOL binding site for both positive and negative modulators of Org 43553 hLH-R agonist activity in close vicinity. Future studies will be necessary to finally clarify whether <b>33</b> binds in a similar way<a onclick="showRef(event, 'ref18 ref33'); return false;" href="javascript:void(0);" class="ref ref18 ref33">(18,33)</a> or to an unrelated, nonoverlapping site within the “ligand-binding landscape” of the δ-subgroup of rhodopsin receptors.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec2_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Short- and Long-Term Effects of the Treatment of Female and Male Rats with <b>33</b> (BAY-298) and <b>36</b> (BAY-899)</h4><div class="NLM_p">On the basis of the promising pharmacokinetic results obtained, we further analyzed the effects of our SMOL LH-R antagonists in vivo. LH receptor signaling rapidly induces specific gene expression cascades, initiates ovulation in the female, and regulates testosterone synthesis in the male. Therefore, the effects of <b>33</b> (BAY-298) both on testosterone synthesis in male rats and ovulatory marker genes and on progesterone plasma concentrations in female rats were evaluated. LH-induced gene expression was studied in female rats following treatment with cetrorelix (a competitive GnRH-R antagonist), which completely blocks the animal’s HPG axis and thus endogenous FSH and LH synthesis and secretion. Intravenous administration of hLH (0.5 μg/animal, 2.27 μg/kg) led to a significant increase in the mRNA levels of known LH-dependent marker genes (i.e., COX-2, Egr-1, and RUNX-1),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> whereas treatment with <b>33</b>, applied simultaneously iv, led to a dose-dependent decrease in their respective mRNA levels (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Suppression of hLH-induced ovarian marker gene expression in cetrorelix-treated female rats after 2 h of iv administration of hLH and <b>33</b> (BAY-298). Control animals received either hLH or vehicle treatment only. Data obtained from four animals (i.e., eight ovaries) per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In accordance with published data,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> administration of hLH also reduced the expression of aromatase (CYP19A1) mRNA in the same animal model. This effect was counteracted by treatment with <b>33</b> in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A). In addition, a marked reduction in plasma progesterone concentrations in comparison to control animals treated with hLH only was demonstrated (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B).</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0021.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Dose-dependent reversal of hLH-induced suppression of aromatase gene expression and (B) suppression of plasma progesterone levels in cetrorelix-treated female rats in the presence of <b>33</b> (BAY-298) (iv administration of both hLH and <b>33</b> (BAY-298) 2 h bevor sample collection, hLH: 0.5 μg/animal, 2.27 μg/kg). Data obtained from four animals (i.e., eight ovaries) per group; *<i>p</i> < 0.05 compared to hLH treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Likewise, iv administration of hLH (0.1 μg and 0.3 μg/animal, i.e., 0.45 and 1.36 μg/kg, respectively) led to a rapid, dose-dependent increase in plasma testosterone levels in cetrorelix-treated male rats 2 h after treatment (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> These levels were significantly lowered in the presence of <b>33</b> (BAY-298), simultaneously applied iv at 3 mg/animal (i.e., 14 mg/kg).</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Treatment with <b>33</b> (BAY-298) counteracts the hLH-induced increase in plasma testosterone levels in male rats 2 h after iv application of hLH and <b>33</b> (BAY-298). Data obtained from four animals per group; **<i>p</i> < 0.01 compared to hLH treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Taken together, the results demonstrate that treatment with <b>33</b> rapidly blocks short-term effects of LH signaling with respect to the expression of known LH receptor-induced genes and by lowering plasma hormone levels in male and female rats in a dose-dependent manner.</div><div class="NLM_p">Therefore, we proceeded to an investigation of long-term effects in naturally cycling female rats upon treatment with <b>33</b>. Checks for changes in the estrus cycle as well as effects on estradiol levels were made. In contrast to a fertile cycle of 28 days in women, the estrus cycle of female rats lasts only 4 days and can be split into four stages, all of which can be routinely monitored via the examination of vaginal smears<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> (i.e., rapid follicle development (diestrus), ovulation (proestrus), formation of corpora lutea and progesterone production (estrus), and the regression of unfertilized corpora lutea (metestrus)). Cycle-staged rats were treated orally with <b>33</b> for 8 days and monitored for two cycles (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). Whereas control animals cycled normally, animals receiving <b>33</b> once daily showed cycle arrest in diestrus and metestrus in a dose-dependent manner, in analogy to the results obtained with LH-R knockout mice<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and in line with known hLH-R mutations in women.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0016.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Treatment with <b>33</b> (BAY-298) led to interrupted folliculogenesis in the 4 day cycle of adult female rats. Cycle stages were determined by vaginal smears and characterized as follows: 1 = diestrus, 2 = proestrus, 3 = estrus, 4 = metestrus. Data are shown for the four animals per treatment group on the 8 treatment days. The green color indicates that the expected cycle stage was detected, whereas the red color shows arrested cycle stages.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Serum estradiol levels were measured after the 8 day treatments and found to be dose-dependently lowered compared to vehicle-treated rats in proestrus, the day of highest estradiol concentrations (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A). Plasma concentrations on day 8 were in the range of 4–39 μM, increased according to the different dose groups (4.5–72 mg/kg). Given a fraction unbound of 0.24%, a plasma concentration of 10 μM results in an unbound plasma concentration of 24 nM, which is close to the IC<sub>50</sub> value of 23 nM. Therefore, the obtained plasma concentrations fit to the general rules for dose selections, which can be summarized as follows: Based on in vitro potency, PK data, and protein binding, the dosing for in vivo studies should result in free plasma concentrations in the range of the in vitro IC<sub>50</sub> values. Higher and lower doses are then selected for dose–response studies. Collectively, these experimental data demonstrate that <b>33</b> is a potent antagonist of LH-R-mediated physiological functions in vivo, both in the ovary and testis. Compound <b>33</b> is equally suited for use in long-term studies addressing the physiological effects of LH-R blockade in reproductive biology and/or pathophysiological conditions.</div><figure id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0018.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Reduction in serum estradiol levels in female rats following treatment for 8 days (q.d., po) with either <b>33</b> (BAY-298) (A, B) or <b>36</b> (BAY-899) (B). Data obtained from 4–5 animals per group; *<i>p</i> < 0.05, **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In an additional study, <b>36</b> (BAY-899) was tested for its ability to reduce serum estradiol levels in intact female rats (oral application for 8 days, 12.5 mg/kg, q.d.), and showed an efficiency comparable to <b>33</b> (BAY-298) (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B). It is also worth noting that two animals of the BAY-899-treated group and three animals of the BAY-298-treated cohort again showed signs in vaginal smears of disturbed estrus cycles. However, given typically high individual variations in natural cycling rats adding to the variability between studies in this model, results should only compared within one experiment. Plasma concentrations on day 8 were 7 ± 2 μM for compound <b>33</b> (BAY-298) and 34 ± 19 μM for compound <b>36</b> (BAY-899), which is in accordance with the pharmacokinetic properties of both compounds. Thus, <b>36</b> (BAY-899) and <b>33</b> (BAY-298) can be regarded as being of comparable efficacy in in vivo studies, as expected from in vitro and pharmacokinetic data. No adverse events or undesired effects (e.g., loss of body weight or lower activity) were observed in in vivo studies with compounds <b>33</b> and <b>36</b>.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74100" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74100" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Comprehensive hit-to-lead activities led to the identification of compound <b>33</b> (BAY-298) and chemical probe <b>36</b> (BAY-899) and their characterization as the first potent and selective LH receptor antagonists suitable for in vivo administration. Both compounds are active at the human, rat, and cynomolgus monkey LH receptors in vitro. They act in an allosteric manner, do not compete with the binding of agonists to the hLH-R, and most likely bind to a putative rhodopsin-like SMOL binding cavity located within the 7-transmembrane region of the hLH-R. Both compounds have druglike properties. In comparison to BAY-298, BAY-899 does not inhibit hTSH-R signaling (>100-fold selectivity), and is significantly less lipophilic with an improved water solubility, CYP inhibition, and hERG profile. In vivo pharmacokinetics of both compounds revealed a low clearance, a high volume of distribution, and a long half-life resulting in good oral bioavailability and a high exposure.</div><div class="NLM_p">Compound <b>33</b> (BAY-298) demonstrated efficacy in different animal models in female and male rats. In short-term experiments, for example, <b>33</b> dose-dependently reduced LH-induced gene expression in the ovary and testosterone production after LH administration in male rats. Furthermore, once daily oral application was sufficient in long-term studies in female rats to demonstrate dose-dependent effects on plasma estradiol concentrations and the estrus cycle.</div><div class="NLM_p last">Recent pipeline news indicates an unchanged high medical need for novel antihormonal treatment options. For example, Arvinas has moved ARV-110, the first androgen receptor-targeted proteolysis targeting chimera (PROTAC), to phase 1 clinical trials;<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> AstraZeneca is testing AZD9496, a new oral, selective estrogen receptor degrader, in advanced breast cancers;<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and Bayer has been investigating vilaprisan, a selective progesterone receptor modulator, in phase 3 clinical trials for the treatment of gynecological diseases such as endometriosis and uterine fibroids.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Thus, BAY-298 (<b>33</b>) and BAY-899 (<b>36</b>) represent valuable chemical tool compounds to study LH receptor-mediated effects on sex hormones and can be used in long-term experiments to examine the receptor’s involvement in reproductive biology or pathophysiological conditions.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68417" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68417" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Methods</h4><div class="NLM_p">All reagents and solvents were used as purchased, unless otherwise specified. All final products were at least 95% pure, as determined by ultraperformance liquid chromatography (UPLC).</div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Compound names</h5><div class="NLM_p last">ICS software was used to generate IUPAC compound names. NMR spectra were recorded as solutions in DMSO-<i>d</i><sub>6</sub> or CDCl<sub>3</sub> on Bruker Avance III HD spectrometers operating at 300 or 400 MHz for <sup>1</sup>H and 101 MHz for <sup>13</sup>C acquisitions. Chemical shifts (δ) are given in parts per million (ppm), and coupling constants (<i>J</i>) are in hertz (Hz). Spin multiplicities are reported as: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. HR-MS images were recorded on an MS Waters XEVO G2XS with Acquity i-Class UPLC, MS images on an MS Waters SQD 2 coupled to an Acquity UPLC, and optical rotations on a JASCO P2000 polarimeter.</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-(4-methoxyphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>1</b>)</h5><div class="NLM_p last">A solution of 4-(4-methoxyphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (<b>4</b>; 2.00 g, 8.15 mmol; commercially available, CAS-RN: [213462-19-2]), 1,3-dichloro-5-isocyanatobenzene (1.53 g, 8.15 mmol; CAS-RN: [34893-92-0]), and triethylamine (3.4 mL) in DMSO (30 mL) was stirred at 70 °C overnight. The reaction mixture was poured into water and filtered (brown slime). The residue was dissolved in EtOAc, dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed under reduced pressure. Column chromatography (silica gel, hexanes/EtOAc) gave <b>1</b>. Yield 920 mg (26%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.96 (s, 1H, NH), 7.59 (d, <i>J</i> = 1.88 Hz, 2H, dichlorophenyl), 7.35 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 7.06–7.14 (m, 3H, methoxyphenyl, dichlorophenyl), 6.86 (d, <i>J</i> = 8.85 Hz, 2H, methoxyphenyl), 6.74 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 6.44 (s, 1H, CHN), 4.13–4.24 (m, 1H, CH<sub>2</sub>N), 3.68 (s, 3H, OMe), 2.81–3.12 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 158.7, 153.9, 143.1, 134.5, 134.3, 133.7, 133.3, 129.2, 126.4, 123.7, 120.9, 117.5, 113.8, 55.1, 54.3, 37.8, 24.9. MS (ESI): <i>m</i>/<i>z</i> = 433.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> (4<i>S</i>)-(+)-<i>N</i>-(3,5-Dichlorophenyl)-4-(4-methoxyphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>1a</b>)</h5><div class="NLM_p last">Obtained via HPLC separation of the enantiomers of <b>1</b> (column: Chiralpak IA 5 μm, 150 mm × 4.6 mm column; solvent A: hexanes, B: 2-propanol; 90% A + 10% B; flow rate: 1 mL/min): <sup><i>t</i></sup>R (min) = 8.82. [α]<sub class="stack">D</sub><sup class="stack">20</sup> + 261.0 ± 0.10 (<i>c</i> 1, DMSO).</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> (4<i>R</i>)-(−)-<i>N</i>-(3,5-Dichlorophenyl)-4-(4-methoxyphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>1b</b>)</h5><div class="NLM_p last">Obtained via HPLC separation of the enantiomers of <b>1</b> (conditions as above): <sup><i>t</i></sup>R (min) = 7.65. [α]<sub class="stack">D</sub><sup class="stack">20</sup> – 301.0 ± 0.06 (<i>c</i> 1, DMSO).</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> (4<i>S</i>)-(+)-<i>N</i>-(3,5-Dimethoxyphenyl)-4-phenyl-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>5</b>)</h5><div class="NLM_p last">Prepared analogously to <b>1</b>, from 4-phenyl-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (commercially available, CAS-RN: [91477-84-8]) and 1-isocyanato-3,5-dimethoxybenzene (CAS-RN: [54132-76-2]). Yield 658 mg (35%). The enantiomers were separated via HPLC (system: Dionex P580 pump, Gilson 215 liquid handler, Knuer K-2501 UV detector; Chiralpak IA 5 μm, 250 mm × 30 mm column; eluent: hexanes/2-propanol 60:40 + 0.1% diethylamine). Analytical HPLC (system: Dionex 680 pump, Dionex ASI 100, Waters 2487 UV detector; Chiralpak IA 5 μm, 150 mm × 4.6 mm column; eluent: hexanes/2-propanol 60:40 + 0.1% diethylamine, flow: 1 mL/min): <sup><i>t</i></sup>R (min) = 5.52 ((<i>S</i>)-(+)-enantiomer), 6.66 ((<i>R</i>)-(−)-enantiomer). [α]<sub class="stack">D</sub><sup class="stack">20</sup> + 203.0 ± 0.45 (<i>c</i> 1, MeOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 7.29–7.40 (m, 5H, phenyl), 7.13 (d, <i>J</i> = 5.05 Hz, 1H, thiophene), 6.71 (d, <i>J</i> = 5.31 Hz, 1H, thiophene), 6.54 (d, <i>J</i> = 2.27 Hz, 2H, dimethoxyphenyl), 6.41 (s, 1H, dimethoxyphenyl), 6.30 (s, 1H, CHN), 6.16 (m, 1H, NH), 4.22 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.76 (s, 6H, OMe), 3.37–3.46 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.99–3.13 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.89–2.97 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>). MS (ESI): <i>m</i>/<i>z</i> = 395.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-phenyl-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>6</b>)</h5><div class="NLM_p last">Prepared analogously to <b>1</b>, from 4-phenyl-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (commercially available, CAS-RN: [91477-84-8]) and 1,3-dichloro-5-isocyanatobenzene. Yield 39 mg (20%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.98 (s, 1H, NH), 7.60 (d, <i>J</i> = 1.88 Hz, 2H, dichlorophenyl), 7.17–7.39 (m, 6H, phenyl, thiophene), 7.11 (t, <i>J</i> = 1.88 Hz, 1H, dichlorophenyl), 6.79 (d, <i>J</i> = 5.09 Hz, 1H, thiophene), 6.50 (s, 1H, CHN), 4.15–4.28 (m, 1H, CH<sub>2</sub>N), 2.82–3.14 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 154.0, 143.1, 141.3, 134.6, 134.0, 133.7, 128.5, 127.9, 127.6, 126.5, 123.7, 120.9, 117.5, 54.8, 38.1, 24.8. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 403.0439; found, 403.0429.</div></div><div id="sec4_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-(pyridin-2-yl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>7</b>)</h5><div class="NLM_p last">Step 1: A solution of pyridine-2-carbaldehyde (1.00 g, 9.34 mmol; commercially available, CAS-RN: [1121-60-4]), 2-(thiophen-2-yl)ethan-1-amine (<b>2</b>; 1.1 mL, 9.3 mmol; commercially available, CAS-RN: [30433-91-1]), and triethylamine (2.06 g) in EtOH (20 mL) was stirred at rt overnight. The volatiles were removed under reduced pressure, and the resulting crude 1-(pyridin-2-yl)-<i>N</i>-[2-(thiophen-2-yl)ethyl]methanimine was used without further purification in the next step. Step 2: To TFA (10 mL) at rt was added 1-(pyridin-2-yl)-<i>N</i>-[2-(thiophen-2-yl)ethyl]methanimine (1.50 g, 6.93 mmol), and the reaction mixture was stirred at rt overnight, then concentrated under reduced pressure and poured into a mixture of saturated NaHCO<sub>3</sub> solution and ice. After extraction with EtOAc (3×), the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent was removed under reduced pressure. The crude product was purified by flash column chromatography (silica gel, EtOAc/hexanes 2:8–1:1, then MeOH/DCM 1:9) to give <i>rac</i>-4-(pyridin-2-yl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine. Yield 362 mg. Step 3: <b>7</b> was prepared analogously to <b>1</b>, from 4-(pyridin-2-yl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 1,3-dichloro-5-isocyanatobenzene. Yield 2 mg (1%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 9.17 (s, 1H, NH), 8.51 (dd, <i>J</i> = 0.88, 4.67 Hz, 1H, pyridine), 7.77 (dt, <i>J</i> = 1.77, 7.71 Hz, 1H, pyridine), 7.55 (d, <i>J</i> = 2.02 Hz, 2H, dichlorophenyl), 7.24–7.36 (m, 3H, pyridine, thiophene), 7.06–7.14 (m, 1H, dichlorophenyl), 6.91 (d, <i>J</i> = 5.31 Hz, 1H, thiophene), 6.36 (s, 1H, CHN), 4.37 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.33–3.53 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.85–2.97 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>). MS (ESI): <i>m</i>/<i>z</i> = 404.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-(pyridin-3-yl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>8</b>)</h5><div class="NLM_p last">Step 1: 1-(Pyridin-3-yl)-<i>N</i>-[2-(thiophen-2-yl)ethyl]methanimine was prepared analogously to <b>7</b> (step 1), using pyridine-3-carbaldehyde. Yield 1.89 g (94%). Step 2: <i>rac</i>-4-(Pyridin-3-yl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine was prepared analogously to <b>7</b> (step 2). Yield 931 mg (62%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.46–8.51 (m, 2H, pyridine), 7.57–7.62 (m, 1H, pyridine), 7.31–7.36 (m, 1H, pyridine), 7.24 (d, <i>J</i> = 5.1 Hz, 1H, thiophene), 6.41 (d, <i>J</i> = 5.3 Hz, 1H, thiophene), 5.16 (s, 1H, CHN), 3.12–3.20 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.94–3.08 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.77–2.92 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>). Step 3: <b>8</b> was prepared analogously to <b>1</b>, from <i>rac</i>-4-(pyridin-3-yl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 1,3-dichloro-5-isocyanatobenzene. Yield 51 mg (18%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 9.02 (s, 1H, pyridine), 8.46 (d, <i>J</i> = 5.41 Hz, 1H, pyridine), 8.45 (s, 1H, pyridine), 7.55–7.63 (m, 3H, dichlorophenyl, NH), 7.39 (d, <i>J</i> = 5.14 Hz, 1H, thiophene), 7.31–7.37 (m, 1H, pyridine), 7.12 (t, <i>J</i> = 1.88 Hz, 1H, dichlorophenyl), 6.82 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 6.52 (s, 1H, CHN), 4.17–4.29 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.06–3.24 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.86–3.02 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 154.1, 149.1, 148.8, 142.9, 136.9, 135.5, 135.0, 133.8, 133.1, 126.3, 124.1, 123.7, 121.0, 117.6, 53.0, 38.5, 24.8. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 404.0391; found, 404.0387.</div></div><div id="sec4_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-(pyridin-4-yl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>9</b>)</h5><div class="NLM_p last">Step 1: 1-(Pyridin-4-yl)-<i>N</i>-[2-(thiophen-2-yl)ethyl]methanimine was prepared analogously to <b>7</b> (step 1), using pyridine-4-carbaldehyde. Yield 1.83 g (91%). Step 2: <i>rac</i>-4-(Pyridin-4-yl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine was prepared analogously to <b>7</b> (step 2). Yield 940 mg (63%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.45 (m, 2H, pyridine), 7.25–7.30 (m, 2H, pyridine), 7.18 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 6.43 (d, <i>J</i> = 5.09 Hz, 1H, thiophene), 4.90 (s, 1H, CHN), 2.99–3.07 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.67–3.03 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). Step 3: <b>9</b> was prepared analogously to <b>1</b>, from <i>rac</i>-4-(pyridin-4-yl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 1,3-dichloro-5-isocyanatobenzene. Yield 7 mg (2%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 9.05 (s, 1H, NH), 8.51 (d, <i>J</i> = 4.72 Hz, 2H, pyridine), 7.59 (d, <i>J</i> = 1.88 Hz, 2H, dichlorophenyl), 7.40 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 7.22 (d, <i>J</i> = 4.70 Hz, 2H, pyridine), 7.12 (m, 1H, dichlorophenyl), 6.91 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 6.45 (s, 1H, CHN), 4.16–4.32 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.84–3.10 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). MS (ESI): <i>m</i>/<i>z</i> = 404.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-(2-methylphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>10</b>)</h5><div class="NLM_p last">Step 1: 1-(2-Methylphenyl)-<i>N</i>-[2-(thiophen-2-yl)ethyl]methanimine was prepared analogously to <b>7</b> (step 1), using <i>o</i>-tolualdehyde. Yield 1.84 g (96%). Step 2: <i>rac</i>-4-(2-Methylphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine was prepared analogously to <b>7</b> (step 2). Yield 377 mg (25%). Step 3: <b>10</b> was prepared analogously to <b>1</b>, from <i>rac</i>-4-(2-methylphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 1,3-dichloro-5-isocyanatobenzene. Yield 91 mg (31%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 9.04 (s, 1H, NH), 7.57 (d, <i>J</i> = 1.88 Hz, 2H, dichlorophenyl), 7.33 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 7.02–7.21 (m, 4H, dichlorophenyl, tolyl), 6.61–6.71 (m, 3H, thiophene, tolyl, CHN), 4.04–4.17 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.08–3.28 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.68–2.98 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>), 2.37 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 154.7, 143.0, 139.3, 137.1, 134.9, 134.4, 133.8, 130.7, 128.9, 127.7, 126.4, 125.5, 123.6, 121.0, 117.5, 52.4, 38.8, 24.5, 19.3. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 417.0595; found, 417.0583.</div></div><div id="sec4_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-(4-methylphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>11</b>)</h5><div class="NLM_p last">Step 1: 1-(4-Methylphenyl)-<i>N</i>-[2-(thiophen-2-yl)ethyl]methanimine was prepared analogously to <b>7</b> (step 1), using <i>p</i>-tolualdehyde. Yield 1.58 g (83%). Step 2: <i>rac</i>-4-(4-Methylphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine was prepared analogously to <b>7</b> (step 2). Yield 730 mg (46%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 7.12–7.19 (m, 4H, phenyl), 7.00 (d, <i>J</i> = 5.05 Hz, 1H, thiophene), 6.47 (d, <i>J</i> = 5.31 Hz, 1H, thiophene), 5.00 (s, 1H, CHN), 3.28–3.35 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.06–3.15 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.81–3.03 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>), 2.34 (s, 3H, Me), 1.80 (s, 1H, NH). Step 3: <b>11</b> was prepared analogously to <b>1</b>, from <i>rac</i>-4-(4-methylphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 1,3-dichloro-5-isocyanatobenzene. Yield 37.6 mg (20%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ = 7.10–7.31 (m, 7H, tolyl, thiophene, dichlorophenyl), 6.95–7.03 (m, 1H, dichlorophenyl), 6.67 (d, <i>J</i> = 5.09 Hz, 1H, thiophene), 6.49 (s, 1H, NH), 6.18 (s, 1H, CHN), 4.23 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.38–3.50 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.90–3.12 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>), 2.36 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 153.9, 143.1, 138.4, 136.8, 134.5, 134.2, 133.7, 129.0, 127.9, 126.5, 123.7, 120.9, 117.5, 54.6, 38.0, 24.9, 20.7. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 417.0595; found, 417.0586.</div></div><div id="sec4_1_1_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-[4-(propan-2-yl)phenyl]-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>12</b>)</h5><div class="NLM_p last">Step 1: 1-[4-(Propan-2-yl)phenyl]-<i>N</i>-[2-(thiophen-2-yl)ethyl]methanimine was prepared analogously to <b>7</b> (step 1), using 4-isopropylbenzaldehyde. Yield 1.73 g (99%). Step 2: <i>rac</i>-4-[4-(Propan-2-yl)phenyl]-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine was prepared analogously to <b>7</b> (step 2); note: the reaction temperature was raised from rt to 60 °C. Yield 1.54 g (91%). Step 3: <b>12</b> was prepared analogously to <b>1</b>, from <i>rac</i>-4-[4-(propan-2-yl)phenyl]-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 1,3-dichloro-5-isocyanatobenzene. Yield 83.7 mg (23%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ = 7.21–7.29 (m, 6H, dichlorophenyl, isopropylphenyl), 7.12 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 6.99 (m, 1H, dichlorophenyl), 6.70 (d, <i>J</i> = 5.09 Hz, 1H, thiophene), 6.48 (s, 1H, NH), 6.20 (s, 1H, CHN), 4.16–4.29 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.45 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.86–3.12 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>, CH(Me)<sub>2</sub>), 1.26 (s, 3H, Me), 1.23 (s, 3H, Me). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 153.9, 147.8, 143.1, 138.7, 134.5, 134.2, 133.7, 127.9, 126.5, 126.3, 123.7, 120.9, 117.5, 54.6, 38.0, 33.2, 24.9, 23.9. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 445.0908; found, 445.0902.</div></div><div id="sec4_1_1_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-[4-(trifluoromethyl)phenyl]-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>13</b>)</h5><div class="NLM_p last">Step 1: <i>N</i>-[2-(Thiophen-2-yl)ethyl]-1-[4-(trifluoromethyl)phenyl]methanimine was prepared analogously to <b>7</b> (step 1), using 4-(trifluoromethyl)benzaldehyde. Yield 950 mg (58%). Step 2: <i>rac</i>-4-[4-(Trifluoromethyl)phenyl]-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine was prepared analogously to <b>7</b> (step 2). Yield 290 mg (29%). Step 3: <b>13</b> was prepared analogously to <b>1</b>, from <i>rac</i>-4-[4-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 1,3-dichloro-5-isocyanatobenzene. Yield 103.1 mg (59%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ = 7.55–7.65 (m, <i>J</i> = 8.29 Hz, 2H, trifluoromethylphenyl), 7.41–7.51 (m, 2H, trifluoromethylphenyl), 7.32 (d, <i>J</i> = 3.03 Hz, 2H, dichlorophenyl), 7.19 (d, <i>J</i> = 5.03 Hz, 1H, thiophene), 7.00–7.07 (m, 1H, dichlorophenyl), 6.71 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 6.55 (s, 1H, NH), 6.45 (s, 1H, CHN), 3.98 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.31–3.44 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.91–3.17 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 154.1, 146.0, 142.9, 135.0, 133.8, 133.2, 128.7, 128.2 (q, <i>J</i> = 31 Hz), 126.5, 125.4 (q, <i>J</i> = 3.7 Hz), 124.0, 122.9, 121.1, 117.7, 54.4, 38.5, 24.8; quartet for CF<sub>3</sub> difficult to identify. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 471.0312; found, 471.0301.</div></div><div id="sec4_1_1_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> <i>rac</i>-4-(4-Chlorophenyl)-<i>N</i>-(3,5-dichlorophenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>14</b>)</h5><div class="NLM_p last">Prepared analogously to <b>1</b>, from 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (commercially available, CAS-RN: [213462-12-5]) and 1,3-dichloro-5-isocyanatobenzene. Yield 26.6 mg (10%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.99 (s, 1H, NH), 7.59 (d, <i>J</i> = 2.02 Hz, 2H, dichlorophenyl), 7.35–7.40 (m, 3H, chlorophenyl, thiophene), 7.22 (d, <i>J</i> = 7.90 Hz, 2H, chlorophenyl), 7.11 (t, <i>J</i> = 1.77 Hz, 1H, dichlorophenyl), 6.80 (d, <i>J</i> = 5.05 Hz, 1H, thiophene), 6.48 (s, 1H, CHN), 4.20 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.84–3.09 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>).</div></div><div id="sec4_1_1_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-(3,4-difluorophenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>15</b>)</h5><div class="NLM_p last">Step 1: 1-(3,4-Difluorophenyl)-<i>N</i>-[2-(thiophen-2-yl)ethyl]methanimine was prepared analogously to <b>7</b> (step 1), using 3,4-difluorobenzaldehyde. Yield 1.84 g (quantitative). Step 2: <i>rac</i>-4-(3,4-Difluorophenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine was prepared analogously to <b>7</b> (step 2); note: the reaction temperature was raised from rt to 60 °C. Yield 1.52 g (76%). Step 3: <b>15</b> was prepared analogously to <b>1</b>, from <i>rac</i>-4-(3,4-difluorophenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 1,3-dichloro-5-isocyanatobenzene. Yield 42.9 mg (12%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ = 7.29–7.37 (m, 2H, dichlorophenyl), 7.02–7.22 (m, 5H, thiophene, dichlorophenyl, difluorophenyl), 6.71 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 6.46 (m, 2H, NH, CHN), 3.94 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.30–3.42 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.90–3.15 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>). HRMS (ESI, [M + H]<sup>+</sup>): calcd, 439.0250; found, 439.0239.</div></div><div id="sec4_1_1_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-(3-fluorophenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>16</b>)</h5><div class="NLM_p last">Step 1: 1-(3-Fluorophenyl)-<i>N</i>-[2-(thiophen-2-yl)ethyl]methanimine was prepared analogously to <b>7</b> (step 1), using 3-fluorobenzaldehyde. Yield 1.88 g (quantitative). Step 2: <i>rac</i>-4-(3-Fluorophenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine was prepared analogously to <b>7</b> (step 2). Yield 522 mg (35%). Step 3: <b>16</b> was prepared analogously to <b>1</b>, from <i>rac</i>-4-(3-fluorophenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 1,3-dichloro-5-isocyanatobenzene. Yield 30.8 mg (11%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 9.00 (s, 1H, NH), 7.59 (d, <i>J</i> = 1.88 Hz, 2H, dichlorophenyl), 7.32–7.43 (m, 2H, fluorophenyl, thiophene), 7.03–7.16 (m, 3H, fluorophenyl, dichlorophenyl), 6.92–7.00 (m, 1H, fluorophenyl), 6.84 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 6.48 (s, 1H, CHN), 4.13–4.30 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.83–3.16 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). MS (ESI): <i>m</i>/<i>z</i> = 421.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-(2-fluorophenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>17</b>)</h5><div class="NLM_p last">Step 1: 1-(2-Fluorophenyl)-<i>N</i>-[2-(thiophen-2-yl)ethyl]methanimine was prepared analogously to <b>7</b> (step 1), using 2-fluorobenzaldehyde. Yield 1.79 g (95%). Step 2: <i>rac</i>-4-(2-Fluorophenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine was prepared analogously to <b>7</b> (step 2). Yield 1.36 g (90%). Step 3: <b>17</b> was prepared analogously to <b>1</b>, from <i>rac</i>-4-(2-fluorophenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 1,3-dichloro-5-isocyanatobenzene. Yield 130.3 mg (48%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 9.06 (s, 1H, NH), 7.55 (d, <i>J</i> = 1.77 Hz, 2H, dichlorophenyl), 7.29–7.38 (m, 2H, thiophene, fluorophenyl), 7.08–7.21 (m, 3H, dichlorophenyl, fluorophenyl), 6.95 (dt, <i>J</i> = 1.52, 7.71 Hz, 1H, fluorophenyl), 6.73 (d, <i>J</i> = 5.23 Hz, 1H, thiophene), 6.71 (s, 1H, CHN), 4.19–4.27 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.15–3.28 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.85–2.94 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 160.0 (d, <i>J</i> = 247 Hz), 154.0, 143.0, 134.8, 133.8, 133.3, 129.9 (m, 2C), 128.5 (d, <i>J</i> = 14 Hz), 126.0, 124.2 (d, <i>J</i> = 3.4 Hz), 124.0, 120.9, 117.3, 115.7 (d, <i>J</i> = 22 Hz), 49.7, 24.6; one carbon under DMSO peak. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 421.0344; found, 421.0336.</div></div><div id="sec4_1_1_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> <i>rac</i>-<i>N</i>-(3,5-Dichlorophenyl)-4-(6-oxo-1,6-dihydropyridin-3-yl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>18</b>)</h5><div class="NLM_p last">Step 1: 5-({[2-(Thiophen-2-yl)ethyl]imino}methyl)pyridin-2(1<i>H</i>)-one was prepared analogously to <b>7</b> (step 1), using 6-hydroxypyridine-3-carbaldehyde. Yield 15.79 g (75%). Step 2: <i>rac</i>-5-(4,5,6,7-Tetrahydrothieno[3,2-<i>c</i>]pyridin-4-yl)pyridin-2(1<i>H</i>)-one was prepared analogously to <b>7</b> (step 2); note: the reaction was performed at 80 °C instead of rt. Yield 3.42 g (59%). Step 3: <b>18</b> was prepared analogously to <b>1</b>, from <i>rac</i>-5-(4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridin-4-yl)pyridin-2(1<i>H</i>)-one and 1,3-dichloro-5-isocyanatobenzene. Yield 1.45 g (80%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.59 (d, <i>J</i> = 2.07 Hz, 2H, dichlorophenyl), 7.34–7.40 (m, 2H, pyridone), 7.11 (t, <i>J</i> = 1.88 Hz, 1H, dichlorophenyl), 6.78–6.84 (m, 2H, thiophene), 6.23–6.31 (m, 2H, CHN, pyridone), 4.19 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.02–3.25 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.77–2.98 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 162.0, 154.0, 143.0, 141.2, 135.2, 134.2, 133.7, 133.0, 126.2, 124.0, 121.0, 120.2, 118.3, 117.6, 51.9, 37.8, 24.8. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 420.0340; found, 420.0335.</div></div><div id="sec4_1_1_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> <i>rac</i>-4-(4-Carbamoylphenyl)-<i>N</i>-(3,5-dichlorophenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>19</b>)</h5><div class="NLM_p last">Step 1: 4-({[2-(Thiophen-2-yl)ethyl]imino}methyl)benzonitrile was prepared analogously to <b>7</b> (step 1), using 4-formylbenzonitrile. Yield 1.71 g (93%). Step 2: <i>rac</i>-4-(4,5,6,7-Tetrahydrothieno[3,2-<i>c</i>]pyridin-4-yl)benzamide was prepared analogously to <b>7</b> (step 2); note: the nitrile group hydrolyzed under the TFA conditions to the corresponding carboxamide. Yield 695 mg (38%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.89 (br s, 1H, CONH<sub>2</sub>), 7.78 (d, <i>J</i> = 8.34 Hz, 2H, phenyl), 7.26–7.46 (m, 3H, phenyl, CONH<sub>2</sub>), 7.14 (d, <i>J</i> = 5.05 Hz, 1H, thiophene), 6.35 (d, <i>J</i> = 5.05 Hz, 1H, thiophene), 4.92 (s, 1H, CHN), 3.00–3.27 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.67–2.92 (m, 4H, NH, CH<sub>2</sub>CH<sub>2</sub>). Step 3: <b>19</b> was prepared analogously to <b>1</b>, from <i>rac</i>-4-(4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridin-4-yl)benzamide and 1,3-dichloro-5-isocyanatobenzene. Yield 58.5 mg (34%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 9.00 (s, 1H, NH), 7.90 (br s, 1H, CONH<sub>2</sub>), 7.79 (d, <i>J</i> = 8.48 Hz, 2H, benzamide), 7.59 (d, <i>J</i> = 1.88 Hz, 2H, dichlorophenyl), 7.22–7.40 (m, 4H, benzamide, CONH<sub>2</sub>, thiophene), 7.11 (t, <i>J</i> = 1.88 Hz, 1H, dichlorophenyl), 6.81 (d, <i>J</i> = 5.09 Hz, 1H, thiophene), 6.51 (s, 1H, CHN), 4.22 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.84–3.15 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 167.7, 154.0, 144.4, 143.0, 134.7, 133.8, 133.7, 133.6, 127.7, 126.5, 123.9, 121.0, 117.6, 54.6, 38.4, 24.8. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 446.0497; found, 446.0488.</div></div><div id="sec4_1_1_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> <i>rac</i>-<i>N</i>-(3,5-Dimethylphenyl)-4-(4-methoxyphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>20</b>)</h5><div class="NLM_p last">Prepared analogously to <b>1</b>, from 4-(4-methoxyphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (<b>4</b>) and 1-isocyanato-3,5-dimethylbenzene (CAS-RN: [54132-75-1]). Yield 68 mg (28%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.43–8.54 (m, 1H, NH), 7.35 (d, <i>J</i> = 5.05 Hz, 1H, thiophene), 7.02–7.16 (m, 4H, methoxyphenyl, dichlorophenyl), 6.82–6.90 (m, 2H, methoxyphenyl), 6.74 (d, <i>J</i> = 5.31 Hz, 1H, thiophene), 6.56 (s, 1H, dichlorophenyl), 6.45 (s, 1H, CHN), 4.19 (br dd, <i>J</i> = 4.17, 13.52 Hz, 1H), 3.26–3.36 (m, 2H), 2.79–3.05 (m, 3H), 2.12–2.33 (m, 7H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 158.6, 154.5, 140.2, 137.2, 134.7, 134.5, 133.8, 129.2, 126.5, 123.6, 123.5, 117.8, 113.7, 55.1, 54.1, 37.6, 24.9, 21.2. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 393.1637; found, 393.1626.</div></div><div id="sec4_1_1_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> <i>rac</i>-<i>N</i>-(3,5-Dimethoxyphenyl)-4-(4-methoxyphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>21</b>)</h5><div class="NLM_p last">Prepared analogously to <b>1</b>, from 4-(4-methoxyphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (<b>4</b>) and 1-isocyanato-3,5-dimethoxybenzene. Yield 702 mg (18%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.56 (s, 1H, NH), 7.34 (d, <i>J</i> = 5.09 Hz, 1H, thiophene), 7.06–7.13 (m, 2H, methoxyphenyl), 6.79–6.91 (m, 2H, methoxyphenyl), 6.72–6.77 (m, 3H, thiophene, dimethoxyphenyl), 6.62 (d, <i>J</i> = 2.26 Hz, 1H, dimethoxyphenyl), 6.46 (s, 1H, CHN), 4.14–4.26 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.68 (s, 6H, OMe), 3.65 (s, 3H, OMe), 2.79–3.10 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 160.3, 158.6, 154.3, 142.2, 134.6, 134.5, 133.7, 129.1, 126.5, 123.5, 113.7, 97.9, 55.1, 55.1, 54.1, 37.6, 24.9. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 425.1535; found, 425.1525.</div></div><div id="sec4_1_1_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> <i>rac</i>-<i>N</i>-(3-Chlorophenyl)-4-(4-methoxyphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>22</b>)</h5><div class="NLM_p last">Prepared analogously to <b>1</b>, from 4-(4-methoxyphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (<b>4</b>) and 1-chloro-3-isocyanatobenzene (CAS-RN: [2909-38-8]). Yield 288 mg (9%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.80 (s, 1H, NH), 7.59–7.68 (m, 1H, chlorophenyl), 7.31–7.43 (m, 2H, chlorophenyl, thiophene), 7.17–7.29 (m, 1H, chlorophenyl), 7.10 (d, <i>J</i> = 8.67 Hz, 2H, methoxyphenyl), 6.95 (m, 1H, chlorophenyl), 6.85 (d, <i>J</i> = 8.67 Hz, 2H, methoxyphenyl), 6.74 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 6.46 (s, 1H, CHN), 4.13–4.29 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.68 (s, 3H, OMe), 2.80–3.11 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 158.6, 154.2, 142.1, 134.5, 134.5, 133.5, 132.8, 130.0, 129.2, 126.5, 123.6, 121.5, 119.1, 118.0, 113.7, 55.1, 54.2, 37.7, 24.9. MS (ESI): <i>m</i>/<i>z</i> = 399.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> <i>rac</i>-4-(4-Chlorophenyl)-<i>N</i>-phenyl-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>23</b>)</h5><div class="NLM_p last">Prepared analogously to <b>1</b>, from 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and isocyanatobenzene (CAS-RN: [103-71-9]). Yield 95 mg (40%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.67 (s, 1H, NH), 7.35–7.45 (m, 5H, phenyl, chlorophenyl, thiophene), 7.18–7.25 (m, 4H, phenyl, chlorophenyl), 6.92 (t, <i>J</i> = 7.14 Hz, 1H, phenyl), 6.80 (d, <i>J</i> = 5.05 Hz, 1H, thiophene), 6.51 (s, 1H, CHN), 4.24 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.82–3.07 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 154.6, 140.8, 140.3, 134.9, 133.9, 132.1, 129.8, 128.4, 126.5, 123.8, 122.1, 120.2, 120.2, 54.0, 38.1, 24.9. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 369.0828; found, 369.0823.</div></div><div id="sec4_1_1_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> <i>rac</i>-<i>N</i>-(4-Chlorophenyl)-4-(4-methoxyphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>24</b>)</h5><div class="NLM_p last">Prepared analogously to <b>1</b>, from 4-(4-methoxyphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (<b>4</b>) and 1-chloro-4-isocyanatobenzene (CAS-RN: [104-12-1]). Yield 23.5 mg (10%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.76 (s, 1H, NH), 7.45–7.52 (m, 2H, chlorophenyl), 7.35 (d, <i>J</i> = 5.31 Hz, 1H, thiophene), 7.23–7.28 (m, 2H, chlorophenyl), 7.08–7.13 (m, 2H, methoxyphenyl), 6.83–6.88 (m, 2H, methoxyphenyl), 6.74 (d, <i>J</i> = 5.31 Hz, 1H, thiophene), 6.46 (s, 1H, CHN), 4.20 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.69 (s, 3H, OMe), 2.99–3.10 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.81–2.96 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>). MS (ESI): <i>m</i>/<i>z</i> = 399.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> <i>rac</i>-<i>N</i>-(3-Chloro-4-fluorophenyl)-4-(4-chlorophenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>25</b>)</h5><div class="NLM_p last">Prepared analogously to <b>1</b>, from 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 2-chloro-1-fluoro-4-isocyanatobenzene (CAS-RN: [50529-33-4]). Yield 5.8 g (36%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.85 (s, 1H, NH), 7.68–7.78 (m, 1H, fluorophenyl), 7.19–7.44 (m, 7H, fluorophenyl, chlorophenyl, thiophene), 6.80 (d, <i>J</i> = 5.09 Hz, 1H, thiophene), 6.48 (s, 1H, CHN), 4.14–4.28 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.81–3.11 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). MS (ESI): <i>m</i>/<i>z</i> = 421.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> <i>rac</i>-4-(4-Chlorophenyl)-<i>N</i>-[4-fluoro-3-(trifluoromethoxy)phenyl]-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>26</b>)</h5><div class="NLM_p last">Prepared analogously to <b>27</b>, from 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 4-fluoro-3-(trifluoromethoxy)aniline (CAS-RN: [113421-98-0]). Yield 2.13 g (54%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.94 (s, 1H, NH), 7.71–7.77 (m, 1H, fluorophenyl), 7.45–7.52 (m, 1H, fluorophenyl), 7.33–7.41 (m, 4H, fluorophenyl, chlorophenyl, thiophene), 7.19–7.24 (m, 2H, chlorophenyl), 6.80 (d, <i>J</i> = 5.05 Hz, 1H, thiophene), 6.50 (s, 1H, CHN), 4.22 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.83–3.09 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 154.3, 148.7 (d, <i>J</i> = 244 Hz), 140.5, 137.7 (d, <i>J</i> = 3 Hz), 134.9, 134.6 (m), 133.7, 132.2, 129.8, 128.4, 126.5, 123.9, 120.1 (m), 117.1 (d, <i>J</i> = 19 Hz), 114.6, 54.1, 38.1, 24.8. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 471.0557; found, 471.0549.</div></div><div id="sec4_1_1_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> <i>rac</i>-<i>N</i>-[3-(1,1-Dioxo-1λ<sup>6</sup>-thiomorpholin-4-yl)-4-fluorophenyl]-4-(4-methoxyphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>27</b>)</h5><div class="NLM_p last">To a solution of 4-nitrophenyl chloroformate (121 mg, 601 μmol) in THF (2.3 mL) was added 3-(1,1-dioxidothiomorpholin-4-yl)-4-fluoroaniline (147 mg, 601 μmol; CAS-RN: [1094562-12-5]) and the mixture was stirred at rt for 1 h. Triethylamine (230 μL, 1.6 mmol) and 4-(4-methoxyphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (<b>4</b>; 147 mg, 601 μmol) were added and the mixture was stirred at 60 °C overnight, then filtered. The filtrate was concentrated under reduced pressure and the crude product was purified by HPLC. Yield 63.3 mg (19%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.60 (s, 1H, NH), 7.35 (d, <i>J</i> = 5.00 Hz, 1H, thiophene), 7.23–7.29 (m, 1H, fluorophenyl), 6.98–7.18 (m, 4H, methoxyphenyl, fluorophenyl), 6.80–6.90 (m, 2H, methoxyphenyl), 6.74 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 6.45 (s, 1H, CHN), 4.13–4.26 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.68 (s, 3H, OMe), 3.36–3.49 (m, 4H, thiomorpholine), 3.18–3.27 (m, 4H, thiomorpholine), 2.79–3.15 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 158.6, 154.5, 150.1 (d, <i>J</i> = 239 Hz), 137.7 (d, <i>J</i> = 10 Hz), 137.1 (d, <i>J</i> = 2.5 Hz), 134.6, 134.5, 133.7, 129.2, 126.5, 123.6, 115.8 (d, <i>J</i> = 21 Hz), 114.6 (d, <i>J</i> = 7 Hz), 113.7, 112.6, 55.2, 54.1, 51.0, 49.3 (d, <i>J</i> = 3 Hz), 37.6, 24.9. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 516.1427; found, 516.1417.</div></div><div id="sec4_1_1_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> <i>rac</i>-<i>N</i>-(3-Carbamoyl-4-fluorophenyl)-4-(4-methoxyphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>28</b>)</h5><div class="NLM_p last">Prepared analogously to <b>27</b>, from 4-(4-methoxyphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (<b>4</b>) and 5-amino-2-fluorobenzamide (CAS-RN: [518057-72-2]). Yield 66.1 mg (25%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.79 (s, 1H, NH), 7.74 (dd, <i>J</i> = 2.83, 6.59 Hz, 1H, fluorophenyl), 7.51–7.66 (m, 3H, CONH<sub>2</sub>, fluorophenyl), 7.34 (d, <i>J</i> = 5.09 Hz, 1H, thiophene), 7.05–7.17 (m, 3H, methoxyphenyl, fluorophenyl), 6.83–6.87 (m, 2H, fluorophenyl), 6.74 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 6.46 (s, 1H, CHN), 4.14–4.26 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.68 (s, 3H, OMe), 2.79–3.11 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 165.2, 156.05 (m, 2C), 136.7 (d, <i>J</i> = 2.5 Hz), 134.6, 134.5, 133.6, 129.2, 126.5, 123.7 (d, <i>J</i> = 8 Hz), 123.6, 123.2 (d, <i>J</i> = 15 Hz), 121.4, 115.9 (d, <i>J</i> = 24 Hz), 113.7, 55.1, 54.2, 37.6, 24.9. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 426.1288; found, 426.1279.</div></div><div id="sec4_1_1_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> <i>rac</i>-4-(4-Chlorophenyl)-<i>N</i>-(3-phenoxyphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>29</b>)</h5><div class="NLM_p last">Prepared analogously to <b>27</b>, from 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 3-phenoxyaniline (CAS-RN: [3586-12-7]). Yield 11.8 mg (4%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.74 (s, 1H, NH), 7.06–7.38 (m, 11H, diphenyl ether, thiophene, chlorophenyl), 6.93–7.00 (m, 2H, diphenyl ether), 6.78 (d, <i>J</i> = 5.27 Hz, 1H, thiophene), 6.54–6.62 (m, 1H, diphenyl ether), 6.47 (s, 1H, CHN), 4.14–4.27 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.77–3.07 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). MS (ESI): <i>m</i>/<i>z</i> = 461.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_1_30" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> <i>rac</i>-4-(4-Chlorophenyl)-<i>N</i>-[4-(4-fluorophenoxy)phenyl]-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carboxamide (<b>30</b>)</h5><div class="NLM_p last">Prepared analogously to <b>27</b>, from 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine and 4-(4-fluorophenoxy)aniline (CAS-RN: [36160-82-4]). Yield 55.4 mg (18%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.70 (s, 1H, NH), 7.41–7.46 (m, 2H, phenyl), 7.35–7.40 (m, 3H, thiophene, phenyl), 7.22 (d, <i>J</i> = 8.59 Hz, 2H, phenyl), 7.13–7.18 (m, 2H, phenyl), 6.93–6.99 (m, 2H, phenyl), 6.87–6.92 (m, 2H, phenyl), 6.80 (d, <i>J</i> = 5.05 Hz, 1H, thiophene), 6.50 (s, 1H, CHN), 4.18–4.28 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.80–3.08 (m, 3H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 157.9 (d, <i>J</i> = 239 Hz), 154.7, 153.7 (d, <i>J</i> = 2 Hz), 151.5, 140.8, 136.2, 134.9, 133.9, 132.2, 129.8, 128.4, 126.5, 123.8, 121.9, 119.7 (d, <i>J</i> = 8.5 Hz), 118.9, 116.5 (d, <i>J</i> = 23 Hz), 54.0, 38.0, 24.9. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 479.0996; found, 479.0991.</div></div><div id="sec4_1_1_31" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> <i>rac</i>-<i>N</i>-(3,5-Dimethoxyphenyl)-4-(4-methoxyphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridine-5(4<i>H</i>)-carbothioamide (<b>31</b>)</h5><div class="NLM_p last">Prepared analogously to <b>1</b>, from 4-(4-methoxyphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (<b>4</b>) and 1-isothiocyanato-3,5-dimethoxybenzene (CAS-RN: [104968-58-3]). Yield 94.8 mg (50%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 7.31–7.39 (m, <i>J</i> = 8.59 Hz, 2H, methoxyphenyl), 7.25 (s, 2H, dimethoxyphenyl), 7.15 (d, <i>J</i> = 5.31 Hz, 1H, thiophene), 6.84–6.90 (m, 2H, methoxyphenyl), 6.67 (d, <i>J</i> = 5.31 Hz, 1H, thiophene), 6.17–6.20 (m, 1H, dimethoxyphenyl), 6.14–6.15 (m, 2H, NH, CHN), 4.59 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.80 (s, 3H, OMe), 3.56–3.63 (s, 6H, OMe), 3.33–3.44 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.01–3.13 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.88 (dd, <i>J</i> = 3.16, 16.29 Hz, 1H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 181.0, 159.9, 158.9, 142.6, 134.4, 134.4, 132.7, 129.2, 126.5, 124.0, 113.8, 103.8, 96.9, 59.1, 55.2, 41.0, 24.9. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 441.1307; found, 441.1289.</div></div><div id="sec4_1_1_32" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> <i>rac</i>-2-(3,5-Dimethylphenyl)-1-[4-(4-methoxyphenyl)-6,7-dihydrothieno[3,2-<i>c</i>]pyridin-5(4<i>H</i>)-yl]ethan-1-one (<b>32</b>)</h5><div class="NLM_p last">A solution of 4-(4-methoxyphenyl)-4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine (<b>4</b>; 100 mg, 408 μmol), 3,5-dimethylphenylacetic acid (100 mg, 611 μmol; CAS-RN: [42288-46-0]), 1-hydroxy-1<i>H</i>-benzotriazole hydrate (62.4 mg, 408 μmol; CAS-RN: [123333-53-9]), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (78.1 mg, 408 μmol; CAS-RN: [25952-53-8]), and triethylamine (110 μL, 820 μmol) in DMSO (2.0 mL) was stirred at rt over the weekend. The reaction mixture was poured into water, extracted with EtOAc (3×), and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>. After removal of the volatiles under reduced pressure, the crude product (170 mg) was purified via HPLC. Yield 54.1 mg (34%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 7.23 (br d, <i>J</i> = 8.59 Hz, 2H, methoxyphenyl), 7.12 (d, <i>J</i> = 5.05 Hz, 1H, thiophene), 6.90 (s, 1H, dimethylphenyl), 6.78–6.87 (m, 5H, methoxyphenyl, dimethylphenyl, CHN), 6.62–6.74 (m, 1H, thiophene), 3.67–3.89 (m, 6H, OMe, C(O)CH<sub>2</sub>, CH<sub>2</sub>CH<sub>2</sub>), 3.18–3.30 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.59–2.83 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>), 2.24 (s, 6H, Me). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 169.2, 158.7, 137.3, 135.5, 134.3, 134.1, 133.3, 129.3, 127.9, 126.6, 126.4, 123.7, 113.6, 55.1, 52.4, 42.2, 40.5, 25.1, 20.9. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 392.1684; found, 392.1677.</div></div><div id="sec4_1_1_33" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> (5<i>S</i>)-5-(4-Chlorophenyl)-<i>N</i>-[4-(4-fluorophenoxy)phenyl]-7,8-dihydro-1,6-naphthyridine-6(5<i>H</i>)-carboxamide (<b>33</b>, BAY-298)</h5><div class="NLM_p last">Step 1: To a 1.0 M solution of 4-chlorophenylmagnesium bromide (<b>37</b>; 50 mL, 50 mmol) in diethylether was added THF (100 mL). Then, 4-methoxypyridine (<b>39</b>; 4.7 mL, 46 mmol) at −30 °C was added and the mixture was stirred for 30 min at −20 °C, cooled to −50 °C, and benzyl chloroformate (<b>38</b>; 7.8 mL, 55 mmol) was added. The reaction mixture was slowly warmed to −15 °C, ice (100 g) was added, and the mixture was stirred for 1 h. 5 M aq citric acid (100 mL) was added, and the mixture was stirred at rt for 30 min, then extracted with EtOAc (3×). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, and the volatiles were removed under reduced pressure. The crude material was crystallized from diisopropyl ether to obtain benzyl 2-(4-chlorophenyl)-4-oxo-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate. Yield 12.79 g (81%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.03 (dd, <i>J</i> = 1.13, 8.29 Hz, 1H, HC═CH), 7.25–7.39 (m, 7H, chlorophenyl, phenyl), 7.19 (d, <i>J</i> = 8.48 Hz, 2H, chlorophenyl), 5.70 (br d, <i>J</i> = 6.97 Hz, 1H, CHN), 5.27 (d, <i>J</i> = 8.29 Hz, 1H, HC═CH), 5.21 (d, <i>J</i> = 3.2 Hz, 2H, benzyl-CH<sub>2</sub>), 2.50–2.75 (m, 2H, CH<sub>2</sub>C(O)). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> = 342 [M + H]<sup>+</sup>. Step 2: A suspension of benzyl 2-(4-chlorophenyl)-4-oxo-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate (5.70 g, 16.7 mmol) and zinc (5.45 g, 83.4 mmol; CAS-RN: [7440-66-6]) in acetic acid (100 mL, 1.7 mol) was stirred at rt overnight. The reaction mixture was filtered and the filtrate was concentrated under reduced pressure. The residue was co-evaporated with MeOH (3×) to remove remaining acetic acid. Crude benzyl 2-(4-chlorophenyl)-4-oxopiperidine-1-carboxylate (<b>40</b>) was obtained in quantitative yield (6.08 g) and used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.12–7.41 (m, 9H, phenyl, chlorophenyl), 5.47 (br s, 1H, CHN), 5.00–5.16 (m, 2H, benzyl-CH<sub>2</sub>), 4.08 (m, 1H, CH<sub>2</sub>N), 3.35–3.52 (m, 1H, CH<sub>2</sub>N), 2.98 (dd, <i>J</i> = 6.82, 15.41 Hz, 1H, CH<sub>2</sub>C(O)), 2.80 (dd, <i>J</i> = 4.80, 15.41 Hz, 1H, CH<sub>2</sub>C(O)), 2.49–2.72 (m, 1H, CH<sub>2</sub>C(O)), 2.22–2.44 (m, 1H, CH<sub>2</sub>C(O)). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> = 344 [M + H]<sup>+</sup>. Step 3: A mixture of <b>40</b> (20.0 g, 58.2 mmol), prop-2-yn-1-amine (20 mL, 290 mmol), and sodium tetrachloroaurate dihydrate (2.31 g, 5.82 mmol) in EtOH (200 mL) was stirred at 80 °C for 4 h. The reaction mixture was filtered and the filtrate was concentrated under reduced pressure. The residue was purified via flash column chromatography (EtOAc/hexanes) to obtain benzyl 5-(4-chlorophenyl)-7,8-dihydro-1,6-naphthyridine-6(5<i>H</i>)-carboxylate (<b>41</b>) [as a mixture with the undesired regioisomer benzyl 7-(4-chlorophenyl)-7,8-dihydro-1,6-naphthyridine-6(5<i>H</i>)-carboxylate (<b>42</b>)]. Yield 5.96 g (27%). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> = 379 [M + H]<sup>+</sup>. Step 4: A mixture of <b>41</b> and its regioisomer <b>42</b> (5.96 g, 15.7 mmol) in TFA (60 mL, 780 mmol) was stirred at 50 °C overnight. The TFA was removed under reduced pressure and the residue was extracted with saturated NaHCO<sub>3</sub>/EtOAc (3×). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent was removed under reduced pressure. Crude <i>rac</i>-5-(4-chlorophenyl)-5,6,7,8-tetrahydro-1,6-naphthyridine (as a mixture with its regioisomer) was obtained in 76% yield (2.91 g) and used in the next step without further purification. MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> = 245 [M + H]<sup>+</sup>. Step 5: <b>33</b> was prepared analogously to <b>27</b>, from crude <i>rac</i>-5-(4-chlorophenyl)-5,6,7,8-tetrahydro-1,6-naphthyridine (as a mixture with its regioisomer) and 4-(4-fluorophenoxy)aniline. Yield 7.21 g (17%). HPLC separation of the two regioisomers (Waters Autopurification system: Pump 254, Sample Manager 2767, CFO, DAD 2996, ELSD 2424, SQD 3001; XBridge C18 5 μm, 100 mm × 30 mm column; solvent A: water + 0.2% ammonia, B: acetonitrile; gradient: 0–1 min 50% B, 1–8 min 50–80% B, 8–8.1 min 80–100% B, 8.1–10 min 100% B; flow rate: 50 mL/min): <sup><i>t</i></sup>R (min) = 5.9–6.1, 6.4–7.2. Yield ∼ 60%. Chiral HPLC separation of the enantiomers (system: Agilent Prep 1200, 2 × Prep Pump, DLA, MWD, Prep FC, ESA Corona; Chiralpak IB 5 μm, 250 mm × 20 mm column; eluent: hexanes/EtOH 80:20 + 0.1% diethylamine; flow rate: 20 mL/min): <sup><i>t</i></sup>R (min) = 7.3–8.3 (<i>R</i>)-(−)-enantiomer, 10.0–11.4 (<i>S</i>)-(+)-enantiomer. Yield: 39%. [α]<sub class="stack">D</sub><sup class="stack">20</sup> + 181.7 ± 0.45 (<i>c</i> 1, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.52 (dd, <i>J</i> = 1.39, 4.67 Hz, 1H, pyridine), 7.44 (dd, <i>J</i> = 1.14, 7.71 Hz, 1H, pyridine), 7.25–7.34 (m, 4H, phenyl), 7.15–7.23 (m, 3H, phenyl, pyridine), 6.88–7.04 (m, 6H, phenyl), 6.66 (s, 1H, NH), 6.51 (s, 1H, CHN), 3.78–3.91 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.52–3.68 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.16–3.29 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.01–3.13 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 157.8 (d, <i>J</i> = 239 Hz), 154.9, 154.6, 153.6, 151.5, 148.4, 141.3, 136.1, 132.1, 130.5, 129.9, 128.4, 121.8, 121.6, 119.6 (d, <i>J</i> = 9 Hz), 118.8, 116.4 (d, <i>J</i> = 23 Hz), 55.0, 38.1, 31.3. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 474.1385; found, 474.1380.</div></div><div id="sec4_1_1_34" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> (5<i>S</i>)-<i>N</i>-[4-(4-Fluorophenoxy)phenyl]-5-(4-fluorophenyl)-7,8-dihydro-1,6-naphthyridine-6(5<i>H</i>)-carboxamide (<b>34</b>)</h5><div class="NLM_p last">Step 1: Benzyl 2-(4-fluorophenyl)-4-oxo-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate was prepared analogously to <b>33</b> (step 1) from 4-fluorophenylmagnesiumbromide. Yield: 336 g (74%). <sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>) δ 8.03 (dd, <i>J</i> = 1.26, 8.34 Hz, 1H), 7.31 (br s, 4H), 7.10–7.27 (m, 5H), 5.70 (d, <i>J</i> = 6.82 Hz, 1H), 5.18–5.30 (m, 3H), 3.23 (dd, <i>J</i> = 7.33, 16.67 Hz, 1H), 2.59 (d, <i>J</i> = 16.67 Hz, 1H). Step 2: benzyl 2-(4-fluorophenyl)-4-oxopiperidine-1-carboxylate was prepared analogously to <b>33</b> (step 2) from benzyl 2-(4-fluorophenyl)-4-oxo-3,4-dihydropyridine-1(2<i>H</i>)-carboxylate. Yield: 360 g (96%). Step 3: Benzyl 5-(4-fluorophenyl)-7,8-dihydro-1,6-naphthyridine-6(5<i>H</i>)-carboxylate was prepared analogously to <b>33</b> (step 3). The mixture of the two regioisomers were separated via flash column chromatography (340 g SNAP column, eluent hexanes/ethyl acetate). Yield: 5.88 g (10%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (dd, <i>J</i> = 1.51, 4.71 Hz, 1H), 7.49 (br d, <i>J</i> = 7.54 Hz, 1H), 7.00-7.36 (m, 11H), 6.33 (br s, 1H), 5.04–5.19 (m, 2H), 3.96–4.15 (m, 1H), 3.09–3.30 (m, 1H), 2.83–3.03 (m, 2H). Step 4: <i>rac</i>-5-(4-fluorophenyl)-5,6,7,8-tetrahydro-1,6-naphthyridine was prepared analogous to <b>33</b> (step 4) from benzyl 5-(4-fluorophenyl)-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate (single regioisomer). Yield: 2.4 g (94%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25–8.32 (m, 1H), 6.93–7.30 (m, 6H), 4.98 (s, 1H), 2.90–3.23 (m, 4H), 2.68–2.90 (m, 1H). Step 5: (<i>rac</i>)-<i>N</i>-[4-(4-fluorophenoxy)phenyl]-5-(4-fluorophenyl)-7,8-dihydro-1,6-naphthyridine-6(5<i>H</i>)-carboxamide was prepared analogously to <b>27</b> from <i>rac</i>-5-(4-fluorophenyl)-5,6,7,8-tetrahydro-1,6-naphthyridine. Yield: 6.14 g (quant.). Step 6: The enantiomers were separated analogously to <b>33</b> (described in step 5). Yield: 2.4 g (39%). [α]<sub class="stack">D</sub><sup class="stack">20</sup> + 155.9 ± 0.17 (<i>c</i> 1, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.51 (dd, <i>J</i> = 1.26, 4.80 Hz, 1H, pyridine), 7.52 (d, <i>J</i> = 7.07 Hz, 1H, pyridine), 7.32–7.38 (m, 2H, phenyl), 7.18–7.29 (m, 3H, phenyl, pyridine), 6.89–7.03 (m, 8H, phenyl), 6.85 (s, 1H, NH), 6.70 (s, 1H, CHN), 3.97 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.47–3.74 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.23–3.47 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.10–3.21 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 161.4 (d, <i>J</i> = 244 Hz), 157.9 (d, <i>J</i> = 239 Hz), 154.9, 154.7, 153.7, 151.5, 148.3, 138.6, 138.5, 136.2, 130.8, 130.2 (d, <i>J</i> = 8.5 Hz), 121.9, 121.6, 119.7 (d, <i>J</i> = 8.5 Hz), 118.9, 116.5 (d, <i>J</i> = 23 Hz), 115.2 (d, <i>J</i> = 22 Hz), 54.9, 38.0, 31.4. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 458.1680; found, 458.1676.</div></div><div id="sec4_1_1_35" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> (5<i>S</i>)-<i>N</i>-[6-(4-Fluorophenoxy)pyridin-3-yl]-5-(4-fluorophenyl)-7,8-dihydro-1,6-naphthyridine-6(5<i>H</i>)-carboxamide (<b>35</b>)</h5><div class="NLM_p last">Step 1: (rac)-<i>N</i>-[6-(4-Fluorophenoxy)pyridin-3-yl]-5-(4-fluorophenyl)-7,8-dihydro-1,6-naphthyridine-6(5<i>H</i>)-carboxamide was prepared analogously to <b>27</b> from <i>rac</i>-5-(4-fluorophenyl)-5,6,7,8-tetrahydro-1,6-naphthyridine (described for the synthesis of <b>34</b>). Yield: 168 g (88%). Step 2: The enantiomers were separated analogously to <b>33</b> (described in step 5). Yield: 70 g (37%). [α]<sub class="stack">D</sub><sup class="stack">20</sup> + 195.2 ± 0.41 (<i>c</i> 1, CHCl<sub>3</sub>). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.82 (s, 1H, pyridine), 8.44 (dd, <i>J</i> = 1.51, 4.71 Hz, 1H, pyridine), 8.18 (d, <i>J</i> = 2.45 Hz, 1H, NH), 7.92 (dd, <i>J</i> = 2.83, 8.85 Hz, 1H, pyridine), 7.54 (dd, <i>J</i> = 1.22, 7.82 Hz, 1H, pyridine), 7.06–7.25 (m, 9H, pyridine, phenyl), 6.93 (d, <i>J</i> = 8.85 Hz, 1H, pyridine), 6.60 (s, 1H, CHN), 4.13 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.30–3.38 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 2.84–3.12 (m, 2H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 161.4 (d, <i>J</i> = 244 Hz), 158.7 (d), 158.2, 154.8, 154.7, 150.6, 148.4, 139.0, 138.4 (d, <i>J</i> = 3 Hz), 136.2, 133.0, 133.0, 130.7, 130.2 (d, <i>J</i> = 8.5 Hz), 122.5 (d, <i>J</i> = 8.5 Hz), 121.7, 116.2 (d, <i>J</i> = 23 Hz), 115.2 (d, <i>J</i> = 22 Hz), 111.1, 55.0, 38.0, 31.3. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 459.1633; found, 459.1625.</div></div><div id="sec4_1_1_36" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> (5<i>S</i>)-<i>N</i>-[2-(4-Fluorophenoxy)pyrimidin-5-yl]-5-(4-fluorophenyl)-7,8-dihydro-1,6-naphthyridine-6(5<i>H</i>)-carboxamide (<b>36</b>, BAY-899)</h5><div class="NLM_p last">Step 1: (rac)-<i>N</i>-[2-(4-Fluorophenoxy)pyrimidin-5-yl]-5-(4-fluorophenyl)-7,8-dihydro-1,6-naphthyridine-6(5<i>H</i>)-carboxamide was prepared analogously to <b>27</b> from <i>rac</i>-5-(4-fluorophenyl)-5,6,7,8-tetrahydro-1,6-naphthyridine (described for the synthesis of <b>34</b>). Yield: 3.38 g (77%). Step 2: The enantiomers were separated analogously to <b>33</b> (described in step 5). Yield: 1.2 g (27%). [α]<sub class="stack">D</sub><sup class="stack">20</sup> + 180.6 ± 0.13 (<i>c</i> 1, CHCl<sub>3</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ = 8.68 (s, 2H, pyrimidine), 8.50–8.55 (m, 1H, pyridine), 7.56 (m, 1H, pyridine), 6.98–7.32 (m, 10H, fluorophenyl, pyridine, NH), 6.72 (s, 1H, CHN), 4.04–4.13 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.53–3.63 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.33–3.40 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>), 3.16–3.22 (m, 1H, CH<sub>2</sub>CH<sub>2</sub>). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 160.2 (m, 3C), 154.7, 154.4, 151.5, 149.4, 148.4, 138.2 (d, <i>J</i> = 3 Hz), 136.2, 131.5, 130.6, 130.2 (d, <i>J</i> = 8.5 Hz), 123.3 (d, <i>J</i> = 8.5 Hz), 121.7, 116.3 (d, <i>J</i> = 23 Hz), 115.3 (d, <i>J</i> = 22 Hz), 55.1, 38.1, 31.3. HRMS (ESI, [M + H]<sup>+</sup>): calcd, 460.1585; found, 460.1580.</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Pharmacology</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> General Methods</h4><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Compound Logistics</h5><div class="NLM_p last">Small volume, ready-to-use microtiter test plates (Greiner Bio-One, Germany) were prepared in advance for all assays used in screening, hit confirmation, and compound characterization of the human LH, FSH, LGR7, and EP2 receptors as well as the membrane adenylate cyclase (mAC) activity assay. 1536-well screening plates received 50 nL of a 1 mM compound solution, whereas 384-well plates were supplied with 50 nL of test compounds (both in 100% DMSO) using a Hummingbird liquid handler (Digilab, MA). Negative and positive control wells, typically 16 wells in a 384-well plate or 64 wells in a 1536-well plate, received 50 nL of 100% DMSO only. A 10 μM compound concentration was used for screening purposes, followed by single concentration confirmation testing in duplicates at 25 and 5 μM. For the establishment of dose–response curves, compounds were typically tested in duplicates at up to 11 concentrations (e.g., 20 μM, 5.7 μM, 1.6 μM, 0.47 μM, 0.13 μM, 38 nM, 11 nM, 3.1 nM, 0.89 nM, 0.25 nM, and 0.073 nM). Compounds used in species specificity testing were always prepared fresh, starting from a 10 mM solution (in 100% DMSO), and initially diluted 1:10 in 100% DMSO to obtain a 1 mM stock solution. Next, 6 μL of this stock solution was transferred into 300 μL of phosphate-buffered saline (PBS) to generate a 20 μM test solution (in 2% DMSO) used as the starting point for serial dilutions prepared shortly after. A Tecan Freedom Evo instrument (Tecan, Germany) was used to transfer 60 μL thereof into a white, 96-well dilution plate (Thermo Fisher Scientific, Germany, Nunc, PP, #249944) containing 200 μL of PBS/2% DMSO already, to prepare first a 1:3.3 dilution followed by an additional nine alternating 1:3/1:3.3 dilution steps (i.e., 67 μL/60 μL), respectively, being transferred to the next well containing 200 μL of PBS/2% DMSO. A total of 10 serial dilutions were prepared containing a 2-fold concentration of test compound (i.e., 6.0 μM, 2.0 μM, 600 nM, 200 nM, 60 nM, 20 nM, 6.0 nM, 2.0 nM, 0.6 nM, and 0.2 nM). Finally, 5 μL thereof was transferred to a black, small volume, 384-well compound test plate (Greiner Bio-One, #784076) to be tested in quadruplicates (CyBi-Well vario, Analytik Jena, Germany). Negative and positive control wells received 5 μL of PBS/2% DMSO only. Standard deviations for IC<sub>50</sub> determinations by this protocol were typically in the range of 15–30%.</div></div><div id="sec4_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> Frozen Cell Assays<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></h5><div class="NLM_p last">All cell lines used were routinely monitored for the presence of mycoplasma and shown to be free of any contamination. Vials containing frozen cells expressing the appropriate receptor were removed from liquid nitrogen storage and rapidly thawed by placement into a 37 °C water bath. Immediately after thawing, the cells were transferred by gently decanting into a 50 mL Falcon tube containing preheated medium (see individual assay protocols for details). Any liquid remaining in the vials was gently rinsed with preheated medium and also transferred into the Falcon tube. Next, the cells were harvested by centrifugation for 5 min at 18.0<i>g</i> and the supernatant was removed by gentle decanting prior to the slow addition of preheated medium and resuspension of the pellet by mild swirling. A small aliquot was removed for cell counting, and the cells were diluted to the final cell number (see assay protocols). Finally, an aliquot of the fluorescent cAMP tracer (cAMP-d2) stock solution (prepared according to the manufacturer’s protocol) was added to achieve a 1:40 dilution step. The cells were used for seeding into assay plates either with or without an additional preincubation step necessary to achieve full functionality (see individual assay protocols for details). With the exception of the hTSH-R antagonism assay and the respective species specificity profiling (see detailed assay protocols below), all steps of the actual primary screening and also of the specific and unspecific off-target assays were performed at rt, and all solutions were added with a Multidrop dispenser (Thermo Labsystems).</div></div><div id="sec4_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> General cAMP HTRF Assay Principle</h5><div class="NLM_p last">Agonist-induced activation of the GPCRs used in cell-based primary screening (hLH-R), species specificity profiling (mLH-R, rLH-R), and specific (hFSH-R, hTSH-R) or unspecific off-target profiling (hRXFP1/LGR7, hEP2 receptor) results in the production of cAMP as is the case in a membrane-based assay using forskolin stimulation to detect unspecific inhibition of mACs. Following lysis of either cells or membranes, any cAMP present competes with the cAMP-d2 tracer for the binding to an europium cryptate-labeled anti-cAMP antibody (Cisbio International; HTRF cAMP assay; see individual assay protocols for details). The maximum signal resulting from time-resolved fluorescence resonance energy transfer (TR-FRET)<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21−23)</a> between the detection reagents is obtained in the absence of cellular cAMP. Any decrease in the TR-FRET signal is indicative of agonist-induced receptor or mAC activation, whereas antagonist activity results in a signal increase. Signal quantification is achieved by using an appropriate plate reader (PHERAstar, RUBYstar, ViewLux). Following excitation at 337 nm, any reduction of FRET-induced emissions at 665 nm is indicative of agonist-induced cAMP production. In addition, a second FRET signal at 620 nm, originating from the europium cryptate-labeled anti-cAMP antibody, is used for well internal referencing (well ratio, defined as signal 665 nm/signal 620 nm × 10 000).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Data Analysis</h4><div class="NLM_p last">Screening results were analyzed and both EC<sub>50</sub> and IC<sub>50</sub> values were calculated by four-parameter fitting using either a commercial software package (Genedata Screener, Switzerland) or proprietary software developed in-house.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Human LH-R Antagonism</h4><div class="NLM_p last">(Frozen cell assay, recovery time: ≤60 min, recovery medium: Ham’s F12 supplemented with 5% charcoal-treated serum). Typically, the reaction volume was 6 μL in white, small volume, 1536- or 384-well plates. Four microliters of the cell suspension containing 625 cells/μL (in Ham’s F12 supplemented with 5% charcoal-treated serum) was added to all wells of a ready-to-use test plate. Following preincubation for 20 min, 2 μL of a 3 × EC<sub>80</sub> hLH agonist solution (1.20 nM; always prepared fresh from a small aliquot of a 15 μM stock in water stored at −20 °C for further dilutions in Ham’s F12, 5% charcoal-treated serum, 2.25 mM 3-isobutyl-1-methylxanthine (IBMX); luteinizing hormone, human pituitary, iodination grade, Sigma-Aldrich, #869003, biological activity ≥5.0 IU/mg, ≈641.03 ng, purity ≥95%, contaminants: hFSH, hTSH ≤ 0.5%, hCG ≤ 0.05%) was added to the test compound and positive control wells (low controls, [C(0)]). The negative control wells (high controls, [C(i)]) received Ham’s F12, 5% charcoal-treated serum, and 0.75 mM IBMX only. Then, the plate was incubated for another 60 min in the presence of a 1 × EC<sub>80</sub> concentration of agonist (0.40 nM). The reaction was stopped by the addition of 2 μL of lysis buffer containing a 1:20 dilution of europium cryptate-labeled anti-cAMP antibody stock prepared according to the manufacturer’s protocol (cAMP-Gs femtomolar kit). Another 20 min later, the cell lysate-containing plate was transferred to a TR-FRET compatible reader to quantify the results.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Rat LH-R Antagonism</h4><div class="NLM_p last">(Frozen cell species specificity assay, recovery time: 60 min, recovery medium: PBS, 0.1% BSA, 0.2% glucose. A 1:40 dilution of the cAMP-d2 tracer (cAMP HiRange Kit, Cisbio, #62AM6PEJ) was added shortly before seeding). The reaction volume was 15 μL in 384-well plates. Five microliters of a rat ovary granulosa GLHR15 cell suspension stably expressing the rat LH-R<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> was seeded to all wells of the compound test plate (2500 cells/well, 500 cells/μL). Following preincubation for 30 min at 37 °C, 5 μL of a 3 × EC<sub>90</sub> hLH agonist solution (3.0 nM; Calbiochem, 869003; prepared fresh in PBS, 2.25 mM IBMX) was added to the test compound and positive control wells (low controls, [C(0)]). The negative control wells (high controls, [C(i)]) received PBS, 0.1% BSA, 0.2% glucose, and 0.75 mM IBMX only. Then, the plate was incubated for another 30 min at 37 °C in the presence of a 1 × EC<sub>90</sub> concentration of agonist (1.00 nM). The reaction was stopped by the addition of 5 μL of lysis buffer containing a 1:20 dilution of the europium cryptate-labeled anti-cAMP antibody stock prepared according to the manufacturer’s protocol (cAMP HiRange Kit, Cisbio, #62AM6PEJ). Another 60 min at rt later, the cell lysate-containing plate was transferred to a TR-FRET compatible reader to quantify the results.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Mouse LH-R Antagonism</h4><div class="NLM_p last">Mouse Leydig tumor MLTC-1 cells endogenously expressing the mouse LH-R<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> were obtained from routine culture (in RPMI-1640 medium, 10% FCS, 10 mM HEPES, 1 mM sodium pyruvate, 100 U/mL penicillin, 100 μg/mL streptomycin, 4 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 2.5 g/L glucose) by Accutase treatment and resuspended at 1000 cells/μL in PBS, 0.1% BSA, and 0.2% glucose to which a 1:40 dilution of the cAMP-d2 tracer (cAMP HiRange Kit, Cisbio, #62AM6PEJ) was added shortly before seeding. Five microliters (i.e., 5000 cells/well) was added to all wells of the compound test plate using a Multidrop Combi instrument (Thermo Fisher Scientific, Germany). Following preincubation for 30 min at 37 °C, 5 μL of a 3 × EC<sub>90</sub> hLH agonist solution (1.00 nM; Calbiochem, 869003; prepared fresh in PBS, 2.25 mM IBMX) was added to the test compound and positive control wells (low controls, [C(0)]). The negative control wells (high controls, [C(i)]) received PBS, 0.1% BSA, 0.2% glucose, and 0.75 mM IBMX only. Then, the plate was incubated for another 30 min at 37 °C in the presence of a 1 × EC<sub>90</sub> concentration of agonist (0.33 nM). The reaction was stopped by the addition 5 μL of lysis buffer containing a 1:20 dilution of the europium cryptate-labeled anti-cAMP antibody stock prepared according to the manufacturer’s protocol. Another 60 min at rt later, the cell lysate-containing plate was transferred to a TR-FRET compatible reader (PHERAstar Plus, BMG Labtech, Germany) to quantify the results.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Cynomolgus Monkey LH-R Antagonism</h4><div class="NLM_p last">HEK293 human embryonic kidney cells (ATCC CRL-1573) transiently expressing the cynomolgus monkey LH receptor (cLH-R) were prepared using a cationic liposome formulation. Plasmid DNA–lipid complexes were formed by dropwise addition of 2.5 mL of Opti-MEM medium containing 20 μL of an expression vector for cLH-R (pLHR-64 #1, kindly provided by Prof. Jörg Gromoll; 10 ng/μL) to a second vial containing 2.5 mL of Opti-MEM medium and 60 μL of Lipofectamine (Thermo Fisher Scientific, #11686-019), followed by an incubation for 45 min. HEK293 cells grown to 80% confluency in 162 cm<sup>2</sup> flasks were washed once with Opti-MEM medium prior to the addition of 15 mL of Opti-MEM medium followed by dropwise addition of 5 mL of Opti-MEM medium containing the DNA–lipid complexes. The cell supernatant was removed following incubation for 5 h at 37 °C, 7% CO<sub>2</sub>, and replaced by 20 mL of Dulbecco’s modified Eagle’s medium (DMEM) containing 5% charcoal-treated serum for overnight incubation at 37 °C, 7% CO<sub>2</sub>. The cells were harvested by Accutase treatment (Sigma-Aldrich, #A6964) the next day and used to prepare a cell suspension of 1000 cells/μL in PBS, 0.1% BSA, 0.2% glucose, 2.25 mM IBMX supplemented with a 1:40 dilution of cAMP-d2 solution prepared according to the manufacturer’s protocol. Five microliters of this cell suspension (i.e., 5000 cells/well) was added to all wells of the compound test plate using a Multidrop Combi instrument (Thermo Fisher Scientific, Germany). Following preincubation for 30 min at 37 °C, 5 μL of a 3 × EC<sub>80</sub> hLH agonist solution (3.00 nM; prepared fresh in PBS, 0.1% BSA, 0.2% glucose, 2.25 mM IBMX) was added to the test compound and positive control wells (low controls, [C(0)]). The negative control wells (high controls, [C(i)]) received PBS, 0.1% BSA, 0.2% glucose, and 2.25 mM IBMX only. Then, the plate was incubated for another 30 min at 37 °C in the presence of a 1 × EC<sub>80</sub> concentration of agonist (1.00 nM). The reaction was stopped by the addition of 5 μL of lysis buffer containing a 1:20 dilution of the europium cryptate-labeled anti-cAMP antibody stock prepared according to the manufacturer’s protocol. Another 90 min later, the cell lysate-containing plate was transferred to a TR-FRET compatible reader (PHERAstar Plus, BMG Labtech, Germany) to quantify the results.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Human FSH-R Antagonism</h4><div class="NLM_p last">(frozen cell selectivity assay, recovery time: 60 min, recovery medium: Ham’s F12 supplemented with 5% charcoal-treated serum). The reaction volume was 6 μL in white, small volume, 384-well plates. Four microliters of the cell suspension containing 625 cells/μL (in Ham’s F12 supplemented with 5% charcoal-treated serum) was added to all wells of a ready-to-use test plate. Following preincubation for 20 min, 2 μL of a 3 × EC<sub>80</sub> hFSH agonist solution (3.00 nM; prepared fresh in Ham’s F12 supplemented with 5% charcoal-treated serum, 2.25 mM IBMX) was added to the test compound and positive control wells (low controls, [C(0)]). The negative control wells (high controls, [C(i)]) received Ham’s F12, 5% charcoal-treated serum, and 0.75 mM IBMX only. Then, the plate was incubated for another 120 min in the presence of a 1 × EC<sub>80</sub> concentration of agonist (1.00 nM). The reaction was stopped by the addition of 2 μL of lysis buffer containing a 1:20 dilution of the europium cryptate-labeled anti-cAMP antibody stock prepared according to the manufacturer’s protocol (cAMP-Gs femtomolar kit). Another 20 min later, the cell lysate-containing plate was transferred to a TR-FRET compatible reader to quantify the results.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Human TSH-R Antagonism</h4><div class="NLM_p last">(frozen cell selectivity assay, recovery time: 60 min, recovery medium: PBS, 0.1% BSA, 0.2% glucose. A 1:40 dilution of the cAMP-d2 tracer was added shortly before seeding). The reaction volume was 15 μL in 384-well plates. Five microliters of a HTC-133wt-TSHr<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> cell suspension stably expressing the human TSH-R was seeded to all wells of the compound test plate (2500 cells/well, 500 cells/μL). Following preincubation for 30 min at 37 °C, 5 μL of a 3 × EC<sub>90</sub> hTSH agonist solution (3.0 nM; Calbiochem, 869006; prepared fresh in PBS, 2.25 mM IBMX) was added to the test compound and positive control wells (low controls, [C(0)]). The negative control wells (high controls, [C(i)]) received PBS, 0.1% BSA, 0.2% glucose, and 0.75 mM IBMX only. Then, the plate was incubated for another 30 min at 37 °C in the presence of a 1 × EC<sub>90</sub> concentration of agonist (1.00 nM). The reaction was stopped by the addition of 5 μL of lysis buffer containing a 1:20 dilution of the europium cryptate-labeled anti-cAMP antibody stock prepared according to the manufacturer’s protocol (cAMP HiRange Kit, Cisbio, #62AM6PEJ). Another 60 min at rt later, the cell lysate-containing plate was transferred to a TR-FRET compatible reader to quantify the results.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Antagonist Dose–Response Studies with Compound <b>33</b></h4><div class="NLM_p last">The effect of multiple, single agonist concentrations on the shift in antagonist potency was determined by antagonist dose–response studies using the antagonist dose–response curve obtained in the presence of 1 × EC<sub>80</sub> as control. A total of four different agonist concentrations were tested (i.e., 4 ×, 10 ×, 16 ×, and 100 × EC<sub>80</sub> of either hLH or the SMOL agonist Org 43553). Typically, the reaction volume was 6 μL in white, small volume, 384-well plates. Four microliters of the cell suspension containing 625 cells/μL (in Ham’s F12 supplemented with 5% charcoal-treated serum) was added to all wells of a ready-to-use test plate containing a 1:3.3 serial dilution of the antagonist (i.e., 17 μM, 5.5 μM, 1.8 μM, 610 nM, 200 nM, 68 nM, 23 nM, 7.5 nM, 2.5 nM, and 0.84 nM). Following preincubation for 20 min, 2 μL containing the given concentration of agonist was added to the test compound and positive control wells (low controls, [C(0)]). The negative control wells (high controls, [C(i)]) received Ham’s F12, 5% charcoal-treated serum, and 0.75 mM IBMX only. Then, the plate was incubated for another 60 min in the presence of agonist. The reaction was stopped by the addition of 2 μL of lysis buffer containing a 1:20 dilution of europium cryptate-labeled anti-cAMP antibody stock prepared according to the manufacturer’s protocol (cAMP-Gs femtomolar kit). Another 20 min later, the cell lysate-containing plate was transferred to a TR-FRET compatible reader to quantify the results.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> X-ray Structure Analysis of Compound <b>5</b></h4><div class="NLM_p">Data for <b>5</b> were collected at 100 K on a Bruker SMART 6000 system equipped with a CCD area detector and Cu X-ray radiation (Cu Kα, λ = 1.54178 Å). X-ray data collection and processing of data were performed using the SHELXTL package (SHELXTL Version 6.14, Bruker AXS Inc.: Madison, Wisconsin, 2012). SHELXM was used for structure solution and SHELXL was used for full-matrix least-squares refinement on <i>F</i><sup>2</sup>.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> All nonhydrogen atoms were refined anisotropically. All hydrogen atoms were placed in geometrically ideal positions using the riding model. The hydrogen atom attached at N11 was identified as a difference peak in the Fourier analysis and refined without restraints. The isotropic temperature factors of all hydrogen atoms were 1.2 and 1.5 times the size of the temperature factors of the corresponding heavy atoms. The program XP from SHELXTL Version 6.14 and Discovery Studio 2018 was used for all molecular representations (SHELXTL Version 6.14, Bruker AXS Inc.: Madison, Wisconsin, 2012; Dassault Systèmes BIOVIA, Discovery Studio, Version 18.1.100.18065, Dassault Systèmes: San Diego, 2017).</div><div class="NLM_p last">Colorless plates of <b>5</b> were obtained by slow evaporation of a 3:4 mixture of hexane/<i>n</i>-butanol solution of the compound at rt. A single crystal with dimensions 0.1 × 0.05 × 0.05 mm<sup>3</sup> was mounted on a CryoLoop using protective oil. One independent molecule of <b>5</b> crystallizes in the orthorhombic space group <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> (<i>Z</i> = 4) with cell constants <i>a</i> = 8.1494(13) Å, <i>b</i> = 10.0083(18) Å, <i>c</i> = 23.823(4) Å. The molecular formula is C<sub>22</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub>S with a molecular weight of 394.48 g/mol. A total of 13 444 reflections, of which 2250 are unique (<i>R</i><sub>int</sub> = 0.0637), were collected. The final <i>R</i> values were <i>R</i><sub>1</sub> = 0.0491, <i>I</i> > 2σ(<i>I</i>), and <i>w<i>R</i></i><sub>2</sub> = 0.1327 for all data. The goodness-of-fit of the data was 1.064. The absolute structure has been determined with a Flack parameter of 0.01(4).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The crystallographic data for <b>5</b> have been deposited with the Cambridge Crystallographic Data Centre (CCDC) with deposition code CCDC 1943802.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Physicochemical Assays</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Stability of Compounds in Solution (pH 10, 7, and 1, at 37 °C)</h4><div class="NLM_p last">Solution stability was determined by HPLC-UV.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Five microliters of a 10 mM solution of compound in DMSO was dissolved in 1 mL of acetonitrile. One hundred microliters of this solution was transferred to 1 mL of the respective buffer and mixed thoroughly. Injections were made immediately after mixing for time zero injection and then again after 1, 2, and 24 h. Compounds were incubated at 37 °C. Degradation rate (recovery in %) was calculated by relating the peak areas after 1, 2, and 24 h to the time zero injection.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Aqueous Solubility of Compounds in DMSO Solutions</h4><div class="NLM_p last">Aqueous solubility at pH 6.5 was determined by an orientating HTS method.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Test compounds were applied as 1 mM DMSO solutions. After addition of buffer pH 6.5, solutions were shaken for 24 h at rt. Undissolved material was removed by filtration. The compound dissolved in the filtrate was quantified by HPLC-MS/MS.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Log D Measurement</h4><div class="NLM_p last">Log D values at pH 7.5 were recorded using an indirect method for determining hydrophobicity constants by reversed-phase HPLC.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> A homologous series of <i>n</i>-alkan-2-ones (C<sub>3</sub>–C<sub>16</sub>, 0.02 M in acetonitrile) was used for calibration. Test compounds were applied as 0.67 mM DMSO stock solutions in acetonitrile/water (1:1). The lipophilicity of compounds was then assessed by comparison to the calibration curve.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Pharmacokinetic Assays</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Caco-2 Permeability Assay</h4><div class="NLM_p last">Caco-2 cells (purchased from DSMZ Braunschweig, Germany) were seeded at a density of 4.5 × 10<sup>4</sup> cells/well on 24-well insert plates, 0.4 μm pore size, and grown for 15 days in DMEM supplemented with 10% FCS, 1% GlutaMAX (100 ×, Gibco), 100 U/mL penicillin, 100 μg/mL streptomycin (Gibco), and 1% nonessential amino acids (100×). The cells were maintained at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere. The medium was changed every 2–3 days. Before the permeation assay was run, the culture medium was replaced by FCS-free HEPES carbonate transport buffer (pH 7.2). For the assessment of monolayer integrity, the transepithelial electrical resistance was measured. Test compounds were predissolved in DMSO and added either to the apical or basolateral compartment at a final concentration of 2 μM. Before and after incubation for 2 h at 37 °C, samples were taken from both compartments and analyzed by LC-MS/MS after precipitation with MeOH. Permeability (<i>P</i><sub>app</sub>) was calculated in the apical to basolateral (A → B) and basolateral to apical (B → A) directions. The apparent permeability was calculated using the following equation: <i>P</i><sub>app</sub> = (<i>V</i><sub>r</sub>/<i>P</i><sub>0</sub>)(1/<i>S</i>)(<i>P</i><sub>2</sub>/<i>t</i>), where <i>V</i><sub>r</sub> is the volume of medium in the receiver chamber, <i>P</i><sub>0</sub> is the measured peak area of the test drug in the donor chamber at <i>t</i> = 0, <i>S</i> is the surface area of the monolayer, <i>P</i><sub>2</sub> is the measured peak area of the test drug in the acceptor chamber after incubation for 2 h, and <i>t</i> is the incubation time. The efflux ratio basolateral (B) to apical (A) was calculated as <i>P</i><sub>app</sub> B–A/<i>P</i><sub>app</sub> A–B. In addition, the compound recovery was calculated. As an assay control, reference compounds were analyzed in parallel.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> In Vitro Metabolic Stability in Human Liver Microsomes</h4><div class="NLM_p last">The in vitro metabolic stability of test compounds was determined by incubation at 1 μM with a suspension of liver microsomes (purchased from Xenotech) in 100 mM phosphate buffer, pH 7.4 (NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O + Na<sub>2</sub>HPO<sub>4</sub>·2H<sub>2</sub>O) at a protein concentration of 0.5 mg/mL at 37 °C. The microsomes were activated by adding a cofactor mix containing 8 mM glucose-6-phosphate (G6P), 4 mM MgCl<sub>2</sub>, 0.5 mM NADP, and 1 IU/mL G6P dehydrogenase in phosphate buffer (pH 7.4). The metabolic assay was started shortly afterward by adding the test compound to the incubation at a final volume of 1 mL. Organic solvent in the incubations was limited to ≤0.01% DMSO and ≤1% acetonitrile. During incubation, the microsomal suspensions were continuously shaken at 580 rpm and aliquots were taken at 2, 8, 16, 30, 45, and 60 min, to which an equal volume of cold MeOH was immediately added. Samples were frozen at −20 °C overnight, subsequently centrifuged for 15 min at 3000 rpm, and the supernatant was analyzed with an Agilent 1200 HPLC system with LC-MS/MS detection. The half-life of a test compound was determined from the concentration–time plot. From the half-life, the intrinsic clearance was calculated. Together with the additional parameters liver blood flow, specific liver weight, and microsomal protein content, the hepatic in vivo blood clearance (CL) and the maximal oral bioavailability (<i>F</i><sub>max</sub>) were calculated using the “well-stirred” liver model. The following parameter values were used: liver blood flow, 1.32 L/(h kg); specific liver weight, 21 g/kg body weight; microsomal protein content, 40 mg/g. For classification of the results, the following criteria were used: <i>F</i><sub>max</sub> > 70% (=CL < 0.4 L/(h kg)) was classified as high metabolic stability (high), <i>F</i><sub>max</sub> = 30–70% (CL 0.4–0.9 L/(h kg)) as moderate stability, and <i>F</i><sub>max</sub> < 30% (CL > 0.9 L/(h kg)) as low metabolic stability</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> In Vitro Metabolic Stability in Rat Liver Microsomes</h4><div class="NLM_p last">The in vitro metabolic stability of test compounds was determined by incubation at 1 μM with a suspension of liver microsomes (purchased from Xenotech) in 100 mM phosphate buffer, pH 7.4 (NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O + Na<sub>2</sub>HPO<sub>4</sub>·2H<sub>2</sub>O), and at a protein concentration of 0.5 mg/mL at 37 °C. The microsomes were activated by adding a cofactor mix containing 8 mM G6P, 4 mM MgCl<sub>2</sub>, 0.5 mM NADP, and 1 IU/mL G6P dehydrogenase in phosphate buffer (pH 7.4). The metabolic assay was started shortly afterward by adding the test compound to the incubation at a final volume of 1 mL. Organic solvent in the incubations was limited to ≤ 0.01% DMSO and ≤ 1% acetonitrile. During incubation, the microsomal suspensions were continuously shaken at 580 rpm and aliquots were taken at 2, 8, 16, 30, 45, and 60 min, to which an equal volume of cold MeOH was immediately added. Samples were frozen at −20 °C overnight, subsequently centrifuged for 15 min at 3000 rpm, and the supernatant was analyzed with an Agilent 1200 HPLC system with LC-MS/MS detection. The half-life of a test compound was determined from the concentration–time plot. From the half-life, the intrinsic clearance was calculated. Together with the additional parameters liver blood flow, specific liver weight, and microsomal protein content, the hepatic in vivo blood clearance (CL) and the maximal oral bioavailability (<i>F</i><sub>max</sub>) were calculated using the well-stirred liver model. The following parameter values were used: liver blood flow, 4.2 L/(h kg); specific liver weight, 32 g/kg rat body weight; microsomal protein content, 40 mg/g.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> In Vitro Metabolic Stability in Rat Hepatocytes</h4><div class="NLM_p last">Hepatocytes from Han Wistar rats (purchased from Harlan, NL) were isolated via a two-step perfusion method. After perfusion, the liver was carefully removed from the rat, the liver capsule was opened, and the hepatocytes were gently shaken out into a Petri dish with ice-cold Williams’ medium E (WME). The resulting cell suspension was filtered through sterile gauze into 50 mL Falcon tubes and centrifuged at 50<i>g</i> for 3 min at rt. The cell pellet was resuspended in 30 mL of WME and centrifuged through a Percoll gradient two times at 100<i>g</i>. The hepatocytes were washed again with WME and resuspended in a medium containing 5% FCS. Cell viability was determined by trypan blue exclusion. For the metabolic stability assay, liver cells were distributed in WME containing 5% FCS to glass vials at a density of 1.0 × 10<sup>6</sup> vital cells/mL. The test compound was added at a final concentration of 1 μM. During incubation, the hepatocyte suspensions were continuously shaken at 580 rpm and aliquots were taken at 2, 8, 16, 30, 45, and 90 min, to which an equal volume of cold MeOH was immediately added. Samples were frozen at −20 °C overnight, subsequently centrifuged for 15 min at 3000 rpm, and the supernatant was analyzed with an Agilent 1200 HPLC system with LC-MS/MS detection. The half-life of a test compound was determined from the concentration–time plot. From the half-life, the intrinsic clearance was calculated using the well-stirred liver model together with the additional parameters liver blood flow and amount of liver cells in vivo and in vitro. The hepatic in vivo blood clearance (CL) and the maximal oral bioavailability (<i>F</i><sub>max</sub>) were calculated. The following parameter were used: liver blood flow, 4.2 L/(h kg) rat; specific liver weight, 32 g/kg rat body weight; liver cells in vivo, 1.1 × 10<sup>8</sup> cells/g liver; liver cells in vitro, 1.0 × 10<sup>6</sup>/mL.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Inhibition of CYP450 Metabolism</h4><div class="NLM_p last">The inhibitory potency of test compounds toward cytochrome P450-dependent metabolic pathways was determined in human liver microsomes (purchased from Xenotech) by applying individual CYP isoform selective standard probes (CYP1A2, phenacetin; CYP2C8, amodiaquine; CYP2C9, diclofenac; CYP2D6, dextromethorphan; CYP3A4, midazolam). Reference inhibitors were included as positive controls. Incubation conditions (protein and substrate concentration, incubation time) were optimized with regard to linearity of metabolite formation. Assays were processed in 96-well plates at 37 °C using a Genesis Workstation (Tecan, Crailsheim, Germany). After protein precipitation, metabolite formation was quantified by LC-MS/MS analysis, which was followed by inhibition evaluation and IC<sub>50</sub> calculation.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Binding to Plasma Proteins</h3><div class="NLM_p">The binding of test compounds to plasma proteins was measured using the method reported by Schuhmacher et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> In Vivo Pharmacokinetics in Rats</h4><div class="NLM_p">All animal studies were conducted in accordance with the German Animal Welfare Act and the ethical guidelines of Bayer AG and were approved by the local ethics committee. Female and male Wistar rats were obtained from Charles River (Germany) and had access to food and water ad libitum. All animals were housed according to institutional guidelines under a 12/12 h light/dark cycle and maintained under standard conditions (20–22 °C, 50–70% humidity). The rats were housed in Makrolon cages type IV, five animals per cage, fed a pelleted diet (Ssniff, Germany), and used for in vivo studies with a weight of 200–230 g (average, 220 g).</div><div class="NLM_p last">For in vivo pharmacokinetic experiments, test compounds were administered to female Wistar rats intravenously at a dose of 0.5 mg/kg and po at a dose of 2.0 mg/kg formulated as solutions using solubilizers such as PEG400 and EtOH in well-tolerated amounts. Blood samples were collected, for example, at 2 min (iv only), 8 min, 15 min, 30 min, 45 min, 1 h, 2 h, 4 h, 6 h, 8 h, 12 h, 14 h, 18 h, 24 h, 48 h, and 72 h after dosing from the vena jugularis into lithium heparin tubes (Monovette, Sarstedt) and centrifuged for 15 min at 3000 rpm. An aliquot of 100 μL from the supernatant (plasma) was taken and precipitated by the addition of 400 μL of cold acetonitrile. Samples were frozen at −20 °C overnight and subsequently thawed and centrifuged at 3000 rpm and 4 °C for 20 min. Aliquots of the supernatant were analyzed with an Agilent HPLC system with LC-MS/MS detection. Pharmacokinetic parameters were calculated by noncompartmental analysis using pharmacokinetics calculation software (e.g., Phoenix WinNonlin, Certara USA, Inc.).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Automated hERG K<sup>+</sup> Current Voltage-Clamp Safety Assay</h4><div class="NLM_p last">The hERG K<sup>+</sup> current assay is based on a recombinant HEK293 cell line with stable expression of the <i>KCNH2</i> (<i>HERG</i>) gene.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The cells were cultured using a humidified incubator (37 °C, 5% CO<sub>2</sub>) and a standard culture medium (MEM with Earle’s salts and <span class="smallcaps smallerCapital">l</span>-glutamine, 10% noninactivated FCS, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, penicillin/streptomycin (50 μg/mL each), 0.4 mg/mL Geneticin). About 0.5–8 h following cell dissociation, the cells were investigated by means of the “whole-cell voltage-clamp” technique<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> in an automated eight-channel system (Patchliner; Nanion Technologies, Munich, Germany) with PatchControlHT software (Nanion) to control the Patchliner system and to handle data acquisition and analysis. Voltage-clamp control was provided by two EPC 10 Quadro amplifiers under control of the PatchMaster Pro software (both: HEKA Elektronik, Lambrecht, Germany) and with NPC-16 medium resistance (∼2 MΩ) chips (Nanion) serving as planar substrate at rt (22–24 °C). NPC-16 chips were filled with intra- and extracellular solution (intracellular solution: 10 mM NaCl, 50 mM KCl, 60 mM KF, 20 mM EGTA, 10 mM HEPES, pH 7.2 (KOH); extracellular solution: 140 mM NaCl, 4 mM KCl, 2 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 5 mM glucose, 10 mM HEPES, pH 7.4 (NaOH)) and with cell suspension. After formation of a GΩ seal and entering whole-cell mode (including several automated quality control steps), the cell membrane was clamped to the holding potential (−80 mV). Following an activating clamp step (+20 mV, 1000 ms), exclusively hERG-mediated inward tail currents were elicited by hyperpolarizing voltage steps from +20 to −120 mV (duration 500 ms); this clamp protocol was repeated every 12 s.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> After an initial stabilization phase (5–6 min), test compounds were added either as a single concentration (10 μM) or in ascending concentrations (0.1, 1, and 10 μM; 5–6 min per concentration), followed by several washout steps. Effects of test compounds were quantified by analyzing the amplitude of the hERG-mediated inward tail currents (in % of predrug control) as a function of test compound concentration (Igor Pro Software). Mean concentration–response data were fitted with a standard sigmoidal four-parameter logistic equation of the form: <i>Y</i> = Bottom + (Top – Bottom)/(1 + 10<sup>∧</sup>((log IC<sub>50</sub> – <i>X</i>) × HillSlope)), where <i>Y</i> is the current inhibition (in % of predrug control), <i>X</i> is the logarithm of drug concentration, and IC<sub>50</sub> is the drug concentration producing half-maximal current inhibition, and using the following constraints: Top = 100%, Bottom = 0%. No curve fitting was performed in cases with an obvious lack of a concentration-dependent current inhibition and/or a too small effect size (ca. ≤20%).</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Gene Expression</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Preparation of Total RNA</h4><div class="NLM_p last">Frozen whole left and right ovaries of each animal were homogenized together in 0.8 mL of RLT buffer (QIAGEN) using a Precellys24 homogenizer (2.8 mm ceramic beads, 2 × 30 s, 6000 rpm, 20 s break). Isolation of total RNA from 0.4 mL of homogenate was performed using a QIAsymphony automat (QIAGEN). Isolated RNA was digested by DNase I (amplification grade, Invitrogen).</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Real-Time Quantitative PCR</h3><div class="NLM_p">Five microliters (2–5 μg) of DNase I digested RNA was transcribed into cDNA using SuperScript III reverse transcriptase and 50 ng of random hexamer primers (SuperScript III First-Strand Synthesis System, Invitrogen). For relative quantification of mRNA levels, TaqMan PCR was carried out with an SDS 7900HT Sequence Detection System (Applied Biosystems). PCRs were performed with 0.8 μL (50–200 ng) of cDNA using Platinum Quantitative PCR SuperMix-UDG (Invitrogen) under standard reaction conditions. The following available TaqMan Gene Expression Assays (Applied Biosystems) were used: COX-2 (Ptgs2) (Assay ID: Rn00568225_m1), Egr-1 (Assay ID: Rn00561138_m1), RUNX-1 (Assay ID: Rn00569082_m1), Cyp19A1 (aromatase) (Assay ID: Rn01422547_m1), PPIA (cyclophilin A) (Assay ID: Rn00690933_m1). Relative mRNA levels were calculated by the comparative ΔCT method. Therefore, cyclophilin A (PPIA) was used as endogenous control and the vehicle group was used as calibrator.</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Measurement of Hormone Concentrations</h4><div class="NLM_p last">Plasma estradiol, progesterone, and testosterone were measured by specific radioimmunoassay methods according to the manufacturer’s instructions (Diagnostic Systems Laboratories, Inc.) as described previously.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> Reagents were provided by the World Health Organization under the Programme for the Provision of Matched Assay Reagents for the Radioimmunoassay of Hormones in Reproductive Physiology.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Animal Treatments</h4><div class="NLM_p">For short-term experiments, female and male rats were treated with the GnRH antagonist cetrorelix acetate in isotonic Ringer’s solution supplemented with 0.1% BSA (Ringer/0.1% BSA), twice: at 17 and 1 h before the experiment (100 mg/rat in 0.1 mL; IM and sc, respectively). Rats were injected with 0.5 μg (female rats) and 0.3 or 0.1 μg (male rats) of hLH in Ringer/0.1% BSA, with a volume of 0.5 mL iv, with or without <b>33</b> (BAY-298, 1-6 mg/animal, average animal weight were 220 g). Autopsy for ovarian analysis was performed after 4 h, and blood samples taken after 2 h for testosterone measurements.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p last">Compound <b>33</b> (BAY-298) or <b>36</b> (BAY-899) was dissolved for q.d. po application of a final volume of 0.5 mL in Myrj53 (Polyoxyl 50 stearate, CAS-RN: [9004-99-3]) in 0.9% w/v NaCl solution (85 mg/100 mL) to achieve the different daily doses. Four to five animals were used per group in long-term experiments for 8 days in normally cycling female rats. Female rats were cycle-staged by vaginal smears<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and treatment started in estrus.</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Statistical Analysis</h4><div class="NLM_p last">Results are expressed as mean + standard deviation, and <i>n</i> represents the number of animals. Statistical significance of differences was tested by one-way analysis of variance (multiple comparisons vs control group) with post hoc Dunnett’s method (<i>p</i> < 0.05).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01382" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01382" class="ext-link">10.1021/acs.jmedchem.9b01382</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Identification of SMOL hLH-R antagonists and summary of the results of HTS; assays used in early screening hit characterization and off-target profiling; GPCR selectivity panel data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01382/suppl_file/jm9b01382_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formular strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01382/suppl_file/jm9b01382_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01382/suppl_file/jm9b01382_si_001.pdf">jm9b01382_si_001.pdf (164.42 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01382/suppl_file/jm9b01382_si_002.csv">jm9b01382_si_002.csv (2.77 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01382" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04150" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04150" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lars Wortmann</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6514-947X" title="Orcid link">http://orcid.org/0000-0001-6514-947X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2d614c5f5e037a425f59404c43436d4f4c54485f034e4240"><span class="__cf_email__" data-cfemail="a7ebc6d5d489f0c8d5d3cac6c9c9e7c5c6dec2d589c4c8ca">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernhard Lindenthal</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#216344534f494053450f6d484f45444f5549404d6143405844530f424e4c"><span class="__cf_email__" data-cfemail="6c2e091e02040d1e084220050208090218040d002c0e0d15091e420f0301">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Muhn</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander Walter</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reinhard Nubbemeyer</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dieter Heldmann</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lothar Sobek</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federica Morandi</span> - <span class="hlFld-Affiliation affiliation">Leibniz Forschungsinstitut für
Molekulare Pharmakologie (FMP), Robert-Rössle Strasse 10, Campus Berlin-Buch, 13125 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna K. Schrey</span> - <span class="hlFld-Affiliation affiliation">Leibniz Forschungsinstitut für
Molekulare Pharmakologie (FMP), Robert-Rössle Strasse 10, Campus Berlin-Buch, 13125 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dieter Moosmayer</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judith Günther</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joachim Kuhnke</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcus Koppitz</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulrich Lücking</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulrike Röhn</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martina Schäfer</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katrin Nowak-Reppel</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronald Kühne</span> - <span class="hlFld-Affiliation affiliation">Leibniz Forschungsinstitut für
Molekulare Pharmakologie (FMP), Robert-Rössle Strasse 10, Campus Berlin-Buch, 13125 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hilmar Weinmann</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gernot Langer</span> - <span class="hlFld-Affiliation affiliation">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written with contributions from all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): L.W., B. L., P. M., A. W., R. N., D. H., L. S., D. M., J. G., J. K., M. K., U. L., U. R., M. S., K. N.-R., H. W., and G. L. are or have been employees and stockholders of Bayer Aktiengesellschaft. F. M., A. K. S., and R. K. are or have been employees of Leibniz Forschungsinstitut fr Molekulare Pharmakologie (FMP).<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5511-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26551" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26551" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to thank Prof. Jörg Gromoll (University of Münster) for providing the plasmid for the cynomolgus monkey LH receptor, Steffen Borden for performing competition experiments, and Kay Greenfield and Ingo Hartung for proofreading the manuscript. They also thank Marco Sommer and Kai Steger (Lead Discovery Berlin, Screening Cell Biology), as well as Manfred Schreiber and Alexandra Goericke (Medicinal Chemistry), and Lam Cam, Manuela Grützner, Mario Klewer, Adelheid Engelhaupt, Elisabeth Krahl, and Oliver Gernetzki (Gynecological Therapies, Berlin), for excellent technical assistance throughout the whole project.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">HPG</td><td class="NLM_def"><p class="first last">hypothalamic–pituitary–gonadal</p></td></tr><tr><td class="NLM_term">7TMR</td><td class="NLM_def"><p class="first last">7-transmembrane region</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">mAC</td><td class="NLM_def"><p class="first last">membrane adenylate cyclase</p></td></tr><tr><td class="NLM_term">IBMX</td><td class="NLM_def"><p class="first last">3-isobutyl-1-methylxanthine</p></td></tr><tr><td class="NLM_term">SMOL</td><td class="NLM_def"><p class="first last">small molecule</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i96">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27334" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27334" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 57 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dagklis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravanos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makedou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kourtis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousso, D.</span></span> <span> </span><span class="NLM_article-title">Common features and differences of the hypothalamic–pituitary–gonadal axis in male and female</span>. <i>Gynecol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.3109/09513590.2014.959917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.3109%2F09513590.2014.959917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=25222843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFSns7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2015&pages=14-17&author=T.+Dagklisauthor=K.+Ravanosauthor=K.+Makedouauthor=A.+Kourtisauthor=D.+Rousso&title=Common+features+and+differences+of+the+hypothalamic%E2%80%93pituitary%E2%80%93gonadal+axis+in+male+and+female&doi=10.3109%2F09513590.2014.959917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Common features and differences of the hypothalamic-pituitary-gonadal axis in male and female</span></div><div class="casAuthors">Dagklis, Themistoklis; Ravanos, Kostas; Makedou, Kali; Kourtis, Anargyros; Rousso, David</div><div class="citationInfo"><span class="NLM_cas:title">Gynecological Endocrinology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-17</span>CODEN:
                <span class="NLM_cas:coden">GYENER</span>;
        ISSN:<span class="NLM_cas:issn">0951-3590</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Male and female reproductive axis, comprised of hypothalamus, pituitary and gonads, present common features and differences, discussed in this review.  These include the way hypothalamus regulates pituitary function, and the way pituitary, in turn, affects gonadal function.  Finally, age plays an important role in axis regulation, in both genders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJDqPDtxn-97Vg90H21EOLACvtfcHk0lhyI6h-OmJACQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFSns7rI&md5=22793920168c17a2368a5b517b46ac04</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3109%2F09513590.2014.959917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F09513590.2014.959917%26sid%3Dliteratum%253Aachs%26aulast%3DDagklis%26aufirst%3DT.%26aulast%3DRavanos%26aufirst%3DK.%26aulast%3DMakedou%26aufirst%3DK.%26aulast%3DKourtis%26aufirst%3DA.%26aulast%3DRousso%26aufirst%3DD.%26atitle%3DCommon%2520features%2520and%2520differences%2520of%2520the%2520hypothalamic%25E2%2580%2593pituitary%25E2%2580%2593gonadal%2520axis%2520in%2520male%2520and%2520female%26jtitle%3DGynecol.%2520Endocrinol.%26date%3D2015%26volume%3D31%26spage%3D14%26epage%3D17%26doi%3D10.3109%2F09513590.2014.959917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeydabadi Nejad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramezani Tehrani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zadeh-Vakili, A.</span></span> <span> </span><span class="NLM_article-title">The role of kisspeptin in female reproduction</span>. <i>Int. J. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>, <span class="NLM_elocation-id">e44337</span> <span class="refDoi"> DOI: 10.5812/ijem.44337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.5812%2Fijem.44337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=29201072" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&author=S.+Zeydabadi+Nejadauthor=F.+Ramezani+Tehraniauthor=A.+Zadeh-Vakili&title=The+role+of+kisspeptin+in+female+reproduction&doi=10.5812%2Fijem.44337"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.5812%2Fijem.44337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5812%252Fijem.44337%26sid%3Dliteratum%253Aachs%26aulast%3DZeydabadi%2BNejad%26aufirst%3DS.%26aulast%3DRamezani%2BTehrani%26aufirst%3DF.%26aulast%3DZadeh-Vakili%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%2520kisspeptin%2520in%2520female%2520reproduction%26jtitle%3DInt.%2520J.%2520Endocrinol.%2520Metab.%26date%3D2017%26volume%3D15%26doi%3D10.5812%2Fijem.44337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaprara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huhtaniemi, I. T.</span></span> <span> </span><span class="NLM_article-title">The hypothalamus-pituitary-gonad axis: tales of mice and men</span>. <i>Metabolism</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.metabol.2017.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2Fj.metabol.2017.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=29223677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFKkur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2018&pages=3-17&author=A.+Kapraraauthor=I.+T.+Huhtaniemi&title=The+hypothalamus-pituitary-gonad+axis%3A+tales+of+mice+and+men&doi=10.1016%2Fj.metabol.2017.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The hypothalamus-pituitary-gonad axis: Tales of mice and men</span></div><div class="casAuthors">Kaprara, Athina; Huhtaniemi, Ilpo T.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3-17</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Reprodn. is controlled by the hypothalamic-pituitary-gonadal (HPG) axis.  Gonadotropin-releasing hormone (GnRH) neurons play a central role in this axis through prodn. of GnRH, which binds to a membrane receptor on pituitary gonadotrophs and stimulates the biosynthesis and secretion of FSH (FSH) and LH (LH).  Multiple factors affect GnRH neuron migration, GnRH gene expression, GnRH pulse generator, GnRH secretion, GnRH receptor expression, and gonadotropin synthesis and release.  Among them anosmin is involved in the guidance of the GnRH neuron migration, and a loss-of-function mutation in its gene leads to a failure of their migration from the olfactory placode to the hypothalamus, with consequent anosmic hypogonadotropic hypogonadism (Kallmann syndrome).  There are also cases of hypogonadotropic hypogonadim with normal sense of smell, due to mutations of other genes.  Another protein, kisspeptin plays a crucial role in the regulation of GnRH pulse generator and the pubertal development.  GnRH is the main hypothalamic regulator of the release of gonadotropins.  Finally, FSH and LH are the essential hormonal regulators of testicular functions, acting through their receptors in Sertoli and Leydig cells, resp.  The main features of the male HPG axis will be described in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxncetfMXZ4bVg90H21EOLACvtfcHk0lhZLkewFPUeKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFKkur8%253D&md5=f79d08e2301eedcee1960228566d4b6b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2017.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2017.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DKaprara%26aufirst%3DA.%26aulast%3DHuhtaniemi%26aufirst%3DI.%2BT.%26atitle%3DThe%2520hypothalamus-pituitary-gonad%2520axis%253A%2520tales%2520of%2520mice%2520and%2520men%26jtitle%3DMetabolism%26date%3D2018%26volume%3D86%26spage%3D3%26epage%3D17%26doi%3D10.1016%2Fj.metabol.2017.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponnusamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers</span>. <i>Endocr. Connect</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">R10</span>– <span class="NLM_lpage">R26</span>, <span class="refDoi"> DOI: 10.1530/EC-18-0425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1530%2FEC-18-0425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=30640710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1CgtLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=R10-R26&author=M.+Ulmauthor=A.+V.+Rameshauthor=K.+M.+McNamaraauthor=S.+Ponnusamyauthor=H.+Sasanoauthor=R.+Narayanan&title=Therapeutic+advances+in+hormone-dependent+cancers%3A+focus+on+prostate%2C+breast+and+ovarian+cancers&doi=10.1530%2FEC-18-0425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers</span></div><div class="casAuthors">Ulm, Michael; Ramesh, Arvind V.; McNamara, Keely M.; Ponnusamy, Suriyan; Sasano, Hironobu; Narayanan, Ramesh</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Connections</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">R10-R26</span>CODEN:
                <span class="NLM_cas:coden">ECNOCX</span>;
        ISSN:<span class="NLM_cas:issn">2049-3614</span>.
    
            (<span class="NLM_cas:orgname">Bioscientifica Ltd.</span>)
        </div><div class="casAbstract">A review.  Hormonal cancers affect over 400,000 men and women and contribute collectively to over 100,000 deaths in the United States alone.  Thanks to advances in the understanding of these cancers at the mol. level and to the discovery of several disease-modifying therapeutics, the last decade has seen a plateauing or even a decreasing trend in the no. of deaths from these cancers.  These advanced therapeutics not only effectively slow the growth of hormonal cancers, but also provide an insight on how these cancers become refractory and evolve as an altogether distinct subset.  This review summarizes the current therapeutic trends in hormonal cancers, with focus on prostate, breast and ovarian cancers.  The review discusses the clin. drugs being used now, promising mols. that are going through various stages of development and makes some predictions on how the therapeutic landscape will shift in the next decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ79Ne7WjUi7Vg90H21EOLACvtfcHk0lhZLkewFPUeKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1CgtLrJ&md5=fc90ea2d4be544b19d078dc4c66bc9da</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1530%2FEC-18-0425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FEC-18-0425%26sid%3Dliteratum%253Aachs%26aulast%3DUlm%26aufirst%3DM.%26aulast%3DRamesh%26aufirst%3DA.%2BV.%26aulast%3DMcNamara%26aufirst%3DK.%2BM.%26aulast%3DPonnusamy%26aufirst%3DS.%26aulast%3DSasano%26aufirst%3DH.%26aulast%3DNarayanan%26aufirst%3DR.%26atitle%3DTherapeutic%2520advances%2520in%2520hormone-dependent%2520cancers%253A%2520focus%2520on%2520prostate%252C%2520breast%2520and%2520ovarian%2520cancers%26jtitle%3DEndocr.%2520Connect%26date%3D2019%26volume%3D8%26spage%3DR10%26epage%3DR26%26doi%3D10.1530%2FEC-18-0425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiga-Carvalho, T. M.</span></span> <span> </span><span class="NLM_article-title">Hormones and pathogenesis of uterine fibroids</span>. <i>Best Pract. Res. Clin. Obstet. Gynaecol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1016/j.bpobgyn.2015.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2Fj.bpobgyn.2015.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=26725037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A280%3ADC%252BC28rms1Khtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=13-24&author=F.+M.+Reisauthor=E.+Bloiseauthor=T.+M.+Ortiga-Carvalho&title=Hormones+and+pathogenesis+of+uterine+fibroids&doi=10.1016%2Fj.bpobgyn.2015.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Hormones and pathogenesis of uterine fibroids</span></div><div class="casAuthors">Reis Fernando M; Bloise Enrrico; Ortiga-Carvalho Tania M</div><div class="citationInfo"><span class="NLM_cas:title">Best practice & research. Clinical obstetrics & gynaecology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The role of ovarian steroid hormones in the pathogenesis of uterine fibroids is supported by epidemiological, clinical, and experimental evidence.  Estradiol and progesterone induce mature leiomyoma cells to release mitogenic stimuli to adjacent immature cells, thereby providing uterine leiomyoma with undifferentiated cells that are likely to support tumor growth.  Progesterone action is required for the complete development and proliferation of leiomyoma cells, while estradiol predominantly increases tissue sensitivity to progesterone by increasing the availability of progesterone receptors (PRs).  The selective estrogen receptor modulator (SERM) raloxifene and the selective PR modulators (SPRMs) mifepristone, asoprisnil, and ulipristal acetate have been shown in clinical trials to inhibit fibroid growth.  The role of sex steroids is critical for leiomyoma development and maintenance, but a number of autocrine and paracrine messengers are involved in this process; hence, numerous pathways remain to be explored in therapeutic innovations for treating this common disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPE_G8ph-J7d-cVm4E2RlLfW6udTcc2eYqA6HiK1CzcLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rms1Khtg%253D%253D&md5=df0979706c38d055b41ce43253be2384</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bpobgyn.2015.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpobgyn.2015.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DReis%26aufirst%3DF.%2BM.%26aulast%3DBloise%26aufirst%3DE.%26aulast%3DOrtiga-Carvalho%26aufirst%3DT.%2BM.%26atitle%3DHormones%2520and%2520pathogenesis%2520of%2520uterine%2520fibroids%26jtitle%3DBest%2520Pract.%2520Res.%2520Clin.%2520Obstet.%2520Gynaecol.%26date%3D2016%26volume%3D34%26spage%3D13%26epage%3D24%26doi%3D10.1016%2Fj.bpobgyn.2015.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Leo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musacchio, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massaro, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgante, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petraglia, F.</span></span> <span> </span><span class="NLM_article-title">Genetic, hormonal and metabolic aspects of PCOS: an update</span>. <i>Reprod. Biol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">38</span> <span class="refDoi"> DOI: 10.1186/s12958-016-0173-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1186%2Fs12958-016-0173-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=27423183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvFemtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&author=V.+De+Leoauthor=M.+C.+Musacchioauthor=V.+Cappelliauthor=M.+G.+Massaroauthor=G.+Morganteauthor=F.+Petraglia&title=Genetic%2C+hormonal+and+metabolic+aspects+of+PCOS%3A+an+update&doi=10.1186%2Fs12958-016-0173-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic, hormonal and metabolic aspects of PCOS: an update</span></div><div class="casAuthors">De Leo, V.; Musacchio, M. C.; Cappelli, V.; Massaro, M. G.; Morgante, G.; Petraglia, F.</div><div class="citationInfo"><span class="NLM_cas:title">Reproductive Biology and Endocrinology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38/1-38/17</span>CODEN:
                <span class="NLM_cas:coden">RBEEBP</span>;
        ISSN:<span class="NLM_cas:issn">1477-7827</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting 5-10 % of women of reproductive age.  It generally manifests with oligo/anovulatory cycles, hirsutism and polycystic ovaries, together with a considerable prevalence of insulin resistance.  Although the etiol. of the syndrome is not completely understood yet, PCOS is considered a multifactorial disorder with various genetic, endocrine and environmental abnormalities.  Moreover, PCOS patients have a higher risk of metabolic and cardiovascular diseases and their related morbidity, if compared to the general population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9rhbonP2i_bVg90H21EOLACvtfcHk0liw3l8H1UK0eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvFemtrk%253D&md5=b987c20a2989d9a562278e4c3d130d0a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2Fs12958-016-0173-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12958-016-0173-x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLeo%26aufirst%3DV.%26aulast%3DMusacchio%26aufirst%3DM.%2BC.%26aulast%3DCappelli%26aufirst%3DV.%26aulast%3DMassaro%26aufirst%3DM.%2BG.%26aulast%3DMorgante%26aufirst%3DG.%26aulast%3DPetraglia%26aufirst%3DF.%26atitle%3DGenetic%252C%2520hormonal%2520and%2520metabolic%2520aspects%2520of%2520PCOS%253A%2520an%2520update%26jtitle%3DReprod.%2520Biol.%2520Endocrinol.%26date%3D2016%26volume%3D14%26doi%3D10.1186%2Fs12958-016-0173-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burney, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giudice, L. C.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis and pathophysiology of endometriosis</span>. <i>Fertil. Steril.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1016/j.fertnstert.2012.06.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2Fj.fertnstert.2012.06.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=22819144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2msr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2012&pages=511-519&author=R.+O.+Burneyauthor=L.+C.+Giudice&title=Pathogenesis+and+pathophysiology+of+endometriosis&doi=10.1016%2Fj.fertnstert.2012.06.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis and pathophysiology of endometriosis</span></div><div class="casAuthors">Burney, Richard O.; Giudice, Linda C.</div><div class="citationInfo"><span class="NLM_cas:title">Fertility and Sterility</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">511-519</span>CODEN:
                <span class="NLM_cas:coden">FESTAS</span>;
        ISSN:<span class="NLM_cas:issn">0015-0282</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Originally described over three hundred years ago, endometriosis is classically defined by the presence of endometrial glands and stroma in extrauterine locations.  Endometriosis is an inflammatory, estrogen-dependent condition assocd. with pelvic pain and infertility.  This work reviews the disease process from theories regarding origin to the mol. basis for disease sequelae.  A thorough understanding of the histopathogenesis and pathophysiol. of endometriosis is essential to the development of novel diagnostic and treatment approaches for this debilitating condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojBtCuFx7E57Vg90H21EOLACvtfcHk0liw3l8H1UK0eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2msr3I&md5=ced33c9bc406c7a2e846788960d5daf3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.fertnstert.2012.06.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fertnstert.2012.06.029%26sid%3Dliteratum%253Aachs%26aulast%3DBurney%26aufirst%3DR.%2BO.%26aulast%3DGiudice%26aufirst%3DL.%2BC.%26atitle%3DPathogenesis%2520and%2520pathophysiology%2520of%2520endometriosis%26jtitle%3DFertil.%2520Steril.%26date%3D2012%26volume%3D98%26spage%3D511%26epage%3D519%26doi%3D10.1016%2Fj.fertnstert.2012.06.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arukha, A. P.</span></span> <span> </span><span class="NLM_article-title">Ovarian and oocyte targets for development of female contraceptives</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1446</span>, <span class="refDoi"> DOI: 10.1517/14728222.2015.1051305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1517%2F14728222.2015.1051305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=26028476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsl2mt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2015&pages=1433-1446&author=S.+K.+Guptaauthor=A.+Malikauthor=A.+P.+Arukha&title=Ovarian+and+oocyte+targets+for+development+of+female+contraceptives&doi=10.1517%2F14728222.2015.1051305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Ovarian and oocyte targets for development of female contraceptives</span></div><div class="casAuthors">Gupta, Satish Kumar; Malik, Ankita; Arukha, Ananta Prasad</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1433-1446</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Steroid hormone-based contraceptives have been used by women for long time since their introduction.  Efforts have been made to make steroidal contraceptives cost-effective, safe and improve their users' compliance.  In addn., attempts have been made to develop nonsteroidal contraceptives.  Contraceptive vaccines have been investigated as an alternate strategy for contraception.  The currently used steroidal contraceptives are reviewed.  In addn., status of emerging nonsteroidal contraceptives that inhibit folliculogenesis, oocyte maturation, ovulation and endometrium receptivity targeting phosphodiesterase 3, angiopoietins, gonadotropin-releasing hormone, COX-2, progesterone/estrogen receptor and FSH receptor are presented.  Various approaches to develop contraceptive vaccines aiming to inhibit ovarian follicle development, ovulation, fertilization and implantation including their current applications and limitations are discussed.  Development of new nonsteroidal contraceptives, in addn. to long-acting steroidal contraceptives, is pertinent for offering wider choice to women.  It is imperative that basic research to discover new targets in the ovaries must be undertaken to facilitate development of novel contraceptives.  Further, efforts on studying the feasibility and safety of contraceptive vaccines may be continued to bring these within the realm of application as contraceptives for humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9cT-whZRU2bVg90H21EOLACvtfcHk0liw3l8H1UK0eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsl2mt7zO&md5=0b423e1ae96229912068bcb071099f51</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F14728222.2015.1051305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2015.1051305%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BK.%26aulast%3DMalik%26aufirst%3DA.%26aulast%3DArukha%26aufirst%3DA.%2BP.%26atitle%3DOvarian%2520and%2520oocyte%2520targets%2520for%2520development%2520of%2520female%2520contraceptives%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2015%26volume%3D19%26spage%3D1433%26epage%3D1446%26doi%3D10.1517%2F14728222.2015.1051305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gava, G.</span>; <span class="NLM_string-name">Meriggiola, M. C.</span></span> <span> </span><span class="NLM_article-title">Update on male hormonal contraception</span> <i>Ther. Adv. Endocrinol. Metab.</i> <span class="NLM_year">2019</span>,  <span class="NLM_volume">10</span>, <span class="refDoi"> DOI: 10.1177/2042018819834846</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1177%2F2042018819834846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=30899448" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=G.+Gava&author=M.+C.+Meriggiola&title=Update+on+male+hormonal+contraception"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1177%2F2042018819834846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1177%252F2042018819834846%26sid%3Dliteratum%253Aachs%26aulast%3DGava%26aufirst%3DG.%26atitle%3DUpdate%2520on%2520male%2520hormonal%2520contraception%26jtitle%3DTher.%2520Adv.%2520Endocrinol.%2520Metab.%26date%3D2019%26volume%3D10%26doi%3D10.1177%2F2042018819834846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredriksson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagerstrom, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundin, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schioth, H. B.</span></span> <span> </span><span class="NLM_article-title">The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1256</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1124/mol.63.6.1256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1124%2Fmol.63.6.1256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=12761335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Shu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1256-1272&author=R.+Fredrikssonauthor=M.+C.+Lagerstromauthor=L.+G.+Lundinauthor=H.+B.+Schioth&title=The+G-protein-coupled+receptors+in+the+human+genome+form+five+main+families.+Phylogenetic+analysis%2C+paralogon+groups%2C+and+fingerprints&doi=10.1124%2Fmol.63.6.1256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</span></div><div class="casAuthors">Fredriksson, Robert; Lagerstrom, Malin C.; Lundin, Lars-Gustav; Schioth, Helgi B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1256-1272</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The superfamily of G-protein-coupled receptors (GPCRs) is very diverse in structure and function and its members are among the most pursued targets for drug development.  We identified more than 800 human GPCR sequences and simultaneously analyzed 342 unique functional nonolfactory human GPCR sequences with phylogenetic analyses.  Our results show, with high bootstrap support, five main families, named glutamate, rhodopsin, adhesion, frizzled/taste2, and secretin, forming the GRAFS classification system.  The rhodopsin family is the largest and forms four main groups with 13 subbranches.  Positions of the GPCRs in chromosomal paralogons regions indicate the importance of tetraploidizations or local gene duplication events for their creation.  We also searched for "fingerprint" motifs using Hidden Markov Models delineating the putative inter-relationship of the GRAFS families.  We show several common structural features indicating that the human GPCRs in the GRAFS families share a common ancestor.  This study represents the first overall map of the GPCRs in a single mammalian genome.  Our novel approach of analyzing such large and diverse sequence sets may be useful for studies on GPCRs in other genomes and divergent protein families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdX4VhTsaDzrVg90H21EOLACvtfcHk0lhL1L7jRWguZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Shu7k%253D&md5=504ea873ee8469cd0b6016bc94943836</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fmol.63.6.1256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.63.6.1256%26sid%3Dliteratum%253Aachs%26aulast%3DFredriksson%26aufirst%3DR.%26aulast%3DLagerstrom%26aufirst%3DM.%2BC.%26aulast%3DLundin%26aufirst%3DL.%2BG.%26aulast%3DSchioth%26aufirst%3DH.%2BB.%26atitle%3DThe%2520G-protein-coupled%2520receptors%2520in%2520the%2520human%2520genome%2520form%2520five%2520main%2520families.%2520Phylogenetic%2520analysis%252C%2520paralogon%2520groups%252C%2520and%2520fingerprints%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D63%26spage%3D1256%26epage%3D1272%26doi%3D10.1124%2Fmol.63.6.1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, J. M.</span></span> <span> </span><span class="NLM_article-title">Structure and function of receptors coupled to G proteins</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/0955-0674(94)90134-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2F0955-0674%2894%2990134-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=8024808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK2cXis1Wns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1994&pages=180-190&author=J.+M.+Baldwin&title=Structure+and+function+of+receptors+coupled+to+G+proteins&doi=10.1016%2F0955-0674%2894%2990134-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of receptors coupled to G proteins</span></div><div class="casAuthors">Baldwin, Joyce M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-90</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    </div><div class="casAbstract">A review, with 43 refs.  Direct structural data on receptors coupled to G proteins were obtained last year in form of a low-resoln. projection map of rhodopsin.  A large no. of receptor sequences have how been detd. and detailed anal. of these has provided structural information about the receptors.  New results from site-directed mutagenesis expts. can be examd. in conjunction with the structural information from sequence anal. and the rhodopsin map.  The identification of constitutively active mutated receptors has influenced the authors' understanding of normal receptor equil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpojkM6fxsYdbVg90H21EOLACvtfcHk0lhL1L7jRWguZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXis1Wns7c%253D&md5=957df72b6200767fa14cd263492057b2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2F0955-0674%2894%2990134-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0955-0674%252894%252990134-1%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DJ.%2BM.%26atitle%3DStructure%2520and%2520function%2520of%2520receptors%2520coupled%2520to%2520G%2520proteins%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D1994%26volume%3D6%26spage%3D180%26epage%3D190%26doi%3D10.1016%2F0955-0674%2894%2990134-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herrlich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudermann, T.</span></span> <span> </span><span class="NLM_article-title">Involvement of Gs and Gi proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">16764</span>– <span class="NLM_lpage">16772</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.28.16764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1074%2Fjbc.271.28.16764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=8663226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK28Xkt1CjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=16764-16772&author=A.+Herrlichauthor=B.+Kuhnauthor=R.+Grosseauthor=A.+Schmidauthor=G.+Schultzauthor=T.+Gudermann&title=Involvement+of+Gs+and+Gi+proteins+in+dual+coupling+of+the+luteinizing+hormone+receptor+to+adenylyl+cyclase+and+phospholipase+C&doi=10.1074%2Fjbc.271.28.16764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of Gs and Gi proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C</span></div><div class="casAuthors">Herrlich, Andreas; Kuehn, Bernhard; Grosse, Robert; Schmid, Andrea; Schultz, Guenter; Gudermann, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">16764-16772</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Binding of lutropin/choriogonadotropin to its cognate receptor results in the activation of adenylyl cyclase and phospholipase C.  The mechanism underlying the generation of this bifurcating signal is presently not known.  To analyze the coupling mechanism of the LH receptor, activated G proteins were labeled with [α-32P]GTP azidoanilide and identified by selective immunopptn.  In membranes of bovine corpora lutea and of L cells stably expressing the murine LH receptor (LHR cells), human chorionic gonadotropin (hCG) led to incorporation of the label into αs and αi2.  Stimulation of LHR cells or of L cells expressing the M5 muscarinic receptor (LM5 cells) with the resp. agonist resulted in activation of phospholipase C in both cell lines.  However, αq and α11 were only labeled upon stimulation of the M5 muscarinic receptor.  Agonist-induced Ca2+ mobilization and inositol phosphate accumulation were partially sensitive to pertussis toxin, and the expression of the βγ-stimulable phospholipase C isoforms β2 and β3 could be demonstrated in LHR cells.  Overexpression of phospholipase C-β2 led to increased hCG-stimulated inositol phosphate accumulation, and expression of a β-ARK1 C-terminal polypeptide effectively suppressed hCG-mediated phosphatidylinositol hydrolysis.  Thus, the LH receptor couples to both Gs and Gi, and βγ-subunits released from either G protein contribute to the stimulation of phospholipase C-β isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkJ3wMPyxJVrVg90H21EOLACvtfcHk0lhL1L7jRWguZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xkt1CjsLs%253D&md5=adc9624f502fe208e299a3c11c5d7434</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.28.16764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.28.16764%26sid%3Dliteratum%253Aachs%26aulast%3DHerrlich%26aufirst%3DA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DGrosse%26aufirst%3DR.%26aulast%3DSchmid%26aufirst%3DA.%26aulast%3DSchultz%26aufirst%3DG.%26aulast%3DGudermann%26aufirst%3DT.%26atitle%3DInvolvement%2520of%2520Gs%2520and%2520Gi%2520proteins%2520in%2520dual%2520coupling%2520of%2520the%2520luteinizing%2520hormone%2520receptor%2520to%2520adenylyl%2520cyclase%2520and%2520phospholipase%2520C%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D16764%26epage%3D16772%26doi%3D10.1074%2Fjbc.271.28.16764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kühn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudermann, T.</span></span> <span> </span><span class="NLM_article-title">The luteinizing hormone receptor activates phospholipase C via preferential coupling to Gi2</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">12490</span>– <span class="NLM_lpage">12498</span>, <span class="refDoi"> DOI: 10.1021/bi990755m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi990755m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK1MXltl2jsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=12490-12498&author=B.+K%C3%BChnauthor=T.+Gudermann&title=The+luteinizing+hormone+receptor+activates+phospholipase+C+via+preferential+coupling+to+Gi2&doi=10.1021%2Fbi990755m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Luteinizing Hormone Receptor Activates Phospholipase C via Preferential Coupling to Gi2</span></div><div class="casAuthors">Kuehn, Bernhard; Gudermann, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">12490-12498</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Binding of lutropin/choriogonadotropin (LH/CG) to its cognate receptor results in the activation of adenylyl cyclase and phospholipase C.  This divergent signaling of the LH receptor is based on the independent activation of distinct G protein subfamilies, i.e., Gs, Gi, and potentially also Gq.  To examine the selectivity of LH receptor coupling to phospholipase C β-activating G proteins, we used an in vivo reconstitution system based on the coexpression of the LH receptor and different G proteins in baculovirus-infected insect cells.  In this paper, we describe a refined expression strategy for the LH receptor in insect cells.  The receptor protein was inserted into the cell membrane at an expression level of 0.8 pmol/mg of membrane protein.  Sf9 cells expressing the LH receptor responded to hCG challenge with a concn.-dependent accumulation of intracellular cAMP (EC50 = 630 nM) but not of inositol phosphates, whereas stimulation of the histamine H1 receptor in Sf9 cells led to increased phospholipase C (PLC) activity.  Immunoblotting expts. using G protein-specific antisera revealed the absence of quant. amts. of αi in Sf9 cells, whereas αs and αq/11 were detected.  We therefore attempted to restore the hCG-dependent PLC activation by infection of Sf9 cells with viruses encoding the LH receptor and different G protein α subunits.  The hCG stimulation of cells coexpressing the LH receptor and exogenous αi2 resulted in stimulation of PLC activity.  In cells coinfected with an αi3-baculovirus, hCG challenge led to a minor activation of PLC, whereas no hCG-dependent PLC stimulation was obsd. in cells coexpressing αi1.  Most notably, coinfection with baculoviruses encoding αq or α11 did not reproduce the PLC activation by the LH receptor.  Thus, the murine LH receptor activates adenylyl cyclase via Gs and PLC via selective coupling to Gi2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJn26tOmto1LVg90H21EOLACvtfcHk0lhpU4U379qM9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltl2jsbg%253D&md5=662f190cb39a205c05968cd8ca1ff400</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbi990755m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi990755m%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25BChn%26aufirst%3DB.%26aulast%3DGudermann%26aufirst%3DT.%26atitle%3DThe%2520luteinizing%2520hormone%2520receptor%2520activates%2520phospholipase%2520C%2520via%2520preferential%2520coupling%2520to%2520Gi2%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D12490%26epage%3D12498%26doi%3D10.1021%2Fbi990755m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werthmann, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sungkaworn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohse, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calebiro, D.</span></span> <span> </span><span class="NLM_article-title">Persistent cAMP signaling by internalized LH receptors in ovarian follicles</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">1613</span>– <span class="NLM_lpage">1621</span>, <span class="refDoi"> DOI: 10.1210/en.2015-1945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1210%2Fen.2015-1945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=26828746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1amurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2016&pages=1613-1621&author=S.+Lygaauthor=S.+Volpeauthor=R.+C.+Werthmannauthor=K.+G%C3%B6tzauthor=T.+Sungkawornauthor=M.+J.+Lohseauthor=D.+Calebiro&title=Persistent+cAMP+signaling+by+internalized+LH+receptors+in+ovarian+follicles&doi=10.1210%2Fen.2015-1945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent cAMP signaling by internalized LH receptors in ovarian follicles</span></div><div class="casAuthors">Lyga, Sandra; Volpe, Silvia; Werthmann, Ruth C.; Goetz, Konrad; Sungkaworn, Titiwat; Lohse, Martin J.; Calebiro, Davide</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1613-1621</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">1945-7170</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A crucial event in female reprodn. occurs at midcycle, when a LH peak induces the final maturation of ovarian follicles.  LH signals via a G protein-coupled receptor selectively expressed in the outermost follicular cell layers.  However, how LH signals are relayed inside these cells and finally to the oocyte is incompletely understood.  Here, we monitored LH signaling in intact ovarian follicles of transgenic mice expressing a fluorescent cAMP sensor.  We found that LH stimulation induces 2 phases of cAMP signaling in all cell layers surrounding the oocyte.  Interfering with LH receptor internalization abolished the second, persistent cAMP phase and partially inhibited oocyte meiosis resumption.  These data suggest that persistent cAMP signals from internalized LH receptors contribute to transmitting LH effects inside follicle cells and ultimately to the oocyte.  Thus, this study indicates that the recently proposed paradigm of cAMP signaling by internalized G protein-coupled receptors is implicated in receptor function and is physiol. relevant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodQrsfvDjb-7Vg90H21EOLACvtfcHk0lhpU4U379qM9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1amurvP&md5=343e651f2f0dd1bccf44700b3029d094</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1210%2Fen.2015-1945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2015-1945%26sid%3Dliteratum%253Aachs%26aulast%3DLyga%26aufirst%3DS.%26aulast%3DVolpe%26aufirst%3DS.%26aulast%3DWerthmann%26aufirst%3DR.%2BC.%26aulast%3DG%25C3%25B6tz%26aufirst%3DK.%26aulast%3DSungkaworn%26aufirst%3DT.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DCalebiro%26aufirst%3DD.%26atitle%3DPersistent%2520cAMP%2520signaling%2520by%2520internalized%2520LH%2520receptors%2520in%2520ovarian%2520follicles%26jtitle%3DEndocrinology%26date%3D2016%26volume%3D157%26spage%3D1613%26epage%3D1621%26doi%3D10.1210%2Fen.2015-1945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casarini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potì, F.</span></span> <span> </span><span class="NLM_article-title">‘Spare’ luteinizing hormone receptors: facts and fiction</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">208</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2018.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2Fj.tem.2018.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=29429918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=208-217&author=L.+Casariniauthor=D.+Santiauthor=M.+Simoniauthor=F.+Pot%C3%AC&title=%E2%80%98Spare%E2%80%99+luteinizing+hormone+receptors%3A+facts+and+fiction&doi=10.1016%2Fj.tem.2018.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Spare Luteinizing Hormone Receptors: Facts and Fiction</span></div><div class="casAuthors">Casarini, Livio; Santi, Daniele; Simoni, Manuela; Poti, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">208-217</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  It is common opinion that maximal activation of LH (LH)-dependent steroidogenic signal occurs at <1% of human LH/choriogonadotropin (hCG) receptor (LHCGR) occupancy.  This effect would be a consequence of an excess of receptors expressed on the surface of theca cells, resulting in a pool of LHCGRs remaining unbound (spare).  This concept was borrowed from historical pharmacol. studies, when discrepancies between ligand-receptor binding and dose-response curves of cAMP were evaluated by treating mouse or rat Leydig cells with hCG in vitro.  Recent findings demonstrated the specificity of LH- and hCG-dependent effects, receptor heterodimerization, and differing behaviors of rodent vs. human gonadotropin-responsive cells, which may help to revise the 'spare' LHCGRs concept applied to human ovarian physiol. and assisted reprodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov6P1C2mOSg7Vg90H21EOLACvtfcHk0lilnYfCXPt4cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyksb4%253D&md5=5e317ac19846da6e48b147f85d53d45e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2018.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2018.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DCasarini%26aufirst%3DL.%26aulast%3DSanti%26aufirst%3DD.%26aulast%3DSimoni%26aufirst%3DM.%26aulast%3DPot%25C3%25AC%26aufirst%3DF.%26atitle%3D%25E2%2580%2598Spare%25E2%2580%2599%2520luteinizing%2520hormone%2520receptors%253A%2520facts%2520and%2520fiction%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2018%26volume%3D29%26spage%3D208%26epage%3D217%26doi%3D10.1016%2Fj.tem.2018.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oosterom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonger, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegerinck, P. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IJzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">[3H]Org 43553, the first low-molecular-weight agonistic and allosteric radioligand for the human luteinizing hormone receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1124/mol.107.039875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1124%2Fmol.107.039875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=17989351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ymtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=518-524&author=L.+H.+Heitmanauthor=J.+Oosteromauthor=K.+M.+Bongerauthor=C.+M.+Timmersauthor=P.+H.+G.+Wiegerinckauthor=A.+P.+IJzerman&title=%5B3H%5DOrg+43553%2C+the+first+low-molecular-weight+agonistic+and+allosteric+radioligand+for+the+human+luteinizing+hormone+receptor&doi=10.1124%2Fmol.107.039875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]Org 43553, the first low-molecular-weight agonistic and allosteric radioligand for the human luteinizing hormone receptor</span></div><div class="casAuthors">Heitman, Laura H.; Oosterom, Julia; Bonger, Kimberly M.; Timmers, Cornelis M.; Wiegerinck, Peter H. G.; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">518-524</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The LH receptor plays a pivotal role in reprodn.  The high-mol.-wt. (HMW) human chorionic gonadotropin (hCG) and LH are the endogenous ligands of this receptor and bind to its large N terminus.  The present study characterizes the binding of a new low-mol.-wt. (LMW) radioligand, [3H]5-amino-2-methylsulfanyl-4-[3-(2-morpholin-4-yl-acetylamino)- phenyl]-thieno[2,3-d]pyrimidine-6-carboxylic acid tert-butylamide (Org 43553), at the LH receptor.  Equil. satn. and displacement assays were developed and optimized.  Specific binding of [3H]Org 43553 to CHO-K1 cell membranes expressing the human LH receptor and a cAMP response element-luciferase reporter gene was saturable with a KD value of 2.4±0.4 nM and a Bmax value of 1.6±0.2 pmol/mg protein.  Affinities of five LMW analogs of Org 43553 were detd.  All displaced the radioligand competitively, with Ki values ranging from 3.3 to 100 nM.  Finally, the potency of these compds. in a cAMP-induced luciferase assay was also detd.  There was a high correlation between affinity and potency (r = 0.99; P < 0.0001) of these compds.  In the search for LMW ligands, which bind allosterically to the seven-transmembrane domain of the LH receptor, a HMW radioligand (e.g., 125I-hCG) is not suitable as it is not displaced by a LMW compd.  Therefore, [3H]Org 43553, a new radioligand with good binding properties, allows screening for new LMW ligands that mimic the action of the endogenous hormone at the LH receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5J_tDsbPkzrVg90H21EOLACvtfcHk0lilnYfCXPt4cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ymtrk%253D&md5=37648f4388831ef48721739ab40d195d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.039875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.039875%26sid%3Dliteratum%253Aachs%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DOosterom%26aufirst%3DJ.%26aulast%3DBonger%26aufirst%3DK.%2BM.%26aulast%3DTimmers%26aufirst%3DC.%2BM.%26aulast%3DWiegerinck%26aufirst%3DP.%2BH.%2BG.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26atitle%3D%255B3H%255DOrg%252043553%252C%2520the%2520first%2520low-molecular-weight%2520agonistic%2520and%2520allosteric%2520radioligand%2520for%2520the%2520human%2520luteinizing%2520hormone%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D518%26epage%3D524%26doi%3D10.1124%2Fmol.107.039875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van Straten, N. C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoonus-Gerritsma, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Someren, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draaijer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adang, A. E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanssen, R. G. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Boeckel, C. A. A.</span></span> <span> </span><span class="NLM_article-title">The first orally active low molecular weight agonists for the LH receptor: thienopyr(im)idines with therapeutic potential for ovulation induction</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1023</span>– <span class="NLM_lpage">1026</span>, <span class="refDoi"> DOI: 10.1002/1439-7633(20021004)3:10<1023::AID-CBIC1023>3.0.CO;2-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1002%2F1439-7633%2820021004%293%3A10%3C1023%3A%3AAID-CBIC1023%3E3.0.CO%3B2-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=12362369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFGnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=1023-1026&author=N.+C.+R.+van+Stratenauthor=G.+G.+Schoonus-Gerritsmaauthor=R.+G.+van+Somerenauthor=J.+Draaijerauthor=A.+E.+P.+Adangauthor=C.+M.+Timmersauthor=R.+G.+J.+M.+Hanssenauthor=C.+A.+A.+van+Boeckel&title=The+first+orally+active+low+molecular+weight+agonists+for+the+LH+receptor%3A+thienopyr%28im%29idines+with+therapeutic+potential+for+ovulation+induction&doi=10.1002%2F1439-7633%2820021004%293%3A10%3C1023%3A%3AAID-CBIC1023%3E3.0.CO%3B2-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The first orally active low molecular weight agonists for the LH receptor: thienopyr(im)idines with therapeutic potential for ovulation induction</span></div><div class="casAuthors">van Straten, N. C. R.; Schoonus-Gerritsma, G. G.; van Someren, R. G.; Draaijer, J.; Adang, A. E. P.; Timmers, C. M.; Hanssen, R. G. J. M.; van Boeckel, C. A. A.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1023-1026</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of thienopyrimidines and thienopyridines was synthesized and identified as orally active low mol. wt. agonists for the LH receptor.  These compds. mimic the mode of action of the high mol. wt. endogenous ligand LH.  Initial structure-activity relationships for this class of compds. were deduced and more than 50-fold improvement in potency was achieved through substitutions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS6-i6gBY1m7Vg90H21EOLACvtfcHk0ljlWiet-hOarw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFGnsrc%253D&md5=666d8fe70584179bec543542a7c03e52</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F1439-7633%2820021004%293%3A10%3C1023%3A%3AAID-CBIC1023%3E3.0.CO%3B2-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1439-7633%252820021004%25293%253A10%253C1023%253A%253AAID-CBIC1023%253E3.0.CO%253B2-9%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BStraten%26aufirst%3DN.%2BC.%2BR.%26aulast%3DSchoonus-Gerritsma%26aufirst%3DG.%2BG.%26aulast%3Dvan%2BSomeren%26aufirst%3DR.%2BG.%26aulast%3DDraaijer%26aufirst%3DJ.%26aulast%3DAdang%26aufirst%3DA.%2BE.%2BP.%26aulast%3DTimmers%26aufirst%3DC.%2BM.%26aulast%3DHanssen%26aufirst%3DR.%2BG.%2BJ.%2BM.%26aulast%3Dvan%2BBoeckel%26aufirst%3DC.%2BA.%2BA.%26atitle%3DThe%2520first%2520orally%2520active%2520low%2520molecular%2520weight%2520agonists%2520for%2520the%2520LH%2520receptor%253A%2520thienopyr%2528im%2529idines%2520with%2520therapeutic%2520potential%2520for%2520ovulation%2520induction%26jtitle%3DChemBioChem%26date%3D2002%26volume%3D3%26spage%3D1023%26epage%3D1026%26doi%3D10.1002%2F1439-7633%2820021004%293%3A10%3C1023%3A%3AAID-CBIC1023%3E3.0.CO%3B2-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narlawar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemsen, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfram, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brussee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IJzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">Substituted terphenyl compounds as the first class of low molecular weight allosteric inhibitors of the luteinizing hormone receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2036</span>– <span class="NLM_lpage">2042</span>, <span class="refDoi"> DOI: 10.1021/jm801561h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801561h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtlOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2036-2042&author=L.+H.+Heitmanauthor=R.+Narlawarauthor=H.+de+Vriesauthor=M.+N.+Willemsenauthor=D.+Wolframauthor=J.+Brusseeauthor=A.+P.+IJzerman&title=Substituted+terphenyl+compounds+as+the+first+class+of+low+molecular+weight+allosteric+inhibitors+of+the+luteinizing+hormone+receptor&doi=10.1021%2Fjm801561h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted Terphenyl Compounds as the First Class of Low-Molecular-Weight Allosteric Inhibitors of the Luteinizing Hormone Receptor</span></div><div class="casAuthors">Heitman, Laura H.; Narlawar, Rajeshwar; de Vries, Henk; Willemsen, Milou N.; Wolfram, Dieter; Brussee, Johannes; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2036-2042</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The LH receptor plays an important role in fertility and certain cancers.  The endogenous ligands human chorionic gonadotropin (hCG) and LH bind to the large N terminal domain of the receptor.  We recently reported on the first radiolabeled low-mol.-wt. (LMW) agonist for this receptor, [3H]Org 43553, which was now used to screen for new LMW ligands.  We identified a terphenyl deriv. that inhibited [3H]Org 43553 binding to the receptor, which led us to synthesize a no. of derivs.  The most potent compd. of this terphenyl series, I (LUF5771), was able to increase the dissocn. rate of [3H]Org 43553 by 3.3-fold (at 10 μM).  In a functional assay, the presence of I resulted in a 2- to 3-fold lower potency of both Org 43553 and LH.  Thus, the compds. presented in this paper are the first LMW ligands that allosterically inhibit the LH receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCl0ftNbm4qbVg90H21EOLACvtfcHk0ljlWiet-hOarw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtlOhtb8%253D&md5=e7a6250d51bd951476a0ddb1a81d071c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm801561h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801561h%26sid%3Dliteratum%253Aachs%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DNarlawar%26aufirst%3DR.%26aulast%3Dde%2BVries%26aufirst%3DH.%26aulast%3DWillemsen%26aufirst%3DM.%2BN.%26aulast%3DWolfram%26aufirst%3DD.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26atitle%3DSubstituted%2520terphenyl%2520compounds%2520as%2520the%2520first%2520class%2520of%2520low%2520molecular%2520weight%2520allosteric%2520inhibitors%2520of%2520the%2520luteinizing%2520hormone%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2036%26epage%3D2042%26doi%3D10.1021%2Fjm801561h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brussee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IJzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">Determination of different putative allosteric binding pockets at the lutropin receptor by using diverse drug-like low molecular weight ligands</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1016/j.mce.2012.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2Fj.mce.2012.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=22269095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVGlsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2012&pages=326-336&author=L.+H.+Heitmanauthor=G.+Kleinauauthor=J.+Brusseeauthor=G.+Krauseauthor=A.+P.+IJzerman&title=Determination+of+different+putative+allosteric+binding+pockets+at+the+lutropin+receptor+by+using+diverse+drug-like+low+molecular+weight+ligands&doi=10.1016%2Fj.mce.2012.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of different putative allosteric binding pockets at the lutropin receptor by using diverse drug-like low molecular weight ligands</span></div><div class="casAuthors">Heitman, Laura H.; Kleinau, Gunnar; Brussee, Johannes; Krause, Gerd; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">326-336</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The lutropin/choriogonadotrophin receptor (LHCGR) is a family A G protein-coupled receptor (GPCR) which binds the endogenous hormone-ligands at the large extracellular domain.  In contrast, several drug-like low-mol.-wt. ligands (LMWs) have been reported to interact allosterically within the seven transmembrane domain (7TMD) of the LHCGR.  Here, we were interested to study the putative allosteric LHCGR binding region with focus on the detn. of two pockets for LMW ligands.  A library of compds. was screened for their ability to modify the binding of an allosteric radiolabeled LMW agonist [3H]Org 43553.  Further exptl. and computational studies revealed that the putative binding pocket for a newly identified allosteric enhancer (LUF5419) and a previously described allosteric inhibitor (LUF5771) are overlapping and that this site is different from the Org 43553 binding site.  The present study showed that these compds. are useful tools to reveal details on different allosteric binding sites located within the 7TMD of the LHCGR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGsZY8OMNXOrVg90H21EOLACvtfcHk0ljlWiet-hOarw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVGlsbo%253D&md5=4c598e9a0eeb04d531aee69919c01dbb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2012.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2012.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DKleinau%26aufirst%3DG.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DKrause%26aufirst%3DG.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26atitle%3DDetermination%2520of%2520different%2520putative%2520allosteric%2520binding%2520pockets%2520at%2520the%2520lutropin%2520receptor%2520by%2520using%2520diverse%2520drug-like%2520low%2520molecular%2520weight%2520ligands%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2012%26volume%3D351%26spage%3D326%26epage%3D336%26doi%3D10.1016%2Fj.mce.2012.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langer, G.</span></span> <span> </span><span class="NLM_article-title">Implementation and Use of State-of-the-Art, Cell-Based In Vitro Assays. In New Approaches to Drug Discovery</span>. In  <i>Handbook of Experimental Pharmacology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsch, U.</span>; <span class="NLM_string-name">Fuhrmann, U.</span>; <span class="NLM_string-name">Jaroch, S.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">232</span>, pp  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">190</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=171-190&author=G.+Langerauthor=U.+Nielsch&author=U.+Fuhrmann&author=S.+Jaroch&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLanger%26aufirst%3DG.%26atitle%3DImplementation%2520and%2520Use%2520of%2520State-of-the-Art%252C%2520Cell-Based%2520In%2520Vitro%2520Assays.%2520In%2520New%2520Approaches%2520to%2520Drug%2520Discovery%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26aulast%3DNielsch%26aufirst%3DU.%26pub%3DSpringer%26date%3D2015%26volume%3D232%26spage%3D171%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, G.</span></span> <span> </span><span class="NLM_article-title">HTRF technology</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1177/108705719900400605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1177%2F108705719900400605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10838427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVWlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=309-314&author=G.+Mathis&title=HTRF+technology&doi=10.1177%2F108705719900400605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">HTRF technology</span></div><div class="casAuthors">Mathis, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">309-313</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review, with 11 refs., on specific properties and characteristics of long-lived fluorescent rare earth cryptates as HTRF (homogeneous time-resolved fluorescence) reagents for use in biol. and screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8FYWqKOSm67Vg90H21EOLACvtfcHk0lg6zmhwb7FDTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVWlu70%253D&md5=b48f80159910aeab181a233e62fe284d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1177%2F108705719900400605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400605%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DG.%26atitle%3DHTRF%2520technology%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26spage%3D309%26epage%3D314%26doi%3D10.1177%2F108705719900400605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, F.</span></span> <span> </span><span class="NLM_article-title">HTRF: pioneering technology for high-throughput screening</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">764</span>, <span class="refDoi"> DOI: 10.1517/17460441.1.7.753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1517%2F17460441.1.7.753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=23495998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVansw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=753-764&author=F.+Degorce&title=HTRF%3A+pioneering+technology+for+high-throughput+screening&doi=10.1517%2F17460441.1.7.753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">HTRF: pioneering technology for high-throughput screening</span></div><div class="casAuthors">Degorce, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">753-764</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Cisbio international pioneered the field of homogeneous fluorescence methodologies and time-resolved fluorescence resonance in particular, through its proprietary technol., HTRF.  The development was based on Professor Jean-Marie Lehn's research on rare earth fluorescence properties (awarded the Nobel Prize in Chem. in 1987) and on Cisbio's expertise in homogeneous time-resolved fluorescence (HTRF).  The technol. is used in assay development and drug screening, most notably in high-throughput screening applications.  This highly powerful technol. is particularly applied to the areas of G-protein-coupled receptor and kinase screening, as well as a series of targets related to inflammation, metabolic diseases and CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3_h88bD-LqLVg90H21EOLACvtfcHk0lg6zmhwb7FDTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVansw%253D%253D&md5=5d88550e4a5c44cf91700c8aafbf5df2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F17460441.1.7.753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.1.7.753%26sid%3Dliteratum%253Aachs%26aulast%3DDegorce%26aufirst%3DF.%26atitle%3DHTRF%253A%2520pioneering%2520technology%2520for%2520high-throughput%2520screening%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D753%26epage%3D764%26doi%3D10.1517%2F17460441.1.7.753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Card, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapik, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, B.</span></span> <span> </span><span class="NLM_article-title">HTRF: a technology tailored for drug discovery – a review of theoretical aspects and recent applications</span>. <i>Curr. Chem. Genomics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.2174/1875397300903010022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.2174%2F1875397300903010022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=20161833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFWnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=22-32&author=F.+Degorceauthor=A.+Cardauthor=S.+Sohauthor=E.+Trinquetauthor=G.+P.+Knapikauthor=B.+Xie&title=HTRF%3A+a+technology+tailored+for+drug+discovery+%E2%80%93+a+review+of+theoretical+aspects+and+recent+applications&doi=10.2174%2F1875397300903010022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">HTRF: a technology tailored for drug discovery - a review of theoretical aspects and recent applications</span></div><div class="casAuthors">Degorce, Francois; Card, Amy; Soh, Sharon; Trinquet, Eric; Knapik, Glenn P.; Xie, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Current Chemical Genomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-32</span>CODEN:
                <span class="NLM_cas:coden">CCGUAQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-3973</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HTRF (Homogeneous Time Resolved Fluorescence) is the most frequently used generic assay technol. to measure analytes in a homogenous format, which is the ideal platform used for drug target studies in high-throughput screening (HTS).  This technol. combines fluorescence resonance energy transfer technol. (FRET) with time-resolved measurement (TR).  In TR-FRET assays, a signal is generated through fluorescent resonance energy transfer between a donor and an acceptor mol. when in close proximity to each other.  Buffer and media interference is dramatically reduced by dual-wavelength detection, and the final signal is proportional to the extent of product formation.  The HTRF assay is usually sensitive and robust that can be miniaturized into the 384 and 1536-well plate formats.  This assay technol. has been applied to many antibody-based assays including GPCR signaling (cAMP and IP-One), kinases, cytokines and biomarkers, bioprocess (antibody and protein prodn.), as well as the assays for protein-protein, protein-peptide, and protein-DNA/RNA interactions.  Since its introduction to the drug-screening world over ten years ago, researchers have used HTRF to expedite the study of GPCRs, kinases, new biomarkers, protein-protein interactions, and other targets of interest.  HTRF has also been utilized as an alternative method for bioprocess monitoring.  The first-generation HTRF technol., which uses Europium cryptate as a fluorescence donor to monitor reactions between biomols., was extended in 2008 through the introduction of a second-generation donor, Terbium cryptate (Tb), enhancing screening performance.  Terbium cryptate possesses different photophys. properties compared to Europium, including increased quantum yield and a higher molar extinction coeff.  In addn. to being compatible with the same acceptor fluorophors used with Europium, it can serve as a donor fluorophore to green-emitting fluors because it has multiple emission peaks including one at 490 nm.  Moreover, all Terbium HTRF assays can be read on the same HTRF-compatible instruments as Europium HTRF assays.  Overall, HTRF is a highly sensitive, robust technol. for the detection of mol. interactions in vitro and is widely used for primary and secondary screening phases of drug development.  This review addresses the general principles of HTRF and its current applications in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKDP8Vd8k247Vg90H21EOLACvtfcHk0lg6zmhwb7FDTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFWnsr4%253D&md5=9590149ceeed17ce424522ef85aa32f9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F1875397300903010022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1875397300903010022%26sid%3Dliteratum%253Aachs%26aulast%3DDegorce%26aufirst%3DF.%26aulast%3DCard%26aufirst%3DA.%26aulast%3DSoh%26aufirst%3DS.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DKnapik%26aufirst%3DG.%2BP.%26aulast%3DXie%26aufirst%3DB.%26atitle%3DHTRF%253A%2520a%2520technology%2520tailored%2520for%2520drug%2520discovery%2520%25E2%2580%2593%2520a%2520review%2520of%2520theoretical%2520aspects%2520and%2520recent%2520applications%26jtitle%3DCurr.%2520Chem.%2520Genomics%26date%3D2009%26volume%3D3%26spage%3D22%26epage%3D32%26doi%3D10.2174%2F1875397300903010022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0liibBuq4Cyo2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0liibBuq4Cyo2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0169-409X%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundbeck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakobsen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varming, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westergaard, N.</span></span> <span> </span><span class="NLM_article-title">Glucose-6-phosphatase catalytic enzyme inhibitors: synthesis and in vitro evaluation of novel 4,5,6,7-tetrahydrothieno[3,2-c]- and -[2,3-c]pyridines</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2277</span>– <span class="NLM_lpage">2289</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(00)00153-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2FS0968-0896%2800%2900153-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=11026540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtF2jtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2000&pages=2277-2289&author=P.+Madsenauthor=J.+M.+Lundbeckauthor=P.+Jakobsenauthor=A.+R.+Varmingauthor=N.+Westergaard&title=Glucose-6-phosphatase+catalytic+enzyme+inhibitors%3A+synthesis+and+in+vitro+evaluation+of+novel+4%2C5%2C6%2C7-tetrahydrothieno%5B3%2C2-c%5D-+and+-%5B2%2C3-c%5Dpyridines&doi=10.1016%2FS0968-0896%2800%2900153-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose-6-phosphatase catalytic enzyme inhibitors: synthesis and in vitro evaluation of novel 4,5,6,7-tetrahydrothieno[3,2-c]- and -[2,3-c]pyridines</span></div><div class="casAuthors">Madsen, P.; Lundbeck, J. M.; Jakobsen, P.; Varming, A. R.; Westergaard, N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2277-2289</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The discovery of the first class of potent glucose-6-phosphatase catalytic site inhibitors, substituted 4,5,6,7-tetrahydrothieno[3,2-c]- and -[2,3-c]pyridines, is described.  Optimization of this series involved soln. phase combinatorial synthesis and very potent compds. were prepd. with IC50 values down to 140 nM.  The structure-activity relationship (SAR) of these compds. indicates that: a tetrahydrothieno[3,2-c]pyridine core ring system and the isomeric [2,3-c] system are equipotent and much better than the corresponding benzo analog, 1,2,3,4-tetrahydro-isoquinoline.  The 4-substituent of the tetrahydrothieno[3,2-c]pyridine ring has to be a Ph group, optionally substituted with a lipophilic 4-substituent, such as trifluoromethoxy or chloro.  The 5-substituent of the tetrahydrothieno[3,2-c]pyridine ring has to be a substituted benzoyl; anisoyl and (E)-3-furan-3-ylacryloyl are the best of the investigated groups.  Substitution in the benzoyl ortho position seems to be forbidden, whereas substitution in the meta position is tolerated only if a methoxy para substituent is present.  These SAR findings were parallel to those obtained in the 4,5,6,7-tetrahydrothieno[2,3-c]pyridine system.  Enantioselectivity in enzyme recognition was obsd. and the activity resided in all cases only in one of the enantiomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6xChFeiBBlbVg90H21EOLACvtfcHk0liibBuq4Cyo2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtF2jtLk%253D&md5=7d5eff438e75cbe228c5ea8239fba054</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2800%2900153-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252800%252900153-X%26sid%3Dliteratum%253Aachs%26aulast%3DMadsen%26aufirst%3DP.%26aulast%3DLundbeck%26aufirst%3DJ.%2BM.%26aulast%3DJakobsen%26aufirst%3DP.%26aulast%3DVarming%26aufirst%3DA.%2BR.%26aulast%3DWestergaard%26aufirst%3DN.%26atitle%3DGlucose-6-phosphatase%2520catalytic%2520enzyme%2520inhibitors%253A%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520novel%25204%252C5%252C6%252C7-tetrahydrothieno%255B3%252C2-c%255D-%2520and%2520-%255B2%252C3-c%255Dpyridines%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2000%26volume%3D8%26spage%3D2277%26epage%3D2289%26doi%3D10.1016%2FS0968-0896%2800%2900153-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gramec, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterlin Mašič, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span> <span> </span><span class="NLM_article-title">Bioactivation potential of thiophene-containing drugs</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1344</span>– <span class="NLM_lpage">1358</span>, <span class="refDoi"> DOI: 10.1021/tx500134g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx500134g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFelurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=1344-1358&author=D.+Gramecauthor=L.+Peterlin+Ma%C5%A1i%C4%8Dauthor=M.+Sollner+Dolenc&title=Bioactivation+potential+of+thiophene-containing+drugs&doi=10.1021%2Ftx500134g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation Potential of Thiophene-Containing Drugs</span></div><div class="casAuthors">Gramec, Darja; Peterlin Masic, Lucija; Sollner Dolenc, Marija</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1344-1358</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Thiophene is a five-membered, sulfur-contg. heteroarom. ring commonly used as a building block in drugs.  It is considered to be a structural alert, as its metab. can lead to the formation of reactive metabolites.  Thiophene S-oxides and thiophene epoxides are highly reactive electrophilic thiophene metabolites whose formation is cytochrome P 450-dependent.  These reactive thiophene-based metabolites are quite often responsible for drug-induced hepatotoxicity.  Tienilic acid is an example of a thiophene-based drug that was withdrawn from the market after only a few months of use, due to severe cases of immune hepatitis.  However, inclusion of the thiophene moiety in drugs does not necessarily result in toxic effects.  The presence of other, less toxic metabolic pathways, as well as an effective detoxification system in our body, protects us from the bioactivation potential of the thiophene ring.  Thus, the presence of a structural alert itself is insufficient to predict a compd.'s toxicity.  The question therefore arises as to which factors significantly influence the toxicity of thiophene-contg. drugs.  There is no easy way to answer this question.  However, the findings presented here indicate that, for a no. of reasons, daily dose and alternative metabolic pathways are important factors when predicting toxicity and will therefore be discussed together with examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0KnyHFkaMsrVg90H21EOLACvtfcHk0ljfLoYveeE1LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFelurjL&md5=65733d5665c8ac67050a60707a2e828b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Ftx500134g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx500134g%26sid%3Dliteratum%253Aachs%26aulast%3DGramec%26aufirst%3DD.%26aulast%3DPeterlin%2BMa%25C5%25A1i%25C4%258D%26aufirst%3DL.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26atitle%3DBioactivation%2520potential%2520of%2520thiophene-containing%2520drugs%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26spage%3D1344%26epage%3D1358%26doi%3D10.1021%2Ftx500134g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bountra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser-Doepner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimshaw, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mader, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Fahrnow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O′Hagan, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schapira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo-Sherman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpole, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">The promise and peril of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">536</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1038%2Fnchembio.1867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=26196764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=536-541&author=C.+H.+Arrowsmithauthor=J.+E.+Audiaauthor=C.+Austinauthor=J.+Baellauthor=J.+Bennettauthor=J.+Blaggauthor=C.+Bountraauthor=P.+E.+Brennanauthor=P.+J.+Brownauthor=M.+E.+Bunnageauthor=C.+Buser-Doepnerauthor=R.+M.+Campbellauthor=A.+J.+Carterauthor=P.+Cohenauthor=R.+A.+Copelandauthor=B.+Cravattauthor=J.+L.+Dahlinauthor=D.+Dhanakauthor=A.+M.+Edwardsauthor=M.+Frederiksenauthor=S.+V.+Fryeauthor=N.+Grayauthor=C.+E.+Grimshawauthor=D.+Hepworthauthor=T.+Howeauthor=K.+V.+M.+Huberauthor=J.+Jinauthor=S.+Knappauthor=J.+D.+Kotzauthor=R.+G.+Krugerauthor=D.+Loweauthor=M.+M.+Maderauthor=B.+Marsdenauthor=A.+Mueller-Fahrnowauthor=S.+M%C3%BCllerauthor=R.+C.+O%E2%80%B2Haganauthor=J.+P.+Overingtonauthor=D.+R.+Owenauthor=S.+H.+Rosenbergauthor=R.+Rossauthor=B.+Rothauthor=M.+Schapiraauthor=S.+L.+Schreiberauthor=B.+Shoichetauthor=M.+Sundstr%C3%B6mauthor=G.+Superti-Furgaauthor=J.+Tauntonauthor=L.+Toledo-Shermanauthor=C.+Walpoleauthor=M.+A.+Waltersauthor=T.+M.+Willsonauthor=P.+Workmanauthor=R.+N.+Youngauthor=W.+J.+Zuercher&title=The+promise+and+peril+of+chemical+probes&doi=10.1038%2Fnchembio.1867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The promise and peril of chemical probes</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Audia, James E.; Austin, Christopher; Baell, Jonathan; Bennett, Jonathan; Blagg, Julian; Bountra, Chas; Brennan, Paul E.; Brown, Peter J.; Bunnage, Mark E.; Buser-Doepner, Carolyn; Campbell, Robert M.; Carter, Adrian J.; Cohen, Philip; Copeland, Robert A.; Cravatt, Ben; Dahlin, Jayme L.; Dhanak, Dashyant; Edwards, Aled M.; Frye, Stephen V.; Gray, Nathanael; Grimshaw, Charles E.; Hepworth, David; Howe, Trevor; Huber, Kilian V. M.; Jin, Jian; Knapp, Stefan; Kotz, Joanne D.; Kruger, Ryan G.; Lowe, Derek; Mader, Mary M.; Marsden, Brian; Mueller-Fahrnow, Anke; Muller, Susanne; O'Hagan, Ronan C.; Overington, John P.; Owen, Dafydd R.; Rosenberg, Saul H.; Roth, Brian; Ross, Ruth; Schapira, Matthieu; Schreiber, Stuart L.; Shoichet, Brian; Sundstrom, Michael; Superti-Furga, Giulio; Taunton, Jack; Toledo-Sherman, Leticia; Walpole, Chris; Walters, Michael A.; Willson, Timothy M.; Workman, Paul; Young, Robert N.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">536-541</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes are powerful reagents with increasing impacts on biomedical research.  However, probes of poor quality or that are used incorrectly generate misleading results.  To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-li4dxq487rVg90H21EOLACvtfcHk0ljfLoYveeE1LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO&md5=d8c7a7af94921ab4cdcc871487cceadd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1867%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBuser-Doepner%26aufirst%3DC.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DCarter%26aufirst%3DA.%2BJ.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGrimshaw%26aufirst%3DC.%2BE.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKotz%26aufirst%3DJ.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DLowe%26aufirst%3DD.%26aulast%3DMader%26aufirst%3DM.%2BM.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DMueller-Fahrnow%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DO%25E2%2580%25B2Hagan%26aufirst%3DR.%2BC.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DToledo-Sherman%26aufirst%3DL.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520promise%2520and%2520peril%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D536%26epage%3D541%26doi%3D10.1038%2Fnchembio.1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Structural Genomics Consortium
(SCG)</span>. <a href="https://www.thesgc.org" class="extLink">https://www.thesgc.org</a> (accessed Aug 15, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Structural+Genomics+Consortium%0A%28SCG%29.+https%3A%2F%2Fwww.thesgc.org+%28accessed+Aug+15%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di Fabio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffante, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzi, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattioli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimarosti, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guercio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchioro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonzini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melotto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerrard, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trist, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsi, M.</span></span> <span> </span><span class="NLM_article-title">Discovery and biological characterization of (2R,4S)-1’-acetyl-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fluoro-2-methylphenyl)-N-methyl-4,4’-bipiperidine-1-carboxamide as a new potent and selective neurokinin 1 (NK1) receptor antagonist clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1021/jm1013264</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013264" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlt1Ogtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1071-1079&author=R.+Di+Fabioauthor=G.+Alvaroauthor=C.+Griffanteauthor=D.+A.+Pizziauthor=D.+Donatiauthor=M.+Mattioliauthor=Z.+Cimarostiauthor=G.+Guercioauthor=C.+Marchioroauthor=S.+Proveraauthor=L.+Zonziniauthor=D.+Montanariauthor=S.+Melottoauthor=P.+A.+Gerrardauthor=D.+G.+Tristauthor=E.+Rattiauthor=M.+Corsi&title=Discovery+and+biological+characterization+of+%282R%2C4S%29-1%E2%80%99-acetyl-N-%7B%281R%29-1-%5B3%2C5-bis%28trifluoromethyl%29phenyl%5Dethyl%7D-2-%284-fluoro-2-methylphenyl%29-N-methyl-4%2C4%E2%80%99-bipiperidine-1-carboxamide+as+a+new+potent+and+selective+neurokinin+1+%28NK1%29+receptor+antagonist+clinical+candidate&doi=10.1021%2Fjm1013264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Biological Characterization of (2R,4S)-1'-Acetyl-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fluoro-2-methylphenyl)-N-methyl-4,4'-bipiperidine-1-carboxamide as a New Potent and Selective Neurokinin 1 (NK1) Receptor Antagonist Clinical Candidate</span></div><div class="casAuthors">Di Fabio, Romano; Alvaro, Giuseppe; Griffante, Cristiana; Pizzi, Domenica A.; Donati, Daniele; Mattioli, Mario; Cimarosti, Zadeo; Guercio, Giuseppe; Marchioro, Carla; Provera, Stefano; Zonzini, Laura; Montanari, Dino; Melotto, Sergio; Gerrard, Philip A.; Trist, David G.; Ratti, Emiliangelo; Corsi, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1071-1079</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A large body of compelling preclin. evidence supports the clin. use of neurokinin (NK) receptor antagonists in a plethora of CNS and non-CNS therapeutic areas.  The significant investment made in this area over the past 2 decades culminated with the observation that NK1 receptor antagonists elicited clin. efficacy in major depression disorders.  In addn., aprepitant (Merck) was launched as a new drug able to prevent chemotherapy-induced nausea and vomiting (CINV).  After the discovery by GlaxoSmithKline of vestipitant, a wide drug discovery program was launched aimed at identifying addnl. clin. candidates.  New compds. were designed to maximize affinity at the NK1 receptor binding site while retaining suitable physicochem. characteristics to ensure excellent pharmacokinetic and pharmacodynamic properties in vivo.  Herein we describe the discovery process of a new NK1 receptor antagonist (casopitant) selected as clin. candidate and progressed into clin. studies to treat major depression disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNXJswsOiu-LVg90H21EOLACvtfcHk0lhjdte0MIOSlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlt1Ogtw%253D%253D&md5=98af29713594b9db404cdec6a4155f1c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm1013264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013264%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFabio%26aufirst%3DR.%26aulast%3DAlvaro%26aufirst%3DG.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DPizzi%26aufirst%3DD.%2BA.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DMattioli%26aufirst%3DM.%26aulast%3DCimarosti%26aufirst%3DZ.%26aulast%3DGuercio%26aufirst%3DG.%26aulast%3DMarchioro%26aufirst%3DC.%26aulast%3DProvera%26aufirst%3DS.%26aulast%3DZonzini%26aufirst%3DL.%26aulast%3DMontanari%26aufirst%3DD.%26aulast%3DMelotto%26aufirst%3DS.%26aulast%3DGerrard%26aufirst%3DP.%2BA.%26aulast%3DTrist%26aufirst%3DD.%2BG.%26aulast%3DRatti%26aufirst%3DE.%26aulast%3DCorsi%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520biological%2520characterization%2520of%2520%25282R%252C4S%2529-1%25E2%2580%2599-acetyl-N-%257B%25281R%2529-1-%255B3%252C5-bis%2528trifluoromethyl%2529phenyl%255Dethyl%257D-2-%25284-fluoro-2-methylphenyl%2529-N-methyl-4%252C4%25E2%2580%2599-bipiperidine-1-carboxamide%2520as%2520a%2520new%2520potent%2520and%2520selective%2520neurokinin%25201%2520%2528NK1%2529%2520receptor%2520antagonist%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1071%26epage%3D1079%26doi%3D10.1021%2Fjm1013264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Comins, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingalls, C. L.</span></span> <span> </span><span class="NLM_article-title">Reduction of N-acyl-2,3-dihydro-4-pyridones to N-acyl-4-piperidones using zinc/acetic acid</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">2181</span>– <span class="NLM_lpage">2182</span>, <span class="refDoi"> DOI: 10.1021/jo001609l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo001609l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlegurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=2181-2182&author=D.+L.+Cominsauthor=C.+A.+Brooksauthor=C.+L.+Ingalls&title=Reduction+of+N-acyl-2%2C3-dihydro-4-pyridones+to+N-acyl-4-piperidones+using+zinc%2Facetic+acid&doi=10.1021%2Fjo001609l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of N-acyl-2,3-dihydro-4-pyridones to N-acyl-4-piperidones using zinc/acetic acid</span></div><div class="casAuthors">Comins, Daniel L.; Brooks, Clinton A.; Ingalls, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2181-2182</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-alkoxycarbonyldihydropyridones I [R1 = vinyl, Ph, PhCH2CH2; R2 = CH2Ph; R1 = Me, Ph, EtO2CCH:CH(CH2)3; R2 = Ph] were reduced using Zn/AcOH to give the corresponding piperidones in 91-95% yields.  Nonracemic bicyclic indolizinedione II was similarly reduced.  This method allows for the simple, mild, and inexpensive prepn. of N-acyl-4-piperidones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZt_Prjn5G1bVg90H21EOLACvtfcHk0lja9nkuM9qpow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlegurk%253D&md5=3211a5fa7ed5eaa468e360022dab5cf0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo001609l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo001609l%26sid%3Dliteratum%253Aachs%26aulast%3DComins%26aufirst%3DD.%2BL.%26aulast%3DBrooks%26aufirst%3DC.%2BA.%26aulast%3DIngalls%26aufirst%3DC.%2BL.%26atitle%3DReduction%2520of%2520N-acyl-2%252C3-dihydro-4-pyridones%2520to%2520N-acyl-4-piperidones%2520using%2520zinc%252Facetic%2520acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D2181%26epage%3D2182%26doi%3D10.1021%2Fjo001609l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbiati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Giuseppe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, E.</span></span> <span> </span><span class="NLM_article-title">Sequential amination/annulation/aromatization reaction of carbonyl compounds and propargylamine: a new one-pot approach to functionalized pyridines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">6959</span>– <span class="NLM_lpage">6966</span>, <span class="refDoi"> DOI: 10.1021/jo0347260</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0347260" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFWmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=6959-6966&author=G.+Abbiatiauthor=A.+Arcadiauthor=G.+Bianchiauthor=S.+Di+Giuseppeauthor=F.+Marinelliauthor=E.+Rossi&title=Sequential+amination%2Fannulation%2Faromatization+reaction+of+carbonyl+compounds+and+propargylamine%3A+a+new+one-pot+approach+to+functionalized+pyridines&doi=10.1021%2Fjo0347260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sequential Amination/Annulation/Aromatization Reaction of Carbonyl Compounds and Propargylamine: A New One-Pot Approach to Functionalized Pyridines</span></div><div class="casAuthors">Abbiati, Giorgio; Arcadi, Antonio; Bianchi, Gabriele; Di Giuseppe, Sabrina; Marinelli, Fabio; Rossi, Elisabetta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6959-6966</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general one-pot synthesis of pyridines, e.g., I, from the reaction of ketones and aldehydes, bearing α-hydrogens, with propargylamine is described.  Gold and copper salts are efficient catalysts for the reaction of ketones with propargylamine.  The formation of the pyridines is suggested to proceed through the sequential amination of carbonyl compds. followed by regioselective 6-endo-dig cyclization of the N-propargylenamine (N-propargyldienamine) intermediate and aromatization reaction.  Whereas the prepn. of linear polycyclic pyridine can be carried out by reacting cholestan-3-one with propargylamine, angular polycyclic pyridine II has been obtained starting from cholest-5-en-3-one.  Selectivity of the reaction of polycyclic dicarbonyls with propargylamine has also been investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq0QcmHCXR9LVg90H21EOLACvtfcHk0lja9nkuM9qpow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFWmt7Y%253D&md5=48e6675f4ee7ba320b5ba1cb4d888308</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo0347260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0347260%26sid%3Dliteratum%253Aachs%26aulast%3DAbbiati%26aufirst%3DG.%26aulast%3DArcadi%26aufirst%3DA.%26aulast%3DBianchi%26aufirst%3DG.%26aulast%3DDi%2BGiuseppe%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DF.%26aulast%3DRossi%26aufirst%3DE.%26atitle%3DSequential%2520amination%252Fannulation%252Faromatization%2520reaction%2520of%2520carbonyl%2520compounds%2520and%2520propargylamine%253A%2520a%2520new%2520one-pot%2520approach%2520to%2520functionalized%2520pyridines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D6959%26epage%3D6966%26doi%3D10.1021%2Fjo0347260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gentry, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Novel allosteric modulators of G protein-coupled receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">19478</span>– <span class="NLM_lpage">19488</span>, <span class="refDoi"> DOI: 10.1074/jbc.R115.662759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1074%2Fjbc.R115.662759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=26100627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12mt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=19478-19488&author=P.+R.+Gentryauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Novel+allosteric+modulators+of+G+protein-coupled+receptors&doi=10.1074%2Fjbc.R115.662759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Allosteric Modulators of G Protein-coupled Receptors</span></div><div class="casAuthors">Gentry, Patrick R.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">19478-19488</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) are allosteric proteins, because their signal transduction relies on interactions between topog. distinct, yet conformationally linked, domains.  Much of the focus on GPCR allostery in the new millennium, however, has been on modes of targeting GPCR allosteric sites with chem. probes due to the potential for novel therapeutics.  It is now apparent that some GPCRs possess more than one targetable allosteric site, in addn. to a growing list of putative endogenous modulators.  Advances in structural biol. are also shedding new insights into mechanisms of allostery, although the complexities of candidate allosteric drugs necessitate rigorous biol. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-w2L2Z2PwrVg90H21EOLACvtfcHk0ljUjrTXbeDasg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12mt7rI&md5=7c3b5c0ddd375e0c05a18b91f2c68e56</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R115.662759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R115.662759%26sid%3Dliteratum%253Aachs%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DNovel%2520allosteric%2520modulators%2520of%2520G%2520protein-coupled%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D19478%26epage%3D19488%26doi%3D10.1074%2Fjbc.R115.662759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span> <span> </span><span class="NLM_article-title">Agonist-bound structure of the human P2Y12 receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>509</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1038/nature13288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1038%2Fnature13288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=24784220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlyis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=509&publication_year=2014&pages=119-122&author=J.+Zhangauthor=K.+Zhangauthor=Z.-G.+Gaoauthor=S.+Paolettaauthor=D.+Zhangauthor=G.+W.+Hanauthor=T.+Liauthor=L.+Maauthor=W.+Zhangauthor=C.+E.+M%C3%BCllerauthor=H.+Yangauthor=H.+Jiangauthor=V.+Cherezovauthor=V.+Katritchauthor=K.+A.+Jacobsonauthor=R.+C.+Stevensauthor=B.+Wuauthor=Q.+Zhao&title=Agonist-bound+structure+of+the+human+P2Y12+receptor&doi=10.1038%2Fnature13288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist-bound structure of the human P2Y12 receptor</span></div><div class="casAuthors">Zhang, Jin; Zhang, Kaihua; Gao, Zhan-Guo; Paoletta, Silvia; Zhang, Dandan; Han, Gye Won; Li, Tingting; Ma, Limin; Zhang, Wenru; Mueller, Christa E.; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Katritch, Vsevolod; Jacobson, Kenneth A.; Stevens, Raymond C.; Wu, Beili; Zhao, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">509</span>
        (<span class="NLM_cas:issue">7498</span>),
    <span class="NLM_cas:pages">119-122</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The P2Y12 receptor (P2Y12R), one of eight members of the P2YR family expressed in humans, is one of the most prominent clin. drug targets for inhibition of platelet aggregation.  Although mutagenesis and modeling studies of the P2Y12R provided useful insights into ligand binding, the agonist and antagonist recognition and function at the P2Y12R remain poorly understood at the mol. level.  Here we report the structures of the human P2Y12R in complex with the full agonist 2-methylthio-adenosine-5'-diphosphate (2MeSADP, a close analog of endogenous agonist ADP) at 2.5 Å resoln., and the corresponding ATP deriv. 2-methylthio-adenosine-5'-triphosphate (2MeSATP) at 3.1 Å resoln.  These structures, together with the structure of the P2Y12R with antagonist Et 6-(4-((benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283), reveal striking conformational changes between nucleotide and non-nucleotide ligand complexes in the extracellular regions.  Further anal. of these changes provides insight into a distinct ligand binding landscape in the δ-group of class A G-protein-coupled receptors (GPCRs).  Agonist and non-nucleotide antagonist adopt different orientations in the P2Y12R, with only partially overlapped binding pockets.  The agonist-bound P2Y12R structure answers long-standing questions surrounding P2Y12R-agonist recognition, and reveals interactions with several residues that had not been reported to be involved in agonist binding.  As a first example, to our knowledge, of a GPCR in which agonist access to the binding pocket requires large-scale rearrangements in the highly malleable extracellular region, the structural and docking studies will therefore provide invaluable insight into the pharmacol. and mechanisms of action of agonists and different classes of antagonists for the P2Y12R and potentially for other closely related P2YRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJkF4VbScbarVg90H21EOLACvtfcHk0ljUjrTXbeDasg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlyis7k%253D&md5=7fdb421ab2f3757a7e7134d586de84bf</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature13288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13288%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DQ.%26atitle%3DAgonist-bound%2520structure%2520of%2520the%2520human%2520P2Y12%2520receptor%26jtitle%3DNature%26date%3D2014%26volume%3D509%26spage%3D119%26epage%3D122%26doi%3D10.1038%2Fnature13288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Espey, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, J. S.</span></span> <span> </span><span class="NLM_article-title">Temporal and spatial patterns of ovarian gene transcription following an ovulatory dose of gonadotropin in the rat</span>. <i>Biol. Reprod.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1662</span>– <span class="NLM_lpage">1670</span>, <span class="refDoi"> DOI: 10.1095/biolreprod.102.005173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1095%2Fbiolreprod.102.005173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=12444039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD38XptVels74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=1662-1670&author=L.+L.+Espeyauthor=J.+S.+Richards&title=Temporal+and+spatial+patterns+of+ovarian+gene+transcription+following+an+ovulatory+dose+of+gonadotropin+in+the+rat&doi=10.1095%2Fbiolreprod.102.005173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Temporal and spatial patterns of ovarian gene transcription following an ovulatory dose of gonadotropin in the rat</span></div><div class="casAuthors">Espey, Lawrence L.; Richards, JoAnne S.</div><div class="citationInfo"><span class="NLM_cas:title">Biology of Reproduction</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1662-1670</span>CODEN:
                <span class="NLM_cas:coden">BIREBV</span>;
        ISSN:<span class="NLM_cas:issn">0006-3363</span>.
    
            (<span class="NLM_cas:orgname">Society for the Study of Reproduction</span>)
        </div><div class="casAbstract">A review.  In recent years, there have been a no. of efforts to identify genes that are expressed in mature ovarian follicles in response to an ovulatory dose of LH or its homolog human chorionic gonadotropin (hCG).  This review keys on 20 ovulation-specific genes that we have identified by the mol. procedure known as differential display.  The objective is to use this sampling of genes to illustrate the diversity in the temporal and spatial patterns of expression of genes in the ovary following the stimulus of this gonadal target tissue by a single glycoprotein hormone.  The specific genes that are surveyed include 5-aminolevulinate synthase; early growth response protein-1; γ-glutamylcysteine synthetase; cyclooxygenase-2; epiregulin; pituitary adenylate cyclase-activating polypeptide; tumor necrosis factor-stimulated gene-6; regulator of G-protein signaling protein-2; adrenodoxin; steroidogenic acute regulatory protein; 3α-hydroxysteroid dehydrogenase; CD63, a disintegrin and metalloproteinase with thrombospondin motifs; tissue inhibitor of metalloproteinase-1; carbonyl reductase, a G-protein-coupled receptor; pancreatitis-assocd. protein-III; glutathione S-transferase; and metallothionein-1.  The ovulatory expression of these different genes is predominantly within the granulosa layer of mature follicles.  However, there were also instances of expression in the thecal and stromal tissue of the ovary, as well as in vascular endothelial cells and in luteal tissue.  The overwhelming impression is that the mol. events of ovulation are far more complex, and therefore more highly ordered, than originally imagined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnt0lhfh717Vg90H21EOLACvtfcHk0ljUjrTXbeDasg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptVels74%253D&md5=69536db980a054a6f8c5dc868c68d04b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1095%2Fbiolreprod.102.005173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1095%252Fbiolreprod.102.005173%26sid%3Dliteratum%253Aachs%26aulast%3DEspey%26aufirst%3DL.%2BL.%26aulast%3DRichards%26aufirst%3DJ.%2BS.%26atitle%3DTemporal%2520and%2520spatial%2520patterns%2520of%2520ovarian%2520gene%2520transcription%2520following%2520an%2520ovulatory%2520dose%2520of%2520gonadotropin%2520in%2520the%2520rat%26jtitle%3DBiol.%2520Reprod.%26date%3D2002%26volume%3D67%26spage%3D1662%26epage%3D1670%26doi%3D10.1095%2Fbiolreprod.102.005173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fitzpatrick, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlone, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robker, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, J. S.</span></span> <span> </span><span class="NLM_article-title">Expression of aromatase in the ovary: down-regulation of mRNA by the ovulatory luteinizing hormone surge</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">206</span>, <span class="refDoi"> DOI: 10.1016/S0039-128X(96)00181-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2FS0039-128X%2896%2900181-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=9029737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK2sXhtVyluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=197-206&author=S.+L.+Fitzpatrickauthor=D.+L.+Carloneauthor=R.+L.+Robkerauthor=J.+S.+Richards&title=Expression+of+aromatase+in+the+ovary%3A+down-regulation+of+mRNA+by+the+ovulatory+luteinizing+hormone+surge&doi=10.1016%2FS0039-128X%2896%2900181-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of aromatase in the ovary: down-regulation of mRNA by the ovulatory luteinizing hormone surge</span></div><div class="casAuthors">Fitzpatrick, Susan L.; Carlone, Diana L.; Robker, Rebecca L.; Richards, JoAnne S.</div><div class="citationInfo"><span class="NLM_cas:title">Steroids</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-206</span>CODEN:
                <span class="NLM_cas:coden">STEDAM</span>;
        ISSN:<span class="NLM_cas:issn">0039-128X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Aromatase (CYP19) mRNA is induced by FSH in granulosa cells of preovulatory follicles and subsequently is rapidly diminished as a consequence of the LH surge.  Primary cultures of rat granulosa cells were used to identify some of the cellular mechanisms by which FSH increases and LH decreases steady-state levels of aromatase mRNA.  Induction of aromatase mRNA by FSH was increased by cycloheximide but was blocked by α-amanitin and the C-kinase activators gonadotropin-releasing hormone (GnRH) and phorbol 12-myristate 13-acetate (PMA).  In contrast, the decrease in steady-state levels of aromatase mRNA by LH was mimicked by A-kinase (forskolin) and C-kinase (PMA or GnRH) activators.  The decrease in aromatase mRNA was assocd. with decreased amts. of mRNA and protein for steroidogenic factor-1 (SF-1), a nuclear orphan receptor that binds and trans-activates the aromatase promoter, and with the A-kinase subunit type II (RIIβ), which is required for mediating cAMP action in these cells.  The down-regulation of aromatase, SF-1, and RIIβ by each kinase activator and α-amanitin was prevented by cycloheximide when the drug was added in combination with the activator.  If, however, cycloheximide was added 2 h after PMA (or LH), the drug did not prevent the rapid loss of mRNA.  When granulosa cells were transfected with an aromatase CAT transgene, CAT activity was stimulated 10- to 20-fold by FSH and forskolin but not by PMA.  Taken together, these results indicate that the A-kinase but not the C-kinase pathway can trans-activate the aromatase gene in immature granulosa cells, whereas the C-kinase, as well as A-kinase pathways, mimic the LH surge to decrease aromatase mRNA in preovulatory cells.  By increasing degrdn. of aromatase mRNA and by inhibiting transcription, the LH surge rapidly terminates the granulosa cell pattern of gene expression while reprogramming the cells to express genes assocd. with ovulation and luteinization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP0oSneYWQjbVg90H21EOLACvtfcHk0li9bKTURcQe1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtVyluro%253D&md5=7f04f1e4a8d47daa09d715993f573191</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0039-128X%2896%2900181-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0039-128X%252896%252900181-X%26sid%3Dliteratum%253Aachs%26aulast%3DFitzpatrick%26aufirst%3DS.%2BL.%26aulast%3DCarlone%26aufirst%3DD.%2BL.%26aulast%3DRobker%26aufirst%3DR.%2BL.%26aulast%3DRichards%26aufirst%3DJ.%2BS.%26atitle%3DExpression%2520of%2520aromatase%2520in%2520the%2520ovary%253A%2520down-regulation%2520of%2520mRNA%2520by%2520the%2520ovulatory%2520luteinizing%2520hormone%2520surge%26jtitle%3DSteroids%26date%3D1997%26volume%3D62%26spage%3D197%26epage%3D206%26doi%3D10.1016%2FS0039-128X%2896%2900181-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hakola, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierroz, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuagnat, B. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huhtaniemi, I.</span></span> <span> </span><span class="NLM_article-title">Dose and time relationships of intravenously injected rat recombinant luteinizing hormone and testicular testosterone secretion in the male rat</span>. <i>Biol. Reprod.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1095/biolreprod59.2.338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1095%2Fbiolreprod59.2.338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=9687305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK1cXltFGntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1998&pages=338-343&author=K.+Hakolaauthor=D.+D.+Pierrozauthor=A.+Aebiauthor=B.+A.+M.+Vuagnatauthor=M.+L.+Aubertauthor=I.+Huhtaniemi&title=Dose+and+time+relationships+of+intravenously+injected+rat+recombinant+luteinizing+hormone+and+testicular+testosterone+secretion+in+the+male+rat&doi=10.1095%2Fbiolreprod59.2.338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Dose and time relationships of intravenously injected rat recombinant luteinizing hormone and testicular testosterone secretion in the male rat</span></div><div class="casAuthors">Hakola, Kati; Pierroz, Dominique D.; Aebi, Audrey; Vuagnat, Beatrice A. M.; Aubert, Michel L.; Huhtaniemi, Ilpo</div><div class="citationInfo"><span class="NLM_cas:title">Biology of Reproduction</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">338-343</span>CODEN:
                <span class="NLM_cas:coden">BIREBV</span>;
        ISSN:<span class="NLM_cas:issn">0006-3363</span>.
    
            (<span class="NLM_cas:orgname">Society for the Study of Reproduction</span>)
        </div><div class="casAbstract">The ability of hCG and LH to induce testosterone (T) secretion by Leydig cells is well documented.  However, the influence of the pulsatile nature of LH secretion, with varying frequency and amplitude, on T prodn. in vivo is less clear.  In the authors' earlier studies on the relationship between pulsatile LH release and T secretion in adult male rats, no simple causality was obsd.  The recent availability of rat recombinant (rec) LH prompted the authors to study the effects of one and of three i.v. pulses of different doses of rat recLH on T secretion in adult male rats rendered hypogonadotropic by treatment with the GnRH antagonist Cetrorelix.  One or three supraphysiol. pulses of 1.0 μg of rat recLH produced similar maximal T responses.  In contrast, high physiol. LH pulses (0.1 μg) produced discrete T-response peaks, whereas multiple low pulses of LH (0.03 μg) were needed before a T response was achieved.  The T stimulation was greatly diminished after an LH pulse of 0.1 μg if rats had been treated on the previous day with pulses of 0.03 vs. 0.1 μg rat recLH, apparently because of prolonged LH deprivation and lack of Leydig cell priming due to the GnRH antagonist treatment.  The novel prepn. of rat recLH provides a physiol. relevant tool for studying the complex relationship between pulsatile LH release and T secretion in male rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojdGTOhcnCj7Vg90H21EOLACvtfcHk0li9bKTURcQe1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFGntrc%253D&md5=1e4515961a36baa3f7cea0610e0a109a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1095%2Fbiolreprod59.2.338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1095%252Fbiolreprod59.2.338%26sid%3Dliteratum%253Aachs%26aulast%3DHakola%26aufirst%3DK.%26aulast%3DPierroz%26aufirst%3DD.%2BD.%26aulast%3DAebi%26aufirst%3DA.%26aulast%3DVuagnat%26aufirst%3DB.%2BA.%2BM.%26aulast%3DAubert%26aufirst%3DM.%2BL.%26aulast%3DHuhtaniemi%26aufirst%3DI.%26atitle%3DDose%2520and%2520time%2520relationships%2520of%2520intravenously%2520injected%2520rat%2520recombinant%2520luteinizing%2520hormone%2520and%2520testicular%2520testosterone%2520secretion%2520in%2520the%2520male%2520rat%26jtitle%3DBiol.%2520Reprod.%26date%3D1998%26volume%3D59%26spage%3D338%26epage%3D343%26doi%3D10.1095%2Fbiolreprod59.2.338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, F. R.</span></span> <span> </span><span class="NLM_article-title">The female rat reproductive cycle: a practical histological guide to staging</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1177/0192623308315665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1177%2F0192623308315665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=18441260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A280%3ADC%252BD1czlslKlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=375-384&author=F.+R.+Westwood&title=The+female+rat+reproductive+cycle%3A+a+practical+histological+guide+to+staging&doi=10.1177%2F0192623308315665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The female rat reproductive cycle: a practical histological guide to staging</span></div><div class="casAuthors">Westwood F Russell</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic pathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">375-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During preclinical investigations into the safety of drugs and chemicals, many are found to interfere with reproductive function in the female rat.  This interference is commonly expressed as a change in normal morphology of the reproductive tract or a disturbance in the duration of particular phases of the estrous cycle.  Such alterations can be recognized only if the pathologist has knowledge of the continuously changing histological appearance of the various components of the reproductive tract during the cycle and can accurately and consistently ascribe an individual tract to a particular phase of the cycle.  Unfortunately, although comprehensive reports illustrating the normal appearance of the tract during the rat estrous cycle have been available over many years, they are generally somewhat ambiguous about distinct criteria for defining the end of one stage and the beginning of another.  This detail is absolutely essential to achieve a consistent approach to staging the cycle.  For the toxicologic pathologist, this report illustrates a pragmatic and practical approach to staging the estrous cycle in the rat based on personal experience and a review of the literature from the last century.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgHhZg9BcGu1vAgqb2vdc5fW6udTcc2eZIFtunzdEwj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czlslKlsA%253D%253D&md5=5a5d21cb6688af39ea1edcf9fa7e20af</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1177%2F0192623308315665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623308315665%26sid%3Dliteratum%253Aachs%26aulast%3DWestwood%26aufirst%3DF.%2BR.%26atitle%3DThe%2520female%2520rat%2520reproductive%2520cycle%253A%2520a%2520practical%2520histological%2520guide%2520to%2520staging%26jtitle%3DToxicol.%2520Pathol.%26date%3D2008%26volume%3D36%26spage%3D375%26epage%3D384%26doi%3D10.1177%2F0192623308315665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foltz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, C. V.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1210/mend.15.1.0586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1210%2Fmend.15.1.0586" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=11145749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=184-200&author=Z.+M.+Leiauthor=S.+Mishraauthor=W.+Zouauthor=B.+Xuauthor=M.+Foltzauthor=X.+Liauthor=C.+V.+Rao&title=Targeted+disruption+of+luteinizing+hormone%2Fhuman+chorionic+gonadotropin+receptor+gene&doi=10.1210%2Fmend.15.1.0586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene</span></div><div class="casAuthors">Lei, Z. M.; Mishra, S.; Zou, W.; Xu, B.; Foltz, M.; Li, X.; Rao, Ch. V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">184-200</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">LH/hCG receptors were disrupted by gene targeting in embryonic stem cells.  The disruption resulted in infertility in both sexes.  The gonads contained no receptor mRNA or receptor protein.  Serum LH levels were greatly elevated, and FSH levels were moderately elevated in both sexes; estradiol and progesterone levels decreased but were not totally suppressed in females; testosterone levels were dramatically decreased and estradiol levels moderately elevated in males.  The external and internal genitalia were grossly underdeveloped in both sexes.  Abnormalities included ambiguous vaginal opening, abdominal testes, micropenis, dramatically decreased wts. of the gonads and reproductive tract, arrested follicular growth beyond antral stage, disarray of seminiferous tubules, diminished no. and hypotrophy of Leydig cells, and spermatogenic arrest beyond the round spermatid stage.  LH/hCG receptor gene disruption had no effect on FSH receptor mRNA levels in ovaries and testes, progesterone receptor (PR) levels in ovaries and androgen receptor (AR) levels in testes.  However, it caused a dramatic decrease in StAR and estrogen receptor-α (ERα) mRNA levels and an increase in ERβ mRNA levels in both ovaries and testes.  Estradiol and progesterone replacement therapy in females and testosterone replacement in males, to det. whether phenotype and biochem. changes were a consequence of decreased gonadal steroid levels or due to a loss of LH signaling, revealed complete restoration of some and partial restoration of others.  Nevertheless, the animals remained infertile.  It is anticipated that the LH receptor knockout animals will increase the authors' current understanding of gonadal and nongonadal actions of LH and hCG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjk5oEbl0biLVg90H21EOLACvtfcHk0ljV28j4fbMSwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVKlsg%253D%253D&md5=38199265d562f5f9ca2cac4d0f6638e2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1210%2Fmend.15.1.0586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.15.1.0586%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DZ.%2BM.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DFoltz%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRao%26aufirst%3DC.%2BV.%26atitle%3DTargeted%2520disruption%2520of%2520luteinizing%2520hormone%252Fhuman%2520chorionic%2520gonadotropin%2520receptor%2520gene%26jtitle%3DMol.%2520Endocrinol.%26date%3D2001%26volume%3D15%26spage%3D184%26epage%3D200%26doi%3D10.1210%2Fmend.15.1.0586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span> <span> </span><span class="NLM_article-title">Genetic evidence of ‘genuine’ empty follicle syndrome: a novel effective mutation in the LHCGR gene and review of the literature</span>. <i>Hum. Reprod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">944</span>– <span class="NLM_lpage">953</span>, <span class="refDoi"> DOI: 10.1093/humrep/dex015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1093%2Fhumrep%2Fdex015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=28175319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFCkurbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=944-953&author=P.+Yuanauthor=Z.+Heauthor=L.+Zhengauthor=W.+Wangauthor=Y.+Liauthor=H.+Zhaoauthor=V.+W.+Zhangauthor=Q.+Zhangauthor=D.+Yang&title=Genetic+evidence+of+%E2%80%98genuine%E2%80%99+empty+follicle+syndrome%3A+a+novel+effective+mutation+in+the+LHCGR+gene+and+review+of+the+literature&doi=10.1093%2Fhumrep%2Fdex015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic evidence of 'genuine' empty follicle syndrome: a novel effective mutation in the LHCGR gene and review of the literature</span></div><div class="casAuthors">Yuan, Ping; He, Zuyong; Zheng, Lingyan; Wang, Wenjun; Li, Yu; Zhao, Haijing; Zhang, Victor Wei; Zhang, Qingxue; Yang, Dongzi</div><div class="citationInfo"><span class="NLM_cas:title">Human Reproduction</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">944-953</span>CODEN:
                <span class="NLM_cas:coden">HUREEE</span>;
        ISSN:<span class="NLM_cas:issn">1460-2350</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Empty follicle syndrome (EFS) is a reproductive disorder in which no oocytes are retrieved during IVF.  The existence of genuine EFS (GEFS) is still controversial, and to date, only one missense mutation of LH/Choriogonadotropin Receptor (LHCGR) has been reported to be assocd. with this disease.  Here, we describe a GEFS patient in a non-consanguineous family from China.  A 27-yr-old woman presented with a 5-yr history of primary infertility and LH resistance-like ovaries of unequal sizes, but with normal levels of circulating LH.  In spite of a satisfactory ovarian reserve and response, no oocytes were retrieved after two cycles of IVF.  Her condition did not appear to be failure of the hCG injection.  It is more likely to be a genetic cause.  A novel homozygous mutation in LHCGR gene, c.1345G>A (p.Ala449Thr), was detected in this patient.  Each of her parents is heterozygous for this change, and the change was absent from 407 control subjects.  Alanine at this amino acid position was highly conserved and replacement of threonine was predicted to disrupt the third transmembrane helix of the rhodopsin-like G protein-coupled receptor domain.  Protein localization studies revealed that a portion of the mutant LHCGR protein mols. was retained intracellularly.  Signalling studies demonstrated that this mutation had differing effects on the response of LHCGR to hCG or LH at different concns.  Specifically, at a concn. <1 IU/mL, the mutant was activated by hCG stimulation but partially resistant to LH stimulation; at a higher concn. (>1 IU/mL), the mutant was activated by both hCG and LH.  These data suggest that screening for mutations in the LHCGR gene may assist in the diagnosis of patients with GEFS.  The literature describing the relationship between phenotype and genotypes in females is reviewed, and possible etiologies and treatment options for this disease are proposed based on our and other studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2wL4Axw87LbVg90H21EOLACvtfcHk0ljV28j4fbMSwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFCkurbN&md5=8795d852e2780fa622025994cb384d5d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fhumrep%2Fdex015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhumrep%252Fdex015%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DV.%2BW.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DD.%26atitle%3DGenetic%2520evidence%2520of%2520%25E2%2580%2598genuine%25E2%2580%2599%2520empty%2520follicle%2520syndrome%253A%2520a%2520novel%2520effective%2520mutation%2520in%2520the%2520LHCGR%2520gene%2520and%2520review%2520of%2520the%2520literature%26jtitle%3DHum.%2520Reprod.%26date%3D2017%26volume%3D32%26spage%3D944%26epage%3D953%26doi%3D10.1093%2Fhumrep%2Fdex015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">First targeted protein degrader hits the clinic</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1038/d41573-019-00043-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1038%2Fd41573-019-00043-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=237-239&author=A.+Mullard&title=First+targeted+protein+degrader+hits+the+clinic&doi=10.1038%2Fd41573-019-00043-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fd41573-019-00043-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fd41573-019-00043-6%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DFirst%2520targeted%2520protein%2520degrader%2520hits%2520the%2520clinic%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2019%26volume%3D18%26spage%3D237%26epage%3D239%26doi%3D10.1038%2Fd41573-019-00043-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nardone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delpuech, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cataldo, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veeraraghavan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimawi, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilsenbeck, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamness, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeselsohn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiff, R.</span></span> <span> </span><span class="NLM_article-title">The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1038/s41416-018-0354-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1038%2Fs41416-018-0354-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=30555156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFCitLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2019&pages=331-339&author=A.+Nardoneauthor=H.+Weirauthor=O.+Delpuechauthor=H.+Brownauthor=C.+De+Angelisauthor=M.+L.+Cataldoauthor=X.+Fuauthor=M.+J.+Sheaauthor=T.+Mitchellauthor=J.+Veeraraghavanauthor=C.+Nagiauthor=M.+Pillingauthor=M.+F.+Rimawiauthor=M.+Trivediauthor=S.+G.+Hilsenbeckauthor=G.+C.+Chamnessauthor=R.+Jeselsohnauthor=C.+K.+Osborneauthor=R.+Schiff&title=The+oral+selective+oestrogen+receptor+degrader+%28SERD%29+AZD9496+is+comparable+to+fulvestrant+in+antagonising+ER+and+circumventing+endocrine+resistance&doi=10.1038%2Fs41416-018-0354-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance</span></div><div class="casAuthors">Nardone, Agostina; Weir, Hazel; Delpuech, Oona; Brown, Henry; De Angelis, Carmine; Cataldo, Maria Letizia; Fu, Xiaoyong; Shea, Martin J.; Mitchell, Tamika; Veeraraghavan, Jamunarani; Nagi, Chandandeep; Pilling, Mark; Rimawi, Mothaffar F.; Trivedi, Meghana; Hilsenbeck, Susan G.; Chamness, Gary C.; Jeselsohn, Rinath; Osborne, C. Kent; Schiff, Rachel</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-339</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Background: The estrogen receptor (ER) is an important therapeutic target in ER-pos. (ER+) breast cancer.  The selective ER degrader (SERD), fulvestrant, is effective in patients with metastatic breast cancer, but its i.m. route of administration and low bioavailability are major clin. limitations.  Methods: Here, we studied the pharmacol. of a new oral SERD, AZD9496, in a panel of in vitro and in vivo endocrine-sensitive and -resistant breast cancer models.  Results: In endocrine-sensitive models, AZD9496 inhibited cell growth and blocked ER activity in the presence or absence of estrogen.  In vivo, in the presence of estrogen, short-term AZD9496 treatment, like fulvestrant, resulted in tumor growth inhibition and reduced expression of ER-dependent genes.  AZD9496 inhibited cell growth in estrogen deprivation-resistant and tamoxifen-resistant cell lines and xenograft models that retain ER expression.  AZD9496 effectively reduced ER levels and ER-induced transcription.  Expression anal. of short-term treated tumors showed that AZD9496 potently inhibited classic estrogen-induced gene transcription, while simultaneously increasing expression of genes neg. regulated by ER, including genes potentially involved in escape pathways of endocrine resistance.  Conclusions: These data suggest that AZD9496 is a potent anti-estrogen that antagonizes and degrades ER with anti-tumor activity in both endocrine-sensitive and endocrine-resistant models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5n15FNP5aPrVg90H21EOLACvtfcHk0lhf6NA2ifnMqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFCitLjE&md5=f33a177b69b0b803e9c2732f97200619</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fs41416-018-0354-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41416-018-0354-9%26sid%3Dliteratum%253Aachs%26aulast%3DNardone%26aufirst%3DA.%26aulast%3DWeir%26aufirst%3DH.%26aulast%3DDelpuech%26aufirst%3DO.%26aulast%3DBrown%26aufirst%3DH.%26aulast%3DDe%2BAngelis%26aufirst%3DC.%26aulast%3DCataldo%26aufirst%3DM.%2BL.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DShea%26aufirst%3DM.%2BJ.%26aulast%3DMitchell%26aufirst%3DT.%26aulast%3DVeeraraghavan%26aufirst%3DJ.%26aulast%3DNagi%26aufirst%3DC.%26aulast%3DPilling%26aufirst%3DM.%26aulast%3DRimawi%26aufirst%3DM.%2BF.%26aulast%3DTrivedi%26aufirst%3DM.%26aulast%3DHilsenbeck%26aufirst%3DS.%2BG.%26aulast%3DChamness%26aufirst%3DG.%2BC.%26aulast%3DJeselsohn%26aufirst%3DR.%26aulast%3DOsborne%26aufirst%3DC.%2BK.%26aulast%3DSchiff%26aufirst%3DR.%26atitle%3DThe%2520oral%2520selective%2520oestrogen%2520receptor%2520degrader%2520%2528SERD%2529%2520AZD9496%2520is%2520comparable%2520to%2520fulvestrant%2520in%2520antagonising%2520ER%2520and%2520circumventing%2520endocrine%2520resistance%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2019%26volume%3D120%26spage%3D331%26epage%3D339%26doi%3D10.1038%2Fs41416-018-0354-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bone, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleve, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotgeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultze-Mosgau, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagenfeld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of vilaprisan (BAY 1002670): a highly potent and selective progesterone receptor modulator optimized for gynecologic therapies</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2271</span>– <span class="NLM_lpage">2280</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201800487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1002%2Fcmdc.201800487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=30407750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A280%3ADC%252BB3cvnvFKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2271-2280&author=C.+M%C3%B6llerauthor=W.+Boneauthor=A.+Cleveauthor=U.+Klarauthor=A.+Rotgeriauthor=A.+Rottmannauthor=M.-H.+Schultze-Mosgauauthor=A.+Wagenfeldauthor=W.+Schwede&title=Discovery+of+vilaprisan+%28BAY+1002670%29%3A+a+highly+potent+and+selective+progesterone+receptor+modulator+optimized+for+gynecologic+therapies&doi=10.1002%2Fcmdc.201800487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies</span></div><div class="casAuthors">Moller Carsten; Bone Wilhelm; Cleve Arwed; Rotgeri Andrea; Rottmann Antje; Schultze-Mosgau Marcus-Hillert; Wagenfeld Andrea; Schwede Wolfgang; Klar Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2271-2280</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Progesterone plays an important role in the female reproductive system.  However, there is also evidence that gynecologic disorders/diseases such as uterine fibroids and endometriosis are progesterone-dependent.  Steroidal and non-steroidal selective progesterone receptor modulators (SPRMs) have shown potential for the treatment of such diseases.  Steroidal SPRMs, including mifepristone and ulipristal acetate, have proven effective in clinical trials.  However, several steroidal SPRMs containing a dimethylamino substituent have been associated with elevated liver enzymes in patients.  An earlier drug discovery program identified lonaprisan as a highly selective SPRM that did not show drug-related change in liver enzyme activity.  Building on data obtained from that work, here we describe the research program that culminated in the discovery of a novel steroidal SPRM, vilaprisan, which combines an extremely high potency with very favorable drug metabolism and pharmacokinetic properties.  Vilaprisan has entered clinical development and is currently undergoing phase 3 clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLFws_wFa1cNNTrvPZP1IpfW6udTcc2eY-WlDUJPxBwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvnvFKguw%253D%253D&md5=9602ce0fb9815b274ae572ac573d763b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201800487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201800487%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DC.%26aulast%3DBone%26aufirst%3DW.%26aulast%3DCleve%26aufirst%3DA.%26aulast%3DKlar%26aufirst%3DU.%26aulast%3DRotgeri%26aufirst%3DA.%26aulast%3DRottmann%26aufirst%3DA.%26aulast%3DSchultze-Mosgau%26aufirst%3DM.-H.%26aulast%3DWagenfeld%26aufirst%3DA.%26aulast%3DSchwede%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520vilaprisan%2520%2528BAY%25201002670%2529%253A%2520a%2520highly%2520potent%2520and%2520selective%2520progesterone%2520receptor%2520modulator%2520optimized%2520for%2520gynecologic%2520therapies%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D2271%26epage%3D2280%26doi%3D10.1002%2Fcmdc.201800487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suh, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keren-Tal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmelhoch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amsterdam, A.</span></span> <span> </span><span class="NLM_article-title">Introduction of a gonadotropin receptor expression plasmid into immortalized granulosa cells leads to reconstitution of hormone-dependent steroidogenesis</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1083/jcb.119.2.439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1083%2Fjcb.119.2.439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1328253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK38XmtVGms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1992&pages=439-450&author=B.+S.+Suhauthor=R.+Sprengelauthor=I.+Keren-Talauthor=S.+Himmelhochauthor=A.+Amsterdam&title=Introduction+of+a+gonadotropin+receptor+expression+plasmid+into+immortalized+granulosa+cells+leads+to+reconstitution+of+hormone-dependent+steroidogenesis&doi=10.1083%2Fjcb.119.2.439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of a gonadotropin receptor expression plasmid into immortalized granulosa cells leads to reconstitution of hormone-dependent steroidogenesis</span></div><div class="casAuthors">Suh, B. S.; Sprengel, R.; Keren-Tal, I.; Himmelhoch, S.; Amsterdam, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">439-50</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    </div><div class="casAbstract">The authors have recently succeeded in immortalizing rat granulosa cells by co-transfection with SV-40 DNA and the Ha-ras oncogene.  These cells lost their response to gonadotropins, but expressed the cytochrome P 450scc mitochondrial system enzymes and produced progesterone and 20α-hydroxy-4-pregnan-3-one (20α-OH-P) upon cAMP stimulation.  In an attempt to restore the steroidogenic response to gonadotropins in immortalized cells, a lutropin/choriogonadotropin (LH/CG-R) receptor expression plasmid was prepd. by introducing the complete coding region of the LH receptor cDNA into a SV-40 early promoter based eukaryotic expression vector.  Granulosa cells from preovulatory follicles were transfected with this LH receptor expression plasmid, together with SV-40 DNA and the Ha-ras oncogene.  Cell lines obtained after this triple transfection accumulated cAMP in a dose-dependent manner in response to hCG.  Moreover, they produced progesterone and 20α-OH-P upon hCG stimulation with ED50 values of 125 pM and 75 pM, resp., which are within the physiol. range.  Concomitantly with hCG-induced differentiation, inhibition of cell proliferation was evident following stimulation with hormone concns. as low as 40 pM.  The no. of hCG receptor sites per cell after numerous passages and several freezing and thawing cycles was 1.9 × 104; they showed a Kd of 180 pM.  Stimulation with hCG induced pronounced morphol. and biochem. changes in these cells, including formation of mitochondrial located adrenodoxin, a marker enzyme for enhanced steroidogenesis.  These findings make possible the expression, in immortalized granulosa cells, of selectively mutated receptor mols. which preserve their steroidogenic potential, thereby opening the way to anal. of structure-function relationships of the receptor mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb8WVHPBVloLVg90H21EOLACvtfcHk0lhf6NA2ifnMqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmtVGms74%253D&md5=d2f3e1b6742b84be63efbdbf934fe149</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1083%2Fjcb.119.2.439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.119.2.439%26sid%3Dliteratum%253Aachs%26aulast%3DSuh%26aufirst%3DB.%2BS.%26aulast%3DSprengel%26aufirst%3DR.%26aulast%3DKeren-Tal%26aufirst%3DI.%26aulast%3DHimmelhoch%26aufirst%3DS.%26aulast%3DAmsterdam%26aufirst%3DA.%26atitle%3DIntroduction%2520of%2520a%2520gonadotropin%2520receptor%2520expression%2520plasmid%2520into%2520immortalized%2520granulosa%2520cells%2520leads%2520to%2520reconstitution%2520of%2520hormone-dependent%2520steroidogenesis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1992%26volume%3D119%26spage%3D439%26epage%3D450%26doi%3D10.1083%2Fjcb.119.2.439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, B. A.</span></span> <span> </span><span class="NLM_article-title">A novel method to modulate desensitization and truncation of luteinizing hormone receptors using antisense oligodeoxynucleotides</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">R9</span>– <span class="NLM_lpage">R14</span>, <span class="refDoi"> DOI: 10.1016/0303-7207(91)90111-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2F0303-7207%2891%2990111-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1657660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK3MXltVKgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1991&pages=R9-R14&author=A.+P.+Westauthor=B.+A.+Cooke&title=A+novel+method+to+modulate+desensitization+and+truncation+of+luteinizing+hormone+receptors+using+antisense+oligodeoxynucleotides&doi=10.1016%2F0303-7207%2891%2990111-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A novel method to modulate desensitization and truncation of luteinizing hormone receptors using antisense oligodeoxynucleotides</span></div><div class="casAuthors">West, Anthony P.; Cooke, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">R9-R14</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    </div><div class="casAbstract">A novel method to study the mechanisms of LH receptor desensitization and truncation, using antisense oligodeoxynucleotides that code for regions of the NH2-terminus, the third extracellular loop and the C-terminus of the LH receptor, was described.  Mouse tumor (MA10) Leydig cells were incubated for 48 h with the addn. of 2.5 μM antisense oligodeoxynucleotides at time 0 and 24 h.  The NH2-terminus oligodeoxynucleotide completely inhibited synthesis of the LH receptor.  Pretreatment with the third extracellular loop oligodeoxynucleotide inhibited LH-, dibutyryl-cAMP (db-cAMP)-, and phorbol 12-myristate 13-acetate (PMA)-induced desensitization and truncation of LH receptors.  Truncation, but not desensitization, of the LH receptor was prevented in cells pretreated with the C-terminus oligodeoxynucleotide.  These results indicate that different sites of the C-terminal intracellular tail of the LH receptor are involved in the regulation of desensitization and truncation of the LH receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfA8yznrIqZ7Vg90H21EOLACvtfcHk0lhnycfe3ca5PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXltVKgsLs%253D&md5=63b9bd74324d8ac5c03d3b26dcfa2853</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2F0303-7207%2891%2990111-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0303-7207%252891%252990111-5%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BP.%26aulast%3DCooke%26aufirst%3DB.%2BA.%26atitle%3DA%2520novel%2520method%2520to%2520modulate%2520desensitization%2520and%2520truncation%2520of%2520luteinizing%2520hormone%2520receptors%2520using%2520antisense%2520oligodeoxynucleotides%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D1991%26volume%3D79%26spage%3DR9%26epage%3DR14%26doi%3D10.1016%2F0303-7207%2891%2990111-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Derwahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuemmel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goretzki, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schatz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broecker, M.</span></span> <span> </span><span class="NLM_article-title">Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">1131</span>– <span class="NLM_lpage">1138</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1993.1334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1006%2Fbbrc.1993.1334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=8385451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK3sXitVGls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=1993&pages=1131-1138&author=M.+Derwahlauthor=M.+Kuemmelauthor=P.+Goretzkiauthor=H.+Schatzauthor=M.+Broecker&title=Expression+of+the+human+TSH+receptor+in+a+human+thyroid+carcinoma+cell+line+that+lacks+an+endogenous+TSH+receptor%3A+growth+inhibition+by+cAMP&doi=10.1006%2Fbbrc.1993.1334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: Growth inhibition by cAMP</span></div><div class="casAuthors">Derwahl, Michael; Kuemmel, Marion; Goretzki, Peter; Schatz, Helmut; Broecker, Martina</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1131-8</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Human thyroid carcinoma cells lacking an endogenous TSH receptor were transfected with the human TSH receptor cDNA.  Transfected cells, designated HTC-TSHr, expressed the TSH receptor mRNA and synthesized a functional TSH receptor with a TSH binding affinity in the order of magnitude of normal thyroid cells.  In response to TSH stimulation, HTC-TSHr cells accumulated cAMP, indicating a functional TSH receptor-adenylate cyclase system.  However, HTC-TSHr cells did not conc. iodide and lacked thyroglobulin immunoreactivity, although they did express low amts. of thyroglobulin mRNA.  Proliferation of HTC-TSHr cells was inhibited by dbcAMP and forskolin and also by TSH via the re-expressed TSH receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLhJNWyCx67Vg90H21EOLACvtfcHk0lhnycfe3ca5PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitVGls74%253D&md5=1de81d7a77a75e5b6fd6d58fd8b339ca</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1993.1334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1993.1334%26sid%3Dliteratum%253Aachs%26aulast%3DDerwahl%26aufirst%3DM.%26aulast%3DKuemmel%26aufirst%3DM.%26aulast%3DGoretzki%26aufirst%3DP.%26aulast%3DSchatz%26aufirst%3DH.%26aulast%3DBroecker%26aufirst%3DM.%26atitle%3DExpression%2520of%2520the%2520human%2520TSH%2520receptor%2520in%2520a%2520human%2520thyroid%2520carcinoma%2520cell%2520line%2520that%2520lacks%2520an%2520endogenous%2520TSH%2520receptor%253A%2520growth%2520inhibition%2520by%2520cAMP%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1993%26volume%3D191%26spage%3D1131%26epage%3D1138%26doi%3D10.1006%2Fbbrc.1993.1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">Crystal structure refinement with SHELXL</span>. <i>Acta Crystallogr., Sect. C: Struct. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053229614024218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1107%2FS2053229614024218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=Crystal+structure+refinement+with+SHELXL&doi=10.1107%2FS2053229614024218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure refinement with SHELXL</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The improvements in the crystal structure refinement program SHELXL have been closely coupled with the development and increasing importance of the CIF (Crystallog. Information Framework) format for validating and archiving crystal structures.  An important simplification is that now only one file in CIF format (for convenience, referred to simply as 'a CIF') contg. embedded reflection data and SHELXL instructions is needed for a complete structure archive; the program SHREDCIF can be used to ext. the and files required for further refinement with SHELXL.  Recent developments in SHELXL facilitate refinement against neutron diffraction data, the treatment of H atoms, the detn. of abs. structure, the input of partial structure factors and the refinement of twinned and disordered structures.  SHELXL is available free to academics for the Windows, Linux and Mac OS X operating systems, and is particularly suitable for multiple-core processors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhk1_pNHwXR7Vg90H21EOLACvtfcHk0lhnycfe3ca5PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D&md5=4a860804b50fc183e8a701098b98ef59</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS2053229614024218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229614024218%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DCrystal%2520structure%2520refinement%2520with%2520SHELXL%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Struct.%2520Chem.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053229614024218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flack, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, T.</span></span> <span> </span><span class="NLM_article-title">Use of intensity quotients and differences in absolute structure refinement</span>. <i>Acta Crystallogr., Sect. B: Struct. Sci., Cryst. Eng. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1107/S2052519213010014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1107%2FS2052519213010014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=23719469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVGntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=249-259&author=S.+Parsonsauthor=H.+D.+Flackauthor=T.+Wagner&title=Use+of+intensity+quotients+and+differences+in+absolute+structure+refinement&doi=10.1107%2FS2052519213010014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Use of intensity quotients and differences in absolute structure refinement</span></div><div class="casAuthors">Parsons, Simon; Flack, Howard D.; Wagner, Trixie</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section B: Structural Science, Crystal Engineering and Materials</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-259</span>CODEN:
                <span class="NLM_cas:coden">ACSBDA</span>;
        ISSN:<span class="NLM_cas:issn">2052-5206</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Several methods for abs. structure refinement were tested using single-crystal x-ray diffraction data collected using Cu Kα radiation for 23 crystals with no element heavier than O: conventional refinement using an inversion twin model, estn. using intensity quotients in SHELXL2012, estn. using Bayesian methods in PLATON, estn. using restraints consisting of numerical intensity differences in CRYSTALS and estn. using differences and quotients in TOPAS-Academic where both quantities were coded in terms of other structural parameters and implemented as restraints.  The conventional refinement approach yielded accurate values of the Flack parameter, but with std. uncertainties ranging from 0.15 to 0.77.  The other methods also yielded accurate values of the Flack parameter, but with much higher precision.  Abs. structure was established in all cases, even for a hydrocarbon.  The procedures in which restraints are coded explicitly in terms of other structural parameters enable the Flack parameter to correlate with these other parameters, so that it is detd. along with those parameters during refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogUlT1yqWxA7Vg90H21EOLACvtfcHk0lg5ukOw5m0K9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVGntL8%253D&md5=37f2e427d6fb24589bddd5b683ea627c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS2052519213010014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2052519213010014%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DFlack%26aufirst%3DH.%2BD.%26aulast%3DWagner%26aufirst%3DT.%26atitle%3DUse%2520of%2520intensity%2520quotients%2520and%2520differences%2520in%2520absolute%2520structure%2520refinement%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520B%253A%2520Struct.%2520Sci.%252C%2520Cryst.%2520Eng.%2520Mater.%26date%3D2013%26volume%3D69%26spage%3D249%26epage%3D259%26doi%3D10.1107%2FS2052519213010014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">In vitro solubility assays in drug discovery</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.2174/138920008786485100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.2174%2F138920008786485100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=18991584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2nsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=879-885&author=E.+H.+Kernsauthor=L.+Diauthor=G.+T.+Carter&title=In+vitro+solubility+assays+in+drug+discovery&doi=10.2174%2F138920008786485100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro solubility assays in drug discovery</span></div><div class="casAuthors">Kerns, Edward H.; Di, Li; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">879-885</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The soly. of a compd. depends on its structure and soln. conditions.  Structure dets. the lipophilicity, hydrogen bonding, mol. vol., crystal energy and ionizability, which det. soly.  Soln. conditions are affected by pH, cosolvents, additives, ionic strength, time and temp.  Many drug discovery expts. are conducted under "kinetic" soly. conditions.  In drug discovery, soly. has a major impact on bioassays, formulation for in vivo dosing, and intestinal absorption.  A good goal for the soly. of drug discovery compds. is >60 ug/mL.  Equil. soly. assays can be conducted in moderate throughput, by incubating excess solid with buffer and agitating for several days, prior to filtration and HPLC quantitation.  Kinetic soly. assays are performed in high throughput with shorter incubation times and high throughput analyses using plate readers.  The most frequently used of these are the nephelometric assay and direct UV assay, which begin by adding a small vol. of DMSO stock soln. of each test compd. to buffer.  In nephelometry, this soln. is serially dild. across a microtiter plate and undissolved particles are detected via light scattering.  In direct UV, undissolved particles are sepd. by filtration, after which the dissolved material is quantitated using UV absorption.  Equil. soly. is useful for preformulation.  Kinetic soly. is useful for rapid compd. assessment, guiding optimization via structure modification, and diagnosing bioassays.  It is often useful to customize soly. expts. using conditions that answer specific research questions of drug discovery teams, such as compd. selection and vehicle development for pharmacol. and PK studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1Pe5z4JU_6LVg90H21EOLACvtfcHk0lg5ukOw5m0K9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2nsb8%253D&md5=416cf5bfde2278eac1ba2c67feb1f62e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.2174%2F138920008786485100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008786485100%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DIn%2520vitro%2520solubility%2520assays%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D879%26epage%3D885%26doi%3D10.2174%2F138920008786485100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Onofrey, T.</span>; <span class="NLM_string-name">Kazan, G.</span></span> <span> </span><span class="NLM_article-title">Performance and correlation of a 96-well high throughput screening method to determine aqueous drug solubility</span>.  <i>Application Note Lit. No. AN1731EN00</i>; <span class="NLM_publisher-name">Millipore Corporation</span>: <span class="NLM_publisher-loc">Billerica, MA</span>, <span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=T.+Onofrey&author=G.+Kazan&title=Application+Note+Lit.+No.+AN1731EN00"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOnofrey%26aufirst%3DT.%26atitle%3DPerformance%2520and%2520correlation%2520of%2520a%252096-well%2520high%2520throughput%2520screening%2520method%2520to%2520determine%2520aqueous%2520drug%2520solubility%26btitle%3DApplication%2520Note%2520Lit.%2520No.%2520AN1731EN00%26pub%3DMillipore%2520Corporation%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minick, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brent, D. A.</span></span> <span> </span><span class="NLM_article-title">A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1923</span>– <span class="NLM_lpage">1933</span>, <span class="refDoi"> DOI: 10.1021/jm00118a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00118a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaL1cXltlGlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=1923-1933&author=D.+J.+Minickauthor=J.+H.+Frenzauthor=M.+A.+Patrickauthor=D.+A.+Brent&title=A+comprehensive+method+for+determining+hydrophobicity+constants+by+reversed-phase+high-performance+liquid+chromatography&doi=10.1021%2Fjm00118a010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography</span></div><div class="casAuthors">Minick, Douglas J.; Frenz, John H.; Patrick, Mark A.; Brent, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1923-33</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A method for detg. hydrophobicity consts. for small, org. mols. by reversed-phase liq. chromatog. (RPLC) is presented.  The method uses capacity ratios measured at a no. of different compns. of MeOH to obtain derived values, denoted log K'w, upon which a new scale of hydrophobicity consts. can be developed.  This scale eliminates potential problems such as peak inversion that hamper RPLC methods by using isocratic data to est. hydrophobicity.  The differential H bonded effect obsd. in most correlations of RPLC data with logarithms of octanol-water partition coeffs. (log Po/w) for compds. of opposite net H bonding capabilities (noncongeners) was minimized by adding trace quantities of n-decylamine and 1-octanol to the eluent and using an octyl-modified silica gel stationary phase.  Values of log K'w are largely column-independent as long as the hydrophobic properties of columns are similar.  The correlation of log k'w values with the logarithms of bovine serum albumin binding consts. (log 1/C) is statistically indistinguishable from the correlation of log 1/C with log Po/w, indicating that this data models log 1/C as well as log Po/w for these compds.  Addnl., the chromatog. system is automatable and thus capable of higher sample throughput than measurements of log Po/w by the shake-flask method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP9rXFRIjKoLVg90H21EOLACvtfcHk0lg5ukOw5m0K9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltlGlt7s%253D&md5=ce6a632baa977f92c51f3341f92e303f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm00118a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00118a010%26sid%3Dliteratum%253Aachs%26aulast%3DMinick%26aufirst%3DD.%2BJ.%26aulast%3DFrenz%26aufirst%3DJ.%2BH.%26aulast%3DPatrick%26aufirst%3DM.%2BA.%26aulast%3DBrent%26aufirst%3DD.%2BA.%26atitle%3DA%2520comprehensive%2520method%2520for%2520determining%2520hydrophobicity%2520constants%2520by%2520reversed-phase%2520high-performance%2520liquid%2520chromatography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D1923%26epage%3D1933%26doi%3D10.1021%2Fjm00118a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlsdorfer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bühner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandenburger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruk, R.</span></span> <span> </span><span class="NLM_article-title">High-throughput determination of the free fraction of drugs strongly bound to plasma proteins</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">816</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1002/jps.10588</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1002%2Fjps.10588" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=14999720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivF2lsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2004&pages=816-830&author=J.+Schuhmacherauthor=C.+Kohlsdorferauthor=K.+B%C3%BChnerauthor=T.+Brandenburgerauthor=R.+Kruk&title=High-throughput+determination+of+the+free+fraction+of+drugs+strongly+bound+to+plasma+proteins&doi=10.1002%2Fjps.10588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput determination of the free fraction of drugs strongly bound to plasma proteins</span></div><div class="casAuthors">Schuhmacher, Joachim; Kohlsdorfer, Christian; Buehner, Klaus; Brandenburger, Tim; Kruk, Renate</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">816-830</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Quantification of protein binding of new chem. entities is an important early screening step during drug discovery and is of fundamental interest for the estn. of safety margins during drug development.  In this publication, we describe the development of a new high-throughput assay for the detn. of the free drug fraction in plasma (fu).  The new technique is an enhancement of the previously published erythrocytes partition method.  It is based on the distribution of drugs between plasma water, plasma proteins, and solid-supported lipid membranes (Transil).  The execution of protein binding studies by partitioning is dramatically simplified by substituting erythrocytes with com. available Transil beads, and makes the method particularly suitable for high-throughput studies.  Eight Bayer compds. from different compd. classes covering a wide range of lipophilicities (log P=1.9-5.6) and fu values (0.018-35%) were selected for validation of the assay.  The results obtained by the new method and by either the erythrocytes partitioning technique or more conventional methods (ultrafiltration and equil. dialysis) are identical, confirming that the new method produces valid results even for drugs that are strongly bound to plasma proteins.  Precision and accuracy of the data in the cases of very low and high fu values are comparable, indicating that the method is esp. suited for highly lipophilic drugs that tend to adsorb to surfaces compared with other methods, like ultrafiltration or equil. dialysis, that may produce biased data.  The method is also useful for the detn. of binding parameters and the pH dependence of fu.  In summary, this assay is well suited for high-throughput detn. of protein binding during drug discovery and for extended protein binding studies during drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpflHhmd5cNbVg90H21EOLACvtfcHk0ljCNPrrCkEbCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivF2lsLc%253D&md5=c5898ab6390b217b9329da01d81f7585</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fjps.10588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10588%26sid%3Dliteratum%253Aachs%26aulast%3DSchuhmacher%26aufirst%3DJ.%26aulast%3DKohlsdorfer%26aufirst%3DC.%26aulast%3DB%25C3%25BChner%26aufirst%3DK.%26aulast%3DBrandenburger%26aufirst%3DT.%26aulast%3DKruk%26aufirst%3DR.%26atitle%3DHigh-throughput%2520determination%2520of%2520the%2520free%2520fraction%2520of%2520drugs%2520strongly%2520bound%2520to%2520plasma%2520proteins%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2004%26volume%3D93%26spage%3D816%26epage%3D830%26doi%3D10.1002%2Fjps.10588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makielski, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">January, C. T.</span></span> <span> </span><span class="NLM_article-title">Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1016/S0006-3495(98)77782-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2FS0006-3495%2898%2977782-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=9449325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK1cXhvFWjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1998&pages=230-241&author=Z.+Zhouauthor=Q.+Gongauthor=B.+Yeauthor=Z.+Fanauthor=J.+C.+Makielskiauthor=G.+A.+Robertsonauthor=C.+T.+January&title=Properties+of+HERG+channels+stably+expressed+in+HEK+293+cells+studied+at+physiological+temperature&doi=10.1016%2FS0006-3495%2898%2977782-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature</span></div><div class="casAuthors">Zhou, Zhengfeng; Gong, Qiuming; Ye, Bin; Fan, Zheng; Makielski, Jonathan C.; Robertson, Gail A.; January, Craig T.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">230-241</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society</span>)
        </div><div class="casAbstract">We have established stably transfected HEK 293 cell lines expressing high levels of functional human ether-a go-go-related gene (HERG) channels.  We used these cells to study biochem. characteristics of HERG protein, and to study electrophysiol. and pharmacol. properties of HERG channel current at 35°C.  HERG-transfected cells expressed an mRNA band at 4.0 kb.  Western blot anal. showed two protein bands (155 and 135 kDa) slightly larger than the predicted mol. mass (127 kDa).  Treatment with N-glycosidase F converted both bands to smaller mol. mass, suggesting that both are glycosylated, but at different levels.  HERG current activated at voltages pos. to -50 mV, max. current was reached with depolarizing steps to -10 mV, and the current amplitude declined at more pos. voltages, similar to HERG channel current expressed in other heterologous systems.  C.d. at 35°C, compared with 23°C, was increased by more than twofold to a max. of 53.4 ± 6.5 pA/pF.  Activation, inactivation, recovery from inactivation, and deactivation kinetics were rapid at 35°C, and more closely resemble values reported for the rapidly activating delayed rectifier K+ current (IKr) at physiol. temps.  HERG channels were highly selective for K+.  When we used an action potential clamp technique, HERG current activation began shortly after the upstroke of the action potential waveform.  HERG current increased during repolarization to reach a max. amplitude during phases 2 and 3 of the cardiac action potential.  HERG contributed current throughout the return of the membrane to the resting potential, and deactivation of HERG current could participate in phase 4 depolarization.  HERG current was blocked by low concns. of E-4031 (IC50 7.7 nM), a value close to that reported for IKr in native cardiac myocytes.  Our data support the postulate that HERG encodes a major constituent of IKr and suggest that at physiol. temps. HERG contributes current throughout most of the action potential and into the postrepolarization period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfeVZx9D4R2LVg90H21EOLACvtfcHk0ljCNPrrCkEbCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvFWjurg%253D&md5=4c7587215c9013a75b34d9fcbaaefc2c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0006-3495%2898%2977782-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3495%252898%252977782-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DYe%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DMakielski%26aufirst%3DJ.%2BC.%26aulast%3DRobertson%26aufirst%3DG.%2BA.%26aulast%3DJanuary%26aufirst%3DC.%2BT.%26atitle%3DProperties%2520of%2520HERG%2520channels%2520stably%2520expressed%2520in%2520HEK%2520293%2520cells%2520studied%2520at%2520physiological%2520temperature%26jtitle%3DBiophys.%2520J.%26date%3D1998%26volume%3D74%26spage%3D230%26epage%3D241%26doi%3D10.1016%2FS0006-3495%2898%2977782-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamill, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neher, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigworth, F. J.</span></span> <span> </span><span class="NLM_article-title">Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches</span>. <i>Pfluegers Arch.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>391</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1007/BF00656997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1007%2FBF00656997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=6270629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A280%3ADyaL38%252FjslWrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=1981&pages=85-100&author=O.+P.+Hamillauthor=A.+Martyauthor=E.+Neherauthor=B.+Sakmannauthor=F.+J.+Sigworth&title=Improved+patch-clamp+techniques+for+high-resolution+current+recording+from+cells+and+cell-free+membrane+patches&doi=10.1007%2FBF00656997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches</span></div><div class="casAuthors">Hamill O P; Marty A; Neher E; Sakmann B; Sigworth F J</div><div class="citationInfo"><span class="NLM_cas:title">Pflugers Archiv : European journal of physiology</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">391</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-100</span>
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    </div><div class="casAbstract">1.  The extracellular patch clamp method, which first allowed the detection of single channel currents in biological membranes, has been further refined to enable higher current resolution, direct membrane patch potential control, and physical isolation of membrane patches. 2.  A description of a convenient method for the fabrication of patch recording pipettes is given together with procedures followed to achieve giga-seals i.e. pipette-membrane seals with resistances of 10(9) - 10(11) omega. 3.  The basic patch clamp recording circuit, and designs for improved frequency response are described along with the present limitations in recording the currents from single channels. 4.  Procedures for preparation and recording from three representative cell types are given.  Some properties of single acetylcholine-activated channels in muscle membrane are described to illustrate the improved current and time resolution achieved with giga-seals. 5.  A description is given of the various ways that patches of membrane can be physically isolated from cells.  This isolation enables the recording of single channel currents with well-defined solutions on both sides of the membrane.  Two types of isolated cell-free patch configurations can be formed: an inside-out patch with its cytoplasmic membrane face exposed to the bath solution, and an outside-out patch with its extracellular membrane face exposed to the bath solution. 6.  The application of the method for the recording of ionic currents and internal dialysis of small cells is considered.  Single channel resolution can be achieved when recording from whole cells, if the cell diameter is small (less than 20 micrometer). 7.  The wide range of cell types amenable to giga-seal formation is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTk3IMHMxuoQXy-c-E1v-fmfW6udTcc2eapQbNKN9lj6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL38%252FjslWrug%253D%253D&md5=c981295f57b3239ca3719093b059f44d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2FBF00656997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00656997%26sid%3Dliteratum%253Aachs%26aulast%3DHamill%26aufirst%3DO.%2BP.%26aulast%3DMarty%26aufirst%3DA.%26aulast%3DNeher%26aufirst%3DE.%26aulast%3DSakmann%26aufirst%3DB.%26aulast%3DSigworth%26aufirst%3DF.%2BJ.%26atitle%3DImproved%2520patch-clamp%2520techniques%2520for%2520high-resolution%2520current%2520recording%2520from%2520cells%2520and%2520cell-free%2520membrane%2520patches%26jtitle%3DPfluegers%2520Arch.%26date%3D1981%26volume%3D391%26spage%3D85%26epage%3D100%26doi%3D10.1007%2FBF00656997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Himmel, H. M.</span></span> <span> </span><span class="NLM_article-title">Suitability of commonly used excipients for electrophysiological in-vitro safety pharmacology assessment of effects on hERG potassium current and on rabbit Purkinje fiber action potential</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1016/j.vascn.2007.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2Fj.vascn.2007.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=17590357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCmtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=145-158&author=H.+M.+Himmel&title=Suitability+of+commonly+used+excipients+for+electrophysiological+in-vitro+safety+pharmacology+assessment+of+effects+on+hERG+potassium+current+and+on+rabbit+Purkinje+fiber+action+potential&doi=10.1016%2Fj.vascn.2007.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Suitability of commonly used excipients for electrophysiological in-vitro safety pharmacology assessment of effects on hERG potassium current and on rabbit Purkinje fiber action potential</span></div><div class="casAuthors">Himmel, Herbert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-158</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: Regulatory guidelines require investigation of the liability for delayed ventricular repolarization by new chem. entities within a broad concn. range in-vitro.  However, investigation can be limited by poor drug aq. soly., and by solvent physicochem. attributes that disrupt cell membrane integrity.  Although excipients or solubilizing agents may aid to achieve the necessary high concns., no comprehensive overview on the suitability of solvents for in-vitro electrophysiol. safety studies exists.  Methods: Excipients were tested for potential interference with the hERG (human ether-a-go-go-related gene) K+ current (whole-cell voltage-clamp, 23±2°), and the shape of rabbit Purkinje fiber action potentials (conventional glass microelectrode technique, 37±1°).  Results and discussion: Water-sol. complexation builders/carriers had little effect on hERG K+ current at up to 50 mg/mL (BSA, bovine serum albumin) and 11 mg/mL (HP-β-CD, hydroxypropyl-β-cyclodextrin; IC20, concn. of 20% inhibition).  Water-sol. org. (co)solvents inhibited hERG K+ currents (IC20, %/mM): 0.7/152, ethanol; 0.9/67, Transcutol; 1.2/154, DMSO (dimethylsulfoxide); 1.6/389, acetonitrile; 1.9/48, polyethylene glycol 400; 2.1/660, methanol.  Part of their inhibitory effect is attributed to the osmolality of extracellular solns., because hERG IC20 and extrapolated osmolality at the hERG IC20 strongly correlate.  Water-sol. nonionic solubilizers/surfactants are potent inhibitors of hERG K+ current with IC20 concns. of 0.07% (Cremophor EL) or lower (Tween 20, Tween 80: ∼ 0.001%).  Part of this inhibitory effect is attributed to their interaction with lipid membranes, because hERG inhibition occurs close to crit. micelle concns. (Cremophor, ∼0.009%; Tween 20, ∼0.007%).  Purkinje fiber action potentials are little affected by HP-β-CD at up to 2 mg/mL, while DMSO tends to shorten the action potential duration at 1%.  Conclusion: When conducting electrophysiol. in-vitro assessments of drug effects, solubilizers/surfactants (Cremophor EL, Tween 20, Tween 80) should be avoided.  Instead, water-sol. org. (co)solvents (methanol, acetonitrile, DMSO) or complexation builders/carriers (HP-β-CD, BSA) appear to be more favorable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsEAdKY44zz7Vg90H21EOLACvtfcHk0lh7Lvk_vCOMKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCmtLbN&md5=49c61123b2fd0c35fcae026a5d45977f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2007.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2007.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DHimmel%26aufirst%3DH.%2BM.%26atitle%3DSuitability%2520of%2520commonly%2520used%2520excipients%2520for%2520electrophysiological%2520in-vitro%2520safety%2520pharmacology%2520assessment%2520of%2520effects%2520on%2520hERG%2520potassium%2520current%2520and%2520on%2520rabbit%2520Purkinje%2520fiber%2520action%2520potential%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2007%26volume%3D56%26spage%3D145%26epage%3D158%26doi%3D10.1016%2Fj.vascn.2007.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jazbutyte, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruchten, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, S. K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritzemeier, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prelle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegele-Hartung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyses, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelzer, T.</span></span> <span> </span><span class="NLM_article-title">Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1161/01.HYP.0000240053.48517.c7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1161%2F01.HYP.0000240053.48517.c7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=16940216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFOrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2006&pages=579-586&author=V.+Jazbutyteauthor=K.+Huauthor=P.+Kruchtenauthor=E.+Beyauthor=S.+K.+G.+Maierauthor=K.-H.+Fritzemeierauthor=K.+Prelleauthor=C.+Hegele-Hartungauthor=R.+W.+Hartmannauthor=L.+Neysesauthor=G.+Ertlauthor=T.+Pelzer&title=Aging+reduces+the+efficacy+of+estrogen+substitution+to+attenuate+cardiac+hypertrophy+in+female+spontaneously+hypertensive+rats&doi=10.1161%2F01.HYP.0000240053.48517.c7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats</span></div><div class="casAuthors">Jazbutyte, Virginija; Hu, Kai; Kruchten, Patricia; Bey, Emmanuel; Maier, Sebastian K. G.; Fritzemeier, Karl-Heinrich; Prelle, Katja; Hegele-Hartung, Christa; Hartmann, Rolf W.; Neyses, Ludwig; Ertl, Georg; Pelzer, Theo</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">579-586</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Clin. trials failed to show a beneficial effect of postmenopausal hormone replacement therapy, whereas exptl. studies in young animals reported a protective function of estrogen replacement in cardiovascular disease.  Because these diverging results could in part be explained by aging effects, we compared the efficacy of estrogen substitution to modulate cardiac hypertrophy and cardiac gene expression among young (age 3 mo) and senescent (age 24 mo) spontaneously hypertensive rats (SHRs), which were sham operated or ovariectomized and injected with placebo or identical doses of 17β-estradiol (E2; 2 μg/kg body wt. per day) for 6 wk (n=10/group).  Blood pressure was comparable among sham-operated senescent and young SHRs and not altered by ovariectomy or E2 treatment among young or among senescent rats.  Estrogen substitution inhibited uterus atrophy and gain of body wt. in young and senescent ovariectomized SHRs, but cardiac hypertrophy was attenuated only in young rats.  Cardiac estrogen receptor-α expression was lower in intact and in ovariectomized senescent compared with young SHRs and increased with estradiol substitution in aged rats.  Plasma estradiol and estrone levels were lower not only in sham-operated but surprisingly also in E2-substituted senescent SHRs and assocd. with a redn. of hepatic 17β-hydroxysteroid dehydrogenase type 1 enzyme activity, which converts weak (ie, estrone) into potent estrogens, such as E2.  Aging attenuates the antihypertrophic effect of estradiol in female SHRs and is assocd. with profound alterations in cardiac estrogen receptor-α expression and estradiol metab.  These observations contribute to explain the lower efficiency of estrogen substitution in senescent SHRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTm54cylwrvrVg90H21EOLACvtfcHk0lh7Lvk_vCOMKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFOrs7c%253D&md5=dfdf87fc2f0fddef972e87d6e635cc8e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000240053.48517.c7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000240053.48517.c7%26sid%3Dliteratum%253Aachs%26aulast%3DJazbutyte%26aufirst%3DV.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DKruchten%26aufirst%3DP.%26aulast%3DBey%26aufirst%3DE.%26aulast%3DMaier%26aufirst%3DS.%2BK.%2BG.%26aulast%3DFritzemeier%26aufirst%3DK.-H.%26aulast%3DPrelle%26aufirst%3DK.%26aulast%3DHegele-Hartung%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DNeyses%26aufirst%3DL.%26aulast%3DErtl%26aufirst%3DG.%26aulast%3DPelzer%26aufirst%3DT.%26atitle%3DAging%2520reduces%2520the%2520efficacy%2520of%2520estrogen%2520substitution%2520to%2520attenuate%2520cardiac%2520hypertrophy%2520in%2520female%2520spontaneously%2520hypertensive%2520rats%26jtitle%3DHypertension%26date%3D2006%26volume%3D48%26spage%3D579%26epage%3D586%26doi%3D10.1161%2F01.HYP.0000240053.48517.c7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katkam, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalkrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chwalisz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schillinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, C. P.</span></span> <span> </span><span class="NLM_article-title">Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception</span>. <i>Am. J. Obstet. Gynecol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">787</span>, <span class="refDoi"> DOI: 10.1016/0002-9378(95)90341-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2F0002-9378%2895%2990341-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=7573244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK2MXpsVSgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=1995&pages=779-787&author=R.+R.+Katkamauthor=K.+Gopalkrishnanauthor=K.+Chwaliszauthor=E.+Schillingerauthor=C.+P.+Puri&title=Onapristone+%28ZK+98.299%29%3A+a+potential+antiprogestin+for+endometrial+contraception&doi=10.1016%2F0002-9378%2895%2990341-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Onapristone (ZK 98.299): A potential antiprogestin for endometrial contraception</span></div><div class="casAuthors">Katkam, Rajendra R.; Gopalkrishnan, Kamla; Chwalisz, Kristof; Schillinger, Eckard; Puri, Chander P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Obstetrics and Gynecology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">3, Pt. 1</span>),
    <span class="NLM_cas:pages">779-87</span>CODEN:
                <span class="NLM_cas:coden">AJOGAH</span>;
        ISSN:<span class="NLM_cas:issn">0002-9378</span>.
    
            (<span class="NLM_cas:orgname">Mosby-Year Book</span>)
        </div><div class="casAbstract">The effects of the antiprogestin onapristone (ZK 98.299) on fertility; menstrual cycle length; duration of menses; serum estradiol, progesterone, and cortisol concns.; and endometrial morphol. features were studied in adult bonnet monkeys.  Five animals were treated s.c. with the vehicle and another nine with either 2.5 or 5 mg of onapristone per animal.  Treatment was initiated on day 5 of the first treatment cycle, and thereafter onapristone was administered every third day for four to seven consecutive cycles.  The females were placed with adult males during the periovulatory period, which was assessed by frequent anal. of serum estradiol concns.  In the final treatment cycle an endometrial biopsy was performed on day 8 after a midcycle estradiol peak in the ovulatory cycle, or around day 20 if the cycle was anovulatory.  Blood samples for estradiol, progesterone, and cortisol measurement were collected every third day, except for the periovulatory period when sampling was more frequent.  Each of the five animals treated with the vehicle became pregnant: one in the first, three in the second, and one in the third mated cycle, whereas only one of nine treated with onapristone became pregnant.  Four animals treated with 2.5 mg of onapristone for 17 cycles and another four treated with a 5 mg dose for 21 cycles did not conceive.  In eight animals that did not conceive the first three treatment cycles of six were ovulatory, and in the remaining two animals two cycles of each were ovulatory.  During treatment the mean menstrual cycle length was not altered significantly; however, in one it was shortened and in another two it was prolonged.  Similarly, the mean duration of menses was not significantly affected, but in some cycles it was reduced.  Moreover, there was only slight bleeding in some treatment cycles.  Ovulation occurred in 30 of 45 treatment cycles, including the final treatment cycle during which the biopsy was taken, as indicated by serum estradiol and progesterone concns.  In some of the ovulatory cycles prolonged treatment suppressed luteal activity; however, in the ovulatory cycles the duration of follicular and luteal phases was not significantly affected.  In the anovulatory cycles there was a delayed increase in serum estradiol concns., suggesting a partial inhibition of folliculogenesis.  In treated animals endometrial growth and development was retarded and rendered out of phase.  In animals treated with the higher (5 mg) onapristone dose the endometrial glands had partially regressed, the secretory activity was blocked, and stromal compaction was evident.  The treatment had no significant effect on serum cortisol levels.  This study demonstrates that low-dose onapristone treatment throughout the menstrual cycle prevents pregnancy without disturbing the menstrual cycle and ovulation in the majority of cycles.  However, anovulation and luteal insufficiency occurred in some animals during prolonged treatment.  The contraceptive effect in the ovulatory cycles seems primarily related to the retardation of endometrial development resulting in the inhibition of endometrial receptivity.  It appears likely that a dose or treatment regimen of onapristone that will inhibit endometrial receptivity and prevent implantation without affecting the menstrual cycle even on prolonged treatment could be identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMM9alzZMOQ7Vg90H21EOLACvtfcHk0lh7Lvk_vCOMKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsVSgsLY%253D&md5=647303f30fbe7f30642112790cd128f3</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0002-9378%2895%2990341-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-9378%252895%252990341-0%26sid%3Dliteratum%253Aachs%26aulast%3DKatkam%26aufirst%3DR.%2BR.%26aulast%3DGopalkrishnan%26aufirst%3DK.%26aulast%3DChwalisz%26aufirst%3DK.%26aulast%3DSchillinger%26aufirst%3DE.%26aulast%3DPuri%26aufirst%3DC.%2BP.%26atitle%3DOnapristone%2520%2528ZK%252098.299%2529%253A%2520a%2520potential%2520antiprogestin%2520for%2520endometrial%2520contraception%26jtitle%3DAm.%2520J.%2520Obstet.%2520Gynecol.%26date%3D1995%26volume%3D173%26spage%3D779%26epage%3D787%26doi%3D10.1016%2F0002-9378%2895%2990341-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mallu  Lavanya</span>, <span class="hlFld-ContribAuthor ">Chong  Lin</span>, <span class="hlFld-ContribAuthor ">Jincheng  Mao</span>, <span class="hlFld-ContribAuthor ">Dhakshanamurthy  Thirumalai</span>, <span class="hlFld-ContribAuthor ">Sreenath Reddy  Aabaka</span>, <span class="hlFld-ContribAuthor ">Xiaojiang  Yang</span>, <span class="hlFld-ContribAuthor ">Jinhua  Mao</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Huang</span>, <span class="hlFld-ContribAuthor ">Jinzhou  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anticancer Properties of Functionalized 1,6-Naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2021,</strong> <em>379 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s41061-020-00314-6" title="DOI URL">https://doi.org/10.1007/s41061-020-00314-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-020-00314-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-020-00314-6%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DSynthesis%252Band%252BAnticancer%252BProperties%252Bof%252BFunctionalized%252B1%25252C6-Naphthyridines%26aulast%3DLavanya%26aufirst%3DMallu%26date%3D2021%26date%3D2021%26volume%3D379%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reported agonist and antagonist for the hLH-R.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of HTS Hit <b>1</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) triethylamine, EtOH; (b) trifluoroacetic acid (TFA); (c) 1,3-dichloro-5-isocyanatobenzene, triethylamine, dimethyl sulfoxide (DMSO), 26%.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray analysis of compound <b>5</b> determined the (<i>S</i>)-configuration of the eutomer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Summary of chemical, physicochemical, safety, in vitro drug metabolism, and pharmacokinetic (DMPK) properties of <b>33</b> (BAY-298).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0017.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Low-dose pharmacokinetic profiles of <b>33</b> (BAY-298) and <b>36</b> (BAY-899) in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Summary of chemical, physicochemical, safety, and in vitro DMPK properties of <b>36</b> (BAY-899).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0020.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 33 (BAY-298)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) tetrahydrofuran (THF), 81%; (b) zinc, acetic acid, quantitative; (c) propargylamine, sodium tetrachloroaurate dihydrate, EtOH, 27% (as a mixture of regioisomers); (d) TFA, 76% (as a mixture of regioisomers); (e) 4-nitrophenyl chloroformate, 4-(4-fluorophenoxy)aniline, THF, 17%; (f) high-performance liquid chromatography (HPLC) separation of regioisomers, ∼60%; separation of enantiomers, 39%.</p></p></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Antagonist dose–response studies with <b>33</b> (BAY-298) in the presence of integral multiples of the EC<sub>80</sub> concentration of hLH-R agonists: (A) the glycoprotein hLH and (B) the SMOL agonist Org 43553.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Suppression of hLH-induced ovarian marker gene expression in cetrorelix-treated female rats after 2 h of iv administration of hLH and <b>33</b> (BAY-298). Control animals received either hLH or vehicle treatment only. Data obtained from four animals (i.e., eight ovaries) per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0021.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Dose-dependent reversal of hLH-induced suppression of aromatase gene expression and (B) suppression of plasma progesterone levels in cetrorelix-treated female rats in the presence of <b>33</b> (BAY-298) (iv administration of both hLH and <b>33</b> (BAY-298) 2 h bevor sample collection, hLH: 0.5 μg/animal, 2.27 μg/kg). Data obtained from four animals (i.e., eight ovaries) per group; *<i>p</i> < 0.05 compared to hLH treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Treatment with <b>33</b> (BAY-298) counteracts the hLH-induced increase in plasma testosterone levels in male rats 2 h after iv application of hLH and <b>33</b> (BAY-298). Data obtained from four animals per group; **<i>p</i> < 0.01 compared to hLH treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0016.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Treatment with <b>33</b> (BAY-298) led to interrupted folliculogenesis in the 4 day cycle of adult female rats. Cycle stages were determined by vaginal smears and characterized as follows: 1 = diestrus, 2 = proestrus, 3 = estrus, 4 = metestrus. Data are shown for the four animals per treatment group on the 8 treatment days. The green color indicates that the expected cycle stage was detected, whereas the red color shows arrested cycle stages.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/medium/jm9b01382_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0018.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Reduction in serum estradiol levels in female rats following treatment for 8 days (q.d., po) with either <b>33</b> (BAY-298) (A, B) or <b>36</b> (BAY-899) (B). Data obtained from 4–5 animals per group; *<i>p</i> < 0.05, **<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-22/acs.jmedchem.9b01382/20210708/images/large/jm9b01382_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01382&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i96">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54347" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54347" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 57 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dagklis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravanos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makedou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kourtis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousso, D.</span></span> <span> </span><span class="NLM_article-title">Common features and differences of the hypothalamic–pituitary–gonadal axis in male and female</span>. <i>Gynecol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.3109/09513590.2014.959917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.3109%2F09513590.2014.959917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=25222843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFSns7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2015&pages=14-17&author=T.+Dagklisauthor=K.+Ravanosauthor=K.+Makedouauthor=A.+Kourtisauthor=D.+Rousso&title=Common+features+and+differences+of+the+hypothalamic%E2%80%93pituitary%E2%80%93gonadal+axis+in+male+and+female&doi=10.3109%2F09513590.2014.959917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Common features and differences of the hypothalamic-pituitary-gonadal axis in male and female</span></div><div class="casAuthors">Dagklis, Themistoklis; Ravanos, Kostas; Makedou, Kali; Kourtis, Anargyros; Rousso, David</div><div class="citationInfo"><span class="NLM_cas:title">Gynecological Endocrinology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-17</span>CODEN:
                <span class="NLM_cas:coden">GYENER</span>;
        ISSN:<span class="NLM_cas:issn">0951-3590</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Male and female reproductive axis, comprised of hypothalamus, pituitary and gonads, present common features and differences, discussed in this review.  These include the way hypothalamus regulates pituitary function, and the way pituitary, in turn, affects gonadal function.  Finally, age plays an important role in axis regulation, in both genders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJDqPDtxn-97Vg90H21EOLACvtfcHk0lg_0lBhPQXLqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFSns7rI&md5=22793920168c17a2368a5b517b46ac04</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3109%2F09513590.2014.959917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F09513590.2014.959917%26sid%3Dliteratum%253Aachs%26aulast%3DDagklis%26aufirst%3DT.%26aulast%3DRavanos%26aufirst%3DK.%26aulast%3DMakedou%26aufirst%3DK.%26aulast%3DKourtis%26aufirst%3DA.%26aulast%3DRousso%26aufirst%3DD.%26atitle%3DCommon%2520features%2520and%2520differences%2520of%2520the%2520hypothalamic%25E2%2580%2593pituitary%25E2%2580%2593gonadal%2520axis%2520in%2520male%2520and%2520female%26jtitle%3DGynecol.%2520Endocrinol.%26date%3D2015%26volume%3D31%26spage%3D14%26epage%3D17%26doi%3D10.3109%2F09513590.2014.959917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeydabadi Nejad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramezani Tehrani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zadeh-Vakili, A.</span></span> <span> </span><span class="NLM_article-title">The role of kisspeptin in female reproduction</span>. <i>Int. J. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>, <span class="NLM_elocation-id">e44337</span> <span class="refDoi"> DOI: 10.5812/ijem.44337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.5812%2Fijem.44337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=29201072" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&author=S.+Zeydabadi+Nejadauthor=F.+Ramezani+Tehraniauthor=A.+Zadeh-Vakili&title=The+role+of+kisspeptin+in+female+reproduction&doi=10.5812%2Fijem.44337"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.5812%2Fijem.44337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5812%252Fijem.44337%26sid%3Dliteratum%253Aachs%26aulast%3DZeydabadi%2BNejad%26aufirst%3DS.%26aulast%3DRamezani%2BTehrani%26aufirst%3DF.%26aulast%3DZadeh-Vakili%26aufirst%3DA.%26atitle%3DThe%2520role%2520of%2520kisspeptin%2520in%2520female%2520reproduction%26jtitle%3DInt.%2520J.%2520Endocrinol.%2520Metab.%26date%3D2017%26volume%3D15%26doi%3D10.5812%2Fijem.44337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaprara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huhtaniemi, I. T.</span></span> <span> </span><span class="NLM_article-title">The hypothalamus-pituitary-gonad axis: tales of mice and men</span>. <i>Metabolism</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.metabol.2017.11.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2Fj.metabol.2017.11.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=29223677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFKkur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2018&pages=3-17&author=A.+Kapraraauthor=I.+T.+Huhtaniemi&title=The+hypothalamus-pituitary-gonad+axis%3A+tales+of+mice+and+men&doi=10.1016%2Fj.metabol.2017.11.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The hypothalamus-pituitary-gonad axis: Tales of mice and men</span></div><div class="casAuthors">Kaprara, Athina; Huhtaniemi, Ilpo T.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3-17</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Reprodn. is controlled by the hypothalamic-pituitary-gonadal (HPG) axis.  Gonadotropin-releasing hormone (GnRH) neurons play a central role in this axis through prodn. of GnRH, which binds to a membrane receptor on pituitary gonadotrophs and stimulates the biosynthesis and secretion of FSH (FSH) and LH (LH).  Multiple factors affect GnRH neuron migration, GnRH gene expression, GnRH pulse generator, GnRH secretion, GnRH receptor expression, and gonadotropin synthesis and release.  Among them anosmin is involved in the guidance of the GnRH neuron migration, and a loss-of-function mutation in its gene leads to a failure of their migration from the olfactory placode to the hypothalamus, with consequent anosmic hypogonadotropic hypogonadism (Kallmann syndrome).  There are also cases of hypogonadotropic hypogonadim with normal sense of smell, due to mutations of other genes.  Another protein, kisspeptin plays a crucial role in the regulation of GnRH pulse generator and the pubertal development.  GnRH is the main hypothalamic regulator of the release of gonadotropins.  Finally, FSH and LH are the essential hormonal regulators of testicular functions, acting through their receptors in Sertoli and Leydig cells, resp.  The main features of the male HPG axis will be described in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxncetfMXZ4bVg90H21EOLACvtfcHk0lg_0lBhPQXLqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFKkur8%253D&md5=f79d08e2301eedcee1960228566d4b6b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2017.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2017.11.018%26sid%3Dliteratum%253Aachs%26aulast%3DKaprara%26aufirst%3DA.%26aulast%3DHuhtaniemi%26aufirst%3DI.%2BT.%26atitle%3DThe%2520hypothalamus-pituitary-gonad%2520axis%253A%2520tales%2520of%2520mice%2520and%2520men%26jtitle%3DMetabolism%26date%3D2018%26volume%3D86%26spage%3D3%26epage%3D17%26doi%3D10.1016%2Fj.metabol.2017.11.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponnusamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasano, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers</span>. <i>Endocr. Connect</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">R10</span>– <span class="NLM_lpage">R26</span>, <span class="refDoi"> DOI: 10.1530/EC-18-0425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1530%2FEC-18-0425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=30640710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1CgtLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=R10-R26&author=M.+Ulmauthor=A.+V.+Rameshauthor=K.+M.+McNamaraauthor=S.+Ponnusamyauthor=H.+Sasanoauthor=R.+Narayanan&title=Therapeutic+advances+in+hormone-dependent+cancers%3A+focus+on+prostate%2C+breast+and+ovarian+cancers&doi=10.1530%2FEC-18-0425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic advances in hormone-dependent cancers: focus on prostate, breast and ovarian cancers</span></div><div class="casAuthors">Ulm, Michael; Ramesh, Arvind V.; McNamara, Keely M.; Ponnusamy, Suriyan; Sasano, Hironobu; Narayanan, Ramesh</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Connections</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">R10-R26</span>CODEN:
                <span class="NLM_cas:coden">ECNOCX</span>;
        ISSN:<span class="NLM_cas:issn">2049-3614</span>.
    
            (<span class="NLM_cas:orgname">Bioscientifica Ltd.</span>)
        </div><div class="casAbstract">A review.  Hormonal cancers affect over 400,000 men and women and contribute collectively to over 100,000 deaths in the United States alone.  Thanks to advances in the understanding of these cancers at the mol. level and to the discovery of several disease-modifying therapeutics, the last decade has seen a plateauing or even a decreasing trend in the no. of deaths from these cancers.  These advanced therapeutics not only effectively slow the growth of hormonal cancers, but also provide an insight on how these cancers become refractory and evolve as an altogether distinct subset.  This review summarizes the current therapeutic trends in hormonal cancers, with focus on prostate, breast and ovarian cancers.  The review discusses the clin. drugs being used now, promising mols. that are going through various stages of development and makes some predictions on how the therapeutic landscape will shift in the next decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ79Ne7WjUi7Vg90H21EOLACvtfcHk0li77yWm5o3IhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1CgtLrJ&md5=fc90ea2d4be544b19d078dc4c66bc9da</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1530%2FEC-18-0425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1530%252FEC-18-0425%26sid%3Dliteratum%253Aachs%26aulast%3DUlm%26aufirst%3DM.%26aulast%3DRamesh%26aufirst%3DA.%2BV.%26aulast%3DMcNamara%26aufirst%3DK.%2BM.%26aulast%3DPonnusamy%26aufirst%3DS.%26aulast%3DSasano%26aufirst%3DH.%26aulast%3DNarayanan%26aufirst%3DR.%26atitle%3DTherapeutic%2520advances%2520in%2520hormone-dependent%2520cancers%253A%2520focus%2520on%2520prostate%252C%2520breast%2520and%2520ovarian%2520cancers%26jtitle%3DEndocr.%2520Connect%26date%3D2019%26volume%3D8%26spage%3DR10%26epage%3DR26%26doi%3D10.1530%2FEC-18-0425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reis, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiga-Carvalho, T. M.</span></span> <span> </span><span class="NLM_article-title">Hormones and pathogenesis of uterine fibroids</span>. <i>Best Pract. Res. Clin. Obstet. Gynaecol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1016/j.bpobgyn.2015.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2Fj.bpobgyn.2015.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=26725037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A280%3ADC%252BC28rms1Khtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=13-24&author=F.+M.+Reisauthor=E.+Bloiseauthor=T.+M.+Ortiga-Carvalho&title=Hormones+and+pathogenesis+of+uterine+fibroids&doi=10.1016%2Fj.bpobgyn.2015.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Hormones and pathogenesis of uterine fibroids</span></div><div class="casAuthors">Reis Fernando M; Bloise Enrrico; Ortiga-Carvalho Tania M</div><div class="citationInfo"><span class="NLM_cas:title">Best practice & research. Clinical obstetrics & gynaecology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The role of ovarian steroid hormones in the pathogenesis of uterine fibroids is supported by epidemiological, clinical, and experimental evidence.  Estradiol and progesterone induce mature leiomyoma cells to release mitogenic stimuli to adjacent immature cells, thereby providing uterine leiomyoma with undifferentiated cells that are likely to support tumor growth.  Progesterone action is required for the complete development and proliferation of leiomyoma cells, while estradiol predominantly increases tissue sensitivity to progesterone by increasing the availability of progesterone receptors (PRs).  The selective estrogen receptor modulator (SERM) raloxifene and the selective PR modulators (SPRMs) mifepristone, asoprisnil, and ulipristal acetate have been shown in clinical trials to inhibit fibroid growth.  The role of sex steroids is critical for leiomyoma development and maintenance, but a number of autocrine and paracrine messengers are involved in this process; hence, numerous pathways remain to be explored in therapeutic innovations for treating this common disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPE_G8ph-J7d-cVm4E2RlLfW6udTcc2eY2F6UScjUr47ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rms1Khtg%253D%253D&md5=df0979706c38d055b41ce43253be2384</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.bpobgyn.2015.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpobgyn.2015.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DReis%26aufirst%3DF.%2BM.%26aulast%3DBloise%26aufirst%3DE.%26aulast%3DOrtiga-Carvalho%26aufirst%3DT.%2BM.%26atitle%3DHormones%2520and%2520pathogenesis%2520of%2520uterine%2520fibroids%26jtitle%3DBest%2520Pract.%2520Res.%2520Clin.%2520Obstet.%2520Gynaecol.%26date%3D2016%26volume%3D34%26spage%3D13%26epage%3D24%26doi%3D10.1016%2Fj.bpobgyn.2015.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Leo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musacchio, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cappelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massaro, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgante, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petraglia, F.</span></span> <span> </span><span class="NLM_article-title">Genetic, hormonal and metabolic aspects of PCOS: an update</span>. <i>Reprod. Biol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">38</span> <span class="refDoi"> DOI: 10.1186/s12958-016-0173-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1186%2Fs12958-016-0173-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=27423183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvFemtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&author=V.+De+Leoauthor=M.+C.+Musacchioauthor=V.+Cappelliauthor=M.+G.+Massaroauthor=G.+Morganteauthor=F.+Petraglia&title=Genetic%2C+hormonal+and+metabolic+aspects+of+PCOS%3A+an+update&doi=10.1186%2Fs12958-016-0173-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic, hormonal and metabolic aspects of PCOS: an update</span></div><div class="casAuthors">De Leo, V.; Musacchio, M. C.; Cappelli, V.; Massaro, M. G.; Morgante, G.; Petraglia, F.</div><div class="citationInfo"><span class="NLM_cas:title">Reproductive Biology and Endocrinology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38/1-38/17</span>CODEN:
                <span class="NLM_cas:coden">RBEEBP</span>;
        ISSN:<span class="NLM_cas:issn">1477-7827</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting 5-10 % of women of reproductive age.  It generally manifests with oligo/anovulatory cycles, hirsutism and polycystic ovaries, together with a considerable prevalence of insulin resistance.  Although the etiol. of the syndrome is not completely understood yet, PCOS is considered a multifactorial disorder with various genetic, endocrine and environmental abnormalities.  Moreover, PCOS patients have a higher risk of metabolic and cardiovascular diseases and their related morbidity, if compared to the general population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9rhbonP2i_bVg90H21EOLACvtfcHk0liWn8-WLAwRFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvFemtrk%253D&md5=b987c20a2989d9a562278e4c3d130d0a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2Fs12958-016-0173-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12958-016-0173-x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLeo%26aufirst%3DV.%26aulast%3DMusacchio%26aufirst%3DM.%2BC.%26aulast%3DCappelli%26aufirst%3DV.%26aulast%3DMassaro%26aufirst%3DM.%2BG.%26aulast%3DMorgante%26aufirst%3DG.%26aulast%3DPetraglia%26aufirst%3DF.%26atitle%3DGenetic%252C%2520hormonal%2520and%2520metabolic%2520aspects%2520of%2520PCOS%253A%2520an%2520update%26jtitle%3DReprod.%2520Biol.%2520Endocrinol.%26date%3D2016%26volume%3D14%26doi%3D10.1186%2Fs12958-016-0173-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burney, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giudice, L. C.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis and pathophysiology of endometriosis</span>. <i>Fertil. Steril.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1016/j.fertnstert.2012.06.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2Fj.fertnstert.2012.06.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=22819144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2msr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2012&pages=511-519&author=R.+O.+Burneyauthor=L.+C.+Giudice&title=Pathogenesis+and+pathophysiology+of+endometriosis&doi=10.1016%2Fj.fertnstert.2012.06.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis and pathophysiology of endometriosis</span></div><div class="casAuthors">Burney, Richard O.; Giudice, Linda C.</div><div class="citationInfo"><span class="NLM_cas:title">Fertility and Sterility</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">511-519</span>CODEN:
                <span class="NLM_cas:coden">FESTAS</span>;
        ISSN:<span class="NLM_cas:issn">0015-0282</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Originally described over three hundred years ago, endometriosis is classically defined by the presence of endometrial glands and stroma in extrauterine locations.  Endometriosis is an inflammatory, estrogen-dependent condition assocd. with pelvic pain and infertility.  This work reviews the disease process from theories regarding origin to the mol. basis for disease sequelae.  A thorough understanding of the histopathogenesis and pathophysiol. of endometriosis is essential to the development of novel diagnostic and treatment approaches for this debilitating condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojBtCuFx7E57Vg90H21EOLACvtfcHk0liWn8-WLAwRFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2msr3I&md5=ced33c9bc406c7a2e846788960d5daf3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.fertnstert.2012.06.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fertnstert.2012.06.029%26sid%3Dliteratum%253Aachs%26aulast%3DBurney%26aufirst%3DR.%2BO.%26aulast%3DGiudice%26aufirst%3DL.%2BC.%26atitle%3DPathogenesis%2520and%2520pathophysiology%2520of%2520endometriosis%26jtitle%3DFertil.%2520Steril.%26date%3D2012%26volume%3D98%26spage%3D511%26epage%3D519%26doi%3D10.1016%2Fj.fertnstert.2012.06.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arukha, A. P.</span></span> <span> </span><span class="NLM_article-title">Ovarian and oocyte targets for development of female contraceptives</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1433</span>– <span class="NLM_lpage">1446</span>, <span class="refDoi"> DOI: 10.1517/14728222.2015.1051305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1517%2F14728222.2015.1051305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=26028476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsl2mt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2015&pages=1433-1446&author=S.+K.+Guptaauthor=A.+Malikauthor=A.+P.+Arukha&title=Ovarian+and+oocyte+targets+for+development+of+female+contraceptives&doi=10.1517%2F14728222.2015.1051305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Ovarian and oocyte targets for development of female contraceptives</span></div><div class="casAuthors">Gupta, Satish Kumar; Malik, Ankita; Arukha, Ananta Prasad</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1433-1446</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Steroid hormone-based contraceptives have been used by women for long time since their introduction.  Efforts have been made to make steroidal contraceptives cost-effective, safe and improve their users' compliance.  In addn., attempts have been made to develop nonsteroidal contraceptives.  Contraceptive vaccines have been investigated as an alternate strategy for contraception.  The currently used steroidal contraceptives are reviewed.  In addn., status of emerging nonsteroidal contraceptives that inhibit folliculogenesis, oocyte maturation, ovulation and endometrium receptivity targeting phosphodiesterase 3, angiopoietins, gonadotropin-releasing hormone, COX-2, progesterone/estrogen receptor and FSH receptor are presented.  Various approaches to develop contraceptive vaccines aiming to inhibit ovarian follicle development, ovulation, fertilization and implantation including their current applications and limitations are discussed.  Development of new nonsteroidal contraceptives, in addn. to long-acting steroidal contraceptives, is pertinent for offering wider choice to women.  It is imperative that basic research to discover new targets in the ovaries must be undertaken to facilitate development of novel contraceptives.  Further, efforts on studying the feasibility and safety of contraceptive vaccines may be continued to bring these within the realm of application as contraceptives for humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9cT-whZRU2bVg90H21EOLACvtfcHk0lhzCS9y6HJs5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsl2mt7zO&md5=0b423e1ae96229912068bcb071099f51</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F14728222.2015.1051305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2015.1051305%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BK.%26aulast%3DMalik%26aufirst%3DA.%26aulast%3DArukha%26aufirst%3DA.%2BP.%26atitle%3DOvarian%2520and%2520oocyte%2520targets%2520for%2520development%2520of%2520female%2520contraceptives%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2015%26volume%3D19%26spage%3D1433%26epage%3D1446%26doi%3D10.1517%2F14728222.2015.1051305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gava, G.</span>; <span class="NLM_string-name">Meriggiola, M. C.</span></span> <span> </span><span class="NLM_article-title">Update on male hormonal contraception</span> <i>Ther. Adv. Endocrinol. Metab.</i> <span class="NLM_year">2019</span>,  <span class="NLM_volume">10</span>, <span class="refDoi"> DOI: 10.1177/2042018819834846</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1177%2F2042018819834846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=30899448" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=G.+Gava&author=M.+C.+Meriggiola&title=Update+on+male+hormonal+contraception"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1177%2F2042018819834846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1177%252F2042018819834846%26sid%3Dliteratum%253Aachs%26aulast%3DGava%26aufirst%3DG.%26atitle%3DUpdate%2520on%2520male%2520hormonal%2520contraception%26jtitle%3DTher.%2520Adv.%2520Endocrinol.%2520Metab.%26date%3D2019%26volume%3D10%26doi%3D10.1177%2F2042018819834846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredriksson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagerstrom, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundin, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schioth, H. B.</span></span> <span> </span><span class="NLM_article-title">The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1256</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1124/mol.63.6.1256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1124%2Fmol.63.6.1256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=12761335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Shu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1256-1272&author=R.+Fredrikssonauthor=M.+C.+Lagerstromauthor=L.+G.+Lundinauthor=H.+B.+Schioth&title=The+G-protein-coupled+receptors+in+the+human+genome+form+five+main+families.+Phylogenetic+analysis%2C+paralogon+groups%2C+and+fingerprints&doi=10.1124%2Fmol.63.6.1256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</span></div><div class="casAuthors">Fredriksson, Robert; Lagerstrom, Malin C.; Lundin, Lars-Gustav; Schioth, Helgi B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1256-1272</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The superfamily of G-protein-coupled receptors (GPCRs) is very diverse in structure and function and its members are among the most pursued targets for drug development.  We identified more than 800 human GPCR sequences and simultaneously analyzed 342 unique functional nonolfactory human GPCR sequences with phylogenetic analyses.  Our results show, with high bootstrap support, five main families, named glutamate, rhodopsin, adhesion, frizzled/taste2, and secretin, forming the GRAFS classification system.  The rhodopsin family is the largest and forms four main groups with 13 subbranches.  Positions of the GPCRs in chromosomal paralogons regions indicate the importance of tetraploidizations or local gene duplication events for their creation.  We also searched for "fingerprint" motifs using Hidden Markov Models delineating the putative inter-relationship of the GRAFS families.  We show several common structural features indicating that the human GPCRs in the GRAFS families share a common ancestor.  This study represents the first overall map of the GPCRs in a single mammalian genome.  Our novel approach of analyzing such large and diverse sequence sets may be useful for studies on GPCRs in other genomes and divergent protein families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdX4VhTsaDzrVg90H21EOLACvtfcHk0lhzCS9y6HJs5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Shu7k%253D&md5=504ea873ee8469cd0b6016bc94943836</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fmol.63.6.1256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.63.6.1256%26sid%3Dliteratum%253Aachs%26aulast%3DFredriksson%26aufirst%3DR.%26aulast%3DLagerstrom%26aufirst%3DM.%2BC.%26aulast%3DLundin%26aufirst%3DL.%2BG.%26aulast%3DSchioth%26aufirst%3DH.%2BB.%26atitle%3DThe%2520G-protein-coupled%2520receptors%2520in%2520the%2520human%2520genome%2520form%2520five%2520main%2520families.%2520Phylogenetic%2520analysis%252C%2520paralogon%2520groups%252C%2520and%2520fingerprints%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D63%26spage%3D1256%26epage%3D1272%26doi%3D10.1124%2Fmol.63.6.1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, J. M.</span></span> <span> </span><span class="NLM_article-title">Structure and function of receptors coupled to G proteins</span>. <i>Curr. Opin. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">180</span>– <span class="NLM_lpage">190</span>, <span class="refDoi"> DOI: 10.1016/0955-0674(94)90134-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2F0955-0674%2894%2990134-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=8024808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK2cXis1Wns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1994&pages=180-190&author=J.+M.+Baldwin&title=Structure+and+function+of+receptors+coupled+to+G+proteins&doi=10.1016%2F0955-0674%2894%2990134-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of receptors coupled to G proteins</span></div><div class="casAuthors">Baldwin, Joyce M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-90</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    </div><div class="casAbstract">A review, with 43 refs.  Direct structural data on receptors coupled to G proteins were obtained last year in form of a low-resoln. projection map of rhodopsin.  A large no. of receptor sequences have how been detd. and detailed anal. of these has provided structural information about the receptors.  New results from site-directed mutagenesis expts. can be examd. in conjunction with the structural information from sequence anal. and the rhodopsin map.  The identification of constitutively active mutated receptors has influenced the authors' understanding of normal receptor equil.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpojkM6fxsYdbVg90H21EOLACvtfcHk0lhzCS9y6HJs5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXis1Wns7c%253D&md5=957df72b6200767fa14cd263492057b2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2F0955-0674%2894%2990134-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0955-0674%252894%252990134-1%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DJ.%2BM.%26atitle%3DStructure%2520and%2520function%2520of%2520receptors%2520coupled%2520to%2520G%2520proteins%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D1994%26volume%3D6%26spage%3D180%26epage%3D190%26doi%3D10.1016%2F0955-0674%2894%2990134-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herrlich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudermann, T.</span></span> <span> </span><span class="NLM_article-title">Involvement of Gs and Gi proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">16764</span>– <span class="NLM_lpage">16772</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.28.16764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1074%2Fjbc.271.28.16764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=8663226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK28Xkt1CjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=16764-16772&author=A.+Herrlichauthor=B.+Kuhnauthor=R.+Grosseauthor=A.+Schmidauthor=G.+Schultzauthor=T.+Gudermann&title=Involvement+of+Gs+and+Gi+proteins+in+dual+coupling+of+the+luteinizing+hormone+receptor+to+adenylyl+cyclase+and+phospholipase+C&doi=10.1074%2Fjbc.271.28.16764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of Gs and Gi proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C</span></div><div class="casAuthors">Herrlich, Andreas; Kuehn, Bernhard; Grosse, Robert; Schmid, Andrea; Schultz, Guenter; Gudermann, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">16764-16772</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Binding of lutropin/choriogonadotropin to its cognate receptor results in the activation of adenylyl cyclase and phospholipase C.  The mechanism underlying the generation of this bifurcating signal is presently not known.  To analyze the coupling mechanism of the LH receptor, activated G proteins were labeled with [α-32P]GTP azidoanilide and identified by selective immunopptn.  In membranes of bovine corpora lutea and of L cells stably expressing the murine LH receptor (LHR cells), human chorionic gonadotropin (hCG) led to incorporation of the label into αs and αi2.  Stimulation of LHR cells or of L cells expressing the M5 muscarinic receptor (LM5 cells) with the resp. agonist resulted in activation of phospholipase C in both cell lines.  However, αq and α11 were only labeled upon stimulation of the M5 muscarinic receptor.  Agonist-induced Ca2+ mobilization and inositol phosphate accumulation were partially sensitive to pertussis toxin, and the expression of the βγ-stimulable phospholipase C isoforms β2 and β3 could be demonstrated in LHR cells.  Overexpression of phospholipase C-β2 led to increased hCG-stimulated inositol phosphate accumulation, and expression of a β-ARK1 C-terminal polypeptide effectively suppressed hCG-mediated phosphatidylinositol hydrolysis.  Thus, the LH receptor couples to both Gs and Gi, and βγ-subunits released from either G protein contribute to the stimulation of phospholipase C-β isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkJ3wMPyxJVrVg90H21EOLACvtfcHk0liJxULStWPDWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xkt1CjsLs%253D&md5=adc9624f502fe208e299a3c11c5d7434</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.28.16764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.28.16764%26sid%3Dliteratum%253Aachs%26aulast%3DHerrlich%26aufirst%3DA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DGrosse%26aufirst%3DR.%26aulast%3DSchmid%26aufirst%3DA.%26aulast%3DSchultz%26aufirst%3DG.%26aulast%3DGudermann%26aufirst%3DT.%26atitle%3DInvolvement%2520of%2520Gs%2520and%2520Gi%2520proteins%2520in%2520dual%2520coupling%2520of%2520the%2520luteinizing%2520hormone%2520receptor%2520to%2520adenylyl%2520cyclase%2520and%2520phospholipase%2520C%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D16764%26epage%3D16772%26doi%3D10.1074%2Fjbc.271.28.16764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kühn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudermann, T.</span></span> <span> </span><span class="NLM_article-title">The luteinizing hormone receptor activates phospholipase C via preferential coupling to Gi2</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">12490</span>– <span class="NLM_lpage">12498</span>, <span class="refDoi"> DOI: 10.1021/bi990755m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi990755m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK1MXltl2jsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=12490-12498&author=B.+K%C3%BChnauthor=T.+Gudermann&title=The+luteinizing+hormone+receptor+activates+phospholipase+C+via+preferential+coupling+to+Gi2&doi=10.1021%2Fbi990755m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Luteinizing Hormone Receptor Activates Phospholipase C via Preferential Coupling to Gi2</span></div><div class="casAuthors">Kuehn, Bernhard; Gudermann, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">12490-12498</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Binding of lutropin/choriogonadotropin (LH/CG) to its cognate receptor results in the activation of adenylyl cyclase and phospholipase C.  This divergent signaling of the LH receptor is based on the independent activation of distinct G protein subfamilies, i.e., Gs, Gi, and potentially also Gq.  To examine the selectivity of LH receptor coupling to phospholipase C β-activating G proteins, we used an in vivo reconstitution system based on the coexpression of the LH receptor and different G proteins in baculovirus-infected insect cells.  In this paper, we describe a refined expression strategy for the LH receptor in insect cells.  The receptor protein was inserted into the cell membrane at an expression level of 0.8 pmol/mg of membrane protein.  Sf9 cells expressing the LH receptor responded to hCG challenge with a concn.-dependent accumulation of intracellular cAMP (EC50 = 630 nM) but not of inositol phosphates, whereas stimulation of the histamine H1 receptor in Sf9 cells led to increased phospholipase C (PLC) activity.  Immunoblotting expts. using G protein-specific antisera revealed the absence of quant. amts. of αi in Sf9 cells, whereas αs and αq/11 were detected.  We therefore attempted to restore the hCG-dependent PLC activation by infection of Sf9 cells with viruses encoding the LH receptor and different G protein α subunits.  The hCG stimulation of cells coexpressing the LH receptor and exogenous αi2 resulted in stimulation of PLC activity.  In cells coinfected with an αi3-baculovirus, hCG challenge led to a minor activation of PLC, whereas no hCG-dependent PLC stimulation was obsd. in cells coexpressing αi1.  Most notably, coinfection with baculoviruses encoding αq or α11 did not reproduce the PLC activation by the LH receptor.  Thus, the murine LH receptor activates adenylyl cyclase via Gs and PLC via selective coupling to Gi2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJn26tOmto1LVg90H21EOLACvtfcHk0liJxULStWPDWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltl2jsbg%253D&md5=662f190cb39a205c05968cd8ca1ff400</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbi990755m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi990755m%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25BChn%26aufirst%3DB.%26aulast%3DGudermann%26aufirst%3DT.%26atitle%3DThe%2520luteinizing%2520hormone%2520receptor%2520activates%2520phospholipase%2520C%2520via%2520preferential%2520coupling%2520to%2520Gi2%26jtitle%3DBiochemistry%26date%3D1999%26volume%3D38%26spage%3D12490%26epage%3D12498%26doi%3D10.1021%2Fbi990755m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werthmann, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sungkaworn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohse, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calebiro, D.</span></span> <span> </span><span class="NLM_article-title">Persistent cAMP signaling by internalized LH receptors in ovarian follicles</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">1613</span>– <span class="NLM_lpage">1621</span>, <span class="refDoi"> DOI: 10.1210/en.2015-1945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1210%2Fen.2015-1945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=26828746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1amurvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2016&pages=1613-1621&author=S.+Lygaauthor=S.+Volpeauthor=R.+C.+Werthmannauthor=K.+G%C3%B6tzauthor=T.+Sungkawornauthor=M.+J.+Lohseauthor=D.+Calebiro&title=Persistent+cAMP+signaling+by+internalized+LH+receptors+in+ovarian+follicles&doi=10.1210%2Fen.2015-1945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent cAMP signaling by internalized LH receptors in ovarian follicles</span></div><div class="casAuthors">Lyga, Sandra; Volpe, Silvia; Werthmann, Ruth C.; Goetz, Konrad; Sungkaworn, Titiwat; Lohse, Martin J.; Calebiro, Davide</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1613-1621</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">1945-7170</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A crucial event in female reprodn. occurs at midcycle, when a LH peak induces the final maturation of ovarian follicles.  LH signals via a G protein-coupled receptor selectively expressed in the outermost follicular cell layers.  However, how LH signals are relayed inside these cells and finally to the oocyte is incompletely understood.  Here, we monitored LH signaling in intact ovarian follicles of transgenic mice expressing a fluorescent cAMP sensor.  We found that LH stimulation induces 2 phases of cAMP signaling in all cell layers surrounding the oocyte.  Interfering with LH receptor internalization abolished the second, persistent cAMP phase and partially inhibited oocyte meiosis resumption.  These data suggest that persistent cAMP signals from internalized LH receptors contribute to transmitting LH effects inside follicle cells and ultimately to the oocyte.  Thus, this study indicates that the recently proposed paradigm of cAMP signaling by internalized G protein-coupled receptors is implicated in receptor function and is physiol. relevant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodQrsfvDjb-7Vg90H21EOLACvtfcHk0lg32fcW6jGmug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1amurvP&md5=343e651f2f0dd1bccf44700b3029d094</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1210%2Fen.2015-1945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2015-1945%26sid%3Dliteratum%253Aachs%26aulast%3DLyga%26aufirst%3DS.%26aulast%3DVolpe%26aufirst%3DS.%26aulast%3DWerthmann%26aufirst%3DR.%2BC.%26aulast%3DG%25C3%25B6tz%26aufirst%3DK.%26aulast%3DSungkaworn%26aufirst%3DT.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DCalebiro%26aufirst%3DD.%26atitle%3DPersistent%2520cAMP%2520signaling%2520by%2520internalized%2520LH%2520receptors%2520in%2520ovarian%2520follicles%26jtitle%3DEndocrinology%26date%3D2016%26volume%3D157%26spage%3D1613%26epage%3D1621%26doi%3D10.1210%2Fen.2015-1945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casarini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potì, F.</span></span> <span> </span><span class="NLM_article-title">‘Spare’ luteinizing hormone receptors: facts and fiction</span>. <i>Trends Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">208</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1016/j.tem.2018.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2Fj.tem.2018.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=29429918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=208-217&author=L.+Casariniauthor=D.+Santiauthor=M.+Simoniauthor=F.+Pot%C3%AC&title=%E2%80%98Spare%E2%80%99+luteinizing+hormone+receptors%3A+facts+and+fiction&doi=10.1016%2Fj.tem.2018.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Spare Luteinizing Hormone Receptors: Facts and Fiction</span></div><div class="casAuthors">Casarini, Livio; Santi, Daniele; Simoni, Manuela; Poti, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">208-217</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  It is common opinion that maximal activation of LH (LH)-dependent steroidogenic signal occurs at <1% of human LH/choriogonadotropin (hCG) receptor (LHCGR) occupancy.  This effect would be a consequence of an excess of receptors expressed on the surface of theca cells, resulting in a pool of LHCGRs remaining unbound (spare).  This concept was borrowed from historical pharmacol. studies, when discrepancies between ligand-receptor binding and dose-response curves of cAMP were evaluated by treating mouse or rat Leydig cells with hCG in vitro.  Recent findings demonstrated the specificity of LH- and hCG-dependent effects, receptor heterodimerization, and differing behaviors of rodent vs. human gonadotropin-responsive cells, which may help to revise the 'spare' LHCGRs concept applied to human ovarian physiol. and assisted reprodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov6P1C2mOSg7Vg90H21EOLACvtfcHk0lg32fcW6jGmug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyksb4%253D&md5=5e317ac19846da6e48b147f85d53d45e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.tem.2018.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tem.2018.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DCasarini%26aufirst%3DL.%26aulast%3DSanti%26aufirst%3DD.%26aulast%3DSimoni%26aufirst%3DM.%26aulast%3DPot%25C3%25AC%26aufirst%3DF.%26atitle%3D%25E2%2580%2598Spare%25E2%2580%2599%2520luteinizing%2520hormone%2520receptors%253A%2520facts%2520and%2520fiction%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D2018%26volume%3D29%26spage%3D208%26epage%3D217%26doi%3D10.1016%2Fj.tem.2018.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oosterom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonger, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegerinck, P. H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IJzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">[3H]Org 43553, the first low-molecular-weight agonistic and allosteric radioligand for the human luteinizing hormone receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1124/mol.107.039875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1124%2Fmol.107.039875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=17989351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1ymtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=518-524&author=L.+H.+Heitmanauthor=J.+Oosteromauthor=K.+M.+Bongerauthor=C.+M.+Timmersauthor=P.+H.+G.+Wiegerinckauthor=A.+P.+IJzerman&title=%5B3H%5DOrg+43553%2C+the+first+low-molecular-weight+agonistic+and+allosteric+radioligand+for+the+human+luteinizing+hormone+receptor&doi=10.1124%2Fmol.107.039875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]Org 43553, the first low-molecular-weight agonistic and allosteric radioligand for the human luteinizing hormone receptor</span></div><div class="casAuthors">Heitman, Laura H.; Oosterom, Julia; Bonger, Kimberly M.; Timmers, Cornelis M.; Wiegerinck, Peter H. G.; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">518-524</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The LH receptor plays a pivotal role in reprodn.  The high-mol.-wt. (HMW) human chorionic gonadotropin (hCG) and LH are the endogenous ligands of this receptor and bind to its large N terminus.  The present study characterizes the binding of a new low-mol.-wt. (LMW) radioligand, [3H]5-amino-2-methylsulfanyl-4-[3-(2-morpholin-4-yl-acetylamino)- phenyl]-thieno[2,3-d]pyrimidine-6-carboxylic acid tert-butylamide (Org 43553), at the LH receptor.  Equil. satn. and displacement assays were developed and optimized.  Specific binding of [3H]Org 43553 to CHO-K1 cell membranes expressing the human LH receptor and a cAMP response element-luciferase reporter gene was saturable with a KD value of 2.4±0.4 nM and a Bmax value of 1.6±0.2 pmol/mg protein.  Affinities of five LMW analogs of Org 43553 were detd.  All displaced the radioligand competitively, with Ki values ranging from 3.3 to 100 nM.  Finally, the potency of these compds. in a cAMP-induced luciferase assay was also detd.  There was a high correlation between affinity and potency (r = 0.99; P < 0.0001) of these compds.  In the search for LMW ligands, which bind allosterically to the seven-transmembrane domain of the LH receptor, a HMW radioligand (e.g., 125I-hCG) is not suitable as it is not displaced by a LMW compd.  Therefore, [3H]Org 43553, a new radioligand with good binding properties, allows screening for new LMW ligands that mimic the action of the endogenous hormone at the LH receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5J_tDsbPkzrVg90H21EOLACvtfcHk0lg32fcW6jGmug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1ymtrk%253D&md5=37648f4388831ef48721739ab40d195d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.039875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.039875%26sid%3Dliteratum%253Aachs%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DOosterom%26aufirst%3DJ.%26aulast%3DBonger%26aufirst%3DK.%2BM.%26aulast%3DTimmers%26aufirst%3DC.%2BM.%26aulast%3DWiegerinck%26aufirst%3DP.%2BH.%2BG.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26atitle%3D%255B3H%255DOrg%252043553%252C%2520the%2520first%2520low-molecular-weight%2520agonistic%2520and%2520allosteric%2520radioligand%2520for%2520the%2520human%2520luteinizing%2520hormone%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D518%26epage%3D524%26doi%3D10.1124%2Fmol.107.039875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van Straten, N. C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoonus-Gerritsma, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Someren, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Draaijer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adang, A. E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmers, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanssen, R. G. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Boeckel, C. A. A.</span></span> <span> </span><span class="NLM_article-title">The first orally active low molecular weight agonists for the LH receptor: thienopyr(im)idines with therapeutic potential for ovulation induction</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1023</span>– <span class="NLM_lpage">1026</span>, <span class="refDoi"> DOI: 10.1002/1439-7633(20021004)3:10<1023::AID-CBIC1023>3.0.CO;2-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1002%2F1439-7633%2820021004%293%3A10%3C1023%3A%3AAID-CBIC1023%3E3.0.CO%3B2-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=12362369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFGnsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=1023-1026&author=N.+C.+R.+van+Stratenauthor=G.+G.+Schoonus-Gerritsmaauthor=R.+G.+van+Somerenauthor=J.+Draaijerauthor=A.+E.+P.+Adangauthor=C.+M.+Timmersauthor=R.+G.+J.+M.+Hanssenauthor=C.+A.+A.+van+Boeckel&title=The+first+orally+active+low+molecular+weight+agonists+for+the+LH+receptor%3A+thienopyr%28im%29idines+with+therapeutic+potential+for+ovulation+induction&doi=10.1002%2F1439-7633%2820021004%293%3A10%3C1023%3A%3AAID-CBIC1023%3E3.0.CO%3B2-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The first orally active low molecular weight agonists for the LH receptor: thienopyr(im)idines with therapeutic potential for ovulation induction</span></div><div class="casAuthors">van Straten, N. C. R.; Schoonus-Gerritsma, G. G.; van Someren, R. G.; Draaijer, J.; Adang, A. E. P.; Timmers, C. M.; Hanssen, R. G. J. M.; van Boeckel, C. A. A.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1023-1026</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of thienopyrimidines and thienopyridines was synthesized and identified as orally active low mol. wt. agonists for the LH receptor.  These compds. mimic the mode of action of the high mol. wt. endogenous ligand LH.  Initial structure-activity relationships for this class of compds. were deduced and more than 50-fold improvement in potency was achieved through substitutions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS6-i6gBY1m7Vg90H21EOLACvtfcHk0lgFkY34O9CGdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFGnsrc%253D&md5=666d8fe70584179bec543542a7c03e52</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2F1439-7633%2820021004%293%3A10%3C1023%3A%3AAID-CBIC1023%3E3.0.CO%3B2-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1439-7633%252820021004%25293%253A10%253C1023%253A%253AAID-CBIC1023%253E3.0.CO%253B2-9%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BStraten%26aufirst%3DN.%2BC.%2BR.%26aulast%3DSchoonus-Gerritsma%26aufirst%3DG.%2BG.%26aulast%3Dvan%2BSomeren%26aufirst%3DR.%2BG.%26aulast%3DDraaijer%26aufirst%3DJ.%26aulast%3DAdang%26aufirst%3DA.%2BE.%2BP.%26aulast%3DTimmers%26aufirst%3DC.%2BM.%26aulast%3DHanssen%26aufirst%3DR.%2BG.%2BJ.%2BM.%26aulast%3Dvan%2BBoeckel%26aufirst%3DC.%2BA.%2BA.%26atitle%3DThe%2520first%2520orally%2520active%2520low%2520molecular%2520weight%2520agonists%2520for%2520the%2520LH%2520receptor%253A%2520thienopyr%2528im%2529idines%2520with%2520therapeutic%2520potential%2520for%2520ovulation%2520induction%26jtitle%3DChemBioChem%26date%3D2002%26volume%3D3%26spage%3D1023%26epage%3D1026%26doi%3D10.1002%2F1439-7633%2820021004%293%3A10%3C1023%3A%3AAID-CBIC1023%3E3.0.CO%3B2-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narlawar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willemsen, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfram, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brussee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IJzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">Substituted terphenyl compounds as the first class of low molecular weight allosteric inhibitors of the luteinizing hormone receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">2036</span>– <span class="NLM_lpage">2042</span>, <span class="refDoi"> DOI: 10.1021/jm801561h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801561h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtlOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2036-2042&author=L.+H.+Heitmanauthor=R.+Narlawarauthor=H.+de+Vriesauthor=M.+N.+Willemsenauthor=D.+Wolframauthor=J.+Brusseeauthor=A.+P.+IJzerman&title=Substituted+terphenyl+compounds+as+the+first+class+of+low+molecular+weight+allosteric+inhibitors+of+the+luteinizing+hormone+receptor&doi=10.1021%2Fjm801561h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted Terphenyl Compounds as the First Class of Low-Molecular-Weight Allosteric Inhibitors of the Luteinizing Hormone Receptor</span></div><div class="casAuthors">Heitman, Laura H.; Narlawar, Rajeshwar; de Vries, Henk; Willemsen, Milou N.; Wolfram, Dieter; Brussee, Johannes; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2036-2042</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The LH receptor plays an important role in fertility and certain cancers.  The endogenous ligands human chorionic gonadotropin (hCG) and LH bind to the large N terminal domain of the receptor.  We recently reported on the first radiolabeled low-mol.-wt. (LMW) agonist for this receptor, [3H]Org 43553, which was now used to screen for new LMW ligands.  We identified a terphenyl deriv. that inhibited [3H]Org 43553 binding to the receptor, which led us to synthesize a no. of derivs.  The most potent compd. of this terphenyl series, I (LUF5771), was able to increase the dissocn. rate of [3H]Org 43553 by 3.3-fold (at 10 μM).  In a functional assay, the presence of I resulted in a 2- to 3-fold lower potency of both Org 43553 and LH.  Thus, the compds. presented in this paper are the first LMW ligands that allosterically inhibit the LH receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCl0ftNbm4qbVg90H21EOLACvtfcHk0lgFkY34O9CGdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtlOhtb8%253D&md5=e7a6250d51bd951476a0ddb1a81d071c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm801561h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801561h%26sid%3Dliteratum%253Aachs%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DNarlawar%26aufirst%3DR.%26aulast%3Dde%2BVries%26aufirst%3DH.%26aulast%3DWillemsen%26aufirst%3DM.%2BN.%26aulast%3DWolfram%26aufirst%3DD.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26atitle%3DSubstituted%2520terphenyl%2520compounds%2520as%2520the%2520first%2520class%2520of%2520low%2520molecular%2520weight%2520allosteric%2520inhibitors%2520of%2520the%2520luteinizing%2520hormone%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2036%26epage%3D2042%26doi%3D10.1021%2Fjm801561h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heitman, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleinau, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brussee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krause, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IJzerman, A. P.</span></span> <span> </span><span class="NLM_article-title">Determination of different putative allosteric binding pockets at the lutropin receptor by using diverse drug-like low molecular weight ligands</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1016/j.mce.2012.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2Fj.mce.2012.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=22269095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVGlsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2012&pages=326-336&author=L.+H.+Heitmanauthor=G.+Kleinauauthor=J.+Brusseeauthor=G.+Krauseauthor=A.+P.+IJzerman&title=Determination+of+different+putative+allosteric+binding+pockets+at+the+lutropin+receptor+by+using+diverse+drug-like+low+molecular+weight+ligands&doi=10.1016%2Fj.mce.2012.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of different putative allosteric binding pockets at the lutropin receptor by using diverse drug-like low molecular weight ligands</span></div><div class="casAuthors">Heitman, Laura H.; Kleinau, Gunnar; Brussee, Johannes; Krause, Gerd; IJzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">326-336</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The lutropin/choriogonadotrophin receptor (LHCGR) is a family A G protein-coupled receptor (GPCR) which binds the endogenous hormone-ligands at the large extracellular domain.  In contrast, several drug-like low-mol.-wt. ligands (LMWs) have been reported to interact allosterically within the seven transmembrane domain (7TMD) of the LHCGR.  Here, we were interested to study the putative allosteric LHCGR binding region with focus on the detn. of two pockets for LMW ligands.  A library of compds. was screened for their ability to modify the binding of an allosteric radiolabeled LMW agonist [3H]Org 43553.  Further exptl. and computational studies revealed that the putative binding pocket for a newly identified allosteric enhancer (LUF5419) and a previously described allosteric inhibitor (LUF5771) are overlapping and that this site is different from the Org 43553 binding site.  The present study showed that these compds. are useful tools to reveal details on different allosteric binding sites located within the 7TMD of the LHCGR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGsZY8OMNXOrVg90H21EOLACvtfcHk0lgFkY34O9CGdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVGlsbo%253D&md5=4c598e9a0eeb04d531aee69919c01dbb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2012.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2012.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DKleinau%26aufirst%3DG.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DKrause%26aufirst%3DG.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26atitle%3DDetermination%2520of%2520different%2520putative%2520allosteric%2520binding%2520pockets%2520at%2520the%2520lutropin%2520receptor%2520by%2520using%2520diverse%2520drug-like%2520low%2520molecular%2520weight%2520ligands%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2012%26volume%3D351%26spage%3D326%26epage%3D336%26doi%3D10.1016%2Fj.mce.2012.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langer, G.</span></span> <span> </span><span class="NLM_article-title">Implementation and Use of State-of-the-Art, Cell-Based In Vitro Assays. In New Approaches to Drug Discovery</span>. In  <i>Handbook of Experimental Pharmacology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsch, U.</span>; <span class="NLM_string-name">Fuhrmann, U.</span>; <span class="NLM_string-name">Jaroch, S.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Cham</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">232</span>, pp  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">190</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=171-190&author=G.+Langerauthor=U.+Nielsch&author=U.+Fuhrmann&author=S.+Jaroch&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLanger%26aufirst%3DG.%26atitle%3DImplementation%2520and%2520Use%2520of%2520State-of-the-Art%252C%2520Cell-Based%2520In%2520Vitro%2520Assays.%2520In%2520New%2520Approaches%2520to%2520Drug%2520Discovery%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26aulast%3DNielsch%26aufirst%3DU.%26pub%3DSpringer%26date%3D2015%26volume%3D232%26spage%3D171%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mathis, G.</span></span> <span> </span><span class="NLM_article-title">HTRF technology</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1177/108705719900400605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1177%2F108705719900400605" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10838427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtVWlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=309-314&author=G.+Mathis&title=HTRF+technology&doi=10.1177%2F108705719900400605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">HTRF technology</span></div><div class="casAuthors">Mathis, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">309-313</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review, with 11 refs., on specific properties and characteristics of long-lived fluorescent rare earth cryptates as HTRF (homogeneous time-resolved fluorescence) reagents for use in biol. and screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8FYWqKOSm67Vg90H21EOLACvtfcHk0lgvAIjP7U4Y7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtVWlu70%253D&md5=b48f80159910aeab181a233e62fe284d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1177%2F108705719900400605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400605%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DG.%26atitle%3DHTRF%2520technology%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26spage%3D309%26epage%3D314%26doi%3D10.1177%2F108705719900400605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, F.</span></span> <span> </span><span class="NLM_article-title">HTRF: pioneering technology for high-throughput screening</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">753</span>– <span class="NLM_lpage">764</span>, <span class="refDoi"> DOI: 10.1517/17460441.1.7.753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1517%2F17460441.1.7.753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=23495998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVansw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=753-764&author=F.+Degorce&title=HTRF%3A+pioneering+technology+for+high-throughput+screening&doi=10.1517%2F17460441.1.7.753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">HTRF: pioneering technology for high-throughput screening</span></div><div class="casAuthors">Degorce, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">753-764</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Cisbio international pioneered the field of homogeneous fluorescence methodologies and time-resolved fluorescence resonance in particular, through its proprietary technol., HTRF.  The development was based on Professor Jean-Marie Lehn's research on rare earth fluorescence properties (awarded the Nobel Prize in Chem. in 1987) and on Cisbio's expertise in homogeneous time-resolved fluorescence (HTRF).  The technol. is used in assay development and drug screening, most notably in high-throughput screening applications.  This highly powerful technol. is particularly applied to the areas of G-protein-coupled receptor and kinase screening, as well as a series of targets related to inflammation, metabolic diseases and CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3_h88bD-LqLVg90H21EOLACvtfcHk0lgvAIjP7U4Y7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVansw%253D%253D&md5=5d88550e4a5c44cf91700c8aafbf5df2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F17460441.1.7.753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.1.7.753%26sid%3Dliteratum%253Aachs%26aulast%3DDegorce%26aufirst%3DF.%26atitle%3DHTRF%253A%2520pioneering%2520technology%2520for%2520high-throughput%2520screening%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D753%26epage%3D764%26doi%3D10.1517%2F17460441.1.7.753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Degorce, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Card, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinquet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapik, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, B.</span></span> <span> </span><span class="NLM_article-title">HTRF: a technology tailored for drug discovery – a review of theoretical aspects and recent applications</span>. <i>Curr. Chem. Genomics</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.2174/1875397300903010022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.2174%2F1875397300903010022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=20161833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFWnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=22-32&author=F.+Degorceauthor=A.+Cardauthor=S.+Sohauthor=E.+Trinquetauthor=G.+P.+Knapikauthor=B.+Xie&title=HTRF%3A+a+technology+tailored+for+drug+discovery+%E2%80%93+a+review+of+theoretical+aspects+and+recent+applications&doi=10.2174%2F1875397300903010022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">HTRF: a technology tailored for drug discovery - a review of theoretical aspects and recent applications</span></div><div class="casAuthors">Degorce, Francois; Card, Amy; Soh, Sharon; Trinquet, Eric; Knapik, Glenn P.; Xie, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Current Chemical Genomics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-32</span>CODEN:
                <span class="NLM_cas:coden">CCGUAQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-3973</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HTRF (Homogeneous Time Resolved Fluorescence) is the most frequently used generic assay technol. to measure analytes in a homogenous format, which is the ideal platform used for drug target studies in high-throughput screening (HTS).  This technol. combines fluorescence resonance energy transfer technol. (FRET) with time-resolved measurement (TR).  In TR-FRET assays, a signal is generated through fluorescent resonance energy transfer between a donor and an acceptor mol. when in close proximity to each other.  Buffer and media interference is dramatically reduced by dual-wavelength detection, and the final signal is proportional to the extent of product formation.  The HTRF assay is usually sensitive and robust that can be miniaturized into the 384 and 1536-well plate formats.  This assay technol. has been applied to many antibody-based assays including GPCR signaling (cAMP and IP-One), kinases, cytokines and biomarkers, bioprocess (antibody and protein prodn.), as well as the assays for protein-protein, protein-peptide, and protein-DNA/RNA interactions.  Since its introduction to the drug-screening world over ten years ago, researchers have used HTRF to expedite the study of GPCRs, kinases, new biomarkers, protein-protein interactions, and other targets of interest.  HTRF has also been utilized as an alternative method for bioprocess monitoring.  The first-generation HTRF technol., which uses Europium cryptate as a fluorescence donor to monitor reactions between biomols., was extended in 2008 through the introduction of a second-generation donor, Terbium cryptate (Tb), enhancing screening performance.  Terbium cryptate possesses different photophys. properties compared to Europium, including increased quantum yield and a higher molar extinction coeff.  In addn. to being compatible with the same acceptor fluorophors used with Europium, it can serve as a donor fluorophore to green-emitting fluors because it has multiple emission peaks including one at 490 nm.  Moreover, all Terbium HTRF assays can be read on the same HTRF-compatible instruments as Europium HTRF assays.  Overall, HTRF is a highly sensitive, robust technol. for the detection of mol. interactions in vitro and is widely used for primary and secondary screening phases of drug development.  This review addresses the general principles of HTRF and its current applications in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKDP8Vd8k247Vg90H21EOLACvtfcHk0litMV-3R4HLhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFWnsr4%253D&md5=9590149ceeed17ce424522ef85aa32f9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F1875397300903010022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1875397300903010022%26sid%3Dliteratum%253Aachs%26aulast%3DDegorce%26aufirst%3DF.%26aulast%3DCard%26aufirst%3DA.%26aulast%3DSoh%26aufirst%3DS.%26aulast%3DTrinquet%26aufirst%3DE.%26aulast%3DKnapik%26aufirst%3DG.%2BP.%26aulast%3DXie%26aufirst%3DB.%26atitle%3DHTRF%253A%2520a%2520technology%2520tailored%2520for%2520drug%2520discovery%2520%25E2%2580%2593%2520a%2520review%2520of%2520theoretical%2520aspects%2520and%2520recent%2520applications%26jtitle%3DCurr.%2520Chem.%2520Genomics%26date%3D2009%26volume%3D3%26spage%3D22%26epage%3D32%26doi%3D10.2174%2F1875397300903010022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0litMV-3R4HLhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0lhu8IHUNI17uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0169-409X%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundbeck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakobsen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varming, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westergaard, N.</span></span> <span> </span><span class="NLM_article-title">Glucose-6-phosphatase catalytic enzyme inhibitors: synthesis and in vitro evaluation of novel 4,5,6,7-tetrahydrothieno[3,2-c]- and -[2,3-c]pyridines</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2277</span>– <span class="NLM_lpage">2289</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(00)00153-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2FS0968-0896%2800%2900153-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=11026540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtF2jtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2000&pages=2277-2289&author=P.+Madsenauthor=J.+M.+Lundbeckauthor=P.+Jakobsenauthor=A.+R.+Varmingauthor=N.+Westergaard&title=Glucose-6-phosphatase+catalytic+enzyme+inhibitors%3A+synthesis+and+in+vitro+evaluation+of+novel+4%2C5%2C6%2C7-tetrahydrothieno%5B3%2C2-c%5D-+and+-%5B2%2C3-c%5Dpyridines&doi=10.1016%2FS0968-0896%2800%2900153-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose-6-phosphatase catalytic enzyme inhibitors: synthesis and in vitro evaluation of novel 4,5,6,7-tetrahydrothieno[3,2-c]- and -[2,3-c]pyridines</span></div><div class="casAuthors">Madsen, P.; Lundbeck, J. M.; Jakobsen, P.; Varming, A. R.; Westergaard, N.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2277-2289</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The discovery of the first class of potent glucose-6-phosphatase catalytic site inhibitors, substituted 4,5,6,7-tetrahydrothieno[3,2-c]- and -[2,3-c]pyridines, is described.  Optimization of this series involved soln. phase combinatorial synthesis and very potent compds. were prepd. with IC50 values down to 140 nM.  The structure-activity relationship (SAR) of these compds. indicates that: a tetrahydrothieno[3,2-c]pyridine core ring system and the isomeric [2,3-c] system are equipotent and much better than the corresponding benzo analog, 1,2,3,4-tetrahydro-isoquinoline.  The 4-substituent of the tetrahydrothieno[3,2-c]pyridine ring has to be a Ph group, optionally substituted with a lipophilic 4-substituent, such as trifluoromethoxy or chloro.  The 5-substituent of the tetrahydrothieno[3,2-c]pyridine ring has to be a substituted benzoyl; anisoyl and (E)-3-furan-3-ylacryloyl are the best of the investigated groups.  Substitution in the benzoyl ortho position seems to be forbidden, whereas substitution in the meta position is tolerated only if a methoxy para substituent is present.  These SAR findings were parallel to those obtained in the 4,5,6,7-tetrahydrothieno[2,3-c]pyridine system.  Enantioselectivity in enzyme recognition was obsd. and the activity resided in all cases only in one of the enantiomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6xChFeiBBlbVg90H21EOLACvtfcHk0lhu8IHUNI17uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtF2jtLk%253D&md5=7d5eff438e75cbe228c5ea8239fba054</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2800%2900153-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252800%252900153-X%26sid%3Dliteratum%253Aachs%26aulast%3DMadsen%26aufirst%3DP.%26aulast%3DLundbeck%26aufirst%3DJ.%2BM.%26aulast%3DJakobsen%26aufirst%3DP.%26aulast%3DVarming%26aufirst%3DA.%2BR.%26aulast%3DWestergaard%26aufirst%3DN.%26atitle%3DGlucose-6-phosphatase%2520catalytic%2520enzyme%2520inhibitors%253A%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520novel%25204%252C5%252C6%252C7-tetrahydrothieno%255B3%252C2-c%255D-%2520and%2520-%255B2%252C3-c%255Dpyridines%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2000%26volume%3D8%26spage%3D2277%26epage%3D2289%26doi%3D10.1016%2FS0968-0896%2800%2900153-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gramec, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterlin Mašič, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span> <span> </span><span class="NLM_article-title">Bioactivation potential of thiophene-containing drugs</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1344</span>– <span class="NLM_lpage">1358</span>, <span class="refDoi"> DOI: 10.1021/tx500134g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx500134g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFelurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=1344-1358&author=D.+Gramecauthor=L.+Peterlin+Ma%C5%A1i%C4%8Dauthor=M.+Sollner+Dolenc&title=Bioactivation+potential+of+thiophene-containing+drugs&doi=10.1021%2Ftx500134g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation Potential of Thiophene-Containing Drugs</span></div><div class="casAuthors">Gramec, Darja; Peterlin Masic, Lucija; Sollner Dolenc, Marija</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1344-1358</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Thiophene is a five-membered, sulfur-contg. heteroarom. ring commonly used as a building block in drugs.  It is considered to be a structural alert, as its metab. can lead to the formation of reactive metabolites.  Thiophene S-oxides and thiophene epoxides are highly reactive electrophilic thiophene metabolites whose formation is cytochrome P 450-dependent.  These reactive thiophene-based metabolites are quite often responsible for drug-induced hepatotoxicity.  Tienilic acid is an example of a thiophene-based drug that was withdrawn from the market after only a few months of use, due to severe cases of immune hepatitis.  However, inclusion of the thiophene moiety in drugs does not necessarily result in toxic effects.  The presence of other, less toxic metabolic pathways, as well as an effective detoxification system in our body, protects us from the bioactivation potential of the thiophene ring.  Thus, the presence of a structural alert itself is insufficient to predict a compd.'s toxicity.  The question therefore arises as to which factors significantly influence the toxicity of thiophene-contg. drugs.  There is no easy way to answer this question.  However, the findings presented here indicate that, for a no. of reasons, daily dose and alternative metabolic pathways are important factors when predicting toxicity and will therefore be discussed together with examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0KnyHFkaMsrVg90H21EOLACvtfcHk0lhu8IHUNI17uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFelurjL&md5=65733d5665c8ac67050a60707a2e828b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Ftx500134g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx500134g%26sid%3Dliteratum%253Aachs%26aulast%3DGramec%26aufirst%3DD.%26aulast%3DPeterlin%2BMa%25C5%25A1i%25C4%258D%26aufirst%3DL.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26atitle%3DBioactivation%2520potential%2520of%2520thiophene-containing%2520drugs%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26spage%3D1344%26epage%3D1358%26doi%3D10.1021%2Ftx500134g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bountra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser-Doepner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimshaw, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mader, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Fahrnow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O′Hagan, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schapira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo-Sherman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpole, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">The promise and peril of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">536</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1038%2Fnchembio.1867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=26196764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=536-541&author=C.+H.+Arrowsmithauthor=J.+E.+Audiaauthor=C.+Austinauthor=J.+Baellauthor=J.+Bennettauthor=J.+Blaggauthor=C.+Bountraauthor=P.+E.+Brennanauthor=P.+J.+Brownauthor=M.+E.+Bunnageauthor=C.+Buser-Doepnerauthor=R.+M.+Campbellauthor=A.+J.+Carterauthor=P.+Cohenauthor=R.+A.+Copelandauthor=B.+Cravattauthor=J.+L.+Dahlinauthor=D.+Dhanakauthor=A.+M.+Edwardsauthor=M.+Frederiksenauthor=S.+V.+Fryeauthor=N.+Grayauthor=C.+E.+Grimshawauthor=D.+Hepworthauthor=T.+Howeauthor=K.+V.+M.+Huberauthor=J.+Jinauthor=S.+Knappauthor=J.+D.+Kotzauthor=R.+G.+Krugerauthor=D.+Loweauthor=M.+M.+Maderauthor=B.+Marsdenauthor=A.+Mueller-Fahrnowauthor=S.+M%C3%BCllerauthor=R.+C.+O%E2%80%B2Haganauthor=J.+P.+Overingtonauthor=D.+R.+Owenauthor=S.+H.+Rosenbergauthor=R.+Rossauthor=B.+Rothauthor=M.+Schapiraauthor=S.+L.+Schreiberauthor=B.+Shoichetauthor=M.+Sundstr%C3%B6mauthor=G.+Superti-Furgaauthor=J.+Tauntonauthor=L.+Toledo-Shermanauthor=C.+Walpoleauthor=M.+A.+Waltersauthor=T.+M.+Willsonauthor=P.+Workmanauthor=R.+N.+Youngauthor=W.+J.+Zuercher&title=The+promise+and+peril+of+chemical+probes&doi=10.1038%2Fnchembio.1867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The promise and peril of chemical probes</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Audia, James E.; Austin, Christopher; Baell, Jonathan; Bennett, Jonathan; Blagg, Julian; Bountra, Chas; Brennan, Paul E.; Brown, Peter J.; Bunnage, Mark E.; Buser-Doepner, Carolyn; Campbell, Robert M.; Carter, Adrian J.; Cohen, Philip; Copeland, Robert A.; Cravatt, Ben; Dahlin, Jayme L.; Dhanak, Dashyant; Edwards, Aled M.; Frye, Stephen V.; Gray, Nathanael; Grimshaw, Charles E.; Hepworth, David; Howe, Trevor; Huber, Kilian V. M.; Jin, Jian; Knapp, Stefan; Kotz, Joanne D.; Kruger, Ryan G.; Lowe, Derek; Mader, Mary M.; Marsden, Brian; Mueller-Fahrnow, Anke; Muller, Susanne; O'Hagan, Ronan C.; Overington, John P.; Owen, Dafydd R.; Rosenberg, Saul H.; Roth, Brian; Ross, Ruth; Schapira, Matthieu; Schreiber, Stuart L.; Shoichet, Brian; Sundstrom, Michael; Superti-Furga, Giulio; Taunton, Jack; Toledo-Sherman, Leticia; Walpole, Chris; Walters, Michael A.; Willson, Timothy M.; Workman, Paul; Young, Robert N.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">536-541</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes are powerful reagents with increasing impacts on biomedical research.  However, probes of poor quality or that are used incorrectly generate misleading results.  To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-li4dxq487rVg90H21EOLACvtfcHk0lgrNVotT6wp4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO&md5=d8c7a7af94921ab4cdcc871487cceadd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1867%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBuser-Doepner%26aufirst%3DC.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DCarter%26aufirst%3DA.%2BJ.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGrimshaw%26aufirst%3DC.%2BE.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKotz%26aufirst%3DJ.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DLowe%26aufirst%3DD.%26aulast%3DMader%26aufirst%3DM.%2BM.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DMueller-Fahrnow%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DO%25E2%2580%25B2Hagan%26aufirst%3DR.%2BC.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DToledo-Sherman%26aufirst%3DL.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520promise%2520and%2520peril%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D536%26epage%3D541%26doi%3D10.1038%2Fnchembio.1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Structural Genomics Consortium
(SCG)</span>. <a href="https://www.thesgc.org" class="extLink">https://www.thesgc.org</a> (accessed Aug 15, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Structural+Genomics+Consortium%0A%28SCG%29.+https%3A%2F%2Fwww.thesgc.org+%28accessed+Aug+15%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di Fabio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffante, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzi, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattioli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimarosti, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guercio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchioro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Provera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonzini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melotto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerrard, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trist, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsi, M.</span></span> <span> </span><span class="NLM_article-title">Discovery and biological characterization of (2R,4S)-1’-acetyl-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fluoro-2-methylphenyl)-N-methyl-4,4’-bipiperidine-1-carboxamide as a new potent and selective neurokinin 1 (NK1) receptor antagonist clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1021/jm1013264</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013264" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlt1Ogtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1071-1079&author=R.+Di+Fabioauthor=G.+Alvaroauthor=C.+Griffanteauthor=D.+A.+Pizziauthor=D.+Donatiauthor=M.+Mattioliauthor=Z.+Cimarostiauthor=G.+Guercioauthor=C.+Marchioroauthor=S.+Proveraauthor=L.+Zonziniauthor=D.+Montanariauthor=S.+Melottoauthor=P.+A.+Gerrardauthor=D.+G.+Tristauthor=E.+Rattiauthor=M.+Corsi&title=Discovery+and+biological+characterization+of+%282R%2C4S%29-1%E2%80%99-acetyl-N-%7B%281R%29-1-%5B3%2C5-bis%28trifluoromethyl%29phenyl%5Dethyl%7D-2-%284-fluoro-2-methylphenyl%29-N-methyl-4%2C4%E2%80%99-bipiperidine-1-carboxamide+as+a+new+potent+and+selective+neurokinin+1+%28NK1%29+receptor+antagonist+clinical+candidate&doi=10.1021%2Fjm1013264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Biological Characterization of (2R,4S)-1'-Acetyl-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fluoro-2-methylphenyl)-N-methyl-4,4'-bipiperidine-1-carboxamide as a New Potent and Selective Neurokinin 1 (NK1) Receptor Antagonist Clinical Candidate</span></div><div class="casAuthors">Di Fabio, Romano; Alvaro, Giuseppe; Griffante, Cristiana; Pizzi, Domenica A.; Donati, Daniele; Mattioli, Mario; Cimarosti, Zadeo; Guercio, Giuseppe; Marchioro, Carla; Provera, Stefano; Zonzini, Laura; Montanari, Dino; Melotto, Sergio; Gerrard, Philip A.; Trist, David G.; Ratti, Emiliangelo; Corsi, Mauro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1071-1079</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A large body of compelling preclin. evidence supports the clin. use of neurokinin (NK) receptor antagonists in a plethora of CNS and non-CNS therapeutic areas.  The significant investment made in this area over the past 2 decades culminated with the observation that NK1 receptor antagonists elicited clin. efficacy in major depression disorders.  In addn., aprepitant (Merck) was launched as a new drug able to prevent chemotherapy-induced nausea and vomiting (CINV).  After the discovery by GlaxoSmithKline of vestipitant, a wide drug discovery program was launched aimed at identifying addnl. clin. candidates.  New compds. were designed to maximize affinity at the NK1 receptor binding site while retaining suitable physicochem. characteristics to ensure excellent pharmacokinetic and pharmacodynamic properties in vivo.  Herein we describe the discovery process of a new NK1 receptor antagonist (casopitant) selected as clin. candidate and progressed into clin. studies to treat major depression disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNXJswsOiu-LVg90H21EOLACvtfcHk0lgL_6GhntvuBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlt1Ogtw%253D%253D&md5=98af29713594b9db404cdec6a4155f1c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm1013264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013264%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFabio%26aufirst%3DR.%26aulast%3DAlvaro%26aufirst%3DG.%26aulast%3DGriffante%26aufirst%3DC.%26aulast%3DPizzi%26aufirst%3DD.%2BA.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DMattioli%26aufirst%3DM.%26aulast%3DCimarosti%26aufirst%3DZ.%26aulast%3DGuercio%26aufirst%3DG.%26aulast%3DMarchioro%26aufirst%3DC.%26aulast%3DProvera%26aufirst%3DS.%26aulast%3DZonzini%26aufirst%3DL.%26aulast%3DMontanari%26aufirst%3DD.%26aulast%3DMelotto%26aufirst%3DS.%26aulast%3DGerrard%26aufirst%3DP.%2BA.%26aulast%3DTrist%26aufirst%3DD.%2BG.%26aulast%3DRatti%26aufirst%3DE.%26aulast%3DCorsi%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520biological%2520characterization%2520of%2520%25282R%252C4S%2529-1%25E2%2580%2599-acetyl-N-%257B%25281R%2529-1-%255B3%252C5-bis%2528trifluoromethyl%2529phenyl%255Dethyl%257D-2-%25284-fluoro-2-methylphenyl%2529-N-methyl-4%252C4%25E2%2580%2599-bipiperidine-1-carboxamide%2520as%2520a%2520new%2520potent%2520and%2520selective%2520neurokinin%25201%2520%2528NK1%2529%2520receptor%2520antagonist%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1071%26epage%3D1079%26doi%3D10.1021%2Fjm1013264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Comins, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingalls, C. L.</span></span> <span> </span><span class="NLM_article-title">Reduction of N-acyl-2,3-dihydro-4-pyridones to N-acyl-4-piperidones using zinc/acetic acid</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">2181</span>– <span class="NLM_lpage">2182</span>, <span class="refDoi"> DOI: 10.1021/jo001609l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo001609l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtlegurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=2181-2182&author=D.+L.+Cominsauthor=C.+A.+Brooksauthor=C.+L.+Ingalls&title=Reduction+of+N-acyl-2%2C3-dihydro-4-pyridones+to+N-acyl-4-piperidones+using+zinc%2Facetic+acid&doi=10.1021%2Fjo001609l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of N-acyl-2,3-dihydro-4-pyridones to N-acyl-4-piperidones using zinc/acetic acid</span></div><div class="casAuthors">Comins, Daniel L.; Brooks, Clinton A.; Ingalls, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2181-2182</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-alkoxycarbonyldihydropyridones I [R1 = vinyl, Ph, PhCH2CH2; R2 = CH2Ph; R1 = Me, Ph, EtO2CCH:CH(CH2)3; R2 = Ph] were reduced using Zn/AcOH to give the corresponding piperidones in 91-95% yields.  Nonracemic bicyclic indolizinedione II was similarly reduced.  This method allows for the simple, mild, and inexpensive prepn. of N-acyl-4-piperidones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZt_Prjn5G1bVg90H21EOLACvtfcHk0lgL_6GhntvuBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtlegurk%253D&md5=3211a5fa7ed5eaa468e360022dab5cf0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo001609l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo001609l%26sid%3Dliteratum%253Aachs%26aulast%3DComins%26aufirst%3DD.%2BL.%26aulast%3DBrooks%26aufirst%3DC.%2BA.%26aulast%3DIngalls%26aufirst%3DC.%2BL.%26atitle%3DReduction%2520of%2520N-acyl-2%252C3-dihydro-4-pyridones%2520to%2520N-acyl-4-piperidones%2520using%2520zinc%252Facetic%2520acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D2181%26epage%3D2182%26doi%3D10.1021%2Fjo001609l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbiati, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Giuseppe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, E.</span></span> <span> </span><span class="NLM_article-title">Sequential amination/annulation/aromatization reaction of carbonyl compounds and propargylamine: a new one-pot approach to functionalized pyridines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">6959</span>– <span class="NLM_lpage">6966</span>, <span class="refDoi"> DOI: 10.1021/jo0347260</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0347260" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFWmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=6959-6966&author=G.+Abbiatiauthor=A.+Arcadiauthor=G.+Bianchiauthor=S.+Di+Giuseppeauthor=F.+Marinelliauthor=E.+Rossi&title=Sequential+amination%2Fannulation%2Faromatization+reaction+of+carbonyl+compounds+and+propargylamine%3A+a+new+one-pot+approach+to+functionalized+pyridines&doi=10.1021%2Fjo0347260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sequential Amination/Annulation/Aromatization Reaction of Carbonyl Compounds and Propargylamine: A New One-Pot Approach to Functionalized Pyridines</span></div><div class="casAuthors">Abbiati, Giorgio; Arcadi, Antonio; Bianchi, Gabriele; Di Giuseppe, Sabrina; Marinelli, Fabio; Rossi, Elisabetta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6959-6966</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general one-pot synthesis of pyridines, e.g., I, from the reaction of ketones and aldehydes, bearing α-hydrogens, with propargylamine is described.  Gold and copper salts are efficient catalysts for the reaction of ketones with propargylamine.  The formation of the pyridines is suggested to proceed through the sequential amination of carbonyl compds. followed by regioselective 6-endo-dig cyclization of the N-propargylenamine (N-propargyldienamine) intermediate and aromatization reaction.  Whereas the prepn. of linear polycyclic pyridine can be carried out by reacting cholestan-3-one with propargylamine, angular polycyclic pyridine II has been obtained starting from cholest-5-en-3-one.  Selectivity of the reaction of polycyclic dicarbonyls with propargylamine has also been investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq0QcmHCXR9LVg90H21EOLACvtfcHk0lhOGP5_v_70EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFWmt7Y%253D&md5=48e6675f4ee7ba320b5ba1cb4d888308</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo0347260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0347260%26sid%3Dliteratum%253Aachs%26aulast%3DAbbiati%26aufirst%3DG.%26aulast%3DArcadi%26aufirst%3DA.%26aulast%3DBianchi%26aufirst%3DG.%26aulast%3DDi%2BGiuseppe%26aufirst%3DS.%26aulast%3DMarinelli%26aufirst%3DF.%26aulast%3DRossi%26aufirst%3DE.%26atitle%3DSequential%2520amination%252Fannulation%252Faromatization%2520reaction%2520of%2520carbonyl%2520compounds%2520and%2520propargylamine%253A%2520a%2520new%2520one-pot%2520approach%2520to%2520functionalized%2520pyridines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D6959%26epage%3D6966%26doi%3D10.1021%2Fjo0347260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gentry, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Novel allosteric modulators of G protein-coupled receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">19478</span>– <span class="NLM_lpage">19488</span>, <span class="refDoi"> DOI: 10.1074/jbc.R115.662759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1074%2Fjbc.R115.662759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=26100627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12mt7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=19478-19488&author=P.+R.+Gentryauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Novel+allosteric+modulators+of+G+protein-coupled+receptors&doi=10.1074%2Fjbc.R115.662759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Allosteric Modulators of G Protein-coupled Receptors</span></div><div class="casAuthors">Gentry, Patrick R.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">19478-19488</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) are allosteric proteins, because their signal transduction relies on interactions between topog. distinct, yet conformationally linked, domains.  Much of the focus on GPCR allostery in the new millennium, however, has been on modes of targeting GPCR allosteric sites with chem. probes due to the potential for novel therapeutics.  It is now apparent that some GPCRs possess more than one targetable allosteric site, in addn. to a growing list of putative endogenous modulators.  Advances in structural biol. are also shedding new insights into mechanisms of allostery, although the complexities of candidate allosteric drugs necessitate rigorous biol. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-w2L2Z2PwrVg90H21EOLACvtfcHk0lhOGP5_v_70EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12mt7rI&md5=7c3b5c0ddd375e0c05a18b91f2c68e56</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R115.662759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R115.662759%26sid%3Dliteratum%253Aachs%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DNovel%2520allosteric%2520modulators%2520of%2520G%2520protein-coupled%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D19478%26epage%3D19488%26doi%3D10.1074%2Fjbc.R115.662759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span> <span> </span><span class="NLM_article-title">Agonist-bound structure of the human P2Y12 receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>509</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1038/nature13288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1038%2Fnature13288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=24784220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlyis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=509&publication_year=2014&pages=119-122&author=J.+Zhangauthor=K.+Zhangauthor=Z.-G.+Gaoauthor=S.+Paolettaauthor=D.+Zhangauthor=G.+W.+Hanauthor=T.+Liauthor=L.+Maauthor=W.+Zhangauthor=C.+E.+M%C3%BCllerauthor=H.+Yangauthor=H.+Jiangauthor=V.+Cherezovauthor=V.+Katritchauthor=K.+A.+Jacobsonauthor=R.+C.+Stevensauthor=B.+Wuauthor=Q.+Zhao&title=Agonist-bound+structure+of+the+human+P2Y12+receptor&doi=10.1038%2Fnature13288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist-bound structure of the human P2Y12 receptor</span></div><div class="casAuthors">Zhang, Jin; Zhang, Kaihua; Gao, Zhan-Guo; Paoletta, Silvia; Zhang, Dandan; Han, Gye Won; Li, Tingting; Ma, Limin; Zhang, Wenru; Mueller, Christa E.; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Katritch, Vsevolod; Jacobson, Kenneth A.; Stevens, Raymond C.; Wu, Beili; Zhao, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">509</span>
        (<span class="NLM_cas:issue">7498</span>),
    <span class="NLM_cas:pages">119-122</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The P2Y12 receptor (P2Y12R), one of eight members of the P2YR family expressed in humans, is one of the most prominent clin. drug targets for inhibition of platelet aggregation.  Although mutagenesis and modeling studies of the P2Y12R provided useful insights into ligand binding, the agonist and antagonist recognition and function at the P2Y12R remain poorly understood at the mol. level.  Here we report the structures of the human P2Y12R in complex with the full agonist 2-methylthio-adenosine-5'-diphosphate (2MeSADP, a close analog of endogenous agonist ADP) at 2.5 Å resoln., and the corresponding ATP deriv. 2-methylthio-adenosine-5'-triphosphate (2MeSATP) at 3.1 Å resoln.  These structures, together with the structure of the P2Y12R with antagonist Et 6-(4-((benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283), reveal striking conformational changes between nucleotide and non-nucleotide ligand complexes in the extracellular regions.  Further anal. of these changes provides insight into a distinct ligand binding landscape in the δ-group of class A G-protein-coupled receptors (GPCRs).  Agonist and non-nucleotide antagonist adopt different orientations in the P2Y12R, with only partially overlapped binding pockets.  The agonist-bound P2Y12R structure answers long-standing questions surrounding P2Y12R-agonist recognition, and reveals interactions with several residues that had not been reported to be involved in agonist binding.  As a first example, to our knowledge, of a GPCR in which agonist access to the binding pocket requires large-scale rearrangements in the highly malleable extracellular region, the structural and docking studies will therefore provide invaluable insight into the pharmacol. and mechanisms of action of agonists and different classes of antagonists for the P2Y12R and potentially for other closely related P2YRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJkF4VbScbarVg90H21EOLACvtfcHk0lhOGP5_v_70EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlyis7k%253D&md5=7fdb421ab2f3757a7e7134d586de84bf</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnature13288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13288%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DQ.%26atitle%3DAgonist-bound%2520structure%2520of%2520the%2520human%2520P2Y12%2520receptor%26jtitle%3DNature%26date%3D2014%26volume%3D509%26spage%3D119%26epage%3D122%26doi%3D10.1038%2Fnature13288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Espey, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, J. S.</span></span> <span> </span><span class="NLM_article-title">Temporal and spatial patterns of ovarian gene transcription following an ovulatory dose of gonadotropin in the rat</span>. <i>Biol. Reprod.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1662</span>– <span class="NLM_lpage">1670</span>, <span class="refDoi"> DOI: 10.1095/biolreprod.102.005173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1095%2Fbiolreprod.102.005173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=12444039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD38XptVels74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2002&pages=1662-1670&author=L.+L.+Espeyauthor=J.+S.+Richards&title=Temporal+and+spatial+patterns+of+ovarian+gene+transcription+following+an+ovulatory+dose+of+gonadotropin+in+the+rat&doi=10.1095%2Fbiolreprod.102.005173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Temporal and spatial patterns of ovarian gene transcription following an ovulatory dose of gonadotropin in the rat</span></div><div class="casAuthors">Espey, Lawrence L.; Richards, JoAnne S.</div><div class="citationInfo"><span class="NLM_cas:title">Biology of Reproduction</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1662-1670</span>CODEN:
                <span class="NLM_cas:coden">BIREBV</span>;
        ISSN:<span class="NLM_cas:issn">0006-3363</span>.
    
            (<span class="NLM_cas:orgname">Society for the Study of Reproduction</span>)
        </div><div class="casAbstract">A review.  In recent years, there have been a no. of efforts to identify genes that are expressed in mature ovarian follicles in response to an ovulatory dose of LH or its homolog human chorionic gonadotropin (hCG).  This review keys on 20 ovulation-specific genes that we have identified by the mol. procedure known as differential display.  The objective is to use this sampling of genes to illustrate the diversity in the temporal and spatial patterns of expression of genes in the ovary following the stimulus of this gonadal target tissue by a single glycoprotein hormone.  The specific genes that are surveyed include 5-aminolevulinate synthase; early growth response protein-1; γ-glutamylcysteine synthetase; cyclooxygenase-2; epiregulin; pituitary adenylate cyclase-activating polypeptide; tumor necrosis factor-stimulated gene-6; regulator of G-protein signaling protein-2; adrenodoxin; steroidogenic acute regulatory protein; 3α-hydroxysteroid dehydrogenase; CD63, a disintegrin and metalloproteinase with thrombospondin motifs; tissue inhibitor of metalloproteinase-1; carbonyl reductase, a G-protein-coupled receptor; pancreatitis-assocd. protein-III; glutathione S-transferase; and metallothionein-1.  The ovulatory expression of these different genes is predominantly within the granulosa layer of mature follicles.  However, there were also instances of expression in the thecal and stromal tissue of the ovary, as well as in vascular endothelial cells and in luteal tissue.  The overwhelming impression is that the mol. events of ovulation are far more complex, and therefore more highly ordered, than originally imagined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnt0lhfh717Vg90H21EOLACvtfcHk0liH1Q4-Jzjk1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptVels74%253D&md5=69536db980a054a6f8c5dc868c68d04b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1095%2Fbiolreprod.102.005173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1095%252Fbiolreprod.102.005173%26sid%3Dliteratum%253Aachs%26aulast%3DEspey%26aufirst%3DL.%2BL.%26aulast%3DRichards%26aufirst%3DJ.%2BS.%26atitle%3DTemporal%2520and%2520spatial%2520patterns%2520of%2520ovarian%2520gene%2520transcription%2520following%2520an%2520ovulatory%2520dose%2520of%2520gonadotropin%2520in%2520the%2520rat%26jtitle%3DBiol.%2520Reprod.%26date%3D2002%26volume%3D67%26spage%3D1662%26epage%3D1670%26doi%3D10.1095%2Fbiolreprod.102.005173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fitzpatrick, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlone, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robker, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, J. S.</span></span> <span> </span><span class="NLM_article-title">Expression of aromatase in the ovary: down-regulation of mRNA by the ovulatory luteinizing hormone surge</span>. <i>Steroids</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">206</span>, <span class="refDoi"> DOI: 10.1016/S0039-128X(96)00181-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2FS0039-128X%2896%2900181-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=9029737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK2sXhtVyluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=197-206&author=S.+L.+Fitzpatrickauthor=D.+L.+Carloneauthor=R.+L.+Robkerauthor=J.+S.+Richards&title=Expression+of+aromatase+in+the+ovary%3A+down-regulation+of+mRNA+by+the+ovulatory+luteinizing+hormone+surge&doi=10.1016%2FS0039-128X%2896%2900181-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of aromatase in the ovary: down-regulation of mRNA by the ovulatory luteinizing hormone surge</span></div><div class="casAuthors">Fitzpatrick, Susan L.; Carlone, Diana L.; Robker, Rebecca L.; Richards, JoAnne S.</div><div class="citationInfo"><span class="NLM_cas:title">Steroids</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-206</span>CODEN:
                <span class="NLM_cas:coden">STEDAM</span>;
        ISSN:<span class="NLM_cas:issn">0039-128X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Aromatase (CYP19) mRNA is induced by FSH in granulosa cells of preovulatory follicles and subsequently is rapidly diminished as a consequence of the LH surge.  Primary cultures of rat granulosa cells were used to identify some of the cellular mechanisms by which FSH increases and LH decreases steady-state levels of aromatase mRNA.  Induction of aromatase mRNA by FSH was increased by cycloheximide but was blocked by α-amanitin and the C-kinase activators gonadotropin-releasing hormone (GnRH) and phorbol 12-myristate 13-acetate (PMA).  In contrast, the decrease in steady-state levels of aromatase mRNA by LH was mimicked by A-kinase (forskolin) and C-kinase (PMA or GnRH) activators.  The decrease in aromatase mRNA was assocd. with decreased amts. of mRNA and protein for steroidogenic factor-1 (SF-1), a nuclear orphan receptor that binds and trans-activates the aromatase promoter, and with the A-kinase subunit type II (RIIβ), which is required for mediating cAMP action in these cells.  The down-regulation of aromatase, SF-1, and RIIβ by each kinase activator and α-amanitin was prevented by cycloheximide when the drug was added in combination with the activator.  If, however, cycloheximide was added 2 h after PMA (or LH), the drug did not prevent the rapid loss of mRNA.  When granulosa cells were transfected with an aromatase CAT transgene, CAT activity was stimulated 10- to 20-fold by FSH and forskolin but not by PMA.  Taken together, these results indicate that the A-kinase but not the C-kinase pathway can trans-activate the aromatase gene in immature granulosa cells, whereas the C-kinase, as well as A-kinase pathways, mimic the LH surge to decrease aromatase mRNA in preovulatory cells.  By increasing degrdn. of aromatase mRNA and by inhibiting transcription, the LH surge rapidly terminates the granulosa cell pattern of gene expression while reprogramming the cells to express genes assocd. with ovulation and luteinization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP0oSneYWQjbVg90H21EOLACvtfcHk0liH1Q4-Jzjk1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtVyluro%253D&md5=7f04f1e4a8d47daa09d715993f573191</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0039-128X%2896%2900181-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0039-128X%252896%252900181-X%26sid%3Dliteratum%253Aachs%26aulast%3DFitzpatrick%26aufirst%3DS.%2BL.%26aulast%3DCarlone%26aufirst%3DD.%2BL.%26aulast%3DRobker%26aufirst%3DR.%2BL.%26aulast%3DRichards%26aufirst%3DJ.%2BS.%26atitle%3DExpression%2520of%2520aromatase%2520in%2520the%2520ovary%253A%2520down-regulation%2520of%2520mRNA%2520by%2520the%2520ovulatory%2520luteinizing%2520hormone%2520surge%26jtitle%3DSteroids%26date%3D1997%26volume%3D62%26spage%3D197%26epage%3D206%26doi%3D10.1016%2FS0039-128X%2896%2900181-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hakola, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierroz, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuagnat, B. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huhtaniemi, I.</span></span> <span> </span><span class="NLM_article-title">Dose and time relationships of intravenously injected rat recombinant luteinizing hormone and testicular testosterone secretion in the male rat</span>. <i>Biol. Reprod.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1095/biolreprod59.2.338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1095%2Fbiolreprod59.2.338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=9687305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK1cXltFGntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1998&pages=338-343&author=K.+Hakolaauthor=D.+D.+Pierrozauthor=A.+Aebiauthor=B.+A.+M.+Vuagnatauthor=M.+L.+Aubertauthor=I.+Huhtaniemi&title=Dose+and+time+relationships+of+intravenously+injected+rat+recombinant+luteinizing+hormone+and+testicular+testosterone+secretion+in+the+male+rat&doi=10.1095%2Fbiolreprod59.2.338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Dose and time relationships of intravenously injected rat recombinant luteinizing hormone and testicular testosterone secretion in the male rat</span></div><div class="casAuthors">Hakola, Kati; Pierroz, Dominique D.; Aebi, Audrey; Vuagnat, Beatrice A. M.; Aubert, Michel L.; Huhtaniemi, Ilpo</div><div class="citationInfo"><span class="NLM_cas:title">Biology of Reproduction</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">338-343</span>CODEN:
                <span class="NLM_cas:coden">BIREBV</span>;
        ISSN:<span class="NLM_cas:issn">0006-3363</span>.
    
            (<span class="NLM_cas:orgname">Society for the Study of Reproduction</span>)
        </div><div class="casAbstract">The ability of hCG and LH to induce testosterone (T) secretion by Leydig cells is well documented.  However, the influence of the pulsatile nature of LH secretion, with varying frequency and amplitude, on T prodn. in vivo is less clear.  In the authors' earlier studies on the relationship between pulsatile LH release and T secretion in adult male rats, no simple causality was obsd.  The recent availability of rat recombinant (rec) LH prompted the authors to study the effects of one and of three i.v. pulses of different doses of rat recLH on T secretion in adult male rats rendered hypogonadotropic by treatment with the GnRH antagonist Cetrorelix.  One or three supraphysiol. pulses of 1.0 μg of rat recLH produced similar maximal T responses.  In contrast, high physiol. LH pulses (0.1 μg) produced discrete T-response peaks, whereas multiple low pulses of LH (0.03 μg) were needed before a T response was achieved.  The T stimulation was greatly diminished after an LH pulse of 0.1 μg if rats had been treated on the previous day with pulses of 0.03 vs. 0.1 μg rat recLH, apparently because of prolonged LH deprivation and lack of Leydig cell priming due to the GnRH antagonist treatment.  The novel prepn. of rat recLH provides a physiol. relevant tool for studying the complex relationship between pulsatile LH release and T secretion in male rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojdGTOhcnCj7Vg90H21EOLACvtfcHk0liH1Q4-Jzjk1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFGntrc%253D&md5=1e4515961a36baa3f7cea0610e0a109a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1095%2Fbiolreprod59.2.338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1095%252Fbiolreprod59.2.338%26sid%3Dliteratum%253Aachs%26aulast%3DHakola%26aufirst%3DK.%26aulast%3DPierroz%26aufirst%3DD.%2BD.%26aulast%3DAebi%26aufirst%3DA.%26aulast%3DVuagnat%26aufirst%3DB.%2BA.%2BM.%26aulast%3DAubert%26aufirst%3DM.%2BL.%26aulast%3DHuhtaniemi%26aufirst%3DI.%26atitle%3DDose%2520and%2520time%2520relationships%2520of%2520intravenously%2520injected%2520rat%2520recombinant%2520luteinizing%2520hormone%2520and%2520testicular%2520testosterone%2520secretion%2520in%2520the%2520male%2520rat%26jtitle%3DBiol.%2520Reprod.%26date%3D1998%26volume%3D59%26spage%3D338%26epage%3D343%26doi%3D10.1095%2Fbiolreprod59.2.338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, F. R.</span></span> <span> </span><span class="NLM_article-title">The female rat reproductive cycle: a practical histological guide to staging</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1177/0192623308315665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1177%2F0192623308315665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=18441260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A280%3ADC%252BD1czlslKlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=375-384&author=F.+R.+Westwood&title=The+female+rat+reproductive+cycle%3A+a+practical+histological+guide+to+staging&doi=10.1177%2F0192623308315665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The female rat reproductive cycle: a practical histological guide to staging</span></div><div class="casAuthors">Westwood F Russell</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic pathology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">375-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During preclinical investigations into the safety of drugs and chemicals, many are found to interfere with reproductive function in the female rat.  This interference is commonly expressed as a change in normal morphology of the reproductive tract or a disturbance in the duration of particular phases of the estrous cycle.  Such alterations can be recognized only if the pathologist has knowledge of the continuously changing histological appearance of the various components of the reproductive tract during the cycle and can accurately and consistently ascribe an individual tract to a particular phase of the cycle.  Unfortunately, although comprehensive reports illustrating the normal appearance of the tract during the rat estrous cycle have been available over many years, they are generally somewhat ambiguous about distinct criteria for defining the end of one stage and the beginning of another.  This detail is absolutely essential to achieve a consistent approach to staging the cycle.  For the toxicologic pathologist, this report illustrates a pragmatic and practical approach to staging the estrous cycle in the rat based on personal experience and a review of the literature from the last century.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgHhZg9BcGu1vAgqb2vdc5fW6udTcc2eau4p55U4JXCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czlslKlsA%253D%253D&md5=5a5d21cb6688af39ea1edcf9fa7e20af</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1177%2F0192623308315665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623308315665%26sid%3Dliteratum%253Aachs%26aulast%3DWestwood%26aufirst%3DF.%2BR.%26atitle%3DThe%2520female%2520rat%2520reproductive%2520cycle%253A%2520a%2520practical%2520histological%2520guide%2520to%2520staging%26jtitle%3DToxicol.%2520Pathol.%26date%3D2008%26volume%3D36%26spage%3D375%26epage%3D384%26doi%3D10.1177%2F0192623308315665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foltz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, C. V.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">200</span>, <span class="refDoi"> DOI: 10.1210/mend.15.1.0586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1210%2Fmend.15.1.0586" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=11145749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=184-200&author=Z.+M.+Leiauthor=S.+Mishraauthor=W.+Zouauthor=B.+Xuauthor=M.+Foltzauthor=X.+Liauthor=C.+V.+Rao&title=Targeted+disruption+of+luteinizing+hormone%2Fhuman+chorionic+gonadotropin+receptor+gene&doi=10.1210%2Fmend.15.1.0586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene</span></div><div class="casAuthors">Lei, Z. M.; Mishra, S.; Zou, W.; Xu, B.; Foltz, M.; Li, X.; Rao, Ch. V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">184-200</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">LH/hCG receptors were disrupted by gene targeting in embryonic stem cells.  The disruption resulted in infertility in both sexes.  The gonads contained no receptor mRNA or receptor protein.  Serum LH levels were greatly elevated, and FSH levels were moderately elevated in both sexes; estradiol and progesterone levels decreased but were not totally suppressed in females; testosterone levels were dramatically decreased and estradiol levels moderately elevated in males.  The external and internal genitalia were grossly underdeveloped in both sexes.  Abnormalities included ambiguous vaginal opening, abdominal testes, micropenis, dramatically decreased wts. of the gonads and reproductive tract, arrested follicular growth beyond antral stage, disarray of seminiferous tubules, diminished no. and hypotrophy of Leydig cells, and spermatogenic arrest beyond the round spermatid stage.  LH/hCG receptor gene disruption had no effect on FSH receptor mRNA levels in ovaries and testes, progesterone receptor (PR) levels in ovaries and androgen receptor (AR) levels in testes.  However, it caused a dramatic decrease in StAR and estrogen receptor-α (ERα) mRNA levels and an increase in ERβ mRNA levels in both ovaries and testes.  Estradiol and progesterone replacement therapy in females and testosterone replacement in males, to det. whether phenotype and biochem. changes were a consequence of decreased gonadal steroid levels or due to a loss of LH signaling, revealed complete restoration of some and partial restoration of others.  Nevertheless, the animals remained infertile.  It is anticipated that the LH receptor knockout animals will increase the authors' current understanding of gonadal and nongonadal actions of LH and hCG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjk5oEbl0biLVg90H21EOLACvtfcHk0lj_OzgQQ4H3Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVKlsg%253D%253D&md5=38199265d562f5f9ca2cac4d0f6638e2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1210%2Fmend.15.1.0586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fmend.15.1.0586%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DZ.%2BM.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DFoltz%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRao%26aufirst%3DC.%2BV.%26atitle%3DTargeted%2520disruption%2520of%2520luteinizing%2520hormone%252Fhuman%2520chorionic%2520gonadotropin%2520receptor%2520gene%26jtitle%3DMol.%2520Endocrinol.%26date%3D2001%26volume%3D15%26spage%3D184%26epage%3D200%26doi%3D10.1210%2Fmend.15.1.0586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span> <span> </span><span class="NLM_article-title">Genetic evidence of ‘genuine’ empty follicle syndrome: a novel effective mutation in the LHCGR gene and review of the literature</span>. <i>Hum. Reprod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">944</span>– <span class="NLM_lpage">953</span>, <span class="refDoi"> DOI: 10.1093/humrep/dex015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1093%2Fhumrep%2Fdex015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=28175319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFCkurbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=944-953&author=P.+Yuanauthor=Z.+Heauthor=L.+Zhengauthor=W.+Wangauthor=Y.+Liauthor=H.+Zhaoauthor=V.+W.+Zhangauthor=Q.+Zhangauthor=D.+Yang&title=Genetic+evidence+of+%E2%80%98genuine%E2%80%99+empty+follicle+syndrome%3A+a+novel+effective+mutation+in+the+LHCGR+gene+and+review+of+the+literature&doi=10.1093%2Fhumrep%2Fdex015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic evidence of 'genuine' empty follicle syndrome: a novel effective mutation in the LHCGR gene and review of the literature</span></div><div class="casAuthors">Yuan, Ping; He, Zuyong; Zheng, Lingyan; Wang, Wenjun; Li, Yu; Zhao, Haijing; Zhang, Victor Wei; Zhang, Qingxue; Yang, Dongzi</div><div class="citationInfo"><span class="NLM_cas:title">Human Reproduction</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">944-953</span>CODEN:
                <span class="NLM_cas:coden">HUREEE</span>;
        ISSN:<span class="NLM_cas:issn">1460-2350</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Empty follicle syndrome (EFS) is a reproductive disorder in which no oocytes are retrieved during IVF.  The existence of genuine EFS (GEFS) is still controversial, and to date, only one missense mutation of LH/Choriogonadotropin Receptor (LHCGR) has been reported to be assocd. with this disease.  Here, we describe a GEFS patient in a non-consanguineous family from China.  A 27-yr-old woman presented with a 5-yr history of primary infertility and LH resistance-like ovaries of unequal sizes, but with normal levels of circulating LH.  In spite of a satisfactory ovarian reserve and response, no oocytes were retrieved after two cycles of IVF.  Her condition did not appear to be failure of the hCG injection.  It is more likely to be a genetic cause.  A novel homozygous mutation in LHCGR gene, c.1345G>A (p.Ala449Thr), was detected in this patient.  Each of her parents is heterozygous for this change, and the change was absent from 407 control subjects.  Alanine at this amino acid position was highly conserved and replacement of threonine was predicted to disrupt the third transmembrane helix of the rhodopsin-like G protein-coupled receptor domain.  Protein localization studies revealed that a portion of the mutant LHCGR protein mols. was retained intracellularly.  Signalling studies demonstrated that this mutation had differing effects on the response of LHCGR to hCG or LH at different concns.  Specifically, at a concn. <1 IU/mL, the mutant was activated by hCG stimulation but partially resistant to LH stimulation; at a higher concn. (>1 IU/mL), the mutant was activated by both hCG and LH.  These data suggest that screening for mutations in the LHCGR gene may assist in the diagnosis of patients with GEFS.  The literature describing the relationship between phenotype and genotypes in females is reviewed, and possible etiologies and treatment options for this disease are proposed based on our and other studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2wL4Axw87LbVg90H21EOLACvtfcHk0lhiNa21ABcf5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFCkurbN&md5=8795d852e2780fa622025994cb384d5d</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fhumrep%2Fdex015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhumrep%252Fdex015%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DV.%2BW.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DD.%26atitle%3DGenetic%2520evidence%2520of%2520%25E2%2580%2598genuine%25E2%2580%2599%2520empty%2520follicle%2520syndrome%253A%2520a%2520novel%2520effective%2520mutation%2520in%2520the%2520LHCGR%2520gene%2520and%2520review%2520of%2520the%2520literature%26jtitle%3DHum.%2520Reprod.%26date%3D2017%26volume%3D32%26spage%3D944%26epage%3D953%26doi%3D10.1093%2Fhumrep%2Fdex015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">First targeted protein degrader hits the clinic</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1038/d41573-019-00043-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1038%2Fd41573-019-00043-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=237-239&author=A.+Mullard&title=First+targeted+protein+degrader+hits+the+clinic&doi=10.1038%2Fd41573-019-00043-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fd41573-019-00043-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fd41573-019-00043-6%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DFirst%2520targeted%2520protein%2520degrader%2520hits%2520the%2520clinic%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2019%26volume%3D18%26spage%3D237%26epage%3D239%26doi%3D10.1038%2Fd41573-019-00043-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nardone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delpuech, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cataldo, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veeraraghavan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimawi, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilsenbeck, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamness, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeselsohn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiff, R.</span></span> <span> </span><span class="NLM_article-title">The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1038/s41416-018-0354-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1038%2Fs41416-018-0354-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=30555156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFCitLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2019&pages=331-339&author=A.+Nardoneauthor=H.+Weirauthor=O.+Delpuechauthor=H.+Brownauthor=C.+De+Angelisauthor=M.+L.+Cataldoauthor=X.+Fuauthor=M.+J.+Sheaauthor=T.+Mitchellauthor=J.+Veeraraghavanauthor=C.+Nagiauthor=M.+Pillingauthor=M.+F.+Rimawiauthor=M.+Trivediauthor=S.+G.+Hilsenbeckauthor=G.+C.+Chamnessauthor=R.+Jeselsohnauthor=C.+K.+Osborneauthor=R.+Schiff&title=The+oral+selective+oestrogen+receptor+degrader+%28SERD%29+AZD9496+is+comparable+to+fulvestrant+in+antagonising+ER+and+circumventing+endocrine+resistance&doi=10.1038%2Fs41416-018-0354-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance</span></div><div class="casAuthors">Nardone, Agostina; Weir, Hazel; Delpuech, Oona; Brown, Henry; De Angelis, Carmine; Cataldo, Maria Letizia; Fu, Xiaoyong; Shea, Martin J.; Mitchell, Tamika; Veeraraghavan, Jamunarani; Nagi, Chandandeep; Pilling, Mark; Rimawi, Mothaffar F.; Trivedi, Meghana; Hilsenbeck, Susan G.; Chamness, Gary C.; Jeselsohn, Rinath; Osborne, C. Kent; Schiff, Rachel</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-339</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Background: The estrogen receptor (ER) is an important therapeutic target in ER-pos. (ER+) breast cancer.  The selective ER degrader (SERD), fulvestrant, is effective in patients with metastatic breast cancer, but its i.m. route of administration and low bioavailability are major clin. limitations.  Methods: Here, we studied the pharmacol. of a new oral SERD, AZD9496, in a panel of in vitro and in vivo endocrine-sensitive and -resistant breast cancer models.  Results: In endocrine-sensitive models, AZD9496 inhibited cell growth and blocked ER activity in the presence or absence of estrogen.  In vivo, in the presence of estrogen, short-term AZD9496 treatment, like fulvestrant, resulted in tumor growth inhibition and reduced expression of ER-dependent genes.  AZD9496 inhibited cell growth in estrogen deprivation-resistant and tamoxifen-resistant cell lines and xenograft models that retain ER expression.  AZD9496 effectively reduced ER levels and ER-induced transcription.  Expression anal. of short-term treated tumors showed that AZD9496 potently inhibited classic estrogen-induced gene transcription, while simultaneously increasing expression of genes neg. regulated by ER, including genes potentially involved in escape pathways of endocrine resistance.  Conclusions: These data suggest that AZD9496 is a potent anti-estrogen that antagonizes and degrades ER with anti-tumor activity in both endocrine-sensitive and endocrine-resistant models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5n15FNP5aPrVg90H21EOLACvtfcHk0lhiNa21ABcf5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFCitLjE&md5=f33a177b69b0b803e9c2732f97200619</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fs41416-018-0354-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41416-018-0354-9%26sid%3Dliteratum%253Aachs%26aulast%3DNardone%26aufirst%3DA.%26aulast%3DWeir%26aufirst%3DH.%26aulast%3DDelpuech%26aufirst%3DO.%26aulast%3DBrown%26aufirst%3DH.%26aulast%3DDe%2BAngelis%26aufirst%3DC.%26aulast%3DCataldo%26aufirst%3DM.%2BL.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DShea%26aufirst%3DM.%2BJ.%26aulast%3DMitchell%26aufirst%3DT.%26aulast%3DVeeraraghavan%26aufirst%3DJ.%26aulast%3DNagi%26aufirst%3DC.%26aulast%3DPilling%26aufirst%3DM.%26aulast%3DRimawi%26aufirst%3DM.%2BF.%26aulast%3DTrivedi%26aufirst%3DM.%26aulast%3DHilsenbeck%26aufirst%3DS.%2BG.%26aulast%3DChamness%26aufirst%3DG.%2BC.%26aulast%3DJeselsohn%26aufirst%3DR.%26aulast%3DOsborne%26aufirst%3DC.%2BK.%26aulast%3DSchiff%26aufirst%3DR.%26atitle%3DThe%2520oral%2520selective%2520oestrogen%2520receptor%2520degrader%2520%2528SERD%2529%2520AZD9496%2520is%2520comparable%2520to%2520fulvestrant%2520in%2520antagonising%2520ER%2520and%2520circumventing%2520endocrine%2520resistance%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2019%26volume%3D120%26spage%3D331%26epage%3D339%26doi%3D10.1038%2Fs41416-018-0354-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Möller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bone, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleve, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotgeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultze-Mosgau, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagenfeld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of vilaprisan (BAY 1002670): a highly potent and selective progesterone receptor modulator optimized for gynecologic therapies</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2271</span>– <span class="NLM_lpage">2280</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201800487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1002%2Fcmdc.201800487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=30407750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A280%3ADC%252BB3cvnvFKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2271-2280&author=C.+M%C3%B6llerauthor=W.+Boneauthor=A.+Cleveauthor=U.+Klarauthor=A.+Rotgeriauthor=A.+Rottmannauthor=M.-H.+Schultze-Mosgauauthor=A.+Wagenfeldauthor=W.+Schwede&title=Discovery+of+vilaprisan+%28BAY+1002670%29%3A+a+highly+potent+and+selective+progesterone+receptor+modulator+optimized+for+gynecologic+therapies&doi=10.1002%2Fcmdc.201800487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies</span></div><div class="casAuthors">Moller Carsten; Bone Wilhelm; Cleve Arwed; Rotgeri Andrea; Rottmann Antje; Schultze-Mosgau Marcus-Hillert; Wagenfeld Andrea; Schwede Wolfgang; Klar Ulrich</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2271-2280</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Progesterone plays an important role in the female reproductive system.  However, there is also evidence that gynecologic disorders/diseases such as uterine fibroids and endometriosis are progesterone-dependent.  Steroidal and non-steroidal selective progesterone receptor modulators (SPRMs) have shown potential for the treatment of such diseases.  Steroidal SPRMs, including mifepristone and ulipristal acetate, have proven effective in clinical trials.  However, several steroidal SPRMs containing a dimethylamino substituent have been associated with elevated liver enzymes in patients.  An earlier drug discovery program identified lonaprisan as a highly selective SPRM that did not show drug-related change in liver enzyme activity.  Building on data obtained from that work, here we describe the research program that culminated in the discovery of a novel steroidal SPRM, vilaprisan, which combines an extremely high potency with very favorable drug metabolism and pharmacokinetic properties.  Vilaprisan has entered clinical development and is currently undergoing phase 3 clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLFws_wFa1cNNTrvPZP1IpfW6udTcc2eb8naX2N8dQsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvnvFKguw%253D%253D&md5=9602ce0fb9815b274ae572ac573d763b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201800487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201800487%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B6ller%26aufirst%3DC.%26aulast%3DBone%26aufirst%3DW.%26aulast%3DCleve%26aufirst%3DA.%26aulast%3DKlar%26aufirst%3DU.%26aulast%3DRotgeri%26aufirst%3DA.%26aulast%3DRottmann%26aufirst%3DA.%26aulast%3DSchultze-Mosgau%26aufirst%3DM.-H.%26aulast%3DWagenfeld%26aufirst%3DA.%26aulast%3DSchwede%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520vilaprisan%2520%2528BAY%25201002670%2529%253A%2520a%2520highly%2520potent%2520and%2520selective%2520progesterone%2520receptor%2520modulator%2520optimized%2520for%2520gynecologic%2520therapies%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D2271%26epage%3D2280%26doi%3D10.1002%2Fcmdc.201800487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suh, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keren-Tal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmelhoch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amsterdam, A.</span></span> <span> </span><span class="NLM_article-title">Introduction of a gonadotropin receptor expression plasmid into immortalized granulosa cells leads to reconstitution of hormone-dependent steroidogenesis</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">439</span>– <span class="NLM_lpage">450</span>, <span class="refDoi"> DOI: 10.1083/jcb.119.2.439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1083%2Fjcb.119.2.439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1328253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK38XmtVGms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1992&pages=439-450&author=B.+S.+Suhauthor=R.+Sprengelauthor=I.+Keren-Talauthor=S.+Himmelhochauthor=A.+Amsterdam&title=Introduction+of+a+gonadotropin+receptor+expression+plasmid+into+immortalized+granulosa+cells+leads+to+reconstitution+of+hormone-dependent+steroidogenesis&doi=10.1083%2Fjcb.119.2.439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction of a gonadotropin receptor expression plasmid into immortalized granulosa cells leads to reconstitution of hormone-dependent steroidogenesis</span></div><div class="casAuthors">Suh, B. S.; Sprengel, R.; Keren-Tal, I.; Himmelhoch, S.; Amsterdam, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">439-50</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    </div><div class="casAbstract">The authors have recently succeeded in immortalizing rat granulosa cells by co-transfection with SV-40 DNA and the Ha-ras oncogene.  These cells lost their response to gonadotropins, but expressed the cytochrome P 450scc mitochondrial system enzymes and produced progesterone and 20α-hydroxy-4-pregnan-3-one (20α-OH-P) upon cAMP stimulation.  In an attempt to restore the steroidogenic response to gonadotropins in immortalized cells, a lutropin/choriogonadotropin (LH/CG-R) receptor expression plasmid was prepd. by introducing the complete coding region of the LH receptor cDNA into a SV-40 early promoter based eukaryotic expression vector.  Granulosa cells from preovulatory follicles were transfected with this LH receptor expression plasmid, together with SV-40 DNA and the Ha-ras oncogene.  Cell lines obtained after this triple transfection accumulated cAMP in a dose-dependent manner in response to hCG.  Moreover, they produced progesterone and 20α-OH-P upon hCG stimulation with ED50 values of 125 pM and 75 pM, resp., which are within the physiol. range.  Concomitantly with hCG-induced differentiation, inhibition of cell proliferation was evident following stimulation with hormone concns. as low as 40 pM.  The no. of hCG receptor sites per cell after numerous passages and several freezing and thawing cycles was 1.9 × 104; they showed a Kd of 180 pM.  Stimulation with hCG induced pronounced morphol. and biochem. changes in these cells, including formation of mitochondrial located adrenodoxin, a marker enzyme for enhanced steroidogenesis.  These findings make possible the expression, in immortalized granulosa cells, of selectively mutated receptor mols. which preserve their steroidogenic potential, thereby opening the way to anal. of structure-function relationships of the receptor mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb8WVHPBVloLVg90H21EOLACvtfcHk0ljHOHdDvolJlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmtVGms74%253D&md5=d2f3e1b6742b84be63efbdbf934fe149</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1083%2Fjcb.119.2.439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.119.2.439%26sid%3Dliteratum%253Aachs%26aulast%3DSuh%26aufirst%3DB.%2BS.%26aulast%3DSprengel%26aufirst%3DR.%26aulast%3DKeren-Tal%26aufirst%3DI.%26aulast%3DHimmelhoch%26aufirst%3DS.%26aulast%3DAmsterdam%26aufirst%3DA.%26atitle%3DIntroduction%2520of%2520a%2520gonadotropin%2520receptor%2520expression%2520plasmid%2520into%2520immortalized%2520granulosa%2520cells%2520leads%2520to%2520reconstitution%2520of%2520hormone-dependent%2520steroidogenesis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1992%26volume%3D119%26spage%3D439%26epage%3D450%26doi%3D10.1083%2Fjcb.119.2.439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, B. A.</span></span> <span> </span><span class="NLM_article-title">A novel method to modulate desensitization and truncation of luteinizing hormone receptors using antisense oligodeoxynucleotides</span>. <i>Mol. Cell. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">R9</span>– <span class="NLM_lpage">R14</span>, <span class="refDoi"> DOI: 10.1016/0303-7207(91)90111-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2F0303-7207%2891%2990111-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1657660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK3MXltVKgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1991&pages=R9-R14&author=A.+P.+Westauthor=B.+A.+Cooke&title=A+novel+method+to+modulate+desensitization+and+truncation+of+luteinizing+hormone+receptors+using+antisense+oligodeoxynucleotides&doi=10.1016%2F0303-7207%2891%2990111-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A novel method to modulate desensitization and truncation of luteinizing hormone receptors using antisense oligodeoxynucleotides</span></div><div class="casAuthors">West, Anthony P.; Cooke, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">R9-R14</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    </div><div class="casAbstract">A novel method to study the mechanisms of LH receptor desensitization and truncation, using antisense oligodeoxynucleotides that code for regions of the NH2-terminus, the third extracellular loop and the C-terminus of the LH receptor, was described.  Mouse tumor (MA10) Leydig cells were incubated for 48 h with the addn. of 2.5 μM antisense oligodeoxynucleotides at time 0 and 24 h.  The NH2-terminus oligodeoxynucleotide completely inhibited synthesis of the LH receptor.  Pretreatment with the third extracellular loop oligodeoxynucleotide inhibited LH-, dibutyryl-cAMP (db-cAMP)-, and phorbol 12-myristate 13-acetate (PMA)-induced desensitization and truncation of LH receptors.  Truncation, but not desensitization, of the LH receptor was prevented in cells pretreated with the C-terminus oligodeoxynucleotide.  These results indicate that different sites of the C-terminal intracellular tail of the LH receptor are involved in the regulation of desensitization and truncation of the LH receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfA8yznrIqZ7Vg90H21EOLACvtfcHk0ljHOHdDvolJlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXltVKgsLs%253D&md5=63b9bd74324d8ac5c03d3b26dcfa2853</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2F0303-7207%2891%2990111-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0303-7207%252891%252990111-5%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BP.%26aulast%3DCooke%26aufirst%3DB.%2BA.%26atitle%3DA%2520novel%2520method%2520to%2520modulate%2520desensitization%2520and%2520truncation%2520of%2520luteinizing%2520hormone%2520receptors%2520using%2520antisense%2520oligodeoxynucleotides%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D1991%26volume%3D79%26spage%3DR9%26epage%3DR14%26doi%3D10.1016%2F0303-7207%2891%2990111-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Derwahl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuemmel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goretzki, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schatz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broecker, M.</span></span> <span> </span><span class="NLM_article-title">Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">1131</span>– <span class="NLM_lpage">1138</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1993.1334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1006%2Fbbrc.1993.1334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=8385451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK3sXitVGls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=1993&pages=1131-1138&author=M.+Derwahlauthor=M.+Kuemmelauthor=P.+Goretzkiauthor=H.+Schatzauthor=M.+Broecker&title=Expression+of+the+human+TSH+receptor+in+a+human+thyroid+carcinoma+cell+line+that+lacks+an+endogenous+TSH+receptor%3A+growth+inhibition+by+cAMP&doi=10.1006%2Fbbrc.1993.1334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: Growth inhibition by cAMP</span></div><div class="casAuthors">Derwahl, Michael; Kuemmel, Marion; Goretzki, Peter; Schatz, Helmut; Broecker, Martina</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1131-8</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Human thyroid carcinoma cells lacking an endogenous TSH receptor were transfected with the human TSH receptor cDNA.  Transfected cells, designated HTC-TSHr, expressed the TSH receptor mRNA and synthesized a functional TSH receptor with a TSH binding affinity in the order of magnitude of normal thyroid cells.  In response to TSH stimulation, HTC-TSHr cells accumulated cAMP, indicating a functional TSH receptor-adenylate cyclase system.  However, HTC-TSHr cells did not conc. iodide and lacked thyroglobulin immunoreactivity, although they did express low amts. of thyroglobulin mRNA.  Proliferation of HTC-TSHr cells was inhibited by dbcAMP and forskolin and also by TSH via the re-expressed TSH receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLhJNWyCx67Vg90H21EOLACvtfcHk0ljuczKOCGMBfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitVGls74%253D&md5=1de81d7a77a75e5b6fd6d58fd8b339ca</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1993.1334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1993.1334%26sid%3Dliteratum%253Aachs%26aulast%3DDerwahl%26aufirst%3DM.%26aulast%3DKuemmel%26aufirst%3DM.%26aulast%3DGoretzki%26aufirst%3DP.%26aulast%3DSchatz%26aufirst%3DH.%26aulast%3DBroecker%26aufirst%3DM.%26atitle%3DExpression%2520of%2520the%2520human%2520TSH%2520receptor%2520in%2520a%2520human%2520thyroid%2520carcinoma%2520cell%2520line%2520that%2520lacks%2520an%2520endogenous%2520TSH%2520receptor%253A%2520growth%2520inhibition%2520by%2520cAMP%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1993%26volume%3D191%26spage%3D1131%26epage%3D1138%26doi%3D10.1006%2Fbbrc.1993.1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheldrick, G. M.</span></span> <span> </span><span class="NLM_article-title">Crystal structure refinement with SHELXL</span>. <i>Acta Crystallogr., Sect. C: Struct. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1107/S2053229614024218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1107%2FS2053229614024218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=25643710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=3-8&author=G.+M.+Sheldrick&title=Crystal+structure+refinement+with+SHELXL&doi=10.1107%2FS2053229614024218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure refinement with SHELXL</span></div><div class="casAuthors">Sheldrick, George M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section C: Structural Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-8</span>CODEN:
                <span class="NLM_cas:coden">ACSCGG</span>;
        ISSN:<span class="NLM_cas:issn">2053-2296</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The improvements in the crystal structure refinement program SHELXL have been closely coupled with the development and increasing importance of the CIF (Crystallog. Information Framework) format for validating and archiving crystal structures.  An important simplification is that now only one file in CIF format (for convenience, referred to simply as 'a CIF') contg. embedded reflection data and SHELXL instructions is needed for a complete structure archive; the program SHREDCIF can be used to ext. the and files required for further refinement with SHELXL.  Recent developments in SHELXL facilitate refinement against neutron diffraction data, the treatment of H atoms, the detn. of abs. structure, the input of partial structure factors and the refinement of twinned and disordered structures.  SHELXL is available free to academics for the Windows, Linux and Mac OS X operating systems, and is particularly suitable for multiple-core processors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhk1_pNHwXR7Vg90H21EOLACvtfcHk0ljuczKOCGMBfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvFaqug%253D%253D&md5=4a860804b50fc183e8a701098b98ef59</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS2053229614024218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2053229614024218%26sid%3Dliteratum%253Aachs%26aulast%3DSheldrick%26aufirst%3DG.%2BM.%26atitle%3DCrystal%2520structure%2520refinement%2520with%2520SHELXL%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520C%253A%2520Struct.%2520Chem.%26date%3D2015%26volume%3D71%26spage%3D3%26epage%3D8%26doi%3D10.1107%2FS2053229614024218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flack, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, T.</span></span> <span> </span><span class="NLM_article-title">Use of intensity quotients and differences in absolute structure refinement</span>. <i>Acta Crystallogr., Sect. B: Struct. Sci., Cryst. Eng. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">259</span>, <span class="refDoi"> DOI: 10.1107/S2052519213010014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1107%2FS2052519213010014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=23719469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVGntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=249-259&author=S.+Parsonsauthor=H.+D.+Flackauthor=T.+Wagner&title=Use+of+intensity+quotients+and+differences+in+absolute+structure+refinement&doi=10.1107%2FS2052519213010014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Use of intensity quotients and differences in absolute structure refinement</span></div><div class="casAuthors">Parsons, Simon; Flack, Howard D.; Wagner, Trixie</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section B: Structural Science, Crystal Engineering and Materials</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-259</span>CODEN:
                <span class="NLM_cas:coden">ACSBDA</span>;
        ISSN:<span class="NLM_cas:issn">2052-5206</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Several methods for abs. structure refinement were tested using single-crystal x-ray diffraction data collected using Cu Kα radiation for 23 crystals with no element heavier than O: conventional refinement using an inversion twin model, estn. using intensity quotients in SHELXL2012, estn. using Bayesian methods in PLATON, estn. using restraints consisting of numerical intensity differences in CRYSTALS and estn. using differences and quotients in TOPAS-Academic where both quantities were coded in terms of other structural parameters and implemented as restraints.  The conventional refinement approach yielded accurate values of the Flack parameter, but with std. uncertainties ranging from 0.15 to 0.77.  The other methods also yielded accurate values of the Flack parameter, but with much higher precision.  Abs. structure was established in all cases, even for a hydrocarbon.  The procedures in which restraints are coded explicitly in terms of other structural parameters enable the Flack parameter to correlate with these other parameters, so that it is detd. along with those parameters during refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogUlT1yqWxA7Vg90H21EOLACvtfcHk0ljuczKOCGMBfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVGntL8%253D&md5=37f2e427d6fb24589bddd5b683ea627c</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS2052519213010014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2052519213010014%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DFlack%26aufirst%3DH.%2BD.%26aulast%3DWagner%26aufirst%3DT.%26atitle%3DUse%2520of%2520intensity%2520quotients%2520and%2520differences%2520in%2520absolute%2520structure%2520refinement%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520B%253A%2520Struct.%2520Sci.%252C%2520Cryst.%2520Eng.%2520Mater.%26date%3D2013%26volume%3D69%26spage%3D249%26epage%3D259%26doi%3D10.1107%2FS2052519213010014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">In vitro solubility assays in drug discovery</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.2174/138920008786485100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.2174%2F138920008786485100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=18991584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivF2nsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=879-885&author=E.+H.+Kernsauthor=L.+Diauthor=G.+T.+Carter&title=In+vitro+solubility+assays+in+drug+discovery&doi=10.2174%2F138920008786485100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro solubility assays in drug discovery</span></div><div class="casAuthors">Kerns, Edward H.; Di, Li; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">879-885</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The soly. of a compd. depends on its structure and soln. conditions.  Structure dets. the lipophilicity, hydrogen bonding, mol. vol., crystal energy and ionizability, which det. soly.  Soln. conditions are affected by pH, cosolvents, additives, ionic strength, time and temp.  Many drug discovery expts. are conducted under "kinetic" soly. conditions.  In drug discovery, soly. has a major impact on bioassays, formulation for in vivo dosing, and intestinal absorption.  A good goal for the soly. of drug discovery compds. is >60 ug/mL.  Equil. soly. assays can be conducted in moderate throughput, by incubating excess solid with buffer and agitating for several days, prior to filtration and HPLC quantitation.  Kinetic soly. assays are performed in high throughput with shorter incubation times and high throughput analyses using plate readers.  The most frequently used of these are the nephelometric assay and direct UV assay, which begin by adding a small vol. of DMSO stock soln. of each test compd. to buffer.  In nephelometry, this soln. is serially dild. across a microtiter plate and undissolved particles are detected via light scattering.  In direct UV, undissolved particles are sepd. by filtration, after which the dissolved material is quantitated using UV absorption.  Equil. soly. is useful for preformulation.  Kinetic soly. is useful for rapid compd. assessment, guiding optimization via structure modification, and diagnosing bioassays.  It is often useful to customize soly. expts. using conditions that answer specific research questions of drug discovery teams, such as compd. selection and vehicle development for pharmacol. and PK studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1Pe5z4JU_6LVg90H21EOLACvtfcHk0liWorBnEZWCiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivF2nsb8%253D&md5=416cf5bfde2278eac1ba2c67feb1f62e</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.2174%2F138920008786485100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008786485100%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DIn%2520vitro%2520solubility%2520assays%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D879%26epage%3D885%26doi%3D10.2174%2F138920008786485100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Onofrey, T.</span>; <span class="NLM_string-name">Kazan, G.</span></span> <span> </span><span class="NLM_article-title">Performance and correlation of a 96-well high throughput screening method to determine aqueous drug solubility</span>.  <i>Application Note Lit. No. AN1731EN00</i>; <span class="NLM_publisher-name">Millipore Corporation</span>: <span class="NLM_publisher-loc">Billerica, MA</span>, <span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=T.+Onofrey&author=G.+Kazan&title=Application+Note+Lit.+No.+AN1731EN00"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOnofrey%26aufirst%3DT.%26atitle%3DPerformance%2520and%2520correlation%2520of%2520a%252096-well%2520high%2520throughput%2520screening%2520method%2520to%2520determine%2520aqueous%2520drug%2520solubility%26btitle%3DApplication%2520Note%2520Lit.%2520No.%2520AN1731EN00%26pub%3DMillipore%2520Corporation%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minick, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brent, D. A.</span></span> <span> </span><span class="NLM_article-title">A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1923</span>– <span class="NLM_lpage">1933</span>, <span class="refDoi"> DOI: 10.1021/jm00118a010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00118a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaL1cXltlGlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=1923-1933&author=D.+J.+Minickauthor=J.+H.+Frenzauthor=M.+A.+Patrickauthor=D.+A.+Brent&title=A+comprehensive+method+for+determining+hydrophobicity+constants+by+reversed-phase+high-performance+liquid+chromatography&doi=10.1021%2Fjm00118a010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography</span></div><div class="casAuthors">Minick, Douglas J.; Frenz, John H.; Patrick, Mark A.; Brent, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1923-33</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A method for detg. hydrophobicity consts. for small, org. mols. by reversed-phase liq. chromatog. (RPLC) is presented.  The method uses capacity ratios measured at a no. of different compns. of MeOH to obtain derived values, denoted log K'w, upon which a new scale of hydrophobicity consts. can be developed.  This scale eliminates potential problems such as peak inversion that hamper RPLC methods by using isocratic data to est. hydrophobicity.  The differential H bonded effect obsd. in most correlations of RPLC data with logarithms of octanol-water partition coeffs. (log Po/w) for compds. of opposite net H bonding capabilities (noncongeners) was minimized by adding trace quantities of n-decylamine and 1-octanol to the eluent and using an octyl-modified silica gel stationary phase.  Values of log K'w are largely column-independent as long as the hydrophobic properties of columns are similar.  The correlation of log k'w values with the logarithms of bovine serum albumin binding consts. (log 1/C) is statistically indistinguishable from the correlation of log 1/C with log Po/w, indicating that this data models log 1/C as well as log Po/w for these compds.  Addnl., the chromatog. system is automatable and thus capable of higher sample throughput than measurements of log Po/w by the shake-flask method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP9rXFRIjKoLVg90H21EOLACvtfcHk0liWorBnEZWCiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltlGlt7s%253D&md5=ce6a632baa977f92c51f3341f92e303f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm00118a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00118a010%26sid%3Dliteratum%253Aachs%26aulast%3DMinick%26aufirst%3DD.%2BJ.%26aulast%3DFrenz%26aufirst%3DJ.%2BH.%26aulast%3DPatrick%26aufirst%3DM.%2BA.%26aulast%3DBrent%26aufirst%3DD.%2BA.%26atitle%3DA%2520comprehensive%2520method%2520for%2520determining%2520hydrophobicity%2520constants%2520by%2520reversed-phase%2520high-performance%2520liquid%2520chromatography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D1923%26epage%3D1933%26doi%3D10.1021%2Fjm00118a010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlsdorfer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bühner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandenburger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruk, R.</span></span> <span> </span><span class="NLM_article-title">High-throughput determination of the free fraction of drugs strongly bound to plasma proteins</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">816</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1002/jps.10588</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1002%2Fjps.10588" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=14999720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivF2lsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2004&pages=816-830&author=J.+Schuhmacherauthor=C.+Kohlsdorferauthor=K.+B%C3%BChnerauthor=T.+Brandenburgerauthor=R.+Kruk&title=High-throughput+determination+of+the+free+fraction+of+drugs+strongly+bound+to+plasma+proteins&doi=10.1002%2Fjps.10588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput determination of the free fraction of drugs strongly bound to plasma proteins</span></div><div class="casAuthors">Schuhmacher, Joachim; Kohlsdorfer, Christian; Buehner, Klaus; Brandenburger, Tim; Kruk, Renate</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">816-830</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Quantification of protein binding of new chem. entities is an important early screening step during drug discovery and is of fundamental interest for the estn. of safety margins during drug development.  In this publication, we describe the development of a new high-throughput assay for the detn. of the free drug fraction in plasma (fu).  The new technique is an enhancement of the previously published erythrocytes partition method.  It is based on the distribution of drugs between plasma water, plasma proteins, and solid-supported lipid membranes (Transil).  The execution of protein binding studies by partitioning is dramatically simplified by substituting erythrocytes with com. available Transil beads, and makes the method particularly suitable for high-throughput studies.  Eight Bayer compds. from different compd. classes covering a wide range of lipophilicities (log P=1.9-5.6) and fu values (0.018-35%) were selected for validation of the assay.  The results obtained by the new method and by either the erythrocytes partitioning technique or more conventional methods (ultrafiltration and equil. dialysis) are identical, confirming that the new method produces valid results even for drugs that are strongly bound to plasma proteins.  Precision and accuracy of the data in the cases of very low and high fu values are comparable, indicating that the method is esp. suited for highly lipophilic drugs that tend to adsorb to surfaces compared with other methods, like ultrafiltration or equil. dialysis, that may produce biased data.  The method is also useful for the detn. of binding parameters and the pH dependence of fu.  In summary, this assay is well suited for high-throughput detn. of protein binding during drug discovery and for extended protein binding studies during drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpflHhmd5cNbVg90H21EOLACvtfcHk0lhldye6AkGLzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivF2lsLc%253D&md5=c5898ab6390b217b9329da01d81f7585</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fjps.10588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10588%26sid%3Dliteratum%253Aachs%26aulast%3DSchuhmacher%26aufirst%3DJ.%26aulast%3DKohlsdorfer%26aufirst%3DC.%26aulast%3DB%25C3%25BChner%26aufirst%3DK.%26aulast%3DBrandenburger%26aufirst%3DT.%26aulast%3DKruk%26aufirst%3DR.%26atitle%3DHigh-throughput%2520determination%2520of%2520the%2520free%2520fraction%2520of%2520drugs%2520strongly%2520bound%2520to%2520plasma%2520proteins%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2004%26volume%3D93%26spage%3D816%26epage%3D830%26doi%3D10.1002%2Fjps.10588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makielski, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">January, C. T.</span></span> <span> </span><span class="NLM_article-title">Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1016/S0006-3495(98)77782-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2FS0006-3495%2898%2977782-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=9449325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK1cXhvFWjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1998&pages=230-241&author=Z.+Zhouauthor=Q.+Gongauthor=B.+Yeauthor=Z.+Fanauthor=J.+C.+Makielskiauthor=G.+A.+Robertsonauthor=C.+T.+January&title=Properties+of+HERG+channels+stably+expressed+in+HEK+293+cells+studied+at+physiological+temperature&doi=10.1016%2FS0006-3495%2898%2977782-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature</span></div><div class="casAuthors">Zhou, Zhengfeng; Gong, Qiuming; Ye, Bin; Fan, Zheng; Makielski, Jonathan C.; Robertson, Gail A.; January, Craig T.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">230-241</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society</span>)
        </div><div class="casAbstract">We have established stably transfected HEK 293 cell lines expressing high levels of functional human ether-a go-go-related gene (HERG) channels.  We used these cells to study biochem. characteristics of HERG protein, and to study electrophysiol. and pharmacol. properties of HERG channel current at 35°C.  HERG-transfected cells expressed an mRNA band at 4.0 kb.  Western blot anal. showed two protein bands (155 and 135 kDa) slightly larger than the predicted mol. mass (127 kDa).  Treatment with N-glycosidase F converted both bands to smaller mol. mass, suggesting that both are glycosylated, but at different levels.  HERG current activated at voltages pos. to -50 mV, max. current was reached with depolarizing steps to -10 mV, and the current amplitude declined at more pos. voltages, similar to HERG channel current expressed in other heterologous systems.  C.d. at 35°C, compared with 23°C, was increased by more than twofold to a max. of 53.4 ± 6.5 pA/pF.  Activation, inactivation, recovery from inactivation, and deactivation kinetics were rapid at 35°C, and more closely resemble values reported for the rapidly activating delayed rectifier K+ current (IKr) at physiol. temps.  HERG channels were highly selective for K+.  When we used an action potential clamp technique, HERG current activation began shortly after the upstroke of the action potential waveform.  HERG current increased during repolarization to reach a max. amplitude during phases 2 and 3 of the cardiac action potential.  HERG contributed current throughout the return of the membrane to the resting potential, and deactivation of HERG current could participate in phase 4 depolarization.  HERG current was blocked by low concns. of E-4031 (IC50 7.7 nM), a value close to that reported for IKr in native cardiac myocytes.  Our data support the postulate that HERG encodes a major constituent of IKr and suggest that at physiol. temps. HERG contributes current throughout most of the action potential and into the postrepolarization period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfeVZx9D4R2LVg90H21EOLACvtfcHk0lhldye6AkGLzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvFWjurg%253D&md5=4c7587215c9013a75b34d9fcbaaefc2c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0006-3495%2898%2977782-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3495%252898%252977782-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DYe%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DMakielski%26aufirst%3DJ.%2BC.%26aulast%3DRobertson%26aufirst%3DG.%2BA.%26aulast%3DJanuary%26aufirst%3DC.%2BT.%26atitle%3DProperties%2520of%2520HERG%2520channels%2520stably%2520expressed%2520in%2520HEK%2520293%2520cells%2520studied%2520at%2520physiological%2520temperature%26jtitle%3DBiophys.%2520J.%26date%3D1998%26volume%3D74%26spage%3D230%26epage%3D241%26doi%3D10.1016%2FS0006-3495%2898%2977782-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamill, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neher, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigworth, F. J.</span></span> <span> </span><span class="NLM_article-title">Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches</span>. <i>Pfluegers Arch.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>391</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1007/BF00656997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1007%2FBF00656997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=6270629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A280%3ADyaL38%252FjslWrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=1981&pages=85-100&author=O.+P.+Hamillauthor=A.+Martyauthor=E.+Neherauthor=B.+Sakmannauthor=F.+J.+Sigworth&title=Improved+patch-clamp+techniques+for+high-resolution+current+recording+from+cells+and+cell-free+membrane+patches&doi=10.1007%2FBF00656997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches</span></div><div class="casAuthors">Hamill O P; Marty A; Neher E; Sakmann B; Sigworth F J</div><div class="citationInfo"><span class="NLM_cas:title">Pflugers Archiv : European journal of physiology</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">391</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-100</span>
        ISSN:<span class="NLM_cas:issn">0031-6768</span>.
    </div><div class="casAbstract">1.  The extracellular patch clamp method, which first allowed the detection of single channel currents in biological membranes, has been further refined to enable higher current resolution, direct membrane patch potential control, and physical isolation of membrane patches. 2.  A description of a convenient method for the fabrication of patch recording pipettes is given together with procedures followed to achieve giga-seals i.e. pipette-membrane seals with resistances of 10(9) - 10(11) omega. 3.  The basic patch clamp recording circuit, and designs for improved frequency response are described along with the present limitations in recording the currents from single channels. 4.  Procedures for preparation and recording from three representative cell types are given.  Some properties of single acetylcholine-activated channels in muscle membrane are described to illustrate the improved current and time resolution achieved with giga-seals. 5.  A description is given of the various ways that patches of membrane can be physically isolated from cells.  This isolation enables the recording of single channel currents with well-defined solutions on both sides of the membrane.  Two types of isolated cell-free patch configurations can be formed: an inside-out patch with its cytoplasmic membrane face exposed to the bath solution, and an outside-out patch with its extracellular membrane face exposed to the bath solution. 6.  The application of the method for the recording of ionic currents and internal dialysis of small cells is considered.  Single channel resolution can be achieved when recording from whole cells, if the cell diameter is small (less than 20 micrometer). 7.  The wide range of cell types amenable to giga-seal formation is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTk3IMHMxuoQXy-c-E1v-fmfW6udTcc2ebS3pMfQ_TP27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL38%252FjslWrug%253D%253D&md5=c981295f57b3239ca3719093b059f44d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2FBF00656997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00656997%26sid%3Dliteratum%253Aachs%26aulast%3DHamill%26aufirst%3DO.%2BP.%26aulast%3DMarty%26aufirst%3DA.%26aulast%3DNeher%26aufirst%3DE.%26aulast%3DSakmann%26aufirst%3DB.%26aulast%3DSigworth%26aufirst%3DF.%2BJ.%26atitle%3DImproved%2520patch-clamp%2520techniques%2520for%2520high-resolution%2520current%2520recording%2520from%2520cells%2520and%2520cell-free%2520membrane%2520patches%26jtitle%3DPfluegers%2520Arch.%26date%3D1981%26volume%3D391%26spage%3D85%26epage%3D100%26doi%3D10.1007%2FBF00656997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Himmel, H. M.</span></span> <span> </span><span class="NLM_article-title">Suitability of commonly used excipients for electrophysiological in-vitro safety pharmacology assessment of effects on hERG potassium current and on rabbit Purkinje fiber action potential</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">158</span>, <span class="refDoi"> DOI: 10.1016/j.vascn.2007.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2Fj.vascn.2007.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=17590357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCmtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=145-158&author=H.+M.+Himmel&title=Suitability+of+commonly+used+excipients+for+electrophysiological+in-vitro+safety+pharmacology+assessment+of+effects+on+hERG+potassium+current+and+on+rabbit+Purkinje+fiber+action+potential&doi=10.1016%2Fj.vascn.2007.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Suitability of commonly used excipients for electrophysiological in-vitro safety pharmacology assessment of effects on hERG potassium current and on rabbit Purkinje fiber action potential</span></div><div class="casAuthors">Himmel, Herbert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-158</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: Regulatory guidelines require investigation of the liability for delayed ventricular repolarization by new chem. entities within a broad concn. range in-vitro.  However, investigation can be limited by poor drug aq. soly., and by solvent physicochem. attributes that disrupt cell membrane integrity.  Although excipients or solubilizing agents may aid to achieve the necessary high concns., no comprehensive overview on the suitability of solvents for in-vitro electrophysiol. safety studies exists.  Methods: Excipients were tested for potential interference with the hERG (human ether-a-go-go-related gene) K+ current (whole-cell voltage-clamp, 23±2°), and the shape of rabbit Purkinje fiber action potentials (conventional glass microelectrode technique, 37±1°).  Results and discussion: Water-sol. complexation builders/carriers had little effect on hERG K+ current at up to 50 mg/mL (BSA, bovine serum albumin) and 11 mg/mL (HP-β-CD, hydroxypropyl-β-cyclodextrin; IC20, concn. of 20% inhibition).  Water-sol. org. (co)solvents inhibited hERG K+ currents (IC20, %/mM): 0.7/152, ethanol; 0.9/67, Transcutol; 1.2/154, DMSO (dimethylsulfoxide); 1.6/389, acetonitrile; 1.9/48, polyethylene glycol 400; 2.1/660, methanol.  Part of their inhibitory effect is attributed to the osmolality of extracellular solns., because hERG IC20 and extrapolated osmolality at the hERG IC20 strongly correlate.  Water-sol. nonionic solubilizers/surfactants are potent inhibitors of hERG K+ current with IC20 concns. of 0.07% (Cremophor EL) or lower (Tween 20, Tween 80: ∼ 0.001%).  Part of this inhibitory effect is attributed to their interaction with lipid membranes, because hERG inhibition occurs close to crit. micelle concns. (Cremophor, ∼0.009%; Tween 20, ∼0.007%).  Purkinje fiber action potentials are little affected by HP-β-CD at up to 2 mg/mL, while DMSO tends to shorten the action potential duration at 1%.  Conclusion: When conducting electrophysiol. in-vitro assessments of drug effects, solubilizers/surfactants (Cremophor EL, Tween 20, Tween 80) should be avoided.  Instead, water-sol. org. (co)solvents (methanol, acetonitrile, DMSO) or complexation builders/carriers (HP-β-CD, BSA) appear to be more favorable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsEAdKY44zz7Vg90H21EOLACvtfcHk0lgb7x1uzyovHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCmtLbN&md5=49c61123b2fd0c35fcae026a5d45977f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2007.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2007.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DHimmel%26aufirst%3DH.%2BM.%26atitle%3DSuitability%2520of%2520commonly%2520used%2520excipients%2520for%2520electrophysiological%2520in-vitro%2520safety%2520pharmacology%2520assessment%2520of%2520effects%2520on%2520hERG%2520potassium%2520current%2520and%2520on%2520rabbit%2520Purkinje%2520fiber%2520action%2520potential%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2007%26volume%3D56%26spage%3D145%26epage%3D158%26doi%3D10.1016%2Fj.vascn.2007.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jazbutyte, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruchten, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, S. K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritzemeier, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prelle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegele-Hartung, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyses, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelzer, T.</span></span> <span> </span><span class="NLM_article-title">Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1161/01.HYP.0000240053.48517.c7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1161%2F01.HYP.0000240053.48517.c7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=16940216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFOrs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2006&pages=579-586&author=V.+Jazbutyteauthor=K.+Huauthor=P.+Kruchtenauthor=E.+Beyauthor=S.+K.+G.+Maierauthor=K.-H.+Fritzemeierauthor=K.+Prelleauthor=C.+Hegele-Hartungauthor=R.+W.+Hartmannauthor=L.+Neysesauthor=G.+Ertlauthor=T.+Pelzer&title=Aging+reduces+the+efficacy+of+estrogen+substitution+to+attenuate+cardiac+hypertrophy+in+female+spontaneously+hypertensive+rats&doi=10.1161%2F01.HYP.0000240053.48517.c7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats</span></div><div class="casAuthors">Jazbutyte, Virginija; Hu, Kai; Kruchten, Patricia; Bey, Emmanuel; Maier, Sebastian K. G.; Fritzemeier, Karl-Heinrich; Prelle, Katja; Hegele-Hartung, Christa; Hartmann, Rolf W.; Neyses, Ludwig; Ertl, Georg; Pelzer, Theo</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">579-586</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Clin. trials failed to show a beneficial effect of postmenopausal hormone replacement therapy, whereas exptl. studies in young animals reported a protective function of estrogen replacement in cardiovascular disease.  Because these diverging results could in part be explained by aging effects, we compared the efficacy of estrogen substitution to modulate cardiac hypertrophy and cardiac gene expression among young (age 3 mo) and senescent (age 24 mo) spontaneously hypertensive rats (SHRs), which were sham operated or ovariectomized and injected with placebo or identical doses of 17β-estradiol (E2; 2 μg/kg body wt. per day) for 6 wk (n=10/group).  Blood pressure was comparable among sham-operated senescent and young SHRs and not altered by ovariectomy or E2 treatment among young or among senescent rats.  Estrogen substitution inhibited uterus atrophy and gain of body wt. in young and senescent ovariectomized SHRs, but cardiac hypertrophy was attenuated only in young rats.  Cardiac estrogen receptor-α expression was lower in intact and in ovariectomized senescent compared with young SHRs and increased with estradiol substitution in aged rats.  Plasma estradiol and estrone levels were lower not only in sham-operated but surprisingly also in E2-substituted senescent SHRs and assocd. with a redn. of hepatic 17β-hydroxysteroid dehydrogenase type 1 enzyme activity, which converts weak (ie, estrone) into potent estrogens, such as E2.  Aging attenuates the antihypertrophic effect of estradiol in female SHRs and is assocd. with profound alterations in cardiac estrogen receptor-α expression and estradiol metab.  These observations contribute to explain the lower efficiency of estrogen substitution in senescent SHRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTm54cylwrvrVg90H21EOLACvtfcHk0lhDmycPDhTFVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFOrs7c%253D&md5=dfdf87fc2f0fddef972e87d6e635cc8e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.0000240053.48517.c7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.0000240053.48517.c7%26sid%3Dliteratum%253Aachs%26aulast%3DJazbutyte%26aufirst%3DV.%26aulast%3DHu%26aufirst%3DK.%26aulast%3DKruchten%26aufirst%3DP.%26aulast%3DBey%26aufirst%3DE.%26aulast%3DMaier%26aufirst%3DS.%2BK.%2BG.%26aulast%3DFritzemeier%26aufirst%3DK.-H.%26aulast%3DPrelle%26aufirst%3DK.%26aulast%3DHegele-Hartung%26aufirst%3DC.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DNeyses%26aufirst%3DL.%26aulast%3DErtl%26aufirst%3DG.%26aulast%3DPelzer%26aufirst%3DT.%26atitle%3DAging%2520reduces%2520the%2520efficacy%2520of%2520estrogen%2520substitution%2520to%2520attenuate%2520cardiac%2520hypertrophy%2520in%2520female%2520spontaneously%2520hypertensive%2520rats%26jtitle%3DHypertension%26date%3D2006%26volume%3D48%26spage%3D579%26epage%3D586%26doi%3D10.1161%2F01.HYP.0000240053.48517.c7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katkam, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopalkrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chwalisz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schillinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, C. P.</span></span> <span> </span><span class="NLM_article-title">Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception</span>. <i>Am. J. Obstet. Gynecol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">779</span>– <span class="NLM_lpage">787</span>, <span class="refDoi"> DOI: 10.1016/0002-9378(95)90341-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=10.1016%2F0002-9378%2895%2990341-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=7573244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;key=1%3ACAS%3A528%3ADyaK2MXpsVSgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=1995&pages=779-787&author=R.+R.+Katkamauthor=K.+Gopalkrishnanauthor=K.+Chwaliszauthor=E.+Schillingerauthor=C.+P.+Puri&title=Onapristone+%28ZK+98.299%29%3A+a+potential+antiprogestin+for+endometrial+contraception&doi=10.1016%2F0002-9378%2895%2990341-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Onapristone (ZK 98.299): A potential antiprogestin for endometrial contraception</span></div><div class="casAuthors">Katkam, Rajendra R.; Gopalkrishnan, Kamla; Chwalisz, Kristof; Schillinger, Eckard; Puri, Chander P.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Obstetrics and Gynecology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">3, Pt. 1</span>),
    <span class="NLM_cas:pages">779-87</span>CODEN:
                <span class="NLM_cas:coden">AJOGAH</span>;
        ISSN:<span class="NLM_cas:issn">0002-9378</span>.
    
            (<span class="NLM_cas:orgname">Mosby-Year Book</span>)
        </div><div class="casAbstract">The effects of the antiprogestin onapristone (ZK 98.299) on fertility; menstrual cycle length; duration of menses; serum estradiol, progesterone, and cortisol concns.; and endometrial morphol. features were studied in adult bonnet monkeys.  Five animals were treated s.c. with the vehicle and another nine with either 2.5 or 5 mg of onapristone per animal.  Treatment was initiated on day 5 of the first treatment cycle, and thereafter onapristone was administered every third day for four to seven consecutive cycles.  The females were placed with adult males during the periovulatory period, which was assessed by frequent anal. of serum estradiol concns.  In the final treatment cycle an endometrial biopsy was performed on day 8 after a midcycle estradiol peak in the ovulatory cycle, or around day 20 if the cycle was anovulatory.  Blood samples for estradiol, progesterone, and cortisol measurement were collected every third day, except for the periovulatory period when sampling was more frequent.  Each of the five animals treated with the vehicle became pregnant: one in the first, three in the second, and one in the third mated cycle, whereas only one of nine treated with onapristone became pregnant.  Four animals treated with 2.5 mg of onapristone for 17 cycles and another four treated with a 5 mg dose for 21 cycles did not conceive.  In eight animals that did not conceive the first three treatment cycles of six were ovulatory, and in the remaining two animals two cycles of each were ovulatory.  During treatment the mean menstrual cycle length was not altered significantly; however, in one it was shortened and in another two it was prolonged.  Similarly, the mean duration of menses was not significantly affected, but in some cycles it was reduced.  Moreover, there was only slight bleeding in some treatment cycles.  Ovulation occurred in 30 of 45 treatment cycles, including the final treatment cycle during which the biopsy was taken, as indicated by serum estradiol and progesterone concns.  In some of the ovulatory cycles prolonged treatment suppressed luteal activity; however, in the ovulatory cycles the duration of follicular and luteal phases was not significantly affected.  In the anovulatory cycles there was a delayed increase in serum estradiol concns., suggesting a partial inhibition of folliculogenesis.  In treated animals endometrial growth and development was retarded and rendered out of phase.  In animals treated with the higher (5 mg) onapristone dose the endometrial glands had partially regressed, the secretory activity was blocked, and stromal compaction was evident.  The treatment had no significant effect on serum cortisol levels.  This study demonstrates that low-dose onapristone treatment throughout the menstrual cycle prevents pregnancy without disturbing the menstrual cycle and ovulation in the majority of cycles.  However, anovulation and luteal insufficiency occurred in some animals during prolonged treatment.  The contraceptive effect in the ovulatory cycles seems primarily related to the retardation of endometrial development resulting in the inhibition of endometrial receptivity.  It appears likely that a dose or treatment regimen of onapristone that will inhibit endometrial receptivity and prevent implantation without affecting the menstrual cycle even on prolonged treatment could be identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMM9alzZMOQ7Vg90H21EOLACvtfcHk0lhDmycPDhTFVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsVSgsLY%253D&md5=647303f30fbe7f30642112790cd128f3</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0002-9378%2895%2990341-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-9378%252895%252990341-0%26sid%3Dliteratum%253Aachs%26aulast%3DKatkam%26aufirst%3DR.%2BR.%26aulast%3DGopalkrishnan%26aufirst%3DK.%26aulast%3DChwalisz%26aufirst%3DK.%26aulast%3DSchillinger%26aufirst%3DE.%26aulast%3DPuri%26aufirst%3DC.%2BP.%26atitle%3DOnapristone%2520%2528ZK%252098.299%2529%253A%2520a%2520potential%2520antiprogestin%2520for%2520endometrial%2520contraception%26jtitle%3DAm.%2520J.%2520Obstet.%2520Gynecol.%26date%3D1995%26volume%3D173%26spage%3D779%26epage%3D787%26doi%3D10.1016%2F0002-9378%2895%2990341-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i91"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01382">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82487"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01382">10.1021/acs.jmedchem.9b01382</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Identification of SMOL hLH-R antagonists and summary of the results of HTS; assays used in early screening hit characterization and off-target profiling; GPCR selectivity panel data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01382/suppl_file/jm9b01382_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formular strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01382/suppl_file/jm9b01382_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01382/suppl_file/jm9b01382_si_001.pdf">jm9b01382_si_001.pdf (164.42 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01382/suppl_file/jm9b01382_si_002.csv">jm9b01382_si_002.csv (2.77 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01382&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01382%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01382" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993f687924d932","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
